apiLogger::2021-10-03 00:25:19,502::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 00:25:19,507::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 00:25:19,507::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpiaj19taq 
apiLogger::2021-10-03 00:25:19,507::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-03 00:25:19,507::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-03 00:25:19,539::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-03 00:25:19,539::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpiaj19taq
apiLogger::2021-10-03 00:25:20,125::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-03 00:25:20,125::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-03 00:25:20,125::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-03 00:25:20,125::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-03 00:25:20,130::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 00:25:20,130::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-03 00:25:20,130::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-03 00:25:20,130::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-03 00:25:20,133::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 00:25:20,133::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-03 00:25:20,133::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-03 00:25:20,133::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88286 (v.1)\nA. GENERAL INFORMATION\nCase Number: REGEMC-88286 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Edwyn Lee, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB. CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Kurtis McGee Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 180-048-62668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC. ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter:    \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD. ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction: \nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE. PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88286 (v.1)\nF. SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial  \nF. CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nF. HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nG. OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH. RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES \nI. PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\n \n \nVersion 16Nov2020']
apiLogger::2021-10-03 00:25:20,134::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-03 00:25:20,134::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-03 00:25:20,429::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 00:25:20,433::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 00:25:20,433::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpastmvmtp 
apiLogger::2021-10-03 00:25:20,697::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 00:25:20,698::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 00:25:20,698::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpk2y52i7c 
apiLogger::2021-10-03 00:25:20,699::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-03 00:25:20,699::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-03 00:25:20,706::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-03 00:25:20,706::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpk2y52i7c
apiLogger::2021-10-03 00:25:20,804::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-03 00:25:20,804::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-03 00:25:20,804::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-03 00:25:20,804::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-03 00:25:20,808::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 00:25:20,808::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-03 00:25:20,808::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-03 00:25:20,808::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 03-Oct-2021 00:23:36 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : FW: <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88286\nVersion 1\n \nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer\n<jeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88286 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88286, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-03 00:25:20,808::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-03 00:25:20,809::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-03 00:31:18,730::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 00:31:18,734::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 00:31:18,734::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphx67k0m5 
apiLogger::2021-10-03 00:31:18,734::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-03 00:31:18,735::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-03 00:31:18,879::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-03 00:31:18,879::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphx67k0m5
apiLogger::2021-10-03 00:31:19,541::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-03 00:31:19,541::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-03 00:31:19,542::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-03 00:31:19,542::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-03 00:31:19,546::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 00:31:19,546::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-03 00:31:19,546::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-03 00:31:19,546::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-03 00:31:19,549::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 00:31:19,549::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-03 00:31:19,549::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-03 00:31:19,549::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88287 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88287 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Edwyn Lee, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Kurtis McGee Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 180-048-62668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88287 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-03 00:31:19,549::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-03 00:31:19,549::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-03 00:31:20,063::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 00:31:20,067::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 00:31:20,067::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpso9n_hbg 
apiLogger::2021-10-03 00:31:20,220::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 00:31:20,221::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 00:31:20,221::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpteq9le14 
apiLogger::2021-10-03 00:31:20,221::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-03 00:31:20,221::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-03 00:31:20,228::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-03 00:31:20,228::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpteq9le14
apiLogger::2021-10-03 00:31:20,315::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-03 00:31:20,315::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-03 00:31:20,315::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-03 00:31:20,315::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-03 00:31:20,319::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 00:31:20,319::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-03 00:31:20,319::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-03 00:31:20,319::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 03-Oct-2021 00:29:53 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88287 Version 1\nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer\n<jeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88286 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88286, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-03 00:31:20,319::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-03 00:31:20,319::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-03 00:35:18,993::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 00:35:18,997::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 00:35:18,997::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp3s2m_9gy 
apiLogger::2021-10-03 00:35:19,065::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 00:35:19,069::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 00:35:19,070::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpmrcq38z2 
apiLogger::2021-10-03 00:35:19,070::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-03 00:35:19,070::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-03 00:35:19,318::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-03 00:35:19,319::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpmrcq38z2
apiLogger::2021-10-03 00:35:20,061::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-03 00:35:20,061::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-03 00:35:20,061::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-03 00:35:20,061::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-03 00:35:20,065::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 00:35:20,065::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-03 00:35:20,065::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-03 00:35:20,065::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-03 00:35:20,068::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 00:35:20,068::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-03 00:35:20,068::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-03 00:35:20,069::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88288 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88288 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Edwyn Lee, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Kurtis McGee Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 180-048-62668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88288 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-03 00:35:20,069::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-03 00:35:20,069::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-03 00:35:20,343::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 00:35:20,343::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 00:35:20,344::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmps80ny5zd 
apiLogger::2021-10-03 00:35:20,344::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-03 00:35:20,344::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-03 00:35:20,351::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-03 00:35:20,351::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmps80ny5zd
apiLogger::2021-10-03 00:35:20,438::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-03 00:35:20,438::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-03 00:35:20,438::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-03 00:35:20,438::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-03 00:35:20,442::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 00:35:20,442::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-03 00:35:20,442::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-03 00:35:20,442::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 03-Oct-2021 00:34:04 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88288 Version 1\n \nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer\n<jeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88286 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88286, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-03 00:35:20,442::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-03 00:35:20,443::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-03 00:37:19,027::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 00:37:19,031::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 00:37:19,031::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpcalyxf_3 
apiLogger::2021-10-03 00:37:19,102::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 00:37:19,109::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 00:37:19,109::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfxwq9t0u 
apiLogger::2021-10-03 00:37:19,109::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-03 00:37:19,110::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-03 00:37:19,575::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-03 00:37:19,575::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfxwq9t0u
apiLogger::2021-10-03 00:37:20,247::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-03 00:37:20,247::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-03 00:37:20,247::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-03 00:37:20,248::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-03 00:37:20,251::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 00:37:20,252::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-03 00:37:20,252::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-03 00:37:20,252::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-03 00:37:20,255::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 00:37:20,255::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-03 00:37:20,255::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-03 00:37:20,255::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88289 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88289 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Edwyn Lee, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Kurtis McGee Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 180-048-62668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88289 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-03 00:37:20,255::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-03 00:37:20,255::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-03 00:37:20,600::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 00:37:20,601::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 00:37:20,601::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmptsgl_nd2 
apiLogger::2021-10-03 00:37:20,602::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-03 00:37:20,602::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-03 00:37:20,608::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-03 00:37:20,609::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmptsgl_nd2
apiLogger::2021-10-03 00:37:20,695::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-03 00:37:20,695::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-03 00:37:20,695::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-03 00:37:20,695::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-03 00:37:20,699::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 00:37:20,700::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-03 00:37:20,700::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-03 00:37:20,700::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 03-Oct-2021 00:36:12 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88289 Version 1\nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer\n<jeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88286 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88286, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-03 00:37:20,700::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-03 00:37:20,700::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-03 00:39:18,788::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 00:39:18,800::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 00:39:18,800::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp1ng8y5e_ 
apiLogger::2021-10-03 00:39:18,801::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-03 00:39:18,801::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-03 00:39:19,770::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-03 00:39:19,770::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp1ng8y5e_
apiLogger::2021-10-03 00:39:20,842::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-03 00:39:20,843::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-03 00:39:20,843::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-03 00:39:20,843::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-03 00:39:20,847::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 00:39:20,847::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-03 00:39:20,847::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-03 00:39:20,847::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-03 00:39:20,850::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 00:39:20,850::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-03 00:39:20,850::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-03 00:39:20,850::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88290 (v.1)\nA.GENERAL INFORMATION\nCase Number: REGEMC-88290 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Edwyn Lee, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB.CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Kurtis McGee Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 180-048-62668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC.ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter: \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD.ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction:\nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE.PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88290 (v.1)\nF.SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial\nF.CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nF.HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\nG.OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH.RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES\nI.PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\nVersion 16Nov2020']
apiLogger::2021-10-03 00:39:20,850::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-03 00:39:20,850::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-03 00:39:21,540::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 00:39:21,544::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 00:39:21,544::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpv_w5d7om 
apiLogger::2021-10-03 00:39:21,743::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 00:39:21,744::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 00:39:21,744::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp3wer377y 
apiLogger::2021-10-03 00:39:21,745::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-03 00:39:21,745::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-03 00:39:21,751::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-03 00:39:21,752::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp3wer377y
apiLogger::2021-10-03 00:39:21,839::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-03 00:39:21,839::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-03 00:39:21,839::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-03 00:39:21,839::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-03 00:39:21,843::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 00:39:21,843::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-03 00:39:21,843::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-03 00:39:21,843::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 03-Oct-2021 00:38:31 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : <External> Regeneron Adverse Event Report for Eylea Vial: REGEMC-88290 Version 1\nFrom: Regeneron Medical Information <regeneronmc@eversana.com> Sent: Thursday, July 8,\n2021 4:17 PM To: Katherine Blocher <katherine.blocher@regeneron.com>; Jeffrey Brimmer\n<jeffrey.brimmer@regeneron.com>; Jaclyn Grimaldi <jaclyn.Grimaldi@regeneron.com>; Christine\nHall <christine.hall@regeneron.com>; Michelle Harden <michelle.harden@regeneron.com>;\nRobert Lewis <robert.lewis@regeneron.com>; Kimberly Reed <kimberly.reed@regeneron.com>;\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Subject: <External> Regeneron\nAdverse Event Report for Eylea Vial: REGEMC-88286 Version 1 \n \nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea Vial received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-88286, Version 1.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nEdwyn Lee, PharmD\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#3E31AA84-8C74-48E0-9702-1334FE9916C4#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-10-03 00:39:21,843::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-03 00:39:21,843::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-03 06:25:18,917::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 06:25:19,017::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 06:25:19,017::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpj7eyi7ob 
apiLogger::2021-10-03 06:25:19,021::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-03 06:25:19,021::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-03 06:25:19,503::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-03 06:25:19,503::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpj7eyi7ob
apiLogger::2021-10-03 06:25:20,448::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-03 06:25:20,448::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-03 06:25:20,449::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-03 06:25:20,449::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-03 06:25:20,452::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 06:25:20,452::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-03 06:25:20,452::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-03 06:25:20,452::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-03 06:25:20,456::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 06:25:20,456::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-03 06:25:20,456::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-03 06:25:20,456::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-03 06:25:20,459::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-03 06:25:20,459::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-03 06:25:20,459::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-03 06:25:20,459::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-03 06:25:20,459::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036026-Cancer Centre, Bendigo Health\nEnvironment Prod\nSubject Details\nStudy Site Number 36,026\nPatient ID 36,026,001\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1947\nAge 73\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14/SEP/2020\nR2810-ONC-1788_SAE REPORT_05-MAR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 16/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 03/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 3/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_05-MAR-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\n1 21/JAN/2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_05-MAR-2021']
apiLogger::2021-10-03 06:25:20,459::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-03 06:25:20,459::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-03 06:25:20,460::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-03 06:25:20,460::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-03 06:25:20,460::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-03 06:25:39,172::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-03 06:25:39,172::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-03 21:47:18,994::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 21:47:19,000::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 21:47:19,001::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmppxs9uqp2 
apiLogger::2021-10-03 21:47:19,001::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-03 21:47:19,001::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-03 21:47:19,112::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-03 21:47:19,113::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmppxs9uqp2
apiLogger::2021-10-03 21:47:19,921::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-03 21:47:19,921::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-03 21:47:19,921::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-03 21:47:19,921::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-03 21:47:19,924::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 21:47:19,924::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-03 21:47:19,925::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-03 21:47:19,925::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-03 21:47:19,928::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 21:47:19,928::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-03 21:47:19,928::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-03 21:47:19,928::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-03 21:47:19,931::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-03 21:47:19,931::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-03 21:47:19,931::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-03 21:47:19,931::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-03 21:47:19,931::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-03 21:47:19,931::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-03 21:47:19,931::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-03 21:47:19,931::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-03 21:47:19,931::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-03 21:47:19,931::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-03 21:47:34,504::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-03 21:47:34,504::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-03 21:47:34,573::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 21:47:34,579::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 21:47:34,580::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp1kbb932d 
apiLogger::2021-10-03 21:47:34,580::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-03 21:47:34,580::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-03 21:47:34,692::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-03 21:47:34,692::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp1kbb932d
apiLogger::2021-10-03 21:47:35,497::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-03 21:47:35,497::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-03 21:47:35,497::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-03 21:47:35,497::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-03 21:47:35,501::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 21:47:35,501::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-03 21:47:35,501::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-03 21:47:35,501::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-03 21:47:35,504::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 21:47:35,504::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-03 21:47:35,504::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-03 21:47:35,504::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-03 21:47:35,507::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-03 21:47:35,507::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-03 21:47:35,507::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-03 21:47:35,507::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-03 21:47:35,507::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-03 21:47:35,507::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-03 21:47:35,507::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-03 21:47:35,508::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-03 21:47:35,508::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-03 21:47:35,508::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-03 21:47:50,070::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-03 21:47:50,070::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-03 22:03:19,033::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 22:03:19,040::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 22:03:19,040::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpsvqw_49f 
apiLogger::2021-10-03 22:03:19,041::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-03 22:03:19,041::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-03 22:03:19,269::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-03 22:03:19,269::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpsvqw_49f
apiLogger::2021-10-03 22:03:20,186::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-03 22:03:20,186::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-03 22:03:20,187::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-03 22:03:20,187::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-03 22:03:20,190::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 22:03:20,190::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-03 22:03:20,190::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-03 22:03:20,190::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-03 22:03:20,193::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 22:03:20,193::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-03 22:03:20,193::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-03 22:03:20,193::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-03 22:03:20,196::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-03 22:03:20,196::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-03 22:03:20,196::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-03 22:03:20,197::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-03 22:03:20,197::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,004\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-03 22:03:20,197::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-03 22:03:20,197::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-03 22:03:20,197::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-03 22:03:20,197::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-03 22:03:20,197::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-03 22:03:35,091::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-03 22:03:35,091::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-03 22:03:35,163::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 22:03:35,170::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 22:03:35,170::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpsan0v3vr 
apiLogger::2021-10-03 22:03:35,171::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-03 22:03:35,171::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-03 22:03:35,492::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-03 22:03:35,492::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpsan0v3vr
apiLogger::2021-10-03 22:03:36,413::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-03 22:03:36,413::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-03 22:03:36,413::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-03 22:03:36,413::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-03 22:03:36,416::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 22:03:36,416::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-03 22:03:36,417::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-03 22:03:36,417::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-03 22:03:36,420::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 22:03:36,420::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-03 22:03:36,420::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-03 22:03:36,420::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-03 22:03:36,423::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-03 22:03:36,423::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-03 22:03:36,423::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-03 22:03:36,423::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-03 22:03:36,423::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,005\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-03 22:03:36,423::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-03 22:03:36,423::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-03 22:03:36,423::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-03 22:03:36,423::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-03 22:03:36,423::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-03 22:03:51,423::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-03 22:03:51,423::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-03 22:05:18,822::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 22:05:18,829::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 22:05:18,830::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpn985ph_e 
apiLogger::2021-10-03 22:05:18,830::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-03 22:05:18,830::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-03 22:05:19,157::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-03 22:05:19,157::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpn985ph_e
apiLogger::2021-10-03 22:05:20,078::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-03 22:05:20,079::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-03 22:05:20,079::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-03 22:05:20,079::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-03 22:05:20,082::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 22:05:20,082::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-03 22:05:20,082::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-03 22:05:20,082::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-03 22:05:20,086::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 22:05:20,086::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-03 22:05:20,086::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-03 22:05:20,086::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-03 22:05:20,089::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-03 22:05:20,089::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-03 22:05:20,089::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-03 22:05:20,089::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-03 22:05:20,089::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,006\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-03 22:05:20,089::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-03 22:05:20,089::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-03 22:05:20,089::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-03 22:05:20,089::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-03 22:05:20,089::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-03 22:05:34,986::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-03 22:05:34,986::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-03 22:07:18,828::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-03 22:07:18,836::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-03 22:07:18,836::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp1nf0y7l6 
apiLogger::2021-10-03 22:07:18,837::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-03 22:07:18,837::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-03 22:07:19,163::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-03 22:07:19,163::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp1nf0y7l6
apiLogger::2021-10-03 22:07:20,080::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-03 22:07:20,080::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-03 22:07:20,080::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-03 22:07:20,080::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-03 22:07:20,084::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 22:07:20,084::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-03 22:07:20,084::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-03 22:07:20,084::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-03 22:07:20,087::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-03 22:07:20,087::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-03 22:07:20,087::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-03 22:07:20,087::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-03 22:07:20,090::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-03 22:07:20,090::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-03 22:07:20,090::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-03 22:07:20,090::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-03 22:07:20,090::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,008\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-03 22:07:20,091::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-03 22:07:20,091::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-03 22:07:20,091::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-03 22:07:20,091::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-03 22:07:20,091::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-03 22:07:35,094::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-03 22:07:35,094::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 00:29:18,835::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 00:29:18,842::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 00:29:18,843::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpc7k8pog3 
apiLogger::2021-10-04 00:29:18,843::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 00:29:18,843::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 00:29:18,955::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 00:29:18,955::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpc7k8pog3
apiLogger::2021-10-04 00:29:19,761::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 00:29:19,761::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 00:29:19,761::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 00:29:19,761::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 00:29:19,765::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 00:29:19,765::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 00:29:19,765::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-04 00:29:19,765::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-04 00:29:19,768::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 00:29:19,768::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-04 00:29:19,768::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-04 00:29:19,768::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-04 00:29:19,771::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-04 00:29:19,771::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-04 00:29:19,771::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 00:29:19,771::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-04 00:29:19,771::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-04 00:29:19,771::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 00:29:19,771::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-04 00:29:19,771::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 00:29:19,771::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 00:29:19,771::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 00:29:34,337::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 00:29:34,337::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 01:09:18,946::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 01:09:19,010::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 01:09:19,011::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpsru0eah9 
apiLogger::2021-10-04 01:09:19,013::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 01:09:19,013::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 01:09:21,034::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 01:09:21,034::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpsru0eah9
apiLogger::2021-10-04 01:09:23,616::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 01:09:23,616::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 01:09:23,616::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 01:09:23,617::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 01:09:23,620::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:09:23,620::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 01:09:23,620::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-04 01:09:23,620::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-04 01:09:23,624::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:09:23,624::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-04 01:09:23,624::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-04 01:09:23,624::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-04 01:09:23,627::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:09:23,627::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-04 01:09:23,627::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-04 01:09:23,627::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-04 01:09:23,631::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:09:23,631::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-04 01:09:23,631::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-04 01:09:23,631::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-04 01:09:23,635::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:09:23,635::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-04 01:09:23,635::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-04 01:09:23,635::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '\x00\x01\x02D\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x07\x08\t\n\x0b\x01 \x0c\r\x0e\x0f\x0e\x10\x11\x12\x13\x10\r\x14\x15\x16ÿ\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x12ÿ\x11\x1b\x1c\x12\x10\x1d\x1a\x1e\x1c\x1dÿ\x1f !"#ÿ \x11ÿ\x1a\x1f\x1f\x1c\x1f\x1fÿ $\x1cÿ\x1a\x12 %\x10 !&\x11\x0cÿ\x1a\x13 %\'% #ÿ\x1a\x12"\n\x1f\x1a(\x1c #ÿ\x11(ÿ\x0c\x1c)\x12\r\x0e\x0f\x0e*ÿ\x1a\x12ÿ\x1a\x12 %\x10\x13"\x15+ÿ,ÿ\x1a\x12 %\x10\x13"-ÿ\x1e%\x1f\x1b\x1c\x13%(%\x13\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x18\x19\x03\x05\x0b\n\x1a\x12 %\x1e\x11"#*ÿ%\x12ÿ\x1b\x1a %\x1c\x12 \x1fÿ.% $ÿ\x0c\x1c\x1d\x1a\x1b\x1f\x1c"ÿ\x11\x0cÿ\x0c\x1c(\x0c\x1a\x13 \x11\x0c#ÿ\x1e\x10\x13\x1c\x1d\x1d\n\x12\x11\x12\x10$\x11")/%\x12ÿ\x1d#&\x1b$\x11&\x1a\n\x1901\x0b0\x03\x192ÿ3\x0b4\x05\x035ÿ6\x03\x0878ÿ9\x027\x0b \r\x0f\x0c)\x1b\x10+++:\n9\x02\t;\x02\x0807 \x0c\x1c)\x12\r\x0e\x0f\x0e\n6\x08\nD\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n6\x19\x03\x0bÿ\x074\t\x0b \x15\x0f\x14++\rÿ\x10ÿ"<=>>ÿ\x10ÿ)=?@ABC\n6\x19\x03\x0bÿ\x07\x08\t\n\x0b\x01 \r\x14\x15\x16\x15\x0f\x14++\r\n6\x08\nD\x0b\x04\x03ÿEFG \x15\x0f\x14++\r++-\n6\x04\x01\x0b\x0b0\x190HÿF4\x03\x0b +\x15ÿ\x1f\x1c\x1bÿ\x15+\x15\r \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06ÿ\t\x16=ÿ?\x0c\r\x06\r\x05\r;ÿ\x12\n\x04\x16=\n\x04\x16\x06ÿ@\x0c\t\x05A\x10\x16\x13\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 :\t\x06\x04ÿ<\x01\x02\x03\x04\x05\x06ÿ<\x10\x13\x16\x04=\nF\x04\x0c\x04ÿ\x06\x11\x04\x0c\x04ÿ\t\x16\x17 :\t\x06\x04ÿ\x00\x01\x02\x03\x04\x05\x06ÿ\x00\x10\x13\x16\x04=\nC;\r\x02\t;ÿ?\x0c\r\x06\r\x05\r;ÿD ÿ\x12\n\x04\x16=\n\x04\x16\x06 ?\x0c\r\x06\r\x05\r;ÿ\x1a\x18\x0fÿ\x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04 \x1a>L \x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04ÿ\x0e\x0c\r\n ;\r\x05\t;ÿ\x1a\x16\x0e\r\x0c\n\x04=\nB ;\r\x05\t; \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 >\r\x16<\x04\x16\x06ÿ@\x17\x1d\x04\n\x12\n\x04\x16=\n\x04\x16\x06ÿE\x04\x0c<\x10\r\x16 E\x04\x0c<\x10\r\x16ÿHI\r\x05\t;Jÿ H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J E\x04\x0c<\x10\r\x16 \x15>M\x1a\x18\x0fÿH==\x1c\n\r\x16\x1c >\r\x16<\x04\x16\x06ÿH==\x1c\n\r\x16\x1c\n\t\n\x04\x16=\n\x04\x16\x06<G H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J\n\x17\x17\x17\x17J \x17\x17\x17\x17J\x19ÿ\x10\x0eÿ\t\x1d\x1d;\x10\x05\t\x02;\x04\nN"$\x1f$9O+P9" \x1e&\n" "$ÿQWUÿ\x1e!\x1e" \'(03ÿ4,31*3- "#ÿ\'QXÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V()\nN"$\x1f$9O+P9" \x1e& U*3,R041ÿYZV9Y-ZS[\n\x1e "$ÿQWUÿ\x1e!\x1e" ""ÿ\\]^ÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V() 4,31*3-\n:\x04\n\r\x13\x0c\t\x1d\x11\x17ÿ:\x04\x06\t\x10;<\n\x18\t\x05\x04\x19ÿ\x1a\x0eÿ\x1b\x06\x11\x04\x0c\x1c\n\x00\x01\x02\x03\x04\x05\x06ÿ\x08\t\n\x04 \x0b\x04\t\x0cÿ\r\x0eÿ\x0f\x10\x0c\x06\x11 \x12\x13\x04 \x00\x04\x14 \x15\x06\x11\x16\x10\x05\x10\x06\x17 \x18\t\x05\x04\n+,-ÿ/012(304 \x00\x1d\x04\x05\x10\x0e\x17\n\x1e\x1f !!"!!# "$#  %& \'()* 780-* 9\n,5ÿ6(-03,\n:\x10<\x04\t<\x04\x1c\x00\x1d\x04\x05\x10\x0e\x10\x05ÿ>\r\x11\r\x0c\x06\n:\x10<\x04\t<\x04ÿ<\x1d\x04\x05\x10\x0e\x10\x05ÿ\x05\r\x11\r\x0c\x06M\x13\x0c\r\x01\x1dÿH\x10\x16\x06\x04\x13\x0c\t\x06\x04=J _6^P6ÿY*)*4-*SÿN*`0R*3 \x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0e\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x19\x06\x0b\x02\n#\x1eÿ\x0c\x11\x12\x0c\x04\x11\x12\n\x18\x0b\x06\r\x0bÿ\x19\x06\x0b\x02 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r \r\x02\n\x0c\x07(\x02\x03 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r\n\x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0eÿ\x0f\x10\x04\x11\x03\x04\x11\x12 !\x11\x12\x0c\x04\x11\x12ÿ\x06\x0b \n$\x02\x05\x04\x1e\x0e\n\x00 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x1f\x11\x1d\x11\x0c \x11ÿ\n\x0b\x06\r\x0b \x13&\x11\x03ÿ\x03\x06\x0b\x02\x17 \x1f\x11\x1d\x11\x0c \x11ÿ\x02\x11\x03\n\x13\x14\x15\x11\x0c\r\x16\x06\x07\x04\x0b\x0e\x17 \n\x0b\x1f\x03\x0eÿ\x02\x11\x0b\r\x0e" \x1b%\x1b\x14&\n\x0e\x0e\x0e\x0e\x17 \x03\x06\x0b\x02 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x03\x06\x0b\x02\n\'\r\x06\x03\x02\n\x0e\x0e\x0e\x0e\x17\n) *+,-./.0ÿ2.33+/40ÿ/56ÿ++ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nG7H7I,H5ÿJ.,H/\nF \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n*+0.,0.\nK ,/H+,3ÿL+-H+33,/+7I \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nM 0+<2,*+N.H/+G4370+0 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nO G,H*+,3ÿ+I04LL+G+.IG5ÿ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\nP ,G.ÿ+IJ+-+/7Hÿ,33.H<5 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nQ J+6ÿH.63.,0.2.I/ÿH+<J/ 4Iÿ,6HÿFR)M B8CD@CE@? H@S:TU@? A 4Iÿ,6HÿFR)M B8CD@CE@?\nV J+6ÿH.63.,0.2.I/ÿ3.L/ 4IÿW4IÿFR)P B8CD@CE@? H@S:TU@? A 4IÿW4IÿFR)P B8CD@CE@?\n3.Lÿ-4I*3.ÿ-H.IGJ\nX \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n-37GY\n)R 6H70/,/,J56.H63,0+. \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)) <</ÿ+IGH.,0.* )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n)F ,I.2+,ÿ )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n63,/.3./ÿG74I*\n)K )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n*.GH.,0.*\n)M +<ÿ<ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)O +<ÿ,ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)P +<ÿ2ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n<34/.,3ÿH.<+7Iÿ3.L/\n)Q \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\n6,+I \x00\x01\x02\x03\x01\x04\x05\x06\x07\x02\x06ÿ\t\n\x0b\x05\x03\x07\x06\x05\x01\x02\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x12\x13 \x12\x13\n\x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02\n\x05\x1aÿ\x04\n\x0b\x05\x03\x07\x18 \x05\x1aÿ\x07\x0b\x1f\n\x0e\x1a\n\n\x12\x13 \x16\x05\x1a\x06\x01\x0e\x17\x1c \n\x1f\n\x02\x06\x1c\n%\x06\x07\x0e\x06ÿ\x0b\x07\x06\n %\x06\x01\x15ÿ\x0b\x07\x06\n\n\x14\x0e\x01\x15\x16\x17\x18\x07\x19\x05\x1a \x14\x18\n\x07\x1a\n \x14\x18\n\x07\x1a\n \r\x01\x1a\n \x1b\x06\x16\n\x0e\x1c \x12\x13ÿ\x1b\x06\x16\n\x0e \x12\x13ÿ\x1b\x06\x16\n\x0e\x1c %\x06\x07\x0e\x06\n\x0c \r\x0e\x0f\x10ÿ\x11\x07\x04\n \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \r\x01\x1a\n #\x0e\n$\x0f\n\x02\x03\x17 &\x01\x0f\x06\n \'\x0b\x0b(\x04\x01\x02( \'\x0b\x0b(\x04\x01\x02( \x1b\x02\x10\x01\x05\x02\x10\n\x1b\x0eÿ\x1b\x06\x16\n\x0e\x1c \x1a\n\x18\n\x03\x06ÿ\x06\x16\n \x1a\n\x18\n\x03\x06ÿ\x06\x16\n "\x02\x05\x06 \x1a\x15\n\x03\x05\x13\x17 %\x15\n\x03\x05\x13\x17 \x1a\x15\n\x03\x05\x13\x17 \r\x07\x06\nÿ"\x02*\n\x17\x17\x17\x17) \x17\x17\x17\x17)\n\x1a\x15\n\x03\x05\x13\x17 \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n\n\t\n\x0b\x05\x03\x07\x18  \x0b\x1f\n\x0e\x1a\n\n\x1d\x05\x1a\x06\x01\x0e\x17 !\x1f\n\x02\x06\n\x0e\n\x03\x01\x0e\x0b\x1e \x0e\n\x03\x01\x0e\x0b\x1e\n@AB30C5A 2LMNLG<O FPÿ2A5 LON9HNSH FUÿ2A5\n+ ,-./0123-4 56789:;<=>? D D EFF CG9H6 I/ JK D D LON9HNSHT\n@-1 H7L? RFR+ T RFR+\n4HT>N<; WXY10K-1.\nR 3C012A4-K V>?G76: D -@2B,,-Y-A D +F \\] D ^-K D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n25-0C.C@1 4HT>N<; WXY10K-1.\nE Y3C@ V>?G76: D -@2B,,-Y-A D RW \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n3142B.C2- 4HT>N<; +FX50C23\n_ @ V>?G76: D 131VZ5A0 D F`_ \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n5.12-AXB@\n145VC4C0\nW 56789:;<=>? 4B[C2-3-2 D D +FF \\]a\\. D J>T D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@1.\n51@3C501 23C41YV\nb cC. 56789:;<=>? 50C3AY3-C D D _F \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@\n4HT>N<; EX130-1. 2LMNLG<O\nP A@Cd150-@ V>?G76: D ,-^0-..13- D UFF CG9H6 -A ^-K D H7L? D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@XB@[\n@Ce14-@2 4HT>N<; +PX/.B3A B@ÿ1B/ LON9HNSH\nU B.,C@ V>?G76: D 1.ÿ0A/-C@ D WFF \\] D 50@ D C6<; D RFR+ T D \x03\x16\n\x03*\n\x0b\n.A,3\nKAd14A3V 1TgH6?H +XY02X+_ -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\nf D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\nKAd14A3V 1TgH6?H RXY02X+b -OG6<gHO7 +bÿ2A5 LON9HNSH +bÿ2A5\n+F D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\n5101YA31 56H\\HT>N<G>7 +_ÿ2A5 LON9HNSH +Wÿ2A5\n++ 4C. Oÿh76 D D D + ] D JK D C6<; D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf\n56H\\HT>N<G>7 -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\n+R 31eA/-. Oÿh76 D D D R \\] D JK D L? D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf \n\x11 \n\x11\n\n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b\n\r\x18ÿ\x08\t\x0c\r\x0e\x07\x16 \r\x18ÿ\x07\x0c\x1e\t\x02\x18\t\n\n\x11 \x14\r\x18\x0f\x10\x02\x15\x1a \t\x1e\t\x0b\x0f\x1a\nREG-2021-00130 GSPV RECEIPT DATE 1$7\x0f\x07S\x02E\x0fÿ\x0cP\x072\x0f\t021 AKA 25 pages$\x0f\x10\x13ÿ\x0c\x07\x0f\t\n\x12\x02\x10\x13\x14\x15\x16\x07\x17\r\x18 \x12\x16\t\x07\x18\t \x12\x16\t\x07\x18\t \x01\x10\x18\t \x19\x0f\x14\t\x02\x1a \n\x11ÿ\x19\x0f\x14\t\x02 \n\x11ÿ\x19\x0f\x14\t\x02\x1a $\x0f\x07\x02\x0f\n\x00 \x01\x02\x03\x04ÿ\x06\x07\x08\t \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \x01\x10\x18\t "\x02\t#\x03\t\x0b\x0e\x15 %\x10\x03\x0f\t &\x0c\x0c\'\x08\x10\x0b\' &\x0c\x0c\'\x08\x10\x0b\' \x19\x0b\x04\x10\r\x0b\x04\n\x19\x02ÿ\x19\x0f\x14\t\x02\x1a \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t !\x0b\r\x0f \x18\x13\t\x0e\r\x11\x15 $\x13\t\x0e\r\x11\x15 \x18\x13\t\x0e\r\x11\x15 \x01\x07\x0f\tÿ!\x0b)\n\x15\x15\x15\x15( \x15\x15\x15\x15(\n\x18\x13\t\x0e\r\x11\x15 \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t\n\x1b\t\x0c\r\x0e\x07\x16 \x1f\x0c\x1e\t\x02\x18\t\n\x1c\r\x18\x0f\x10\x02\x15  \x1e\t\x0b\x0f\n\x02\t\x0e\x10\x02\x0c\x1d \x02\t\x0e\x10\x02\x0c\x1d\nHIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\n*+ ,-./01/23 456789:;<=> /?. @ @ ABC DE @ FG @ @ MIR8LRSLT\nM> PQP* T PQP*\nG2U-V2/W 45LDLT=R;J=6 HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Cÿ.24\n*N -.XY IÿZ65 @ @ @ PQ DE @ FG @ M> @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nW]G1XVX1 VLT=R;: *A^[?0/2 .M_RMJ;I *Nÿ.24 MIR8LRSL\n*C 4WXY W=>J659 @ -?ÿ12[HXY @ * DE @ 41Y @ L6M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nW]G1X3W? ?2,/\n4-1-32/- VLT=R;: *A^[?0/2 HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*` VX? W=>J659 @ -?ÿ12[HXY @ * E @ 41Y @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n?2,/\n3X/1HV +ÿ/HV2. *Cÿ.24 MIR8LRSL\n*A 456789:;<=> a-3/21H-? @ @ \\`Q DE @ XJ8L5 X5;: @ @ \x0e\x14\t\x0e)\t\x0c\n,X1/2 -ÿb22c PQP* T\n*ÿ@ÿPÿ@ÿ* *Cÿ.24 MIR8LRSL\n*d -3H3?XeH1 456789:;<=> eH1-? @ @ NQQ DE @ XJ8L5 /a?ÿ- X5;: @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nG-]ÿ\nY-/1H0V3W HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*\\ 456789:;<=> /?. @ @ PCQ D? @ 36IJ=IM6M> @ @ @ \x0e\x14\t\x0e)\t\x0c\n?X1HG M> PQP* T\n4H421-3H?H Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nPQ 456789:;<=> a-3/21H-? @ @ NB*A E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nYÿY-/1H0V -ÿG-] M> PQP* T\n/-fXa-3/- Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nP* 456789:;<=> a-3/21H-? @ @ QBC E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nVÿY-/1H0V -ÿG-] M> PQP* T\nG2U-V2/W 45LDLT=R;J=6 *+ÿ.24 MIR8LRSL *+ÿ.24\nPP -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W 45LDLT=R;J=6 *`ÿ.24 MIR8LRSL *`ÿ.24\nP+ -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W -TKL5>L *^31.^*N HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\nPN @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L P^31.^*` HIJ5;KLI6 *`ÿ.24 MIR8LRSL *`ÿ.24\nPC @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L N^2Y324W HIJ5;KLI6 *`ÿ.24 MIR8LRSL\nP` -.XY 2KLIJ @ @ -?X4-/W] *Q DE @ aHG @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n^*`ÿ.24']
apiLogger::2021-10-04 01:09:23,635::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-04 01:09:23,635::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 01:09:24,460::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 01:09:24,461::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 01:09:24,461::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpnfz45boa 
apiLogger::2021-10-04 01:09:24,462::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 01:09:24,462::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 01:09:24,475::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 01:09:24,475::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpnfz45boa
apiLogger::2021-10-04 01:09:24,613::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 01:09:24,613::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 01:09:24,613::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 01:09:24,613::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 01:09:24,617::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-04 01:09:24,617::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 01:09:24,617::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 01:09:24,617::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-04 01:09:24,617::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 04-Oct-2021 01:07:43 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : R1979-ONC-1625 Sponsor Notification: Site: 1625276001, Subject: 276001003; event:\nENCEPHALOPATHY- Initial\n \nFrom: SafetyPV <safetypv@syneoshealth.com> Sent: Friday, September 17, 2021 12:02 PM To:\nBarwick, Ashley <ashley.barwick@syneoshealth.com>; Ayesha Sabir\n<asra.sabir@regeneron.com>; Bertha Fearon-Chalet <bertha.fearonchalet@regeneron.com>;\nCarolina Leite de Oliveira <carolina.oliveira@regeneron.com>; chili.deng@zailaboratory.com;\nClaire Hearnden <claire.hearnden@regeneron.com>; Cristina Frias-External\n<cristina.frias@regeneron.com>; Pakendorf, Dee <deirdre.pakendorf1@syneoshealth.com>;\ndorothy.ogwuru@regeneron.com; De Mori, Giacomo <giacomo.demori@syneoshealth.com>;\nGuillermo Perez de Lema-External <guillermo.perezde@regeneron.com>; Scian, Joanna\n<joanna.scian@syneoshealth.com>; Juan Esquivel-External <juan.esquivel@regeneron.com>;\nKonopka, Katarzyna <katarzyna.konopka@syneoshealth.com>; Lakshmi Pulavarthi\n<lakshmi.pulavarthi@regeneron.com>; Lieve Adriaens <lieve.adriaens@regeneron.com>; Meyers,\nMark <mark.meyers@syneoshealth.com>; Regeneron Medical Safety\n<Medical.Safety@regeneron.com>; Melanie Ufkin <melanie.ufkin@regeneron.com>; Nickolas\nSophos <nickolas.sophos@regeneron.com>; Quasheeda Fields\n<quasheeda.fields@regeneron.com>; DL R1979-ONC-1625 Medical Team <R1979-ONC-\n1625MedicalTeam@regeneron.com>; SafetyPV <safetypv@syneoshealth.com>; Saleem Shariff\n<saleem.shariff@regeneron.com>; sharon.gao@zailaboratory.com; Srikanth Ambati\n<srikanth.ambati@regeneron.com>; Teresa Has <teresa.has@regeneron.com>; Tsimogianni,\nVeta <veta.tsimogianni@syneoshealth.com>; Tan, Wee Lin <weelin.tan@syneoshealth.com>\nSubject: <External> R1979-ONC-1625 Sponsor Notification: Site: 1625276001, Subject:\n276001003; event: ENCEPHALOPATHY- Initial \n \nEXTERNAL MESSAGE\n \n \nDear All, \n \nPlease note that Syneos Health received initial information regarding the following event. \n \nProtocol: R1979-ONC-1625\nDay 0: 17-SEP-2021\nCountry: Germany\nSite # /Investigator: 1625276001/Duell, Johannes\nSubject ID: 276001003\nStudy Drug(s): REGN1979\nEvent Term: ENCEPHALOPATHY Onset date: 16-SEP-2021\nSeverity/Grade: Grade 2\nSAE Criteria and/or AESI Criteria: Hospitalization/No\nInvestigator Relationship to Study Drug: Related\nInvestigator Relationship to Study Conduct: No\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2021-00130\n \n \nKind regards, \n \nAmy \n \nAmy Amazeen Safety &PV Specialist I, Drug Safety and Pharmacovigilance Syneos Health US\nRegional- Michigan Mobile  +1 734 265 6653 \namy.amazeen@syneoshealth.com \nsyneoshealth.com']
apiLogger::2021-10-04 01:09:24,618::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 01:09:24,618::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-04 01:09:24,618::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 01:09:24,618::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 01:09:24,618::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 01:09:26,330::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 01:09:26,330::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 01:23:19,260::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 01:23:19,341::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 01:23:19,342::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfh31_zhr 
apiLogger::2021-10-04 01:23:19,345::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 01:23:19,345::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 01:23:23,149::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 01:23:23,149::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfh31_zhr
apiLogger::2021-10-04 01:23:25,789::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 01:23:25,789::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 01:23:25,789::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 01:23:25,789::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 01:23:25,793::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:23:25,793::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 01:23:25,793::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-04 01:23:25,793::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-04 01:23:25,796::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:23:25,796::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-04 01:23:25,796::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-04 01:23:25,797::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-04 01:23:25,800::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:23:25,800::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-04 01:23:25,800::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-04 01:23:25,800::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-04 01:23:25,803::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:23:25,803::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-04 01:23:25,803::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-04 01:23:25,803::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-04 01:23:25,807::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:23:25,807::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-04 01:23:25,807::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-04 01:23:25,807::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '\x00\x01\x02D\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x07\x08\t\n\x0b\x01 \x0c\r\x0e\x0f\x0e\x10\x11\x12\x13\x10\r\x14\x15\x16ÿ\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x12ÿ\x11\x1b\x1c\x12\x10\x1d\x1a\x1e\x1c\x1dÿ\x1f !"#ÿ \x11ÿ\x1a\x1f\x1f\x1c\x1f\x1fÿ $\x1cÿ\x1a\x12 %\x10 !&\x11\x0cÿ\x1a\x13 %\'% #ÿ\x1a\x12"\n\x1f\x1a(\x1c #ÿ\x11(ÿ\x0c\x1c)\x12\r\x0e\x0f\x0e*ÿ\x1a\x12ÿ\x1a\x12 %\x10\x13"\x15+ÿ,ÿ\x1a\x12 %\x10\x13"-ÿ\x1e%\x1f\x1b\x1c\x13%(%\x13\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x18\x19\x03\x05\x0b\n\x1a\x12 %\x1e\x11"#*ÿ%\x12ÿ\x1b\x1a %\x1c\x12 \x1fÿ.% $ÿ\x0c\x1c\x1d\x1a\x1b\x1f\x1c"ÿ\x11\x0cÿ\x0c\x1c(\x0c\x1a\x13 \x11\x0c#ÿ\x1e\x10\x13\x1c\x1d\x1d\n\x12\x11\x12\x10$\x11")/%\x12ÿ\x1d#&\x1b$\x11&\x1a\n\x1901\x0b0\x03\x192ÿ3\x0b4\x05\x035ÿ6\x03\x0878ÿ9\x027\x0b \r\x0f\x0c)\x1b\x10+++:\n9\x02\t;\x02\x0807 \x0c\x1c)\x12\r\x0e\x0f\x0e\n6\x08\nD\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n6\x19\x03\x0bÿ\x074\t\x0b \x15\x0f\x14++\rÿ\x10ÿ"<=>>ÿ\x10ÿ)=?@ABC\n6\x19\x03\x0bÿ\x07\x08\t\n\x0b\x01\n6\x08\nD\x0b\x04\x03ÿEFG\n6\x04\x01\x0b\x0b0\x190HÿF4\x03\x0b\n1625276001\n276001004\n02 SEP 2021 \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06ÿ\t\x16=ÿ?\x0c\r\x06\r\x05\r;ÿ\x12\n\x04\x16=\n\x04\x16\x06ÿ@\x0c\t\x05A\x10\x16\x13\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 :\t\x06\x04ÿ<\x01\x02\x03\x04\x05\x06ÿ<\x10\x13\x16\x04=\nF\x04\x0c\x04ÿ\x06\x11\x04\x0c\x04ÿ\t\x16\x17 :\t\x06\x04ÿ\x00\x01\x02\x03\x04\x05\x06ÿ\x00\x10\x13\x16\x04=\nC;\r\x02\t;ÿ?\x0c\r\x06\r\x05\r;ÿD ÿ\x12\n\x04\x16=\n\x04\x16\x06 ?\x0c\r\x06\r\x05\r;ÿ\x1a\x18\x0fÿ\x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04 \x1a>L \x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04ÿ\x0e\x0c\r\n ;\r\x05\t;ÿ\x1a\x16\x0e\r\x0c\n\x04=\nB ;\r\x05\t; \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 >\r\x16<\x04\x16\x06ÿ@\x17\x1d\x04\n\x12\n\x04\x16=\n\x04\x16\x06ÿE\x04\x0c<\x10\r\x16 E\x04\x0c<\x10\r\x16ÿHI\r\x05\t;Jÿ H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J E\x04\x0c<\x10\r\x16 \x15>M\x1a\x18\x0fÿH==\x1c\n\r\x16\x1c >\r\x16<\x04\x16\x06ÿH==\x1c\n\r\x16\x1c\n\t\n\x04\x16=\n\x04\x16\x06<G H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J\n\x17\x17\x17\x17J \x17\x17\x17\x17J\x19ÿ\x10\x0eÿ\t\x1d\x1d;\x10\x05\t\x02;\x04\nN"$\x1f$9O+P9" \x1e&\n" "$ÿQWUÿ\x1e!\x1e" \'(03ÿ4,31*3- "#ÿ\'QXÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V()\nN"$\x1f$9O+P9" \x1e& U*3,R041ÿYZV9Y-ZS[\n\x1e "$ÿQWUÿ\x1e!\x1e" ""ÿ\\]^ÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V() 4,31*3-\n:\x04\n\r\x13\x0c\t\x1d\x11\x17ÿ:\x04\x06\t\x10;<\n\x18\t\x05\x04\x19ÿ\x1a\x0eÿ\x1b\x06\x11\x04\x0c\x1c\n\x00\x01\x02\x03\x04\x05\x06ÿ\x08\t\n\x04 \x0b\x04\t\x0cÿ\r\x0eÿ\x0f\x10\x0c\x06\x11 \x12\x13\x04 \x00\x04\x14 \x15\x06\x11\x16\x10\x05\x10\x06\x17 \x18\t\x05\x04\n+,-ÿ/012(304 \x00\x1d\x04\x05\x10\x0e\x17\n\x1e\x1f !!"!!# "$#  %& \'()* 780-* 9\n,5ÿ6(-03,\n:\x10<\x04\t<\x04\x1c\x00\x1d\x04\x05\x10\x0e\x10\x05ÿ>\r\x11\r\x0c\x06\n:\x10<\x04\t<\x04ÿ<\x1d\x04\x05\x10\x0e\x10\x05ÿ\x05\r\x11\r\x0c\x06M\x13\x0c\r\x01\x1dÿH\x10\x16\x06\x04\x13\x0c\t\x06\x04=J _6^P6ÿY*)*4-*SÿN*`0R*3 \x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0e\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x19\x06\x0b\x02\n#\x1eÿ\x0c\x11\x12\x0c\x04\x11\x12\n\x18\x0b\x06\r\x0bÿ\x19\x06\x0b\x02 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r \r\x02\n\x0c\x07(\x02\x03 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r\n\x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0eÿ\x0f\x10\x04\x11\x03\x04\x11\x12 !\x11\x12\x0c\x04\x11\x12ÿ\x06\x0b \n$\x02\x05\x04\x1e\x0e\n\x00 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x1f\x11\x1d\x11\x0c \x11ÿ\n\x0b\x06\r\x0b \x13&\x11\x03ÿ\x03\x06\x0b\x02\x17 \x1f\x11\x1d\x11\x0c \x11ÿ\x02\x11\x03\n\x13\x14\x15\x11\x0c\r\x16\x06\x07\x04\x0b\x0e\x17 \n\x0b\x1f\x03\x0eÿ\x02\x11\x0b\r\x0e" \x1b%\x1b\x14&\n\x0e\x0e\x0e\x0e\x17 \x03\x06\x0b\x02 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x03\x06\x0b\x02\n\'\r\x06\x03\x02\n\x0e\x0e\x0e\x0e\x17\n) *+,-./.0ÿ2.33+/40ÿ/56ÿ++ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nG7H7I,H5ÿJ.,H/\nF \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n*+0.,0.\nK ,/H+,3ÿL+-H+33,/+7I \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nM 0+<2,*+N.H/+G4370+0 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nO G,H*+,3ÿ+I04LL+G+.IG5ÿ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\nP ,G.ÿ+IJ+-+/7Hÿ,33.H<5 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nQ J+6ÿH.63.,0.2.I/ÿH+<J/ 4Iÿ,6HÿFR)M B8CD@CE@? H@S:TU@? A 4Iÿ,6HÿFR)M B8CD@CE@?\nV J+6ÿH.63.,0.2.I/ÿ3.L/ 4IÿW4IÿFR)P B8CD@CE@? H@S:TU@? A 4IÿW4IÿFR)P B8CD@CE@?\n3.Lÿ-4I*3.ÿ-H.IGJ\nX \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n-37GY\n)R 6H70/,/,J56.H63,0+. \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)) <</ÿ+IGH.,0.* )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n)F ,I.2+,ÿ )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n63,/.3./ÿG74I*\n)K )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n*.GH.,0.*\n)M +<ÿ<ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)O +<ÿ,ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)P +<ÿ2ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n<34/.,3ÿH.<+7Iÿ3.L/\n)Q \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\n6,+I \x00\x01\x02\x03\x01\x04\x05\x06\x07\x02\x06ÿ\t\n\x0b\x05\x03\x07\x06\x05\x01\x02\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x12\x13 \x12\x13\n\x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02\n\x05\x1aÿ\x04\n\x0b\x05\x03\x07\x18 \x05\x1aÿ\x07\x0b\x1f\n\x0e\x1a\n\n\x12\x13 \x16\x05\x1a\x06\x01\x0e\x17\x1c \n\x1f\n\x02\x06\x1c\n%\x06\x07\x0e\x06ÿ\x0b\x07\x06\n %\x06\x01\x15ÿ\x0b\x07\x06\n\n\x14\x0e\x01\x15\x16\x17\x18\x07\x19\x05\x1a \x14\x18\n\x07\x1a\n \x14\x18\n\x07\x1a\n \r\x01\x1a\n \x1b\x06\x16\n\x0e\x1c \x12\x13ÿ\x1b\x06\x16\n\x0e \x12\x13ÿ\x1b\x06\x16\n\x0e\x1c %\x06\x07\x0e\x06\n\x0c \r\x0e\x0f\x10ÿ\x11\x07\x04\n \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \r\x01\x1a\n #\x0e\n$\x0f\n\x02\x03\x17 &\x01\x0f\x06\n \'\x0b\x0b(\x04\x01\x02( \'\x0b\x0b(\x04\x01\x02( \x1b\x02\x10\x01\x05\x02\x10\n\x1b\x0eÿ\x1b\x06\x16\n\x0e\x1c \x1a\n\x18\n\x03\x06ÿ\x06\x16\n \x1a\n\x18\n\x03\x06ÿ\x06\x16\n "\x02\x05\x06 \x1a\x15\n\x03\x05\x13\x17 %\x15\n\x03\x05\x13\x17 \x1a\x15\n\x03\x05\x13\x17 \r\x07\x06\nÿ"\x02*\n\x17\x17\x17\x17) \x17\x17\x17\x17)\n\x1a\x15\n\x03\x05\x13\x17 \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n\n\t\n\x0b\x05\x03\x07\x18  \x0b\x1f\n\x0e\x1a\n\n\x1d\x05\x1a\x06\x01\x0e\x17 !\x1f\n\x02\x06\n\x0e\n\x03\x01\x0e\x0b\x1e \x0e\n\x03\x01\x0e\x0b\x1e\n@AB30C5A 2LMNLG<O FPÿ2A5 LON9HNSH FUÿ2A5\n+ ,-./0123-4 56789:;<=>? D D EFF CG9H6 I/ JK D D LON9HNSHT\n@-1 H7L? RFR+ T RFR+\n4HT>N<; WXY10K-1.\nR 3C012A4-K V>?G76: D -@2B,,-Y-A D +F \\] D ^-K D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n25-0C.C@1 4HT>N<; WXY10K-1.\nE Y3C@ V>?G76: D -@2B,,-Y-A D RW \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n3142B.C2- 4HT>N<; +FX50C23\n_ @ V>?G76: D 131VZ5A0 D F`_ \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n5.12-AXB@\n145VC4C0\nW 56789:;<=>? 4B[C2-3-2 D D +FF \\]a\\. D J>T D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@1.\n51@3C501 23C41YV\nb cC. 56789:;<=>? 50C3AY3-C D D _F \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@\n4HT>N<; EX130-1. 2LMNLG<O\nP A@Cd150-@ V>?G76: D ,-^0-..13- D UFF CG9H6 -A ^-K D H7L? D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@XB@[\n@Ce14-@2 4HT>N<; +PX/.B3A B@ÿ1B/ LON9HNSH\nU B.,C@ V>?G76: D 1.ÿ0A/-C@ D WFF \\] D 50@ D C6<; D RFR+ T D \x03\x16\n\x03*\n\x0b\n.A,3\nKAd14A3V 1TgH6?H +XY02X+_ -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\nf D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\nKAd14A3V 1TgH6?H RXY02X+b -OG6<gHO7 +bÿ2A5 LON9HNSH +bÿ2A5\n+F D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\n5101YA31 56H\\HT>N<G>7 +_ÿ2A5 LON9HNSH +Wÿ2A5\n++ 4C. Oÿh76 D D D + ] D JK D C6<; D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf\n56H\\HT>N<G>7 -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\n+R 31eA/-. Oÿh76 D D D R \\] D JK D L? D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf \n\x11 \n\x11\n\n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b\n\r\x18ÿ\x08\t\x0c\r\x0e\x07\x16 \r\x18ÿ\x07\x0c\x1e\t\x02\x18\t\n\n\x11 \x14\r\x18\x0f\x10\x02\x15\x1a \t\x1e\t\x0b\x0f\x1a\nREG-2021-00130 GSPV RECEIPT DATE 1$7\x0f\x07S\x02E\x0fÿ\x0cP\x072\x0f\t021 AKA 25 pages$\x0f\x10\x13ÿ\x0c\x07\x0f\t\n\x12\x02\x10\x13\x14\x15\x16\x07\x17\r\x18 \x12\x16\t\x07\x18\t \x12\x16\t\x07\x18\t \x01\x10\x18\t \x19\x0f\x14\t\x02\x1a \n\x11ÿ\x19\x0f\x14\t\x02 \n\x11ÿ\x19\x0f\x14\t\x02\x1a $\x0f\x07\x02\x0f\n\x00 \x01\x02\x03\x04ÿ\x06\x07\x08\t \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \x01\x10\x18\t "\x02\t#\x03\t\x0b\x0e\x15 %\x10\x03\x0f\t &\x0c\x0c\'\x08\x10\x0b\' &\x0c\x0c\'\x08\x10\x0b\' \x19\x0b\x04\x10\r\x0b\x04\n\x19\x02ÿ\x19\x0f\x14\t\x02\x1a \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t !\x0b\r\x0f \x18\x13\t\x0e\r\x11\x15 $\x13\t\x0e\r\x11\x15 \x18\x13\t\x0e\r\x11\x15 \x01\x07\x0f\tÿ!\x0b)\n\x15\x15\x15\x15( \x15\x15\x15\x15(\n\x18\x13\t\x0e\r\x11\x15 \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t\n\x1b\t\x0c\r\x0e\x07\x16 \x1f\x0c\x1e\t\x02\x18\t\n\x1c\r\x18\x0f\x10\x02\x15  \x1e\t\x0b\x0f\n\x02\t\x0e\x10\x02\x0c\x1d \x02\t\x0e\x10\x02\x0c\x1d\nHIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\n*+ ,-./01/23 456789:;<=> /?. @ @ ABC DE @ FG @ @ MIR8LRSLT\nM> PQP* T PQP*\nG2U-V2/W 45LDLT=R;J=6 HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Cÿ.24\n*N -.XY IÿZ65 @ @ @ PQ DE @ FG @ M> @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nW]G1XVX1 VLT=R;: *A^[?0/2 .M_RMJ;I *Nÿ.24 MIR8LRSL\n*C 4WXY W=>J659 @ -?ÿ12[HXY @ * DE @ 41Y @ L6M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nW]G1X3W? ?2,/\n4-1-32/- VLT=R;: *A^[?0/2 HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*` VX? W=>J659 @ -?ÿ12[HXY @ * E @ 41Y @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n?2,/\n3X/1HV +ÿ/HV2. *Cÿ.24 MIR8LRSL\n*A 456789:;<=> a-3/21H-? @ @ \\`Q DE @ XJ8L5 X5;: @ @ \x0e\x14\t\x0e)\t\x0c\n,X1/2 -ÿb22c PQP* T\n*ÿ@ÿPÿ@ÿ* *Cÿ.24 MIR8LRSL\n*d -3H3?XeH1 456789:;<=> eH1-? @ @ NQQ DE @ XJ8L5 /a?ÿ- X5;: @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nG-]ÿ\nY-/1H0V3W HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*\\ 456789:;<=> /?. @ @ PCQ D? @ 36IJ=IM6M> @ @ @ \x0e\x14\t\x0e)\t\x0c\n?X1HG M> PQP* T\n4H421-3H?H Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nPQ 456789:;<=> a-3/21H-? @ @ NB*A E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nYÿY-/1H0V -ÿG-] M> PQP* T\n/-fXa-3/- Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nP* 456789:;<=> a-3/21H-? @ @ QBC E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nVÿY-/1H0V -ÿG-] M> PQP* T\nG2U-V2/W 45LDLT=R;J=6 *+ÿ.24 MIR8LRSL *+ÿ.24\nPP -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W 45LDLT=R;J=6 *`ÿ.24 MIR8LRSL *`ÿ.24\nP+ -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W -TKL5>L *^31.^*N HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\nPN @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L P^31.^*` HIJ5;KLI6 *`ÿ.24 MIR8LRSL *`ÿ.24\nPC @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L N^2Y324W HIJ5;KLI6 *`ÿ.24 MIR8LRSL\nP` -.XY 2KLIJ @ @ -?X4-/W] *Q DE @ aHG @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n^*`ÿ.24']
apiLogger::2021-10-04 01:23:25,807::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-04 01:23:25,807::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 01:23:25,885::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 01:23:25,960::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 01:23:25,960::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpu4xtr5ov 
apiLogger::2021-10-04 01:23:25,963::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 01:23:25,963::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 01:23:29,587::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 01:23:29,587::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpu4xtr5ov
apiLogger::2021-10-04 01:23:32,309::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 01:23:32,309::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 01:23:32,309::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 01:23:32,309::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 01:23:32,312::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:23:32,313::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 01:23:32,313::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-04 01:23:32,313::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-04 01:23:32,316::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:23:32,316::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-04 01:23:32,316::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-04 01:23:32,316::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-04 01:23:32,319::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:23:32,319::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-04 01:23:32,320::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-04 01:23:32,320::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-04 01:23:32,323::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:23:32,323::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-04 01:23:32,323::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-04 01:23:32,323::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-04 01:23:32,327::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:23:32,327::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-04 01:23:32,327::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-04 01:23:32,327::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '\x00\x01\x02D\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x07\x08\t\n\x0b\x01 \x0c\r\x0e\x0f\x0e\x10\x11\x12\x13\x10\r\x14\x15\x16ÿ\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x12ÿ\x11\x1b\x1c\x12\x10\x1d\x1a\x1e\x1c\x1dÿ\x1f !"#ÿ \x11ÿ\x1a\x1f\x1f\x1c\x1f\x1fÿ $\x1cÿ\x1a\x12 %\x10 !&\x11\x0cÿ\x1a\x13 %\'% #ÿ\x1a\x12"\n\x1f\x1a(\x1c #ÿ\x11(ÿ\x0c\x1c)\x12\r\x0e\x0f\x0e*ÿ\x1a\x12ÿ\x1a\x12 %\x10\x13"\x15+ÿ,ÿ\x1a\x12 %\x10\x13"-ÿ\x1e%\x1f\x1b\x1c\x13%(%\x13\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x18\x19\x03\x05\x0b\n\x1a\x12 %\x1e\x11"#*ÿ%\x12ÿ\x1b\x1a %\x1c\x12 \x1fÿ.% $ÿ\x0c\x1c\x1d\x1a\x1b\x1f\x1c"ÿ\x11\x0cÿ\x0c\x1c(\x0c\x1a\x13 \x11\x0c#ÿ\x1e\x10\x13\x1c\x1d\x1d\n\x12\x11\x12\x10$\x11")/%\x12ÿ\x1d#&\x1b$\x11&\x1a\n\x1901\x0b0\x03\x192ÿ3\x0b4\x05\x035ÿ6\x03\x0878ÿ9\x027\x0b \r\x0f\x0c)\x1b\x10+++:\n9\x02\t;\x02\x0807 \x0c\x1c)\x12\r\x0e\x0f\x0e\n6\x08\nD\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n6\x19\x03\x0bÿ\x074\t\x0b \x15\x0f\x14++\rÿ\x10ÿ"<=>>ÿ\x10ÿ)=?@ABC\n6\x19\x03\x0bÿ\x07\x08\t\n\x0b\x01\n6\x08\nD\x0b\x04\x03ÿEFG\n6\x04\x01\x0b\x0b0\x190HÿF4\x03\x0b\n1625276001\n276001005\n02 SEP 2021 \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06ÿ\t\x16=ÿ?\x0c\r\x06\r\x05\r;ÿ\x12\n\x04\x16=\n\x04\x16\x06ÿ@\x0c\t\x05A\x10\x16\x13\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 :\t\x06\x04ÿ<\x01\x02\x03\x04\x05\x06ÿ<\x10\x13\x16\x04=\nF\x04\x0c\x04ÿ\x06\x11\x04\x0c\x04ÿ\t\x16\x17 :\t\x06\x04ÿ\x00\x01\x02\x03\x04\x05\x06ÿ\x00\x10\x13\x16\x04=\nC;\r\x02\t;ÿ?\x0c\r\x06\r\x05\r;ÿD ÿ\x12\n\x04\x16=\n\x04\x16\x06 ?\x0c\r\x06\r\x05\r;ÿ\x1a\x18\x0fÿ\x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04 \x1a>L \x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04ÿ\x0e\x0c\r\n ;\r\x05\t;ÿ\x1a\x16\x0e\r\x0c\n\x04=\nB ;\r\x05\t; \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 >\r\x16<\x04\x16\x06ÿ@\x17\x1d\x04\n\x12\n\x04\x16=\n\x04\x16\x06ÿE\x04\x0c<\x10\r\x16 E\x04\x0c<\x10\r\x16ÿHI\r\x05\t;Jÿ H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J E\x04\x0c<\x10\r\x16 \x15>M\x1a\x18\x0fÿH==\x1c\n\r\x16\x1c >\r\x16<\x04\x16\x06ÿH==\x1c\n\r\x16\x1c\n\t\n\x04\x16=\n\x04\x16\x06<G H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J\n\x17\x17\x17\x17J \x17\x17\x17\x17J\x19ÿ\x10\x0eÿ\t\x1d\x1d;\x10\x05\t\x02;\x04\nN"$\x1f$9O+P9" \x1e&\n" "$ÿQWUÿ\x1e!\x1e" \'(03ÿ4,31*3- "#ÿ\'QXÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V()\nN"$\x1f$9O+P9" \x1e& U*3,R041ÿYZV9Y-ZS[\n\x1e "$ÿQWUÿ\x1e!\x1e" ""ÿ\\]^ÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V() 4,31*3-\n:\x04\n\r\x13\x0c\t\x1d\x11\x17ÿ:\x04\x06\t\x10;<\n\x18\t\x05\x04\x19ÿ\x1a\x0eÿ\x1b\x06\x11\x04\x0c\x1c\n\x00\x01\x02\x03\x04\x05\x06ÿ\x08\t\n\x04 \x0b\x04\t\x0cÿ\r\x0eÿ\x0f\x10\x0c\x06\x11 \x12\x13\x04 \x00\x04\x14 \x15\x06\x11\x16\x10\x05\x10\x06\x17 \x18\t\x05\x04\n+,-ÿ/012(304 \x00\x1d\x04\x05\x10\x0e\x17\n\x1e\x1f !!"!!# "$#  %& \'()* 780-* 9\n,5ÿ6(-03,\n:\x10<\x04\t<\x04\x1c\x00\x1d\x04\x05\x10\x0e\x10\x05ÿ>\r\x11\r\x0c\x06\n:\x10<\x04\t<\x04ÿ<\x1d\x04\x05\x10\x0e\x10\x05ÿ\x05\r\x11\r\x0c\x06M\x13\x0c\r\x01\x1dÿH\x10\x16\x06\x04\x13\x0c\t\x06\x04=J _6^P6ÿY*)*4-*SÿN*`0R*3 \x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0e\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x19\x06\x0b\x02\n#\x1eÿ\x0c\x11\x12\x0c\x04\x11\x12\n\x18\x0b\x06\r\x0bÿ\x19\x06\x0b\x02 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r \r\x02\n\x0c\x07(\x02\x03 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r\n\x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0eÿ\x0f\x10\x04\x11\x03\x04\x11\x12 !\x11\x12\x0c\x04\x11\x12ÿ\x06\x0b \n$\x02\x05\x04\x1e\x0e\n\x00 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x1f\x11\x1d\x11\x0c \x11ÿ\n\x0b\x06\r\x0b \x13&\x11\x03ÿ\x03\x06\x0b\x02\x17 \x1f\x11\x1d\x11\x0c \x11ÿ\x02\x11\x03\n\x13\x14\x15\x11\x0c\r\x16\x06\x07\x04\x0b\x0e\x17 \n\x0b\x1f\x03\x0eÿ\x02\x11\x0b\r\x0e" \x1b%\x1b\x14&\n\x0e\x0e\x0e\x0e\x17 \x03\x06\x0b\x02 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x03\x06\x0b\x02\n\'\r\x06\x03\x02\n\x0e\x0e\x0e\x0e\x17\n) *+,-./.0ÿ2.33+/40ÿ/56ÿ++ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nG7H7I,H5ÿJ.,H/\nF \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n*+0.,0.\nK ,/H+,3ÿL+-H+33,/+7I \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nM 0+<2,*+N.H/+G4370+0 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nO G,H*+,3ÿ+I04LL+G+.IG5ÿ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\nP ,G.ÿ+IJ+-+/7Hÿ,33.H<5 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nQ J+6ÿH.63.,0.2.I/ÿH+<J/ 4Iÿ,6HÿFR)M B8CD@CE@? H@S:TU@? A 4Iÿ,6HÿFR)M B8CD@CE@?\nV J+6ÿH.63.,0.2.I/ÿ3.L/ 4IÿW4IÿFR)P B8CD@CE@? H@S:TU@? A 4IÿW4IÿFR)P B8CD@CE@?\n3.Lÿ-4I*3.ÿ-H.IGJ\nX \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n-37GY\n)R 6H70/,/,J56.H63,0+. \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)) <</ÿ+IGH.,0.* )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n)F ,I.2+,ÿ )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n63,/.3./ÿG74I*\n)K )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n*.GH.,0.*\n)M +<ÿ<ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)O +<ÿ,ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)P +<ÿ2ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n<34/.,3ÿH.<+7Iÿ3.L/\n)Q \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\n6,+I \x00\x01\x02\x03\x01\x04\x05\x06\x07\x02\x06ÿ\t\n\x0b\x05\x03\x07\x06\x05\x01\x02\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x12\x13 \x12\x13\n\x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02\n\x05\x1aÿ\x04\n\x0b\x05\x03\x07\x18 \x05\x1aÿ\x07\x0b\x1f\n\x0e\x1a\n\n\x12\x13 \x16\x05\x1a\x06\x01\x0e\x17\x1c \n\x1f\n\x02\x06\x1c\n%\x06\x07\x0e\x06ÿ\x0b\x07\x06\n %\x06\x01\x15ÿ\x0b\x07\x06\n\n\x14\x0e\x01\x15\x16\x17\x18\x07\x19\x05\x1a \x14\x18\n\x07\x1a\n \x14\x18\n\x07\x1a\n \r\x01\x1a\n \x1b\x06\x16\n\x0e\x1c \x12\x13ÿ\x1b\x06\x16\n\x0e \x12\x13ÿ\x1b\x06\x16\n\x0e\x1c %\x06\x07\x0e\x06\n\x0c \r\x0e\x0f\x10ÿ\x11\x07\x04\n \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \r\x01\x1a\n #\x0e\n$\x0f\n\x02\x03\x17 &\x01\x0f\x06\n \'\x0b\x0b(\x04\x01\x02( \'\x0b\x0b(\x04\x01\x02( \x1b\x02\x10\x01\x05\x02\x10\n\x1b\x0eÿ\x1b\x06\x16\n\x0e\x1c \x1a\n\x18\n\x03\x06ÿ\x06\x16\n \x1a\n\x18\n\x03\x06ÿ\x06\x16\n "\x02\x05\x06 \x1a\x15\n\x03\x05\x13\x17 %\x15\n\x03\x05\x13\x17 \x1a\x15\n\x03\x05\x13\x17 \r\x07\x06\nÿ"\x02*\n\x17\x17\x17\x17) \x17\x17\x17\x17)\n\x1a\x15\n\x03\x05\x13\x17 \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n\n\t\n\x0b\x05\x03\x07\x18  \x0b\x1f\n\x0e\x1a\n\n\x1d\x05\x1a\x06\x01\x0e\x17 !\x1f\n\x02\x06\n\x0e\n\x03\x01\x0e\x0b\x1e \x0e\n\x03\x01\x0e\x0b\x1e\n@AB30C5A 2LMNLG<O FPÿ2A5 LON9HNSH FUÿ2A5\n+ ,-./0123-4 56789:;<=>? D D EFF CG9H6 I/ JK D D LON9HNSHT\n@-1 H7L? RFR+ T RFR+\n4HT>N<; WXY10K-1.\nR 3C012A4-K V>?G76: D -@2B,,-Y-A D +F \\] D ^-K D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n25-0C.C@1 4HT>N<; WXY10K-1.\nE Y3C@ V>?G76: D -@2B,,-Y-A D RW \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n3142B.C2- 4HT>N<; +FX50C23\n_ @ V>?G76: D 131VZ5A0 D F`_ \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n5.12-AXB@\n145VC4C0\nW 56789:;<=>? 4B[C2-3-2 D D +FF \\]a\\. D J>T D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@1.\n51@3C501 23C41YV\nb cC. 56789:;<=>? 50C3AY3-C D D _F \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@\n4HT>N<; EX130-1. 2LMNLG<O\nP A@Cd150-@ V>?G76: D ,-^0-..13- D UFF CG9H6 -A ^-K D H7L? D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@XB@[\n@Ce14-@2 4HT>N<; +PX/.B3A B@ÿ1B/ LON9HNSH\nU B.,C@ V>?G76: D 1.ÿ0A/-C@ D WFF \\] D 50@ D C6<; D RFR+ T D \x03\x16\n\x03*\n\x0b\n.A,3\nKAd14A3V 1TgH6?H +XY02X+_ -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\nf D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\nKAd14A3V 1TgH6?H RXY02X+b -OG6<gHO7 +bÿ2A5 LON9HNSH +bÿ2A5\n+F D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\n5101YA31 56H\\HT>N<G>7 +_ÿ2A5 LON9HNSH +Wÿ2A5\n++ 4C. Oÿh76 D D D + ] D JK D C6<; D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf\n56H\\HT>N<G>7 -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\n+R 31eA/-. Oÿh76 D D D R \\] D JK D L? D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf \n\x11 \n\x11\n\n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b\n\r\x18ÿ\x08\t\x0c\r\x0e\x07\x16 \r\x18ÿ\x07\x0c\x1e\t\x02\x18\t\n\n\x11 \x14\r\x18\x0f\x10\x02\x15\x1a \t\x1e\t\x0b\x0f\x1a\nREG-2021-00130 GSPV RECEIPT DATE 1$7\x0f\x07S\x02E\x0fÿ\x0cP\x072\x0f\t021 AKA 25 pages$\x0f\x10\x13ÿ\x0c\x07\x0f\t\n\x12\x02\x10\x13\x14\x15\x16\x07\x17\r\x18 \x12\x16\t\x07\x18\t \x12\x16\t\x07\x18\t \x01\x10\x18\t \x19\x0f\x14\t\x02\x1a \n\x11ÿ\x19\x0f\x14\t\x02 \n\x11ÿ\x19\x0f\x14\t\x02\x1a $\x0f\x07\x02\x0f\n\x00 \x01\x02\x03\x04ÿ\x06\x07\x08\t \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \x01\x10\x18\t "\x02\t#\x03\t\x0b\x0e\x15 %\x10\x03\x0f\t &\x0c\x0c\'\x08\x10\x0b\' &\x0c\x0c\'\x08\x10\x0b\' \x19\x0b\x04\x10\r\x0b\x04\n\x19\x02ÿ\x19\x0f\x14\t\x02\x1a \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t !\x0b\r\x0f \x18\x13\t\x0e\r\x11\x15 $\x13\t\x0e\r\x11\x15 \x18\x13\t\x0e\r\x11\x15 \x01\x07\x0f\tÿ!\x0b)\n\x15\x15\x15\x15( \x15\x15\x15\x15(\n\x18\x13\t\x0e\r\x11\x15 \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t\n\x1b\t\x0c\r\x0e\x07\x16 \x1f\x0c\x1e\t\x02\x18\t\n\x1c\r\x18\x0f\x10\x02\x15  \x1e\t\x0b\x0f\n\x02\t\x0e\x10\x02\x0c\x1d \x02\t\x0e\x10\x02\x0c\x1d\nHIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\n*+ ,-./01/23 456789:;<=> /?. @ @ ABC DE @ FG @ @ MIR8LRSLT\nM> PQP* T PQP*\nG2U-V2/W 45LDLT=R;J=6 HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Cÿ.24\n*N -.XY IÿZ65 @ @ @ PQ DE @ FG @ M> @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nW]G1XVX1 VLT=R;: *A^[?0/2 .M_RMJ;I *Nÿ.24 MIR8LRSL\n*C 4WXY W=>J659 @ -?ÿ12[HXY @ * DE @ 41Y @ L6M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nW]G1X3W? ?2,/\n4-1-32/- VLT=R;: *A^[?0/2 HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*` VX? W=>J659 @ -?ÿ12[HXY @ * E @ 41Y @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n?2,/\n3X/1HV +ÿ/HV2. *Cÿ.24 MIR8LRSL\n*A 456789:;<=> a-3/21H-? @ @ \\`Q DE @ XJ8L5 X5;: @ @ \x0e\x14\t\x0e)\t\x0c\n,X1/2 -ÿb22c PQP* T\n*ÿ@ÿPÿ@ÿ* *Cÿ.24 MIR8LRSL\n*d -3H3?XeH1 456789:;<=> eH1-? @ @ NQQ DE @ XJ8L5 /a?ÿ- X5;: @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nG-]ÿ\nY-/1H0V3W HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*\\ 456789:;<=> /?. @ @ PCQ D? @ 36IJ=IM6M> @ @ @ \x0e\x14\t\x0e)\t\x0c\n?X1HG M> PQP* T\n4H421-3H?H Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nPQ 456789:;<=> a-3/21H-? @ @ NB*A E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nYÿY-/1H0V -ÿG-] M> PQP* T\n/-fXa-3/- Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nP* 456789:;<=> a-3/21H-? @ @ QBC E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nVÿY-/1H0V -ÿG-] M> PQP* T\nG2U-V2/W 45LDLT=R;J=6 *+ÿ.24 MIR8LRSL *+ÿ.24\nPP -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W 45LDLT=R;J=6 *`ÿ.24 MIR8LRSL *`ÿ.24\nP+ -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W -TKL5>L *^31.^*N HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\nPN @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L P^31.^*` HIJ5;KLI6 *`ÿ.24 MIR8LRSL *`ÿ.24\nPC @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L N^2Y324W HIJ5;KLI6 *`ÿ.24 MIR8LRSL\nP` -.XY 2KLIJ @ @ -?X4-/W] *Q DE @ aHG @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n^*`ÿ.24']
apiLogger::2021-10-04 01:23:32,327::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-04 01:23:32,327::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 01:23:32,406::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 01:23:32,407::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 01:23:32,407::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmprz5tzign 
apiLogger::2021-10-04 01:23:32,408::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 01:23:32,408::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 01:23:32,420::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 01:23:32,420::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmprz5tzign
apiLogger::2021-10-04 01:23:32,546::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 01:23:32,546::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 01:23:32,546::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 01:23:32,546::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 01:23:32,550::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-04 01:23:32,550::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 01:23:32,550::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 01:23:32,551::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-04 01:23:32,551::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 04-Oct-2021 01:21:42 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : R1979-ONC-1625 Sponsor Notification: Site: 1625276001, Subject: 276001004; event:\nENCEPHALOPATHY- Initial\nFrom: SafetyPV <safetypv@syneoshealth.com> Sent: Friday, September 17, 2021 12:02 PM To:\nBarwick, Ashley <ashley.barwick@syneoshealth.com>; Ayesha Sabir\n<asra.sabir@regeneron.com>; Bertha Fearon-Chalet <bertha.fearonchalet@regeneron.com>;\nCarolina Leite de Oliveira <carolina.oliveira@regeneron.com>; chili.deng@zailaboratory.com;\nClaire Hearnden <claire.hearnden@regeneron.com>; Cristina Frias-External\n<cristina.frias@regeneron.com>; Pakendorf, Dee <deirdre.pakendorf1@syneoshealth.com>;\ndorothy.ogwuru@regeneron.com; De Mori, Giacomo <giacomo.demori@syneoshealth.com>;\nGuillermo Perez de Lema-External <guillermo.perezde@regeneron.com>; Scian, Joanna\n<joanna.scian@syneoshealth.com>; Juan Esquivel-External <juan.esquivel@regeneron.com>;\nKonopka, Katarzyna <katarzyna.konopka@syneoshealth.com>; Lakshmi Pulavarthi\n<lakshmi.pulavarthi@regeneron.com>; Lieve Adriaens <lieve.adriaens@regeneron.com>; Meyers,\nMark <mark.meyers@syneoshealth.com>; Regeneron Medical Safety\n<Medical.Safety@regeneron.com>; Melanie Ufkin <melanie.ufkin@regeneron.com>; Nickolas\nSophos <nickolas.sophos@regeneron.com>; Quasheeda Fields\n<quasheeda.fields@regeneron.com>; DL R1979-ONC-1625 Medical Team <R1979-ONC-\n1625MedicalTeam@regeneron.com>; SafetyPV <safetypv@syneoshealth.com>; Saleem Shariff\n<saleem.shariff@regeneron.com>; sharon.gao@zailaboratory.com; Srikanth Ambati\n<srikanth.ambati@regeneron.com>; Teresa Has <teresa.has@regeneron.com>; Tsimogianni,\nVeta <veta.tsimogianni@syneoshealth.com>; Tan, Wee Lin <weelin.tan@syneoshealth.com>\nSubject: <External> R1979-ONC-1625 Sponsor Notification: Site: 1625276001, Subject:\n276001004; event: ENCEPHALOPATHY- Initial \n \nEXTERNAL MESSAGE\n \n \nDear All, \n \nPlease note that Syneos Health received initial information regarding the following event. \n \nProtocol: R1979-ONC-1625\nDay 0: 17-SEP-2021\nCountry: Germany\nSite # /Investigator: 1625276001/Duell, Johannes\nSubject ID: 276001004\nStudy Drug(s): REGN1979\nEvent Term: ENCEPHALOPATHY\nOnset date: 16-SEP-2021 Severity/Grade: Grade 2\nSAE Criteria and/or AESI Criteria: Hospitalization/No\nInvestigator Relationship to Study Drug: Related\nInvestigator Relationship to Study Conduct: No\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2021-00130\n \n \nKind regards, \n \nAmy \n \nAmy Amazeen Safety &PV Specialist I, Drug Safety and Pharmacovigilance Syneos Health US\nRegional- Michigan Mobile  +1 734 265 6653 \namy.amazeen@syneoshealth.com \nsyneoshealth.com']
apiLogger::2021-10-04 01:23:32,551::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 01:23:32,551::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-04 01:23:32,551::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 01:23:32,551::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 01:23:32,551::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 01:23:34,145::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 01:23:34,145::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 01:23:34,212::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 01:23:34,214::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 01:23:34,214::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpyw6ta2bf 
apiLogger::2021-10-04 01:23:34,214::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 01:23:34,214::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 01:23:34,227::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 01:23:34,227::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpyw6ta2bf
apiLogger::2021-10-04 01:23:34,351::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 01:23:34,352::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 01:23:34,352::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 01:23:34,352::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 01:23:34,356::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-04 01:23:34,356::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 01:23:34,356::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 01:23:34,356::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-04 01:23:34,356::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 04-Oct-2021 01:22:34 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : R1979-ONC-1625 Sponsor Notification: Site: 1625276001, Subject: 276001005; event:\nENCEPHALOPATHY- Initial\nFrom: SafetyPV <safetypv@syneoshealth.com> Sent: Friday, September 17, 2021 12:02 PM To:\nBarwick, Ashley <ashley.barwick@syneoshealth.com>; Ayesha Sabir\n<asra.sabir@regeneron.com>; Bertha Fearon-Chalet <bertha.fearonchalet@regeneron.com>;\nCarolina Leite de Oliveira <carolina.oliveira@regeneron.com>; chili.deng@zailaboratory.com;\nClaire Hearnden <claire.hearnden@regeneron.com>; Cristina Frias-External\n<cristina.frias@regeneron.com>; Pakendorf, Dee <deirdre.pakendorf1@syneoshealth.com>;\ndorothy.ogwuru@regeneron.com; De Mori, Giacomo <giacomo.demori@syneoshealth.com>;\nGuillermo Perez de Lema-External <guillermo.perezde@regeneron.com>; Scian, Joanna\n<joanna.scian@syneoshealth.com>; Juan Esquivel-External <juan.esquivel@regeneron.com>;\nKonopka, Katarzyna <katarzyna.konopka@syneoshealth.com>; Lakshmi Pulavarthi\n<lakshmi.pulavarthi@regeneron.com>; Lieve Adriaens <lieve.adriaens@regeneron.com>; Meyers,\nMark <mark.meyers@syneoshealth.com>; Regeneron Medical Safety\n<Medical.Safety@regeneron.com>; Melanie Ufkin <melanie.ufkin@regeneron.com>; Nickolas\nSophos <nickolas.sophos@regeneron.com>; Quasheeda Fields\n<quasheeda.fields@regeneron.com>; DL R1979-ONC-1625 Medical Team <R1979-ONC-\n1625MedicalTeam@regeneron.com>; SafetyPV <safetypv@syneoshealth.com>; Saleem Shariff\n<saleem.shariff@regeneron.com>; sharon.gao@zailaboratory.com; Srikanth Ambati\n<srikanth.ambati@regeneron.com>; Teresa Has <teresa.has@regeneron.com>; Tsimogianni,\nVeta <veta.tsimogianni@syneoshealth.com>; Tan, Wee Lin <weelin.tan@syneoshealth.com>\nSubject: <External> R1979-ONC-1625 Sponsor Notification: Site: 1625276001, Subject:\n276001005; event: ENCEPHALOPATHY- Initial \n \nEXTERNAL MESSAGE\n \n \nDear All, \n \nPlease note that Syneos Health received initial information regarding the following event. \n \nProtocol: R1979-ONC-1625\nDay 0: 17-SEP-2021\nCountry: Germany\nSite # /Investigator: 1625276001/Duell, Johannes\nSubject ID: 276001005\nStudy Drug(s): REGN1979\nEvent Term: ENCEPHALOPATHY\nOnset date: 16-SEP-2021 Severity/Grade: Grade 2\nSAE Criteria and/or AESI Criteria: Hospitalization/No\nInvestigator Relationship to Study Drug: Related\nInvestigator Relationship to Study Conduct: No\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2021-00130\n \n \nKind regards, \n \nAmy \n \nAmy Amazeen Safety &PV Specialist I, Drug Safety and Pharmacovigilance Syneos Health US\nRegional- Michigan Mobile  +1 734 265 6653 \namy.amazeen@syneoshealth.com \nsyneoshealth.com']
apiLogger::2021-10-04 01:23:34,356::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 01:23:34,356::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-04 01:23:34,356::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 01:23:34,356::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 01:23:34,356::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 01:23:35,957::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 01:23:35,957::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 01:25:19,394::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 01:25:19,468::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 01:25:19,468::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqo_146lz 
apiLogger::2021-10-04 01:25:19,471::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 01:25:19,471::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 01:25:23,082::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 01:25:23,082::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqo_146lz
apiLogger::2021-10-04 01:25:25,802::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 01:25:25,802::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 01:25:25,802::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 01:25:25,802::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 01:25:25,806::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:25:25,806::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 01:25:25,806::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-04 01:25:25,806::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-04 01:25:25,810::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:25:25,810::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-04 01:25:25,810::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-04 01:25:25,810::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-04 01:25:25,813::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:25:25,813::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-04 01:25:25,813::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-04 01:25:25,813::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-04 01:25:25,817::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:25:25,817::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-04 01:25:25,817::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-04 01:25:25,817::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-04 01:25:25,821::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:25:25,821::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-04 01:25:25,821::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-04 01:25:25,821::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '\x00\x01\x02D\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x07\x08\t\n\x0b\x01 \x0c\r\x0e\x0f\x0e\x10\x11\x12\x13\x10\r\x14\x15\x16ÿ\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x12ÿ\x11\x1b\x1c\x12\x10\x1d\x1a\x1e\x1c\x1dÿ\x1f !"#ÿ \x11ÿ\x1a\x1f\x1f\x1c\x1f\x1fÿ $\x1cÿ\x1a\x12 %\x10 !&\x11\x0cÿ\x1a\x13 %\'% #ÿ\x1a\x12"\n\x1f\x1a(\x1c #ÿ\x11(ÿ\x0c\x1c)\x12\r\x0e\x0f\x0e*ÿ\x1a\x12ÿ\x1a\x12 %\x10\x13"\x15+ÿ,ÿ\x1a\x12 %\x10\x13"-ÿ\x1e%\x1f\x1b\x1c\x13%(%\x13\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x18\x19\x03\x05\x0b\n\x1a\x12 %\x1e\x11"#*ÿ%\x12ÿ\x1b\x1a %\x1c\x12 \x1fÿ.% $ÿ\x0c\x1c\x1d\x1a\x1b\x1f\x1c"ÿ\x11\x0cÿ\x0c\x1c(\x0c\x1a\x13 \x11\x0c#ÿ\x1e\x10\x13\x1c\x1d\x1d\n\x12\x11\x12\x10$\x11")/%\x12ÿ\x1d#&\x1b$\x11&\x1a\n\x1901\x0b0\x03\x192ÿ3\x0b4\x05\x035ÿ6\x03\x0878ÿ9\x027\x0b \r\x0f\x0c)\x1b\x10+++:\n9\x02\t;\x02\x0807 \x0c\x1c)\x12\r\x0e\x0f\x0e\n6\x08\nD\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n6\x19\x03\x0bÿ\x074\t\x0b \x15\x0f\x14++\rÿ\x10ÿ"<=>>ÿ\x10ÿ)=?@ABC\n6\x19\x03\x0bÿ\x07\x08\t\n\x0b\x01\n6\x08\nD\x0b\x04\x03ÿEFG\n6\x04\x01\x0b\x0b0\x190HÿF4\x03\x0b\n1625276001\n276001006\n02 SEP 2021 \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06ÿ\t\x16=ÿ?\x0c\r\x06\r\x05\r;ÿ\x12\n\x04\x16=\n\x04\x16\x06ÿ@\x0c\t\x05A\x10\x16\x13\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 :\t\x06\x04ÿ<\x01\x02\x03\x04\x05\x06ÿ<\x10\x13\x16\x04=\nF\x04\x0c\x04ÿ\x06\x11\x04\x0c\x04ÿ\t\x16\x17 :\t\x06\x04ÿ\x00\x01\x02\x03\x04\x05\x06ÿ\x00\x10\x13\x16\x04=\nC;\r\x02\t;ÿ?\x0c\r\x06\r\x05\r;ÿD ÿ\x12\n\x04\x16=\n\x04\x16\x06 ?\x0c\r\x06\r\x05\r;ÿ\x1a\x18\x0fÿ\x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04 \x1a>L \x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04ÿ\x0e\x0c\r\n ;\r\x05\t;ÿ\x1a\x16\x0e\r\x0c\n\x04=\nB ;\r\x05\t; \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 >\r\x16<\x04\x16\x06ÿ@\x17\x1d\x04\n\x12\n\x04\x16=\n\x04\x16\x06ÿE\x04\x0c<\x10\r\x16 E\x04\x0c<\x10\r\x16ÿHI\r\x05\t;Jÿ H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J E\x04\x0c<\x10\r\x16 \x15>M\x1a\x18\x0fÿH==\x1c\n\r\x16\x1c >\r\x16<\x04\x16\x06ÿH==\x1c\n\r\x16\x1c\n\t\n\x04\x16=\n\x04\x16\x06<G H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J\n\x17\x17\x17\x17J \x17\x17\x17\x17J\x19ÿ\x10\x0eÿ\t\x1d\x1d;\x10\x05\t\x02;\x04\nN"$\x1f$9O+P9" \x1e&\n" "$ÿQWUÿ\x1e!\x1e" \'(03ÿ4,31*3- "#ÿ\'QXÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V()\nN"$\x1f$9O+P9" \x1e& U*3,R041ÿYZV9Y-ZS[\n\x1e "$ÿQWUÿ\x1e!\x1e" ""ÿ\\]^ÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V() 4,31*3-\n:\x04\n\r\x13\x0c\t\x1d\x11\x17ÿ:\x04\x06\t\x10;<\n\x18\t\x05\x04\x19ÿ\x1a\x0eÿ\x1b\x06\x11\x04\x0c\x1c\n\x00\x01\x02\x03\x04\x05\x06ÿ\x08\t\n\x04 \x0b\x04\t\x0cÿ\r\x0eÿ\x0f\x10\x0c\x06\x11 \x12\x13\x04 \x00\x04\x14 \x15\x06\x11\x16\x10\x05\x10\x06\x17 \x18\t\x05\x04\n+,-ÿ/012(304 \x00\x1d\x04\x05\x10\x0e\x17\n\x1e\x1f !!"!!# "$#  %& \'()* 780-* 9\n,5ÿ6(-03,\n:\x10<\x04\t<\x04\x1c\x00\x1d\x04\x05\x10\x0e\x10\x05ÿ>\r\x11\r\x0c\x06\n:\x10<\x04\t<\x04ÿ<\x1d\x04\x05\x10\x0e\x10\x05ÿ\x05\r\x11\r\x0c\x06M\x13\x0c\r\x01\x1dÿH\x10\x16\x06\x04\x13\x0c\t\x06\x04=J _6^P6ÿY*)*4-*SÿN*`0R*3 \x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0e\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x19\x06\x0b\x02\n#\x1eÿ\x0c\x11\x12\x0c\x04\x11\x12\n\x18\x0b\x06\r\x0bÿ\x19\x06\x0b\x02 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r \r\x02\n\x0c\x07(\x02\x03 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r\n\x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0eÿ\x0f\x10\x04\x11\x03\x04\x11\x12 !\x11\x12\x0c\x04\x11\x12ÿ\x06\x0b \n$\x02\x05\x04\x1e\x0e\n\x00 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x1f\x11\x1d\x11\x0c \x11ÿ\n\x0b\x06\r\x0b \x13&\x11\x03ÿ\x03\x06\x0b\x02\x17 \x1f\x11\x1d\x11\x0c \x11ÿ\x02\x11\x03\n\x13\x14\x15\x11\x0c\r\x16\x06\x07\x04\x0b\x0e\x17 \n\x0b\x1f\x03\x0eÿ\x02\x11\x0b\r\x0e" \x1b%\x1b\x14&\n\x0e\x0e\x0e\x0e\x17 \x03\x06\x0b\x02 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x03\x06\x0b\x02\n\'\r\x06\x03\x02\n\x0e\x0e\x0e\x0e\x17\n) *+,-./.0ÿ2.33+/40ÿ/56ÿ++ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nG7H7I,H5ÿJ.,H/\nF \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n*+0.,0.\nK ,/H+,3ÿL+-H+33,/+7I \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nM 0+<2,*+N.H/+G4370+0 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nO G,H*+,3ÿ+I04LL+G+.IG5ÿ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\nP ,G.ÿ+IJ+-+/7Hÿ,33.H<5 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nQ J+6ÿH.63.,0.2.I/ÿH+<J/ 4Iÿ,6HÿFR)M B8CD@CE@? H@S:TU@? A 4Iÿ,6HÿFR)M B8CD@CE@?\nV J+6ÿH.63.,0.2.I/ÿ3.L/ 4IÿW4IÿFR)P B8CD@CE@? H@S:TU@? A 4IÿW4IÿFR)P B8CD@CE@?\n3.Lÿ-4I*3.ÿ-H.IGJ\nX \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n-37GY\n)R 6H70/,/,J56.H63,0+. \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)) <</ÿ+IGH.,0.* )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n)F ,I.2+,ÿ )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n63,/.3./ÿG74I*\n)K )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n*.GH.,0.*\n)M +<ÿ<ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)O +<ÿ,ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)P +<ÿ2ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n<34/.,3ÿH.<+7Iÿ3.L/\n)Q \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\n6,+I \x00\x01\x02\x03\x01\x04\x05\x06\x07\x02\x06ÿ\t\n\x0b\x05\x03\x07\x06\x05\x01\x02\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x12\x13 \x12\x13\n\x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02\n\x05\x1aÿ\x04\n\x0b\x05\x03\x07\x18 \x05\x1aÿ\x07\x0b\x1f\n\x0e\x1a\n\n\x12\x13 \x16\x05\x1a\x06\x01\x0e\x17\x1c \n\x1f\n\x02\x06\x1c\n%\x06\x07\x0e\x06ÿ\x0b\x07\x06\n %\x06\x01\x15ÿ\x0b\x07\x06\n\n\x14\x0e\x01\x15\x16\x17\x18\x07\x19\x05\x1a \x14\x18\n\x07\x1a\n \x14\x18\n\x07\x1a\n \r\x01\x1a\n \x1b\x06\x16\n\x0e\x1c \x12\x13ÿ\x1b\x06\x16\n\x0e \x12\x13ÿ\x1b\x06\x16\n\x0e\x1c %\x06\x07\x0e\x06\n\x0c \r\x0e\x0f\x10ÿ\x11\x07\x04\n \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \r\x01\x1a\n #\x0e\n$\x0f\n\x02\x03\x17 &\x01\x0f\x06\n \'\x0b\x0b(\x04\x01\x02( \'\x0b\x0b(\x04\x01\x02( \x1b\x02\x10\x01\x05\x02\x10\n\x1b\x0eÿ\x1b\x06\x16\n\x0e\x1c \x1a\n\x18\n\x03\x06ÿ\x06\x16\n \x1a\n\x18\n\x03\x06ÿ\x06\x16\n "\x02\x05\x06 \x1a\x15\n\x03\x05\x13\x17 %\x15\n\x03\x05\x13\x17 \x1a\x15\n\x03\x05\x13\x17 \r\x07\x06\nÿ"\x02*\n\x17\x17\x17\x17) \x17\x17\x17\x17)\n\x1a\x15\n\x03\x05\x13\x17 \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n\n\t\n\x0b\x05\x03\x07\x18  \x0b\x1f\n\x0e\x1a\n\n\x1d\x05\x1a\x06\x01\x0e\x17 !\x1f\n\x02\x06\n\x0e\n\x03\x01\x0e\x0b\x1e \x0e\n\x03\x01\x0e\x0b\x1e\n@AB30C5A 2LMNLG<O FPÿ2A5 LON9HNSH FUÿ2A5\n+ ,-./0123-4 56789:;<=>? D D EFF CG9H6 I/ JK D D LON9HNSHT\n@-1 H7L? RFR+ T RFR+\n4HT>N<; WXY10K-1.\nR 3C012A4-K V>?G76: D -@2B,,-Y-A D +F \\] D ^-K D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n25-0C.C@1 4HT>N<; WXY10K-1.\nE Y3C@ V>?G76: D -@2B,,-Y-A D RW \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n3142B.C2- 4HT>N<; +FX50C23\n_ @ V>?G76: D 131VZ5A0 D F`_ \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n5.12-AXB@\n145VC4C0\nW 56789:;<=>? 4B[C2-3-2 D D +FF \\]a\\. D J>T D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@1.\n51@3C501 23C41YV\nb cC. 56789:;<=>? 50C3AY3-C D D _F \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@\n4HT>N<; EX130-1. 2LMNLG<O\nP A@Cd150-@ V>?G76: D ,-^0-..13- D UFF CG9H6 -A ^-K D H7L? D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@XB@[\n@Ce14-@2 4HT>N<; +PX/.B3A B@ÿ1B/ LON9HNSH\nU B.,C@ V>?G76: D 1.ÿ0A/-C@ D WFF \\] D 50@ D C6<; D RFR+ T D \x03\x16\n\x03*\n\x0b\n.A,3\nKAd14A3V 1TgH6?H +XY02X+_ -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\nf D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\nKAd14A3V 1TgH6?H RXY02X+b -OG6<gHO7 +bÿ2A5 LON9HNSH +bÿ2A5\n+F D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\n5101YA31 56H\\HT>N<G>7 +_ÿ2A5 LON9HNSH +Wÿ2A5\n++ 4C. Oÿh76 D D D + ] D JK D C6<; D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf\n56H\\HT>N<G>7 -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\n+R 31eA/-. Oÿh76 D D D R \\] D JK D L? D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf \n\x11 \n\x11\n\n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b\n\r\x18ÿ\x08\t\x0c\r\x0e\x07\x16 \r\x18ÿ\x07\x0c\x1e\t\x02\x18\t\n\n\x11 \x14\r\x18\x0f\x10\x02\x15\x1a \t\x1e\t\x0b\x0f\x1a\nREG-2021-00130 GSPV RECEIPT DATE 1$7\x0f\x07S\x02E\x0fÿ\x0cP\x072\x0f\t021 AKA 25 pages$\x0f\x10\x13ÿ\x0c\x07\x0f\t\n\x12\x02\x10\x13\x14\x15\x16\x07\x17\r\x18 \x12\x16\t\x07\x18\t \x12\x16\t\x07\x18\t \x01\x10\x18\t \x19\x0f\x14\t\x02\x1a \n\x11ÿ\x19\x0f\x14\t\x02 \n\x11ÿ\x19\x0f\x14\t\x02\x1a $\x0f\x07\x02\x0f\n\x00 \x01\x02\x03\x04ÿ\x06\x07\x08\t \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \x01\x10\x18\t "\x02\t#\x03\t\x0b\x0e\x15 %\x10\x03\x0f\t &\x0c\x0c\'\x08\x10\x0b\' &\x0c\x0c\'\x08\x10\x0b\' \x19\x0b\x04\x10\r\x0b\x04\n\x19\x02ÿ\x19\x0f\x14\t\x02\x1a \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t !\x0b\r\x0f \x18\x13\t\x0e\r\x11\x15 $\x13\t\x0e\r\x11\x15 \x18\x13\t\x0e\r\x11\x15 \x01\x07\x0f\tÿ!\x0b)\n\x15\x15\x15\x15( \x15\x15\x15\x15(\n\x18\x13\t\x0e\r\x11\x15 \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t\n\x1b\t\x0c\r\x0e\x07\x16 \x1f\x0c\x1e\t\x02\x18\t\n\x1c\r\x18\x0f\x10\x02\x15  \x1e\t\x0b\x0f\n\x02\t\x0e\x10\x02\x0c\x1d \x02\t\x0e\x10\x02\x0c\x1d\nHIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\n*+ ,-./01/23 456789:;<=> /?. @ @ ABC DE @ FG @ @ MIR8LRSLT\nM> PQP* T PQP*\nG2U-V2/W 45LDLT=R;J=6 HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Cÿ.24\n*N -.XY IÿZ65 @ @ @ PQ DE @ FG @ M> @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nW]G1XVX1 VLT=R;: *A^[?0/2 .M_RMJ;I *Nÿ.24 MIR8LRSL\n*C 4WXY W=>J659 @ -?ÿ12[HXY @ * DE @ 41Y @ L6M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nW]G1X3W? ?2,/\n4-1-32/- VLT=R;: *A^[?0/2 HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*` VX? W=>J659 @ -?ÿ12[HXY @ * E @ 41Y @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n?2,/\n3X/1HV +ÿ/HV2. *Cÿ.24 MIR8LRSL\n*A 456789:;<=> a-3/21H-? @ @ \\`Q DE @ XJ8L5 X5;: @ @ \x0e\x14\t\x0e)\t\x0c\n,X1/2 -ÿb22c PQP* T\n*ÿ@ÿPÿ@ÿ* *Cÿ.24 MIR8LRSL\n*d -3H3?XeH1 456789:;<=> eH1-? @ @ NQQ DE @ XJ8L5 /a?ÿ- X5;: @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nG-]ÿ\nY-/1H0V3W HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*\\ 456789:;<=> /?. @ @ PCQ D? @ 36IJ=IM6M> @ @ @ \x0e\x14\t\x0e)\t\x0c\n?X1HG M> PQP* T\n4H421-3H?H Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nPQ 456789:;<=> a-3/21H-? @ @ NB*A E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nYÿY-/1H0V -ÿG-] M> PQP* T\n/-fXa-3/- Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nP* 456789:;<=> a-3/21H-? @ @ QBC E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nVÿY-/1H0V -ÿG-] M> PQP* T\nG2U-V2/W 45LDLT=R;J=6 *+ÿ.24 MIR8LRSL *+ÿ.24\nPP -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W 45LDLT=R;J=6 *`ÿ.24 MIR8LRSL *`ÿ.24\nP+ -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W -TKL5>L *^31.^*N HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\nPN @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L P^31.^*` HIJ5;KLI6 *`ÿ.24 MIR8LRSL *`ÿ.24\nPC @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L N^2Y324W HIJ5;KLI6 *`ÿ.24 MIR8LRSL\nP` -.XY 2KLIJ @ @ -?X4-/W] *Q DE @ aHG @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n^*`ÿ.24']
apiLogger::2021-10-04 01:25:25,821::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-04 01:25:25,821::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 01:25:25,899::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 01:25:25,965::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 01:25:25,965::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_72433je 
apiLogger::2021-10-04 01:25:25,967::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 01:25:25,967::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 01:25:28,268::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 01:25:28,268::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_72433je
apiLogger::2021-10-04 01:25:30,904::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 01:25:30,904::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 01:25:30,904::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 01:25:30,904::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 01:25:30,908::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:25:30,908::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 01:25:30,908::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-04 01:25:30,908::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-04 01:25:30,911::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:25:30,911::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-04 01:25:30,911::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-04 01:25:30,911::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-04 01:25:30,915::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:25:30,915::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-04 01:25:30,915::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-04 01:25:30,915::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-04 01:25:30,918::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:25:30,919::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-04 01:25:30,919::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-04 01:25:30,919::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-04 01:25:30,922::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 01:25:30,922::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-04 01:25:30,922::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-04 01:25:30,922::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '\x00\x01\x02D\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x07\x08\t\n\x0b\x01 \x0c\r\x0e\x0f\x0e\x10\x11\x12\x13\x10\r\x14\x15\x16ÿ\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x12ÿ\x11\x1b\x1c\x12\x10\x1d\x1a\x1e\x1c\x1dÿ\x1f !"#ÿ \x11ÿ\x1a\x1f\x1f\x1c\x1f\x1fÿ $\x1cÿ\x1a\x12 %\x10 !&\x11\x0cÿ\x1a\x13 %\'% #ÿ\x1a\x12"\n\x1f\x1a(\x1c #ÿ\x11(ÿ\x0c\x1c)\x12\r\x0e\x0f\x0e*ÿ\x1a\x12ÿ\x1a\x12 %\x10\x13"\x15+ÿ,ÿ\x1a\x12 %\x10\x13"-ÿ\x1e%\x1f\x1b\x1c\x13%(%\x13\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x18\x19\x03\x05\x0b\n\x1a\x12 %\x1e\x11"#*ÿ%\x12ÿ\x1b\x1a %\x1c\x12 \x1fÿ.% $ÿ\x0c\x1c\x1d\x1a\x1b\x1f\x1c"ÿ\x11\x0cÿ\x0c\x1c(\x0c\x1a\x13 \x11\x0c#ÿ\x1e\x10\x13\x1c\x1d\x1d\n\x12\x11\x12\x10$\x11")/%\x12ÿ\x1d#&\x1b$\x11&\x1a\n\x1901\x0b0\x03\x192ÿ3\x0b4\x05\x035ÿ6\x03\x0878ÿ9\x027\x0b \r\x0f\x0c)\x1b\x10+++:\n9\x02\t;\x02\x0807 \x0c\x1c)\x12\r\x0e\x0f\x0e\n6\x08\nD\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n6\x19\x03\x0bÿ\x074\t\x0b \x15\x0f\x14++\rÿ\x10ÿ"<=>>ÿ\x10ÿ)=?@ABC\n6\x19\x03\x0bÿ\x07\x08\t\n\x0b\x01\n6\x08\nD\x0b\x04\x03ÿEFG\n6\x04\x01\x0b\x0b0\x190HÿF4\x03\x0b\n1625276001\n276001006\n02 SEP 2021 \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06ÿ\t\x16=ÿ?\x0c\r\x06\r\x05\r;ÿ\x12\n\x04\x16=\n\x04\x16\x06ÿ@\x0c\t\x05A\x10\x16\x13\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 :\t\x06\x04ÿ<\x01\x02\x03\x04\x05\x06ÿ<\x10\x13\x16\x04=\nF\x04\x0c\x04ÿ\x06\x11\x04\x0c\x04ÿ\t\x16\x17 :\t\x06\x04ÿ\x00\x01\x02\x03\x04\x05\x06ÿ\x00\x10\x13\x16\x04=\nC;\r\x02\t;ÿ?\x0c\r\x06\r\x05\r;ÿD ÿ\x12\n\x04\x16=\n\x04\x16\x06 ?\x0c\r\x06\r\x05\r;ÿ\x1a\x18\x0fÿ\x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04 \x1a>L \x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04ÿ\x0e\x0c\r\n ;\r\x05\t;ÿ\x1a\x16\x0e\r\x0c\n\x04=\nB ;\r\x05\t; \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 >\r\x16<\x04\x16\x06ÿ@\x17\x1d\x04\n\x12\n\x04\x16=\n\x04\x16\x06ÿE\x04\x0c<\x10\r\x16 E\x04\x0c<\x10\r\x16ÿHI\r\x05\t;Jÿ H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J E\x04\x0c<\x10\r\x16 \x15>M\x1a\x18\x0fÿH==\x1c\n\r\x16\x1c >\r\x16<\x04\x16\x06ÿH==\x1c\n\r\x16\x1c\n\t\n\x04\x16=\n\x04\x16\x06<G H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J\n\x17\x17\x17\x17J \x17\x17\x17\x17J\x19ÿ\x10\x0eÿ\t\x1d\x1d;\x10\x05\t\x02;\x04\nN"$\x1f$9O+P9" \x1e&\n" "$ÿQWUÿ\x1e!\x1e" \'(03ÿ4,31*3- "#ÿ\'QXÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V()\nN"$\x1f$9O+P9" \x1e& U*3,R041ÿYZV9Y-ZS[\n\x1e "$ÿQWUÿ\x1e!\x1e" ""ÿ\\]^ÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V() 4,31*3-\n:\x04\n\r\x13\x0c\t\x1d\x11\x17ÿ:\x04\x06\t\x10;<\n\x18\t\x05\x04\x19ÿ\x1a\x0eÿ\x1b\x06\x11\x04\x0c\x1c\n\x00\x01\x02\x03\x04\x05\x06ÿ\x08\t\n\x04 \x0b\x04\t\x0cÿ\r\x0eÿ\x0f\x10\x0c\x06\x11 \x12\x13\x04 \x00\x04\x14 \x15\x06\x11\x16\x10\x05\x10\x06\x17 \x18\t\x05\x04\n+,-ÿ/012(304 \x00\x1d\x04\x05\x10\x0e\x17\n\x1e\x1f !!"!!# "$#  %& \'()* 780-* 9\n,5ÿ6(-03,\n:\x10<\x04\t<\x04\x1c\x00\x1d\x04\x05\x10\x0e\x10\x05ÿ>\r\x11\r\x0c\x06\n:\x10<\x04\t<\x04ÿ<\x1d\x04\x05\x10\x0e\x10\x05ÿ\x05\r\x11\r\x0c\x06M\x13\x0c\r\x01\x1dÿH\x10\x16\x06\x04\x13\x0c\t\x06\x04=J _6^P6ÿY*)*4-*SÿN*`0R*3 \x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0e\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x19\x06\x0b\x02\n#\x1eÿ\x0c\x11\x12\x0c\x04\x11\x12\n\x18\x0b\x06\r\x0bÿ\x19\x06\x0b\x02 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r \r\x02\n\x0c\x07(\x02\x03 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r\n\x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0eÿ\x0f\x10\x04\x11\x03\x04\x11\x12 !\x11\x12\x0c\x04\x11\x12ÿ\x06\x0b \n$\x02\x05\x04\x1e\x0e\n\x00 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x1f\x11\x1d\x11\x0c \x11ÿ\n\x0b\x06\r\x0b \x13&\x11\x03ÿ\x03\x06\x0b\x02\x17 \x1f\x11\x1d\x11\x0c \x11ÿ\x02\x11\x03\n\x13\x14\x15\x11\x0c\r\x16\x06\x07\x04\x0b\x0e\x17 \n\x0b\x1f\x03\x0eÿ\x02\x11\x0b\r\x0e" \x1b%\x1b\x14&\n\x0e\x0e\x0e\x0e\x17 \x03\x06\x0b\x02 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x03\x06\x0b\x02\n\'\r\x06\x03\x02\n\x0e\x0e\x0e\x0e\x17\n) *+,-./.0ÿ2.33+/40ÿ/56ÿ++ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nG7H7I,H5ÿJ.,H/\nF \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n*+0.,0.\nK ,/H+,3ÿL+-H+33,/+7I \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nM 0+<2,*+N.H/+G4370+0 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nO G,H*+,3ÿ+I04LL+G+.IG5ÿ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\nP ,G.ÿ+IJ+-+/7Hÿ,33.H<5 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nQ J+6ÿH.63.,0.2.I/ÿH+<J/ 4Iÿ,6HÿFR)M B8CD@CE@? H@S:TU@? A 4Iÿ,6HÿFR)M B8CD@CE@?\nV J+6ÿH.63.,0.2.I/ÿ3.L/ 4IÿW4IÿFR)P B8CD@CE@? H@S:TU@? A 4IÿW4IÿFR)P B8CD@CE@?\n3.Lÿ-4I*3.ÿ-H.IGJ\nX \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n-37GY\n)R 6H70/,/,J56.H63,0+. \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)) <</ÿ+IGH.,0.* )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n)F ,I.2+,ÿ )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n63,/.3./ÿG74I*\n)K )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n*.GH.,0.*\n)M +<ÿ<ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)O +<ÿ,ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)P +<ÿ2ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n<34/.,3ÿH.<+7Iÿ3.L/\n)Q \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\n6,+I \x00\x01\x02\x03\x01\x04\x05\x06\x07\x02\x06ÿ\t\n\x0b\x05\x03\x07\x06\x05\x01\x02\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x12\x13 \x12\x13\n\x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02\n\x05\x1aÿ\x04\n\x0b\x05\x03\x07\x18 \x05\x1aÿ\x07\x0b\x1f\n\x0e\x1a\n\n\x12\x13 \x16\x05\x1a\x06\x01\x0e\x17\x1c \n\x1f\n\x02\x06\x1c\n%\x06\x07\x0e\x06ÿ\x0b\x07\x06\n %\x06\x01\x15ÿ\x0b\x07\x06\n\n\x14\x0e\x01\x15\x16\x17\x18\x07\x19\x05\x1a \x14\x18\n\x07\x1a\n \x14\x18\n\x07\x1a\n \r\x01\x1a\n \x1b\x06\x16\n\x0e\x1c \x12\x13ÿ\x1b\x06\x16\n\x0e \x12\x13ÿ\x1b\x06\x16\n\x0e\x1c %\x06\x07\x0e\x06\n\x0c \r\x0e\x0f\x10ÿ\x11\x07\x04\n \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \r\x01\x1a\n #\x0e\n$\x0f\n\x02\x03\x17 &\x01\x0f\x06\n \'\x0b\x0b(\x04\x01\x02( \'\x0b\x0b(\x04\x01\x02( \x1b\x02\x10\x01\x05\x02\x10\n\x1b\x0eÿ\x1b\x06\x16\n\x0e\x1c \x1a\n\x18\n\x03\x06ÿ\x06\x16\n \x1a\n\x18\n\x03\x06ÿ\x06\x16\n "\x02\x05\x06 \x1a\x15\n\x03\x05\x13\x17 %\x15\n\x03\x05\x13\x17 \x1a\x15\n\x03\x05\x13\x17 \r\x07\x06\nÿ"\x02*\n\x17\x17\x17\x17) \x17\x17\x17\x17)\n\x1a\x15\n\x03\x05\x13\x17 \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n\n\t\n\x0b\x05\x03\x07\x18  \x0b\x1f\n\x0e\x1a\n\n\x1d\x05\x1a\x06\x01\x0e\x17 !\x1f\n\x02\x06\n\x0e\n\x03\x01\x0e\x0b\x1e \x0e\n\x03\x01\x0e\x0b\x1e\n@AB30C5A 2LMNLG<O FPÿ2A5 LON9HNSH FUÿ2A5\n+ ,-./0123-4 56789:;<=>? D D EFF CG9H6 I/ JK D D LON9HNSHT\n@-1 H7L? RFR+ T RFR+\n4HT>N<; WXY10K-1.\nR 3C012A4-K V>?G76: D -@2B,,-Y-A D +F \\] D ^-K D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n25-0C.C@1 4HT>N<; WXY10K-1.\nE Y3C@ V>?G76: D -@2B,,-Y-A D RW \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n3142B.C2- 4HT>N<; +FX50C23\n_ @ V>?G76: D 131VZ5A0 D F`_ \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n5.12-AXB@\n145VC4C0\nW 56789:;<=>? 4B[C2-3-2 D D +FF \\]a\\. D J>T D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@1.\n51@3C501 23C41YV\nb cC. 56789:;<=>? 50C3AY3-C D D _F \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@\n4HT>N<; EX130-1. 2LMNLG<O\nP A@Cd150-@ V>?G76: D ,-^0-..13- D UFF CG9H6 -A ^-K D H7L? D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@XB@[\n@Ce14-@2 4HT>N<; +PX/.B3A B@ÿ1B/ LON9HNSH\nU B.,C@ V>?G76: D 1.ÿ0A/-C@ D WFF \\] D 50@ D C6<; D RFR+ T D \x03\x16\n\x03*\n\x0b\n.A,3\nKAd14A3V 1TgH6?H +XY02X+_ -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\nf D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\nKAd14A3V 1TgH6?H RXY02X+b -OG6<gHO7 +bÿ2A5 LON9HNSH +bÿ2A5\n+F D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\n5101YA31 56H\\HT>N<G>7 +_ÿ2A5 LON9HNSH +Wÿ2A5\n++ 4C. Oÿh76 D D D + ] D JK D C6<; D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf\n56H\\HT>N<G>7 -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\n+R 31eA/-. Oÿh76 D D D R \\] D JK D L? D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf \n\x11 \n\x11\n\n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b\n\r\x18ÿ\x08\t\x0c\r\x0e\x07\x16 \r\x18ÿ\x07\x0c\x1e\t\x02\x18\t\n\n\x11 \x14\r\x18\x0f\x10\x02\x15\x1a \t\x1e\t\x0b\x0f\x1a\nREG-2021-00130 GSPV RECEIPT DATE 1$7\x0f\x07S\x02E\x0fÿ\x0cP\x072\x0f\t021 AKA 25 pages$\x0f\x10\x13ÿ\x0c\x07\x0f\t\n\x12\x02\x10\x13\x14\x15\x16\x07\x17\r\x18 \x12\x16\t\x07\x18\t \x12\x16\t\x07\x18\t \x01\x10\x18\t \x19\x0f\x14\t\x02\x1a \n\x11ÿ\x19\x0f\x14\t\x02 \n\x11ÿ\x19\x0f\x14\t\x02\x1a $\x0f\x07\x02\x0f\n\x00 \x01\x02\x03\x04ÿ\x06\x07\x08\t \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \x01\x10\x18\t "\x02\t#\x03\t\x0b\x0e\x15 %\x10\x03\x0f\t &\x0c\x0c\'\x08\x10\x0b\' &\x0c\x0c\'\x08\x10\x0b\' \x19\x0b\x04\x10\r\x0b\x04\n\x19\x02ÿ\x19\x0f\x14\t\x02\x1a \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t !\x0b\r\x0f \x18\x13\t\x0e\r\x11\x15 $\x13\t\x0e\r\x11\x15 \x18\x13\t\x0e\r\x11\x15 \x01\x07\x0f\tÿ!\x0b)\n\x15\x15\x15\x15( \x15\x15\x15\x15(\n\x18\x13\t\x0e\r\x11\x15 \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t\n\x1b\t\x0c\r\x0e\x07\x16 \x1f\x0c\x1e\t\x02\x18\t\n\x1c\r\x18\x0f\x10\x02\x15  \x1e\t\x0b\x0f\n\x02\t\x0e\x10\x02\x0c\x1d \x02\t\x0e\x10\x02\x0c\x1d\nHIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\n*+ ,-./01/23 456789:;<=> /?. @ @ ABC DE @ FG @ @ MIR8LRSLT\nM> PQP* T PQP*\nG2U-V2/W 45LDLT=R;J=6 HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Cÿ.24\n*N -.XY IÿZ65 @ @ @ PQ DE @ FG @ M> @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nW]G1XVX1 VLT=R;: *A^[?0/2 .M_RMJ;I *Nÿ.24 MIR8LRSL\n*C 4WXY W=>J659 @ -?ÿ12[HXY @ * DE @ 41Y @ L6M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nW]G1X3W? ?2,/\n4-1-32/- VLT=R;: *A^[?0/2 HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*` VX? W=>J659 @ -?ÿ12[HXY @ * E @ 41Y @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n?2,/\n3X/1HV +ÿ/HV2. *Cÿ.24 MIR8LRSL\n*A 456789:;<=> a-3/21H-? @ @ \\`Q DE @ XJ8L5 X5;: @ @ \x0e\x14\t\x0e)\t\x0c\n,X1/2 -ÿb22c PQP* T\n*ÿ@ÿPÿ@ÿ* *Cÿ.24 MIR8LRSL\n*d -3H3?XeH1 456789:;<=> eH1-? @ @ NQQ DE @ XJ8L5 /a?ÿ- X5;: @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nG-]ÿ\nY-/1H0V3W HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*\\ 456789:;<=> /?. @ @ PCQ D? @ 36IJ=IM6M> @ @ @ \x0e\x14\t\x0e)\t\x0c\n?X1HG M> PQP* T\n4H421-3H?H Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nPQ 456789:;<=> a-3/21H-? @ @ NB*A E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nYÿY-/1H0V -ÿG-] M> PQP* T\n/-fXa-3/- Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nP* 456789:;<=> a-3/21H-? @ @ QBC E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nVÿY-/1H0V -ÿG-] M> PQP* T\nG2U-V2/W 45LDLT=R;J=6 *+ÿ.24 MIR8LRSL *+ÿ.24\nPP -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W 45LDLT=R;J=6 *`ÿ.24 MIR8LRSL *`ÿ.24\nP+ -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W -TKL5>L *^31.^*N HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\nPN @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L P^31.^*` HIJ5;KLI6 *`ÿ.24 MIR8LRSL *`ÿ.24\nPC @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L N^2Y324W HIJ5;KLI6 *`ÿ.24 MIR8LRSL\nP` -.XY 2KLIJ @ @ -?X4-/W] *Q DE @ aHG @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n^*`ÿ.24']
apiLogger::2021-10-04 01:25:30,923::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-04 01:25:30,923::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 01:25:31,000::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 01:25:31,002::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 01:25:31,002::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpp6snoqd1 
apiLogger::2021-10-04 01:25:31,002::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 01:25:31,002::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 01:25:31,015::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 01:25:31,015::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpp6snoqd1
apiLogger::2021-10-04 01:25:31,140::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 01:25:31,140::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 01:25:31,140::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 01:25:31,140::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 01:25:31,145::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-04 01:25:31,145::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 01:25:31,145::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 01:25:31,145::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-04 01:25:31,145::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 04-Oct-2021 01:23:29 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : R1979-ONC-1625 Sponsor Notification: Site: 1625276001, Subject: 276001006; event:\nENCEPHALOPATHY- Initial\nFrom: SafetyPV <safetypv@syneoshealth.com> Sent: Friday, September 17, 2021 12:02 PM To:\nBarwick, Ashley <ashley.barwick@syneoshealth.com>; Ayesha Sabir\n<asra.sabir@regeneron.com>; Bertha Fearon-Chalet <bertha.fearonchalet@regeneron.com>;\nCarolina Leite de Oliveira <carolina.oliveira@regeneron.com>; chili.deng@zailaboratory.com;\nClaire Hearnden <claire.hearnden@regeneron.com>; Cristina Frias-External\n<cristina.frias@regeneron.com>; Pakendorf, Dee <deirdre.pakendorf1@syneoshealth.com>;\ndorothy.ogwuru@regeneron.com; De Mori, Giacomo <giacomo.demori@syneoshealth.com>;\nGuillermo Perez de Lema-External <guillermo.perezde@regeneron.com>; Scian, Joanna\n<joanna.scian@syneoshealth.com>; Juan Esquivel-External <juan.esquivel@regeneron.com>;\nKonopka, Katarzyna <katarzyna.konopka@syneoshealth.com>; Lakshmi Pulavarthi\n<lakshmi.pulavarthi@regeneron.com>; Lieve Adriaens <lieve.adriaens@regeneron.com>; Meyers,\nMark <mark.meyers@syneoshealth.com>; Regeneron Medical Safety\n<Medical.Safety@regeneron.com>; Melanie Ufkin <melanie.ufkin@regeneron.com>; Nickolas\nSophos <nickolas.sophos@regeneron.com>; Quasheeda Fields\n<quasheeda.fields@regeneron.com>; DL R1979-ONC-1625 Medical Team <R1979-ONC-\n1625MedicalTeam@regeneron.com>; SafetyPV <safetypv@syneoshealth.com>; Saleem Shariff\n<saleem.shariff@regeneron.com>; sharon.gao@zailaboratory.com; Srikanth Ambati\n<srikanth.ambati@regeneron.com>; Teresa Has <teresa.has@regeneron.com>; Tsimogianni,\nVeta <veta.tsimogianni@syneoshealth.com>; Tan, Wee Lin <weelin.tan@syneoshealth.com>\nSubject: <External> R1979-ONC-1625 Sponsor Notification: Site: 1625276001, Subject:\n276001006; event: ENCEPHALOPATHY- Initial \n \nEXTERNAL MESSAGE\n \n \nDear All, \n \nPlease note that Syneos Health received initial information regarding the following event. \n \nProtocol: R1979-ONC-1625\nDay 0: 17-SEP-2021\nCountry: Germany\nSite # /Investigator: 1625276001/Duell, Johannes\nSubject ID: 276001006\nStudy Drug(s): REGN1979\nEvent Term: ENCEPHALOPATHY\nOnset date: 16-SEP-2021 Severity/Grade: Grade 2\nSAE Criteria and/or AESI Criteria: Hospitalization/No\nInvestigator Relationship to Study Drug: Related\nInvestigator Relationship to Study Conduct: No\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2021-00130\n \n \nKind regards, \n \nAmy \n \nAmy Amazeen Safety &PV Specialist I, Drug Safety and Pharmacovigilance Syneos Health US\nRegional- Michigan Mobile  +1 734 265 6653 \namy.amazeen@syneoshealth.com \nsyneoshealth.com']
apiLogger::2021-10-04 01:25:31,145::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 01:25:31,145::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-04 01:25:31,145::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 01:25:31,145::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 01:25:31,145::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 01:25:32,898::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 01:25:32,899::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 01:25:32,966::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 01:25:32,967::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 01:25:32,968::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpogz3v8lg 
apiLogger::2021-10-04 01:25:32,968::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 01:25:32,968::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 01:25:32,981::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 01:25:32,981::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpogz3v8lg
apiLogger::2021-10-04 01:25:33,106::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 01:25:33,106::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 01:25:33,106::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 01:25:33,106::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 01:25:33,110::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-04 01:25:33,111::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 01:25:33,111::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 01:25:33,111::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-04 01:25:33,111::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 04-Oct-2021 01:24:27 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : R1979-ONC-1625 Sponsor Notification: Site: 1625276001, Subject: 276001007; event:\nENCEPHALOPATHY- Initial\nFrom: SafetyPV <safetypv@syneoshealth.com> Sent: Friday, September 17, 2021 12:02 PM To:\nBarwick, Ashley <ashley.barwick@syneoshealth.com>; Ayesha Sabir\n<asra.sabir@regeneron.com>; Bertha Fearon-Chalet <bertha.fearonchalet@regeneron.com>;\nCarolina Leite de Oliveira <carolina.oliveira@regeneron.com>; chili.deng@zailaboratory.com;\nClaire Hearnden <claire.hearnden@regeneron.com>; Cristina Frias-External\n<cristina.frias@regeneron.com>; Pakendorf, Dee <deirdre.pakendorf1@syneoshealth.com>;\ndorothy.ogwuru@regeneron.com; De Mori, Giacomo <giacomo.demori@syneoshealth.com>;\nGuillermo Perez de Lema-External <guillermo.perezde@regeneron.com>; Scian, Joanna\n<joanna.scian@syneoshealth.com>; Juan Esquivel-External <juan.esquivel@regeneron.com>;\nKonopka, Katarzyna <katarzyna.konopka@syneoshealth.com>; Lakshmi Pulavarthi\n<lakshmi.pulavarthi@regeneron.com>; Lieve Adriaens <lieve.adriaens@regeneron.com>; Meyers,\nMark <mark.meyers@syneoshealth.com>; Regeneron Medical Safety\n<Medical.Safety@regeneron.com>; Melanie Ufkin <melanie.ufkin@regeneron.com>; Nickolas\nSophos <nickolas.sophos@regeneron.com>; Quasheeda Fields\n<quasheeda.fields@regeneron.com>; DL R1979-ONC-1625 Medical Team <R1979-ONC-\n1625MedicalTeam@regeneron.com>; SafetyPV <safetypv@syneoshealth.com>; Saleem Shariff\n<saleem.shariff@regeneron.com>; sharon.gao@zailaboratory.com; Srikanth Ambati\n<srikanth.ambati@regeneron.com>; Teresa Has <teresa.has@regeneron.com>; Tsimogianni,\nVeta <veta.tsimogianni@syneoshealth.com>; Tan, Wee Lin <weelin.tan@syneoshealth.com>\nSubject: <External> R1979-ONC-1625 Sponsor Notification: Site: 1625276001, Subject:\n276001007; event: ENCEPHALOPATHY- Initial \n \nEXTERNAL MESSAGE\n \n \nDear All, \n \nPlease note that Syneos Health received initial information regarding the following event. \n \nProtocol: R1979-ONC-1625\nDay 0: 17-SEP-2021\nCountry: Germany\nSite # /Investigator: 1625276001/Duell, Johannes\nSubject ID: 276001007\nStudy Drug(s): REGN1979\nEvent Term: ENCEPHALOPATHY\nOnset date: 16-SEP-2021 Severity/Grade: Grade 2\nSAE Criteria and/or AESI Criteria: Hospitalization/No\nInvestigator Relationship to Study Drug: Related\nInvestigator Relationship to Study Conduct: No\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2021-00130\n \n \nKind regards, \n \nAmy \n \nAmy Amazeen Safety &PV Specialist I, Drug Safety and Pharmacovigilance Syneos Health US\nRegional- Michigan Mobile  +1 734 265 6653 \namy.amazeen@syneoshealth.com \nsyneoshealth.com']
apiLogger::2021-10-04 01:25:33,111::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 01:25:33,111::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-04 01:25:33,111::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 01:25:33,111::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 01:25:33,111::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 01:25:34,599::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 01:25:34,599::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 01:53:18,978::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 01:53:18,999::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 01:53:18,999::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxb71hxkp 
apiLogger::2021-10-04 01:53:19,000::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 01:53:19,000::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 01:53:19,204::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 01:53:19,205::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxb71hxkp
apiLogger::2021-10-04 01:53:20,545::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 01:53:20,545::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 01:53:20,545::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 01:53:20,545::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 01:53:20,549::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-04 01:53:20,549::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 01:53:20,549::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 01:53:20,549::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-04 01:53:20,550::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -']
apiLogger::2021-10-04 01:53:20,550::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 01:53:20,550::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-04 01:53:20,550::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 01:53:20,550::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 01:53:20,550::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 01:53:39,911::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 01:53:39,911::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 01:57:18,892::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 01:57:18,913::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 01:57:18,914::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpo8pejlvb 
apiLogger::2021-10-04 01:57:18,915::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 01:57:18,915::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 01:57:19,196::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 01:57:19,196::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpo8pejlvb
apiLogger::2021-10-04 01:57:20,597::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 01:57:20,598::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 01:57:20,601::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 01:57:20,601::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 01:57:20,604::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-04 01:57:20,605::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 01:57:20,605::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 01:57:20,605::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-04 01:57:20,605::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005015\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -']
apiLogger::2021-10-04 01:57:20,605::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 01:57:20,605::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-04 01:57:20,605::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 01:57:20,605::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 01:57:20,605::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 01:57:39,951::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 01:57:39,952::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 01:59:18,879::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 01:59:18,901::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 01:59:18,901::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp9o47qi67 
apiLogger::2021-10-04 01:59:18,902::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 01:59:18,903::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 01:59:19,273::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 01:59:19,274::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp9o47qi67
apiLogger::2021-10-04 01:59:20,757::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 01:59:20,757::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 01:59:20,757::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 01:59:20,757::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 01:59:20,761::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-04 01:59:20,761::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 01:59:20,761::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 01:59:20,761::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-04 01:59:20,761::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005016\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -']
apiLogger::2021-10-04 01:59:20,761::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 01:59:20,762::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-04 01:59:20,762::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 01:59:20,762::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 01:59:20,762::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 01:59:40,533::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 01:59:40,533::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 02:01:19,041::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 02:01:19,063::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 02:01:19,063::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_5ykb779 
apiLogger::2021-10-04 02:01:19,064::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 02:01:19,065::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 02:01:19,436::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 02:01:19,436::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_5ykb779
apiLogger::2021-10-04 02:01:20,919::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 02:01:20,919::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 02:01:20,919::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 02:01:20,919::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 02:01:20,923::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-04 02:01:20,923::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 02:01:20,923::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 02:01:20,923::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-04 02:01:20,923::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005017\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -']
apiLogger::2021-10-04 02:01:20,923::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 02:01:20,923::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-04 02:01:20,923::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 02:01:20,923::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 02:01:20,923::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 02:01:40,775::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 02:01:40,775::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 02:01:40,853::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 02:01:40,875::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 02:01:40,875::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmplx_7e2al 
apiLogger::2021-10-04 02:01:40,877::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 02:01:40,877::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 02:01:41,248::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 02:01:41,249::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmplx_7e2al
apiLogger::2021-10-04 02:01:42,733::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 02:01:42,733::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 02:01:42,734::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 02:01:42,734::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 02:01:42,738::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-04 02:01:42,738::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 02:01:42,738::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 02:01:42,738::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-04 02:01:42,738::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005018\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -']
apiLogger::2021-10-04 02:01:42,738::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 02:01:42,738::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-04 02:01:42,738::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 02:01:42,738::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 02:01:42,738::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 02:02:02,391::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 02:02:02,391::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 05:05:18,608::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 05:05:18,609::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 05:05:18,609::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpd1msy_jr 
apiLogger::2021-10-04 05:05:18,609::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 05:05:18,610::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 05:05:18,633::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 05:05:18,633::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpd1msy_jr
apiLogger::2021-10-04 05:05:19,031::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 05:05:19,031::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 05:05:19,031::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 05:05:19,032::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 05:05:19,035::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-04 05:05:19,035::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 05:05:19,035::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 05:05:19,035::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-04 05:05:19,035::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\n(fiUrstn, lakst) CZECH REPUBLIC\xa0 Day Month 1Y9e6ar6 Ye5a4rs\xa0 Female\xa0 Unk D1a1y DMoEnCth 2Y0e2ar0 AAPDPVREORSPER IRATEEA CTTOION\nPATIENT DIED\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas)\nINVOLVED OR\nDyspnoe [Dyspnoea] PROLONGED INPATIENT\nHOSPITALISATION\nINVOLVED PERSISTENT\nCase Description: A 54-year-old female subject (0201-001) enrolled in the ISA101b-HN-01-17 study, A  OR SIGNIFICANT\nRandomized Double Blind, Placebo Controlled Phase II Study of Cemiplimab vs Combination of Cemiplimab  DISABILITY OR\nINCAPACITY\nwith ISA101b in the Treatment of Subject with HPV16-Positive Oropharyngeal Cancer (OPC), experienced the \nLIFE\nserious adverse event of dyspnoe (dyspnoea).  THREATENING\nCONGENITAL\nThe subject’s medical history included hypercalcemia.\xa0 ANOMALY\nOTHER\n (Continued on Additional Information Page)\xa0\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ISA101b/Placebo (Code not broken) Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n#2 ) Cemiplimab (Cemiplimab) Infusion\xa0  (Continued on Additional Information Page)\xa0\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 100 microgram/peptide\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n#2 ) 350 mg, every 3 weeks\xa0 #2 ) Intravenous\xa0\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) HPV16-Positive Oropharyngeal Cancer \xa0 REAPPEAR AFTER\nREINTRODUCTION?\n#2 ) HPV16-Positive Oropharyngeal Cancer \xa0  (Continued on Additional Information Page)\xa0\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) 06-NOV-2020 / Unknown\xa0 #1 ) Unknown\xa0 YES NO NA\n#2 ) 13-NOV-2020 / Unknown\xa0 #2 ) Unknown\xa0\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n#1 ) TRITTICO (TRAZODONE HYDROCHLORIDE)  Tablet ; 2018 / Ongoing\xa0\n#2 ) NEUROL [ALPRAZOLAM] (ALPRAZOLAM)  Tablet ; 2018 / Ongoing\xa0\n#3 ) DEGAN (METOCLOPRAMIDE HYDROCHLORIDE)  Tablet ; 13-NOV-2020 / Ongoing\xa0\n#4 ) SEVREDOL (MORPHINE SULFATE)  Tablet ; 13-NOV-2020 / Ongoing\xa0\n#5 ) NOVALGIN [METAMIZOLE SODIUM] (METAMIZOLE SODIUM)  Tabl\xa0\n#6 ) ZOLEDRONIC ACID (ZOLEDRONIC ACID)   ; 04-DEC-2020 / 04-DEC-2020\xa0  (Continued on Additional Information Page)\xa0\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 Smoker (Tobacco user)\xa0\nApprox 36 years, 15 cigarettes/cigars per day\xa0\nJUN-2020 to 07-DEC-2020 Medical History\xa0 Hypercalcemia (Hypercalcaemia)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nISA Therapeutics B.V\nJ.H Oortweg 19-21\nLeiden,  2333 CH  NETHERLANDS\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nPetra  Holeckova \nCZ-ISA-000106\xa0\n \n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE CZECH REPUBLIC\n11-DEC-2020\xa0 HEALTH OTHER: Lenka  Balazova \nPROFESSIONAL Hospital Na Bulovce\nDATE OF THIS REPORT 25a. REPORT TYPE\n21-DEC-2020\xa0 Prague,   \nINITIAL FOLLOWUP:  (Continued on Additional Information Page)\xa0\n21-Dec-2020 11:11 Page 2 of 2\nMfr. Control Number: CZ-ISA-000106\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\n The subject is a current smoker.\nConcomitant medications included Trittico (trazodone hydrochloride), Neurol (alprazolam), Degan (metoclopramide hydrochloride), \nSevredol (morphine sulfate), Novalgin (metamizole sodium), and zoledronic acid.\nOn 06-Nov-2020, the subject was administered their first dose of ISA101b/placebo (100 microgram/peptide) via subcutaneous (SC) \ninjection.\nOn 13-Nov-2020, the subject was administered their first dose of cemiplimab (350mg; every three weeks) via intravenous (IV) \ninfusion. \nOn 04-Dec-2020 the subject received their last dose of ISA101b/placebo and cemiplimab, prior to event onset.\nOn 11-Dec-2020, approximately 7 days after receiving their last dose of ISA101b/placebo and cemiplimab, the subject was \nhospitalised for worsening dyspnoea. It was reported that this was due to the underlying disease.\nAt the time of this report, the subject had not yet recovered from the event of dyspnoea. \nAction was taken with ISA101b/placebo or cemiplimab, in response to the reported events was unknown.\nAdditional information is expected. \nThe investigator assessed the event of dyspnoea as severe in intensity and not related to ISA101b/placebo or cemiplimab. Alternate \ncausality provided was primary disease.\nThe company concurred with the investigator’s assessment of the event.\xa0\n14-19. SUSPECT DRUG(S) continued\n15. DAILY DOSE(S); 18. THERAPY DATES (from/to);\n14. SUSPECT DRUG(S) (include generic name) 16. ROUTE(S) OF ADMIN 17. INDICATION(S) FOR USE 19. THERAPY DURATION\n#1 ) ISA101b/Placebo (Code not broken)  100 microgram/peptide;  HPV16-Positive  06-NOV-2020 / \nInjection; Regimen #1\xa0 Subcutaneous\xa0 Oropharyngeal Cancer (OPC)  Unknown;\n(Oropharyngeal cancer)\xa0 Unknown\xa0\n#2 ) Cemiplimab (Cemiplimab) Infusion;  350 mg, every 3 weeks;  HPV16-Positive  13-NOV-2020 / \nRegimen #1\xa0 Intravenous\xa0 Oropharyngeal Cancer (OPC)  Unknown;\n(Oropharyngeal cancer)\xa0 Unknown\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION continued\n#5 ) NOVALGIN [METAMIZOLE SODIUM] (METAMIZOLE SODIUM)  Tablet ; 30-OCT-2020 / Ongoing\xa0\n25b. Name And Address of Reporters continued\nPetra  Holeckova \n \nCZECH REPUBLIC\nLenka  Balazova \nHospital Na Bulovce\nPrague,   \nCZECH REPUBLIC\nAntonin  Vrana \nHospital Na Bulovce\nPrague,   \nCZECH REPUBLIC\xa0\n21-Dec-2020 11:11']
apiLogger::2021-10-04 05:05:19,035::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 05:05:19,035::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-04 05:05:19,035::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 05:05:19,035::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 05:05:19,035::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 05:05:28,557::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 05:05:28,557::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 07:15:18,658::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 07:15:18,664::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 07:15:18,674::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp4ils9st9 
apiLogger::2021-10-04 07:15:18,675::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 07:15:18,675::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 07:15:18,749::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 07:15:18,749::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp4ils9st9
apiLogger::2021-10-04 07:15:19,715::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 07:15:19,715::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 07:15:19,715::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 07:15:19,715::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 07:15:19,720::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-04 07:15:19,720::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 07:15:19,720::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 07:15:19,720::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-04 07:15:19,720::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_03-SEP-2021']
apiLogger::2021-10-04 07:15:19,720::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 07:15:19,721::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-04 07:15:19,721::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 07:15:19,721::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 07:15:19,721::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 07:15:34,387::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 07:15:34,388::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 07:31:18,729::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 07:31:18,735::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 07:31:18,735::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpn8wfkc8u 
apiLogger::2021-10-04 07:31:18,736::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 07:31:18,736::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 07:31:18,834::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 07:31:18,834::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpn8wfkc8u
apiLogger::2021-10-04 07:31:19,726::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 07:31:19,726::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 07:31:19,726::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 07:31:19,726::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 07:31:19,730::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 07:31:19,730::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 07:31:19,730::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-04 07:31:19,730::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-04 07:31:19,734::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-04 07:31:19,734::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-04 07:31:19,734::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 07:31:19,734::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-04 07:31:19,734::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,001\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1952\nAge 68\nSex Female\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential? No\nIf No, please specify reason: Post-menopausal status\nRandomization Details\nRandomization Date 28/OCT/2020\nR2810-ONC-1788_SAE REPORT_03-NOV-2020 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25/SEP/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25/SEP/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25/SEP/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_03-NOV-2020 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_03-NOV-2020 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_03-NOV-2020']
apiLogger::2021-10-04 07:31:19,734::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 07:31:19,734::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-04 07:31:19,734::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 07:31:19,734::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 07:31:19,734::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 07:31:35,662::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 07:31:35,663::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 07:41:08,453::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 07:41:08,459::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 07:41:08,459::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp0bcdavm2 
apiLogger::2021-10-04 07:41:08,460::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 07:41:08,460::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 07:41:08,534::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 07:41:08,534::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp0bcdavm2
apiLogger::2021-10-04 07:41:09,497::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 07:41:09,497::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 07:41:09,497::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 07:41:09,497::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 07:41:09,501::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-04 07:41:09,501::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 07:41:09,501::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 07:41:09,501::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-04 07:41:09,501::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 36,022,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_03-SEP-2021']
apiLogger::2021-10-04 07:41:09,502::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 07:41:09,502::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-04 07:41:09,502::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 07:41:09,502::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 07:41:09,502::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 07:41:24,274::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 07:41:24,274::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 07:53:18,713::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 07:53:18,719::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 07:53:18,720::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp4zsys734 
apiLogger::2021-10-04 07:53:18,720::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 07:53:18,720::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 07:53:18,856::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 07:53:18,856::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp4zsys734
apiLogger::2021-10-04 07:53:19,726::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 07:53:19,726::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 07:53:19,726::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 07:53:19,726::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 07:53:19,730::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 07:53:19,730::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 07:53:19,730::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-04 07:53:19,730::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-04 07:53:19,734::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-04 07:53:19,734::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-04 07:53:19,734::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 07:53:19,734::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-04 07:53:19,734::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036001-Peter Maccallum Cancer Centre (PMCC)\nEnvironment Prod\nSubject Details\nStudy Site Number 36,001\nPatient ID 36,001,556\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1946\nAge 74\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 19/MAY/2020\nR2810-ONC-1788_SAE REPORT_19-FEB-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 28/APR/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 28/APR/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 28/APR/2020 Amendment 1\n2 10/JUN/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_19-FEB-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_19-FEB-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_19-FEB-2021']
apiLogger::2021-10-04 07:53:19,734::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 07:53:19,734::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-04 07:53:19,734::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 07:53:19,734::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 07:53:19,734::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 07:53:36,393::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 07:53:36,393::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 07:55:18,722::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 07:55:18,726::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 07:55:18,727::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp0nod80cq 
apiLogger::2021-10-04 07:55:18,727::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 07:55:18,727::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 07:55:18,847::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 07:55:18,847::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp0nod80cq
apiLogger::2021-10-04 07:55:19,777::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 07:55:19,777::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 07:55:19,777::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 07:55:19,778::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 07:55:19,781::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-04 07:55:19,781::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 07:55:19,781::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 07:55:19,781::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-04 07:55:19,781::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 66,022,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_03-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_03-SEP-2021']
apiLogger::2021-10-04 07:55:19,782::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 07:55:19,782::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-04 07:55:19,782::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 07:55:19,782::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 07:55:19,782::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 07:55:34,453::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 07:55:34,453::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 08:02:14,377::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 08:02:14,385::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 08:02:14,385::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpmeohy5fi 
apiLogger::2021-10-04 08:02:14,385::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 08:02:14,386::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 08:02:14,521::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 08:02:14,521::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpmeohy5fi
apiLogger::2021-10-04 08:02:15,390::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 08:02:15,390::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 08:02:15,390::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 08:02:15,390::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 08:02:15,394::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 08:02:15,394::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 08:02:15,394::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-04 08:02:15,394::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-04 08:02:15,397::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-04 08:02:15,398::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-04 08:02:15,398::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 08:02:15,398::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-04 08:02:15,398::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036001-Peter Maccallum Cancer Centre (PMCC)\nEnvironment Prod\nSubject Details\nStudy Site Number 36,001\nPatient ID 36,001,556\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1946\nAge 74\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 19/MAY/2020\nR2810-ONC-1788_SAE REPORT_19-FEB-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 28/APR/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 28/APR/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 28/APR/2020 Amendment 1\n2 10/JUN/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_19-FEB-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_19-FEB-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_19-FEB-2021']
apiLogger::2021-10-04 08:02:15,398::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 08:02:15,398::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-04 08:02:15,398::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 08:02:15,398::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 08:02:15,398::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 08:02:32,069::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 08:02:32,070::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 10:39:18,760::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 10:39:18,765::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 10:39:18,765::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpb2vd7r60 
apiLogger::2021-10-04 10:39:18,766::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 10:39:18,766::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 10:39:18,901::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 10:39:18,901::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpb2vd7r60
apiLogger::2021-10-04 10:39:19,741::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 10:39:19,741::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 10:39:19,741::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 10:39:19,742::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 10:39:19,745::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 10:39:19,745::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 10:39:19,745::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-04 10:39:19,746::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-04 10:39:19,749::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-04 10:39:19,749::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-04 10:39:19,749::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 10:39:19,749::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-04 10:39:19,749::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036022-GenesisCare Bundaberg\nEnvironment Prod\nSubject Details\nStudy Site Number 36,022\nPatient ID 66,022,002\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1973\nAge 48\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 14 JUN 2021\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 20 MAY 2021\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 MAY 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 MAY 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_06-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_06-SEP-2021']
apiLogger::2021-10-04 10:39:19,749::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 10:39:19,749::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-04 10:39:19,749::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 10:39:19,749::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 10:39:19,749::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 10:39:34,669::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 10:39:34,670::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 10:49:18,736::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 10:49:18,742::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 10:49:18,742::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpjjq84aow 
apiLogger::2021-10-04 10:49:18,743::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 10:49:18,743::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 10:49:18,879::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 10:49:18,879::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpjjq84aow
apiLogger::2021-10-04 10:49:19,749::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 10:49:19,749::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 10:49:19,750::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 10:49:19,750::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 10:49:19,753::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 10:49:19,754::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 10:49:19,754::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-04 10:49:19,754::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-04 10:49:19,757::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-04 10:49:19,757::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-04 10:49:19,757::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 10:49:19,757::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-04 10:49:19,757::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036001-Peter Maccallum Cancer Centre (PMCC)\nEnvironment Prod\nSubject Details\nStudy Site Number 36,001\nPatient ID 36,001,556\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1946\nAge 74\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 19/MAY/2020\nR2810-ONC-1788_SAE REPORT_19-FEB-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 28/APR/2020\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 28/APR/2020\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 28/APR/2020 Amendment 1\n2 10/JUN/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_19-FEB-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_19-FEB-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_19-FEB-2021']
apiLogger::2021-10-04 10:49:19,757::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 10:49:19,757::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-04 10:49:19,757::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 10:49:19,757::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 10:49:19,757::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 10:49:36,644::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 10:49:36,644::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 11:37:18,849::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 11:37:18,913::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 11:37:18,913::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxsqyxax5 
apiLogger::2021-10-04 11:37:18,916::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 11:37:18,916::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 11:37:19,854::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 11:37:19,854::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxsqyxax5
apiLogger::2021-10-04 11:37:21,491::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 11:37:21,491::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 11:37:21,491::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 11:37:21,491::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 11:37:21,495::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-04 11:37:21,495::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 11:37:21,495::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-04 11:37:21,495::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-04 11:37:21,495::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 01 July 2021 16:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/YWqACW7OVH5KzlwmH6f0d1?domain=login.imedidata.com\n*** IMPORTANT: As we approach Day 1 of the ICON / PRA combined organization we ask that all staff \nremain vigilant, especially with unsolicited telephone calls, new email interactions or any emails which are \nsuspicious in nature. Please report any suspicious emails to Information Security using the "Report Phish" \nbutton in Outlook. ***  \n \n \nAn AESI of INFUSION REACTION has been reported for Subject Number 616008034 with  \nStart Date (dd-mon-yyyy) : 17 OCT 2019 \nwith AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 01 Jul 2021 10:38:17 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse \'Other\' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_02-JUL-2021']
apiLogger::2021-10-04 11:37:21,495::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-04 11:37:21,495::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-04 11:37:21,496::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-04 11:37:21,496::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-04 11:37:21,496::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-04 11:37:45,040::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-04 11:37:45,040::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-04 15:01:18,855::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-04 15:01:18,856::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-04 15:01:18,856::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp3fcfdvd0 
apiLogger::2021-10-04 15:01:18,857::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-04 15:01:18,857::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-04 15:01:18,862::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-04 15:01:18,862::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp3fcfdvd0
apiLogger::2021-10-04 15:01:18,874::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-04 15:01:18,874::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-04 15:01:18,874::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-04 15:01:18,874::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-04 15:01:18,878::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-04 15:01:18,878::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-04 15:01:18,878::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-04 15:01:18,878::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 04-Oct-2021 15:00:34 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Create a Case\nTest ']
apiLogger::2021-10-04 15:01:18,878::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-04 15:01:18,878::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 02:27:18,803::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 02:27:18,810::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 02:27:18,810::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmps97q_d2v 
apiLogger::2021-10-05 02:27:18,811::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 02:27:18,811::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 02:27:18,891::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 02:27:18,891::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmps97q_d2v
apiLogger::2021-10-05 02:27:19,716::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 02:27:19,716::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 02:27:19,717::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 02:27:19,717::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 02:27:19,721::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-05 02:27:19,721::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 02:27:19,721::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 02:27:19,721::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 02:27:19,721::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 14 September 2021 14:33\nTo: SAEALERT16113_PROD; SAEALERT16113_PROD2\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16113. Please review ASAP at https://protect-\neu.mimecast.com/s/73ITCVPpRHxAXnwrFG28vY?domain=login.imedidata.com\nSAE/AESI Narrative Text :  has been updated from AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH \nGRADE 2 AND RESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 \nMG HYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION \nWAS RESUMED. to AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH(DYSPNEA) GRADE 2 AND \nRESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 MG \nHYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION WAS \nRESUMED., for SAE INFUSION REACTION for Subject Number 616008034 \n \n1  Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_15-SEP-2021']
apiLogger::2021-10-05 02:27:19,721::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 02:27:19,721::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-05 02:27:19,721::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 02:27:19,721::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 02:27:19,721::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 02:27:30,466::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 02:27:30,466::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 02:41:18,891::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 02:41:18,935::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 02:41:18,935::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwetaj3j8 
apiLogger::2021-10-05 02:41:18,937::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 02:41:18,937::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 02:41:19,413::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 02:41:19,413::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwetaj3j8
apiLogger::2021-10-05 02:41:21,062::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 02:41:21,062::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 02:41:21,062::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 02:41:21,062::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 02:41:21,066::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-05 02:41:21,067::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 02:41:21,067::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 02:41:21,067::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 02:41:21,067::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 01 July 2021 16:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/YWqACW7OVH5KzlwmH6f0d1?domain=login.imedidata.com\n*** IMPORTANT: As we approach Day 1 of the ICON / PRA combined organization we ask that all staff \nremain vigilant, especially with unsolicited telephone calls, new email interactions or any emails which are \nsuspicious in nature. Please report any suspicious emails to Information Security using the "Report Phish" \nbutton in Outlook. ***  \n \n \nAn AESI of INFUSION REACTION has been reported for Subject Number 616008034 with  \nStart Date (dd-mon-yyyy) : 17 OCT 2019 \nwith AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 01 Jul 2021 10:38:17 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 716008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse \'Other\' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_02-JUL-2021']
apiLogger::2021-10-05 02:41:21,067::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 02:41:21,067::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-05 02:41:21,067::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 02:41:21,067::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 02:41:21,067::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 02:41:44,135::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 02:41:44,135::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 03:07:18,820::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 03:07:18,847::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 03:07:18,847::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpmrzfu1gc 
apiLogger::2021-10-05 03:07:18,849::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 03:07:18,849::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 03:07:19,223::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 03:07:19,224::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpmrzfu1gc
apiLogger::2021-10-05 03:07:21,579::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 03:07:21,579::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 03:07:21,579::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 03:07:21,579::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 03:07:21,583::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-05 03:07:21,584::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 03:07:21,584::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 03:07:21,584::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 03:07:21,584::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM']
apiLogger::2021-10-05 03:07:21,584::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 03:07:21,584::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-05 03:07:21,584::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 03:07:21,584::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 03:07:21,584::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 03:07:41,942::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 03:07:41,942::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 03:27:19,027::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 03:27:19,084::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 03:27:19,085::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp2t_pcvip 
apiLogger::2021-10-05 03:27:19,088::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 03:27:19,088::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 03:27:23,871::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 03:27:23,871::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp2t_pcvip
apiLogger::2021-10-05 03:27:25,663::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 03:27:25,663::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 03:27:25,663::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 03:27:25,663::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 03:27:25,668::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-05 03:27:25,668::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 03:27:25,668::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 03:27:25,668::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 03:27:25,668::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\n792012004\nAn AESI of TROMBOITOPENIA has been reported for Subject Number   with Start Date (dd-mon-\n   \nyyyy) :27JUL 2021  with AE suspected to be caused by blinded study drug? : NO \nWWRD (GMT): 27 Jul 2021 20:56:17 \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 79201200\n4 \nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana \n  Folder: Screening >>  Prior Cancer Therapies (1) Hastanesi:\n792012009 \nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012004\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021']
apiLogger::2021-10-05 03:27:25,668::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 03:27:25,668::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-05 03:27:25,668::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 03:27:25,668::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 03:27:25,668::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 03:28:09,058::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 03:28:09,058::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 03:29:18,867::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 03:29:18,915::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 03:29:18,916::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp87s83wx2 
apiLogger::2021-10-05 03:29:18,919::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 03:29:18,919::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 03:29:23,326::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 03:29:23,326::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp87s83wx2
apiLogger::2021-10-05 03:29:24,669::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 03:29:24,669::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 03:29:24,669::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 03:29:24,669::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 03:29:24,673::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-05 03:29:24,673::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 03:29:24,673::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 03:29:24,674::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 03:29:24,674::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\n6\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 79201200  with Start Date (dd-mon-yyyy) : 27 \nJUL 2021  with AE suspected to be caused by blinded study drug? : NO \nWWRD (GMT): 27 Jul 2021 20:56:17 \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 79201200  \n6\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 79201200  \n6\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012006\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021']
apiLogger::2021-10-05 03:29:24,674::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 03:29:24,674::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-05 03:29:24,674::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 03:29:24,674::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 03:29:24,674::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 03:30:10,143::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 03:30:10,143::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 03:31:19,207::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 03:31:19,256::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 03:31:19,257::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpk0r0ncad 
apiLogger::2021-10-05 03:31:19,260::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 03:31:19,260::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 03:31:23,989::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 03:31:23,989::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpk0r0ncad
apiLogger::2021-10-05 03:31:25,625::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 03:31:25,625::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 03:31:25,625::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 03:31:25,625::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 03:31:25,629::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-05 03:31:25,629::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 03:31:25,630::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 03:31:25,630::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 03:31:25,630::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\n7  \nAn AESI of TROMBOITOPENIA has been reported for Subject Number 79201200  with Start Date (dd-mon-yyyy) : 27\nJUL 2021  with AE suspected to be caused by blinded study drug? : NO \nWWRD (GMT): 27 Jul 2021 20:56:17 \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: \n792012007 \nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: \n792012007 \nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012007\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021']
apiLogger::2021-10-05 03:31:25,630::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 03:31:25,630::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-05 03:31:25,630::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 03:31:25,630::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 03:31:25,630::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 03:32:10,309::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 03:32:10,309::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 03:32:10,394::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 03:32:10,444::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 03:32:10,445::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpn42d580p 
apiLogger::2021-10-05 03:32:10,448::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 03:32:10,448::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 03:32:15,156::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 03:32:15,156::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpn42d580p
apiLogger::2021-10-05 03:32:16,804::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 03:32:16,804::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 03:32:16,804::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 03:32:16,804::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 03:32:16,808::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-05 03:32:16,808::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 03:32:16,808::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 03:32:16,808::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 03:32:16,808::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\n792012008\nAn AESI of TROMBOITOPENIA has been reported for Subject Number   with Start Date (dd-mon-yyyy) : \n \n27JUL 2021  with AE suspected to be caused by blinded study drug? : NO \nWWRD (GMT): 27 Jul 2021 20:56:17 \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: \nFolder: Screening\n792012008 \nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: \nFolder: Screening >>  Prior Cancer Therapies (1)\n792012008 \nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012008\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021']
apiLogger::2021-10-05 03:32:16,808::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 03:32:16,808::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-05 03:32:16,809::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 03:32:16,809::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 03:32:16,809::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 03:33:01,584::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 03:33:01,584::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 03:33:18,830::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 03:33:18,885::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 03:33:18,885::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmprulakfv8 
apiLogger::2021-10-05 03:33:18,888::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 03:33:18,889::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 03:33:23,698::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 03:33:23,698::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmprulakfv8
apiLogger::2021-10-05 03:33:25,355::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 03:33:25,356::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 03:33:25,356::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 03:33:25,356::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 03:33:25,360::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-05 03:33:25,360::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 03:33:25,360::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 03:33:25,360::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 03:33:25,360::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\n792012009  \nAn AESI of TROMBOITOPENIA has been reported for Subject Number   with Start Date (dd-mon-yyyy) :\n \n27JUL 2021  with AE suspected to be caused by blinded study drug? : NO \nWWRD (GMT): 27 Jul 2021 20:56:17 \n1   R2810-FOoNldCe-1r:6 S1c1r3e:e 7n9in2g012-Baskent Universitesi Tip Fakultesi Adana Hastanesi:\n792012009 \nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana \n  Folder: Screening >>  Prior Cancer Therapies (1) Hastanesi:\n792012009 \nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012009\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021']
apiLogger::2021-10-05 03:33:25,360::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 03:33:25,360::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-05 03:33:25,360::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 03:33:25,360::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 03:33:25,360::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 03:34:10,455::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 03:34:10,455::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:05:18,689::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:05:18,695::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:05:18,695::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpc0wgkewg 
apiLogger::2021-10-05 04:05:18,696::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:05:18,696::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:05:18,821::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:05:18,821::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpc0wgkewg
apiLogger::2021-10-05 04:05:19,612::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:05:19,612::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:05:19,612::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:05:19,612::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:05:19,616::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-05 04:05:19,616::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:05:19,616::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 04:05:19,616::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 04:05:19,616::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 14 September 2021 14:33\nTo: SAEALERT16113_PROD; SAEALERT16113_PROD2\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16113. Please review ASAP at https://protect-\neu.mimecast.com/s/73ITCVPpRHxAXnwrFG28vY?domain=login.imedidata.com\nSAE/AESI Narrative Text :  has been updated from AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH \nGRADE 2 AND RESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 \nMG HYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION \nWAS RESUMED. to AFTER5 MIN OF PACLITAXEL INFUSION SHORTNESS OF BREATH(DYSPNEA) GRADE 2 AND \nRESTLESSNESS GRADE 2 OCCURED.THE INFUSION WAS STOPED (RR ON THAT POINT: 125/80 HR 92),100 MG \nHYDROCORTISON WAS ADMINISTRED IV, AFTER 5 MIN SYMPTOMS SIBSIDED, AFTER A 15 MIN BREAK, INFUSION WAS \nRESUMED., for SAE INFUSION REACTION for Subject Number 616008034 \n \n1  Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 716008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_15-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_15-SEP-2021']
apiLogger::2021-10-05 04:05:19,617::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 04:05:19,617::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-05 04:05:19,617::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 04:05:19,617::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 04:05:19,617::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 04:05:30,590::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 04:05:30,590::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:23:18,908::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:23:18,947::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:23:18,948::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpjfdf83_r 
apiLogger::2021-10-05 04:23:18,950::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:23:18,950::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:23:19,582::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:23:19,582::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpjfdf83_r
apiLogger::2021-10-05 04:23:21,082::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:23:21,082::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:23:21,082::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:23:21,082::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:23:21,086::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-05 04:23:21,087::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:23:21,087::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 04:23:21,087::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 04:23:21,087::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410002 - Cho - South Korea@KOR\nSite Number 1625410002\nSubject ID: 410002002\nScreening Date 10 FEB 2020 REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nGlobal\nR1979-ONC-1625 Original ICF\n1 No 24 JUL 2019 10 FEB 2020 Main consent 24 JUL 2019 10 FEB 2020\nProtocol Version\n1.0\nR1979-ONC-1625\n2 09 JUN 2020 Main consent 28 MAY 2020 10 FEB 2020\nAmendment 1 Global\nR1979-ONC-1625 Original Genomics Sub-Study\n3 10 FEB 2020 24 JUL 2019 10 FEB 2020\nProtocol consent\nFuture Biomedical\nR1979-ONC-1625 Original\n4 10 FEB 2020 Research Sub-Study 24 JUL 2019 10 FEB 2020\nProtocol\nconsent\nR1979-ONC-1625 Genomics Sub-Study\n5 09 JUN 2020 28 MAY 2020 10 FEB 2020\nAmendment 1 Global consent\nFuture Biomedical\nR1979-ONC-1625\n6 09 JUN 2020 Research Sub-Study 28 MAY 2020 10 FEB 2020\nAmendment 1 Global\nconsent\nR1979-ONC-1625\n7 12 JAN 2021 Main consent 30 DEC 2020 10 FEB 2020\nAmendment 2 Global\nR1979-ONC-1625\n8 06 APR 2021 Main consent 02 MAR 2021 10 FEB 2020\nAmendment 3 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410002002 1959 61 Female Asian -\nor Latino\nDisease-Specific Cohort REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) Follicular Lymphoma Grade 1-3a REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1    HEPATITIS B CARRIER      checked Ongoing Grade 1 - unchecked REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nMedical 1_HEPATIT 20 JAN unchecke\n1 ENTECAVIR History - IS B - 0.5 mg - QD - Oral - 2012 d - checked\nCARRIER_\nDEXAMETH Premedicatio Intraveno 11 FEB unchecke 19 FEB\n2 ASONE n for - - - 20 mg - PRN - us - 2020 d 2020 unchecked\nREGN1979\nCHLORPHE Premedicatio Intraveno 11 FEB unchecke 12 FEB\n3 NIRAMINE n for - - - 4 mg - QD - us - 2020 d 2020 unchecked\nREGN1979\nACETAMINO Premedicatio 11 FEB unchecke 12 FEB\n4 PHEN n for - - - 600 mg - Qid - Oral - 2020 d 2020 unchecked\nREGN1979\nALOPURINO PROPHYLA 11 FEB unchecke\n5 L Prophylaxis XIS FOR - - 100 mg - PRN - Oral - 2020 d - checked\nTLS\nPROPHYLA 11 FEB unchecke\n6 MOSAPRIDE Prophylaxis XIS FOR - - 5 mg - PRN - Oral - 2020 d - checked\nINDIGESTIO\nDIMENHYD Premedicatio 11 FEB unchecke 12 FEB\n7 RINATE n for - - - 50 mg - QD - Oral - 2020 d 2020 unchecked\nREGN1979\nSODIUM Premedicatio Intraveno 11 FEB unchecke 12 FEB\n8 BICARBONA n for - - - 80 mEq - QD - us - 2020 d 2020 unchecked\nTE REGN1979\nNEUTROPE Subcutan 11 FEB unchecke 11 FEB\n9 FILGRASTIM Prophylaxis NIC - - 300 mcg - QD - eous - 2020 d 2020 unchecked\nPROPHYLA\nPACKED PROPHYLA Intraveno 11 FEB unchecke 11 FEB\n10 RBC Prophylaxis XIS FOR - - 2 Unit - QD - us - 2020 d 2020 unchecked\nANEMIA\nPROPHYLA Intraveno 11 FEB unchecke 11 FEB\n11 PLATELETS Prophylaxis XIS FOR - - 1 Unit - QD - us - 2020 d 2020 unchecked\nBLEEDING\nPROPHYLA Intraveno 13 FEB unchecke 13 FEB\n12 PLATELETS Prophylaxis XIS FOR - - 1 Unit - QD - us - 2020 d 2020 unchecked\nBLEEDING']
apiLogger::2021-10-05 04:23:21,087::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 04:23:21,087::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-05 04:23:21,087::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 04:23:21,087::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 04:23:21,087::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 04:24:24,690::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 04:24:24,690::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:25:19,042::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:25:19,061::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:25:19,061::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpdieabvsv 
apiLogger::2021-10-05 04:25:19,063::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:25:19,063::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:25:20,634::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:25:20,634::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpdieabvsv
apiLogger::2021-10-05 04:25:30,073::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:25:30,073::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:25:30,073::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:25:30,073::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:25:30,078::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:30,079::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:25:30,079::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:25:30,079::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:25:30,083::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:30,083::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:25:30,084::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 04:25:30,084::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 04:25:30,088::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:30,088::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 04:25:30,088::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 04:25:30,088::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 04:25:30,093::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:30,093::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 04:25:30,093::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 04:25:30,093::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 04:25:30,098::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:30,098::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 04:25:30,098::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 04:25:30,098::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '8/6/2021 CRF\n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Agamdeep Saini (Safety)\nR4018-ONC-1721 840005 - Liu - USA 840005025 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS Subject ID: 840005025\nAdverse Events Yes/No\nAdverse Event Subject: 840005025\nPage: Adverse Event - ADVERSE EVENTS\nCRF History   CCulicrrke hnetlyre v tioe wreintugr nlin teo  1"C6 oomf 1p6le.te View". Apply to Record\n840005025 - Adverse\nEvent Main Adverse Event Description (Term) NEUTROPENIA\n   \n840005025 - Adverse\nEvents Yes/No SOC 10005329Blood and lymphatic system disorders\n840005025 - Serious HLGT10047954White blood cell disorders\nAdverse Event/AESI # 16 HLT 10029355Neutropenias\nPT 10029354Neutropenia\n840005025 - Serious LLT 10029354Neutropenia\nAdverse Event/AESI # 01\n840009008 - Concomitant Start date (dd-mon-yyyy) 6 AUG 2021\nMedications\n840009008 - Concomitant If event occurred on study day 1, did the event occur prior to first study drug administration Not Applicable\nMedications Yes/No\n840009008 - Combination If the event is part of an Infusion Related Reaction or Cytokine Release Syndrome, please check the box and\npatients – administration of complete Immune Related Response/Cytokine Release Syndrome CRF\nREGN4018\nIs this AE related to the immune-mediated mechanism of action of REGN4018/Cemiplimab?\n840009008 - Monotherapy\npatients – administration of\nREGN4018 (Please complete associated CRFs for time frame, symptoms and signs, and vital sign changes. On the\ncorresponding CRFs for this AE, please enter interventions for management (eg. Medications, rate\n840009008 - Serious reduction))\nAdverse Event/AESI # 02\n840009008 - Serious Select if AE is intermittent No\nAdverse Event/AESI # 01\n840009008 - Adverse CAUSALITY\nEvent\n840009008 - Adverse AE suspected to be caused by REGN4018? Yes\nEvents Yes/No\nAE suspected to be caused by cemiplimab? Not Applicable\nAE suspected to be caused by study conduct? No\n---If Yes, specify\nACTION TAKEN\nAction taken with REGN4018 Not Applicable\nAction taken with cemiplimab Not Applicable\nIf Other, specify\nIf the Event is not study drug related but belongs to the sponsor list of immune related event, please provide\nthe etiology\nIf Other, specify\nOutcome of AE Not recovered/Not resolved\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy)\nAE initial severity CTCAE grade Grade 4 - Life threatening\nAE most extreme severity CTCAE grade Grade 4 - Life threatening\nDate Event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 6 AUG 2021\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication\nClick Hperlee faors Ceu setonmteer Sr uipnptoort  Incfoormnactioonmitant medications eCRF; If procedure or surgery please enter into the on- Medidata Classic Rave® 2021.1.0 \nstudy procedure/surgery eCRF Copyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(3hie4rvsvtuy4qwchgyjqfhr))/Modules/EDC/CRFPage.aspx?DP=96374520 1/3 8/6/2021 CRF\nNone  iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Agamdeep Saini (Safety)\nDrug therapy/ Medication\nR4018-ONC-1721 840005 - Liu - USA 840005025 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS Concomitant Medication #1\nAdverse Events Yes/No\nAdverse Event Concomitant Medication #2\nConcomitant Medication #3\nCRF History\n840005025 - Adverse Concomitant Medication #4\nEvent\n840005025 - Adverse Concomitant Medication #5\nEvents Yes/No\n840005025 - Serious Concomitant Medication #6\nAdverse Event/AESI # 16\n840005025 - Serious Concomitant Medication #7\nAdverse Event/AESI # 01\n840009008 - Concomitant Concomitant Medication #8\nMedications\n840009008 - Concomitant Concomitant Medication #9\nMedications Yes/No\n840009008 - Combination\npatients – administration of Concomitant Medication #10\nREGN4018\n840009008 - Monotherapy Concomitant Procedure/surgery\npatients – administration of\nREGN4018 Concomitant procedure/surgery #1\n840009008 - Serious\nAdverse Event/AESI # 02 Concomitant procedure/surgery #2\n840009008 - Serious\nAdverse Event/AESI # 01 Concomitant procedure/surgery #3\n840009008 - Adverse\nEvent Concomitant procedure/surgery #4\n840009008 - Adverse\nEvents Yes/No Concomitant procedure/surgery #5\nOther\nIf Other, specify\nDoes this AE qualify as Serious? (If YES, complete SAE/AESI Form) Yes\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of\nspecial interest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may\njeopardize the subject, and may require medical or surgical intervention to prevent one of the outcomes\nlisted above).\nIf Other, specify\nIs this an AE of Special Interest (AESI)? (If YES, complete SAE/AESI Form) No\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nAny AE that meets DLT criteria at any time while on treatment\nClick Here for Customer Support Information Medidata Classic Rave® 2021.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(3hie4rvsvtuy4qwchgyjqfhr))/Modules/EDC/CRFPage.aspx?DP=96374520 2/3 8/6/2021 CRF\nGrade 2 or greater Infusion-Related Reactions associated with study drug infusions\n iMedidata   Messages   My Profile   Help   Home   Logout\nGrade 2 or greater pain syndrome temporally related to study drug infusion in the opinion of the investigator User: Agamdeep Saini (Safety)\nR4018-ONC-1721 840005 - Liu - USA 840005025 ADVERSE EVENTS Adverse Event\nGrade 2 or greater Cytokine Release Syndrome\nADVERSE EVENTS\nAdverse Events Yes/No Grade 2 or greater allergic/hypersensitivity reactions\nAdverse Event\nAn irAE of any grade in a patient previously treated with a PI 3-K inhibitor\nCRF History\nPericardial effusions of any size\n840005025 - Adverse\nEvent\nGrade ≥2 treatment-emergent pleural effusion (clinically significant new effusion and/or a clinically significant\n840005025 - Adverse change in size of an existing effusion)\nEvents Yes/No\n840005025 - Serious Grade ≥2 Treatment-emergent ascites (clinically significant new ascite and/or a clinically significant change in\nAdverse Event/AESI # 16 size of existing ascites)\n840005025 - Serious Note: An irAE can occur shortly after the first dose or several months after the last dose of treatment. All AEs of\nAdverse Event/AESI # 01 unknown etiology associated with drug exposure should be evaluated to determine possible immune etiology. If\n840009008 - Concomitant an irAE is suspected, efforts should be made to rule out neoplastic, infectious, metabolic, toxin or other\nMedications etiologic causes prior to labeling an AE as an irAE.\n840009008 - Concomitant Date Time 06 AUG 2021 02:57:04\nMedications Yes/No\n840009008 - Combination  \npatients – administration of Printable Version  View PDF   Icon Key Save   Cancel\nREGN4018 CRF Version 9443 - Page Generated: 06 Aug 2021 15:24:05 Eastern Daylight Time\n840009008 - Monotherapy\npatients – administration of\nREGN4018\n840009008 - Serious\nAdverse Event/AESI # 02\n840009008 - Serious\nAdverse Event/AESI # 01\n840009008 - Adverse\nEvent\n840009008 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2021.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(3hie4rvsvtuy4qwchgyjqfhr))/Modules/EDC/CRFPage.aspx?DP=96374520 3/3 8/6/2021 CRF\n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Agamdeep Saini (Safety)\nR4018-ONC-1721 840005 - Liu - USA 840005025 SERIOUS ADVERSE EVENTS/AESI (1) Serious Adverse Event/AESI # 16\nSERIOUS ADVERSE Subject ID: 840005025\nEVENTS/AESI (1)\nSerious Adverse Subject: 840005025\nEvent/AESI # 01\nPage: Serious Adverse Event/AESI # 16 - SERIOUS ADVERSE EVENTS/AESI (1)\nSerious Adverse\nEvent/AESI # 02 AE number 16\nSerious Adverse\nEvent/AESI # 12 Adverse Event Description (Term) NEUTROPENIA\nSerious Adverse    \nEvent/AESI # 13\nSOC 10005329Blood and lymphatic system disorders\nSerious Adverse HLGT10047954White blood cell disorders\nEvent/AESI # 14 HLT 10029355Neutropenias\nSerious Adverse PT 10029354Neutropenia\nEvent/AESI # 15 LLT 10029354Neutropenia\nSerious Adverse Start Date (dd-mon-yyyy) 6 AUG 2021\nEvent/AESI # 16\nRATIONALE FOR CAUSALITY ASSESSMENT\nCRF History\nSpecify the Rationale for Causality to REGN4018 TEMPORAL\n840005025 - Serious\nAdverse Event/AESI # 16\nSpecify Rationale for Causality to cemiplimab\n840005025 - Serious\nAdverse Event/AESI # 01\nSpecify the Rationale for Causality to Study Conduct\n840005025 - Adverse\nEvent\nSAE/AESI NARRATIVE\n840005025 - Adverse\nEvents Yes/No #  SAE/AESI Narrative Text\n840009008 - Concomitant PATIENT 840005025 ON REGN4108 MONOTHERAPY CAME OFF OF STUDY ON JULY 16, 2021 FOLLOWING PROGRESSION OF DISEASE.\nMedications SHE FOLLOWED UP IN OUR CLINIC TODAY AND LABS REVEALED REBOUND GRADE 4 NEUTROPENIA (270). IF YOU RECALL, THIS\nPATIENT HAD GR 4 NEUTROPENIA FROM 6/30/21-7/16/21 REQUIRING NEUPOGEN SUPPORT FOR RECOVERY. SHE WILL FOLLOW UP\n840009008 - Concomitant\nWITH OUTPATIENT HEMATOLOGY FOR ASSESSMENT AND POTENTIAL BONE MARROW BIOPSY LIKELY WITHIN THE WEEK. NO\nMedications Yes/No 1\nGROWTH STIMULATING FACTOR WAS GIVEN IN OUR CLINIC TODAY. SHE IS FEELING WELL AND AFEBRILE AT THIS TIME. WE WILL\n840009008 - Combination FOLLOW UP AS WE KNOW MORE ABOUT THIS UNDERLYING PROCESS AND MANAGEMENT GUIDANCE FROM HEMATOLOGY. OUT\npatients – administration of TREATING INVESTIGATOR FEELS THIS IS RELATED TO REGN4018.\nREGN4018\n840009008 - Monotherapy    \npatients – administration of Printable Version  View PDF   Icon Key\nSave   Cancel\nREGN4018 CRF Version 9443 - Page Generated: 06 Aug 2021 15:27:50 Eastern Daylight Time\n840009008 - Serious\nAdverse Event/AESI # 02\n840009008 - Serious\nAdverse Event/AESI # 01\n840009008 - Adverse\nEvent\n840009008 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2021.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(3hie4rvsvtuy4qwchgyjqfhr))/Modules/EDC/CRFPage.aspx?DP=98276730 1/1 8/6/2021 CRF\n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Agamdeep Saini (Safety)\nR4018-ONC-1721 840005 - Liu - USA 840005025 TREATMENT (1) Monotherapy patients – administration of R...\nTREATMENT (1) Subject ID: 840005025\nMonotherapy patients –\nadministration of Subject: 840005025\nREGN4018 Page: Monotherapy patients – administration of REGN4018 - TREATMENT (1)\nCombination patients –\nCRFaRCac eddHEommmmiGsiiitbpNnnoiliir4nissmy0tatrra1taaibo8ttiinoo nnp  aootffients – # VSistuitdy  srsmDeutuecibddedj eyiitvchceaettion? PSrIeflp eaNeascoosi,efny HOIDADf doabYidmstsee pessi/sirT,utv saipbmailor jtefoenioocv/rnDtid  sipesteacrhyi oaindrg?e : A(yDdyddaym ytMe)is MosfiMon A(2T03di0m:m5:0e9is0 )os –ifon D(yDdyidsayc ytMeh) aMorfMge D(2T03ii0sm:5c:0eh90 a)o r-fge IP Lot #  I#OP tLhoetr DLPeolvasenelned pdmWloaosandesnifieedd? dmwpdinIfoloaaco psssrndeeelanifaineesnddee,dd? dmwpddIfoloeaao psscsndeerlaniefineaendsdee,dd? DAocstueal dispcbIsfpholo etlesxiahtces,eke ADdamtein oisftration TISnimftuaesrti oonf TISnimftuoespi oonf dAedlamyiendis?tration sIpf eyecisfy, inIntefurrsuiopnted? ILnetenrgruthp toiofn raiwirrnnIeaeffatf tstdeuieesnuursrfmrciuuoesepndidto?ionn, IRnteearrsuopnti ofonr: dsIpnueteec rtiorfuy A:ptEe,d dpOsIpnultaheteneec nrtirorf,euyd:p toerd\n8p4a0tie0n0t5s0 –2 5a d- mMionnisotrtahteioranp oyf 1C11 YDCALYEYes _ Yes 0280 2J1UN 15:47 1220 2J1UN 14:20 8227800006_ DL7a No _ _ 1 09 JUN 202112:13 16:04 No _ No _ _ _ _ _\nR8p4aE0tGie0Nn0t54s00 –21 58a d- mCionmisbtriantaiotino nof 2C18 YDCALYEYes _ Yes 1250 2J1UN 16:21 _ _ 8227800006_ DL7a No _ _ 10 16 JUN 202111:04 14:48 No _ No _ _ _ _ _\nc8pe4am0tie0ipn0lt5ism0 –2a 5ba d- mCionmisbtriantaiotino nof 3C19 YDCALYEYes _ Yes 1250 2J1UN 16:21 _ _ 8227800006_ DL7a No _ _ 10 17 JUN 202111:19 15:18 No _ No _ _ _ _ _\nR84E0G0N054002158 - Serious 4C11 5YDCALYEYes _ Yes 2220 2J1UN 16:51 2250 2J1UN 15:00 8261900004_ DL7a No _ _ 50 23 JUN 202112:06 16:00 No _ No _ _ _ _ _\nA8A4dd0vv0ee0rrss5ee0  2EE5vv ee- nnStt//eAArEEioSSuIIs  ##  1061 5C11 6YDCALYEYes _ Yes 2220 2J1UN 16:51 2250 2J1UN 15:00 8261900004_ DL7a No _ _ 200 24 JUN 202112:11 16:21 No _ No _ _ _ _ _\n840005025 - Adverse  \nEvent Printable Version  View PDF   Icon Key Save Cancel\n840005025 - Adverse CRF Version 9443 - Page Generated: 06 Aug 2021 15:28:26 Eastern Daylight Time\nEvents Yes/No\n840009008 - Concomitant\nMedications\n840009008 - Concomitant\nMedications Yes/No\n840009008 - Combination\npatients – administration of\nREGN4018\n840009008 - Monotherapy\npatients – administration of\nREGN4018\n840009008 - Serious\nAdverse Event/AESI # 02\n840009008 - Serious\nAdverse Event/AESI # 01\n840009008 - Adverse\nEvent\n840009008 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2021.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(3hie4rvsvtuy4qwchgyjqfhr))/Modules/EDC/CRFPage.aspx?DP=96856400 1/1']
apiLogger::2021-10-05 04:25:30,098::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 04:25:30,098::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:25:30,197::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:25:30,266::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:25:30,267::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpi7v8i0ru 
apiLogger::2021-10-05 04:25:30,269::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:25:30,269::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:25:33,359::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:25:33,359::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpi7v8i0ru
apiLogger::2021-10-05 04:25:35,050::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:25:35,051::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:25:35,051::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:25:35,051::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:25:35,055::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:35,055::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:25:35,055::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:25:35,055::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:25:35,059::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:35,059::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:25:35,059::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 04:25:35,059::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 04:25:35,063::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:35,063::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 04:25:35,063::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 04:25:35,063::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 04:25:35,067::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:35,067::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 04:25:35,067::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 04:25:35,067::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 04:25:35,072::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:35,072::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 04:25:35,072::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 04:25:35,072::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Project Details\nProtocol Number R4018-ONC-1721\nA Phase 1/2 Study of REGN4018 Administered Alone or in\nProtocol Title Combination with Cemiplimab in Patients with Platinum-\nResistant Ovarian Cancer\nSyneos Health Study Code 1011649\nCompound REGN4018\nSubject Details\nSite Name: 840005 - Liu - USA\nSite Number 1721840005\nSubject ID 840005025\nDisease Indication Patients with advanced platinum-experienced ovarian cancer\nStudy Phase 1/2\nScreening Date 5/28/21\nDate of Informed Consent: 28 MAY 2021 Demography Details\nYear of If Other,\nAge Sex Race Ethnicity Height Weight\nBirth (yyyy) specify\nNot Hispanic or\n1958 62 FEMALE White Latino 53.6kg Pregnancy Test\nIf post-\nIf sterile, If sterile, Date of Confirm\nIf No, menopausa\nWas test If Other, surgical surgical If Other, Pregnancy Pregnancy the patient\nreason not l, Result\nperformed? specify procedure procedure specify Test Type Test (dd- is not\nperformed menopause\ndate name mon-yyyy) pregnant\ndate\nHysterecto\n31 OCT my with\nNo Sterile No\n2017 Oophorect\nomy Medical History\nCheck for Check for\nMedical History /Finding Start Date (dd-mon- Ongoing at Date resolved (End\n# unknown start unknown end\n(Abnormality) yyyy) study entry? date) (dd-mon-yyyy)\ndate date\n1 DEPRESSION   Ongoing -\n2 ANXIETY   Ongoing -\n3 DYSPEPSIA   Ongoing -\n4 HAY FEVER   Ongoing -\n5 ANEMIA   Ongoing - Concomitant Medications\nDose Start Stop\n# Drug Name Indication Dose Frequency Route Ongoing\nUnit date date\nAdverse Intraveno 09 JUN\n1 MORPHINE 2 mg PRN  \nEvent us 2021\nAdverse 09 JUN\n2 TYLENOL 650 mg PRN Oral  \nEvent 2021\nMedical 24 JUL\n3 WELLBUTRIN 150 mg QD Oral  \nHistory 2019\nMedical 16 JUN\n4 PEPCID 20 mg QD Oral  \nHistory 2020\nMedical 17 JUL\n5 ATIVAN 1 mg PRN Oral  \nHistory 2019\nMedical\n6 BENADRYL 25 mg PRN Oral  \nHistory\nAdverse Subcuta 09 JUN 09 JUN\n7 DEMOROL 12.5 mg PRN -\nEvent neous 2021 2021\nSODIUM CHLORIDE Adverse Intraveno 10 JUN 10 JUN\n8 1000 mL PRN -\n0.9% BOLUS Event us 2021 2021\nProphylaxis 09 JUN 09 JUN\n9 ACETAMINOPHEN 650 mg Other Oral -\nOr Other 2021 2021\nProphylaxis Intraveno 09 JUN 09 JUN\n10 DIPHENHDYRAMINE 25 mg Other -\nOr Other us 2021 2021\nProphylaxis Intraveno 09 JUN 09 JUN\n11 FAMOTIDINE 20 mg Other -\nOr Other us 2021 2021\nProphylaxis 09 JUN 09 JUN\n12 IBUPROFEN 600 mg Other Oral -\nOr Other 2021 2021\nProphylaxis 16 JUN 17 JUN\n13 ACETAMINOPHEN 650 mg Other Oral -\nOr Other 2021 2021\nProphylaxis Intraveno 16 JUN 17 JUN\n14 DIPHENHYDRAMINE 25 mg Other -\nOr Other us 2021 2021\nProphylaxis Intraveno 16 JUN 17 JUN\n15 FAMOTIDINE 20 mg Other -\nOr Other us 2021 2021\nProphylaxis 16 JUN 17 JUN\n16 IBUPROFEN 600 mg Other Oral -\nOr Other 2021 2021\nProphylaxis 23 JUN 24 JUN\n17 ACETAMINOPHEN 650 mg Other Oral -\nOr Other 2021 2021\nProphylaxis Intraveno 23 JUN 24 JUN\n18 DIPHENHYDRAMINE 25 mg Other -\nOr Other us 2021 2021\nProphylaxis Intraveno 23 JUN 24 JUN\n19 FAMOTIDINE 20 mg Other -\nOr Other us 2021 2021\nProphylaxis 23 JUN 24 JUN\n20 IBUPROFEN 600 mg Other Oral -\nOr Other 2021 2021']
apiLogger::2021-10-05 04:25:35,072::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 04:25:35,072::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:25:35,153::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:25:35,157::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:25:35,158::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpipgixz3i 
apiLogger::2021-10-05 04:25:35,158::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:25:35,158::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:25:35,211::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:25:35,211::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpipgixz3i
apiLogger::2021-10-05 04:25:35,466::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:25:35,466::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:25:35,466::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:25:35,466::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:25:35,471::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:35,471::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:25:35,471::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:25:35,471::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:25:35,475::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:35,475::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:25:35,476::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 04:25:35,476::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From: noreply@mdsol.com\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 SAE/AESI form has been updated for Site : 1721840005, Subject : 840005025, AE number : 16\nDate: Friday, August 6, 2021 3:11:05 PM\nDear Project Member,\nPlease be informed that below updates have been made for SAE/AESI in R4018-ONC-1721.\nCountry : World\nSite Number : 1721840005\nSite Name : 840005 - Liu - USA\nSubject number : 840005025\nAdverse event number : 16\nAdverse event term : NEUTROPENIA\nAdverse Start Date : 6 AUG 2021\nSpecify Rationale for Causality to cemiplimab -\nSpecify the Rationale for Causality to REGN4018 - TEMPORAL\nSpecify the Rationale for Causality to Study Conduct -\nSAE/AESI Narrative Text - PATIENT 840005025 ON REGN4108 MONOTHERAPY CAME OFF OF STUDY ON JULY 16, 2021 FOLLOWING\nPROGRESSION OF DISEASE. SHE FOLLOWED UP IN OUR CLINIC TODAY AND LABS REVEALED REBOUND GRADE 4 NEUTROPENIA\n(270). IF YOU RECALL, THIS PATIENT HAD GR 4 NEUTROPENIA FROM 6/30/21-7/16/21 REQUIRING NEUPOGEN SUPPORT FOR\nRECOVERY. SHE WILL FOLLOW UP WITH OUTPATIENT HEMATOLOGY FOR ASSESSMENT AND POTENTIAL BONE MARROW BIOPSY\nLIKELY WITHIN THE WEEK. NO GROWTH STIMULATING FACTOR WAS GIVEN IN OUR CLINIC TODAY. SHE IS FEELING WELL AND\nAFEBRILE AT THIS TIME. WE WILL FOLLOW UP AS WE KNOW MORE ABOUT THIS UNDERLYING PROCESS AND MANAGEMENT\nGUIDANCE FROM HEMATOLOGY. OUT TREATING INVESTIGATOR FEELS THIS IS RELATED TO REGN4018.\nEvent Description (Split 0-200) -\nEvent Description (Split 201-400) -\nEvent Description (Split 401-600) -\nEvent Description (Split 601-800) -\nEvent Description (Split 801-1000) -\nEvent Description (Split 1001-1200) -\nEvent Description (Split 1201-1400) -\nEvent Description (Split 1401-1600) -\nEvent Description (Split 1601-1800) -\nEvent Description (Split 1801-1999) -\nWWRD (GMT): 06 Aug 2021 07:11\nThank you,\nSyneos Health Data Management\nCreated by : Alexis Rabbitt [alexism_rabbitt@dfci.harvard.edu]\nFor further details, please log on to Medidata Rave using the following link :\nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?\nPage=CRFPage.aspx&DP=98276730__;!!OR9aRoiw!Ypf8G7LoFHhfZsSKQhXJC5VbpNIHfJbqWi6WAEPiYQLPpDQKiMRehdjCA5SjppwwEUyHS3A$\n ***********This is a system generated message, Please do not respond to this e-mail.*********** From: noreply@mdsol.com\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 SAE Alert: A new SAE has been reported for the Site : 1721840005, Subject : 840005025, AE Number : 16\nDate: Friday, August 6, 2021 2:58:00 PM\nDear Project Member,\nPlease be informed that a new SAE has been reported for Study R4018-ONC-1721.\nCountry : World\nSite Number : 1721840005\nSite Name : 840005 - Liu - USA\nSubject number : 840005025\nAdverse event number : 16\nMain Adverse Event Description (Term) - NEUTROPENIA\nStart date (dd-mon-yyyy) - 6 AUG 2021\nAE suspected to be caused by REGN4018? - Yes\nAE suspected to be caused by cemiplimab? - Not Applicable\nAE suspected to be caused by study conduct? - No\nIt resulted in death - Not Checked\nIt was life-threatening - Checked\nIt required or prolonged inpatient hospitalization - Not Checked\nPersistent or significant disability / incapacity - Not Checked\nIt is a congenital anomaly/birth defect in offspring of study subject - Not Checked\nOther medically serious important event - Not Checked\nIf Other, specify -\nWWRD (GMT): 06 Aug 2021 06:57\nThank you,\nSyneos Health Data Management\nCreated by : Alexis Rabbitt [alexism_rabbitt@dfci.harvard.edu]\nFor further details, please log on to Medidata Rave using the following link :\nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?\nPage=CRFPage.aspx&DP=96374520__;!!OR9aRoiw!Z236qziaiMmz7Ps89DG7dMxNaBsvrQzqmNK9_v5gtT_G9SQaxAR5PrvWnd3MROjATSk9Gds$\n***********This is a system generated message, Please do not respond to this e-mail.***********']
apiLogger::2021-10-05 04:25:35,476::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 04:25:35,476::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:25:35,551::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:25:35,556::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:25:35,557::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmptml15lt0 
apiLogger::2021-10-05 04:25:35,557::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:25:35,557::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:25:35,686::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:25:35,686::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmptml15lt0
apiLogger::2021-10-05 04:25:36,910::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:25:36,910::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:25:36,910::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:25:36,910::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:25:36,915::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:36,915::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:25:36,915::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:25:36,915::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:25:36,919::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:36,919::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:25:36,920::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 04:25:36,920::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 04:25:36,923::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:36,923::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 04:25:36,924::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 04:25:36,924::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 04:25:36,928::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:36,928::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 04:25:36,928::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 04:25:36,928::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 04:25:36,932::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:36,932::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 04:25:36,932::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 04:25:36,932::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Mandal, Mukesh\nFrom: noreply@mdsol.com\nSent: Wednesday, June 30, 2021 1:20 AM\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 SAE Alert: A new SAE has been reported for\nthe Site : 1721840005, Subject : 840005025, AE Number : 12\nCategories: Mukesh, Agamdeep\nDear\xa0Project\xa0Member,\xa0\n\xa0\nPlease\xa0be\xa0informed\xa0that\xa0a\xa0new\xa0SAE\xa0has\xa0been\xa0reported\xa0for\xa0Study\xa0R4018‐ONC‐1721.\xa0\n\xa0\nCountry\xa0:\xa0World\xa0\nSite\xa0Number\xa0:\xa01721840005\xa0\nSite\xa0Name\xa0:\xa0840005\xa0‐\xa0Liu\xa0‐\xa0USA\xa0\nSubject\xa0number\xa0:\xa0840005025\xa0\nAdverse\xa0event\xa0number\xa0:\xa012\xa0\nMain\xa0Adverse\xa0Event\xa0Description\xa0(Term)\xa0‐\xa0DECREASE\xa0IN\xa0EJECTION\xa0FRACTION\xa0Start\xa0date\xa0(dd‐mon‐yyyy)\xa0‐\xa029\xa0JUN\xa02021\xa0AE\xa0\nsuspected\xa0to\xa0be\xa0caused\xa0by\xa0REGN4018?\xa0‐\xa0Yes\xa0AE\xa0suspected\xa0to\xa0be\xa0caused\xa0by\xa0cemiplimab?\xa0‐\xa0Not\xa0Applicable\xa0AE\xa0suspected\xa0to\xa0\nbe\xa0caused\xa0by\xa0study\xa0conduct?\xa0‐\xa0No\xa0It\xa0resulted\xa0in\xa0death\xa0‐\xa0Not\xa0Checked\xa0It\xa0was\xa0life‐threatening\xa0‐\xa0Not\xa0Checked\xa0It\xa0required\xa0or\xa0\nprolonged\xa0inpatient\xa0hospitalization\xa0‐\xa0Checked\xa0Persistent\xa0or\xa0significant\xa0disability\xa0/\xa0incapacity\xa0‐\xa0Not\xa0Checked\xa0It\xa0is\xa0a\xa0\ncongenital\xa0anomaly/birth\xa0defect\xa0in\xa0offspring\xa0of\xa0study\xa0subject\xa0‐\xa0Not\xa0Checked\xa0Other\xa0medically\xa0serious\xa0important\xa0event\xa0‐\xa0\nNot\xa0Checked\xa0If\xa0Other,\xa0specify\xa0‐\xa0\xa0\n\xa0\nWWRD\xa0(GMT):\xa029\xa0Jun\xa02021\xa007:49\xa0\n\xa0\nThank\xa0you,\xa0\nSyneos\xa0Health\xa0Data\xa0Management\xa0\n\xa0\n\xa0\nCreated\xa0by\xa0:\xa0Alexis\xa0Rabbitt\xa0[alexism_rabbitt@dfci.harvard.edu]\xa0\nFor\xa0further\xa0details,\xa0please\xa0log\xa0on\xa0to\xa0Medidata\xa0Rave\xa0using\xa0the\xa0following\xa0link\xa0:\xa0\nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?Page=CRFPage.aspx&DP=9\n6374520__;!!OR9aRoiw!ehjnsQr98VnP2V0M8vdQ4nFfTC4DFyGi2E03ZRO8maLqWjzoM6D83zlcY7cWQp0Of4MevZ4$\xa0\xa0\n\xa0\n***********This\xa0is\xa0a\xa0system\xa0generated\xa0message,\xa0Please\xa0do\xa0not\xa0respond\xa0to\xa0this\xa0e‐mail.***********\xa0\n1 Mandal, Mukesh\nFrom: noreply@mdsol.com\nSent: Wednesday, June 30, 2021 1:26 AM\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 SAE/AESI form has been updated for Site : \n1721840005, Subject : 840005025, AE number : 12\nCategories: Mukesh, Agamdeep\nDear\xa0Project\xa0Member,\xa0\n\xa0\nPlease\xa0be\xa0informed\xa0that\xa0below\xa0updates\xa0have\xa0been\xa0made\xa0for\xa0SAE/AESI\xa0in\xa0R4018‐ONC‐1721.\xa0\n\xa0\nCountry\xa0:\xa0World\xa0\nSite\xa0Number\xa0:\xa01721840005\xa0\nSite\xa0Name\xa0:\xa0840005\xa0‐\xa0Liu\xa0‐\xa0USA\xa0\nSubject\xa0number\xa0:\xa0840005025\xa0\nAdverse\xa0event\xa0number\xa0:\xa012\xa0\nAdverse\xa0event\xa0term\xa0:\xa0DECREASE\xa0IN\xa0EJECTION\xa0FRACTION\xa0Adverse\xa0Start\xa0Date\xa0:\xa029\xa0JUN\xa02021\xa0Specify\xa0Rationale\xa0for\xa0Causality\xa0\nto\xa0cemiplimab\xa0‐\xa0Specify\xa0the\xa0Rationale\xa0for\xa0Causality\xa0to\xa0REGN4018\xa0‐\xa0Specify\xa0the\xa0Rationale\xa0for\xa0Causality\xa0to\xa0Study\xa0Conduct\xa0‐\xa0\nSAE/AESI\xa0Narrative\xa0Text\xa0‐\xa0Event\xa0Description\xa0(Split\xa00‐200)\xa0‐\xa0Event\xa0Description\xa0(Split\xa0201‐400)\xa0‐\xa0Event\xa0Description\xa0(Split\xa0\n401‐600)\xa0‐\xa0Event\xa0Description\xa0(Split\xa0601‐800)\xa0‐\xa0Event\xa0Description\xa0(Split\xa0801‐1000)\xa0‐\xa0Event\xa0Description\xa0(Split\xa01001‐1200)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa01201‐1400)\xa0‐\xa0Event\xa0Description\xa0(Split\xa01401‐1600)\xa0‐\xa0Event\xa0Description\xa0(Split\xa01601‐1800)\xa0‐\xa0Event\xa0\nDescription\xa0(Split\xa01801‐1999)\xa0‐\xa0SAE/AESI\xa0Narrative\xa0Text\xa0‐\xa0PATIENT\xa0840005025\xa0ON\xa0REGN4018\xa0PRESENTED\xa0TO\xa0CLINIC\xa0\nTODAY\xa06/29/2021\xa0PRIOR\xa0TO\xa0ADMISSION\xa0FOR\xa0C1D22\xa0FULL\xa0DOSE\xa0250MG.\xa0HER\xa0ECHO\xa0PERFORMED\xa0TODAY\xa0SHOWED\xa0\nGRADE\xa0TWO\xa0DECREASE\xa0IN\xa0EJECTION\xa0FRACTION.\xa0BASELINE\xa0EF\xa060%,\xa0TODAY’S\xa0ECHO\xa0REPORTED\xa050%.\xa0LABS\xa0REVEALED\xa0\nGRADE\xa0ONE\xa0TROPONIN\xa0INCREASE.\xa0SHE\xa0REPORTS\xa0NO\xa0CARDIOPULMONARY\xa0SYMPTOMS.\xa0TREATMENT\xa0WILL\xa0BE\xa0HELD\xa0THIS\xa0\nWEEK\xa0AND\xa0SHE\xa0WILL\xa0BE\xa0ADMITTED\xa0FOR\xa0FURTHER\xa0WORK\xa0UP\xa0OF\xa0HER\xa0CARDIAC\xa0FINDINGS.\xa0A\xa0FOLLOW\xa0UP\xa0WITH\xa0BE\xa0\nREPORTED\xa0WHEN\xa0MORE\xa0INFORMATION\xa0BECOMES\xa0AVAILABLE.\xa0THESE\xa0EVENTS\xa0AS\xa0POSSIBLY\xa0RELATED\xa0TO\xa0REGN4018.\xa0\nEvent\xa0Description\xa0(Split\xa00‐200)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa0201‐400)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa0401‐600)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa0601‐800)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa0801‐1000)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa01001‐1200)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa01201‐1400)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa01401‐1600)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa01601‐1800)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa01801‐1999)\xa0‐\xa0\xa0\n\xa0\nWWRD\xa0(GMT):\xa029\xa0Jun\xa02021\xa007:56\xa0\n\xa0\nThank\xa0you,\xa0\nSyneos\xa0Health\xa0Data\xa0Management\xa0\n\xa0\n\xa0\nCreated\xa0by\xa0:\xa0Alexis\xa0Rabbitt\xa0[alexism_rabbitt@dfci.harvard.edu]\xa0\nFor\xa0further\xa0details,\xa0please\xa0log\xa0on\xa0to\xa0Medidata\xa0Rave\xa0using\xa0the\xa0following\xa0link\xa0:\xa0\n1 https://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?Page=CRFPage.aspx&DP=9\n7299239__;!!OR9aRoiw!f6xvGANdhY6aMoHhdtoueqWHKEEE6EUbAUwG6vEU4aI_iW3SHvnoKjBxfIiesYf1voQxTqo$\xa0\xa0\n\xa0\n\xa0\n\xa0***********This\xa0is\xa0a\xa0system\xa0generated\xa0message,\xa0Please\xa0do\xa0not\xa0respond\xa0to\xa0this\xa0e‐mail.***********\xa0\n2 Mandal, Mukesh\nFrom: noreply@mdsol.com\nSent: Wednesday, June 30, 2021 1:27 AM\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 SAE/AESI form has been updated for Site : \n1721840005, Subject : 840005025, AE number : 12\nCategories: Mukesh, Agamdeep\nDear\xa0Project\xa0Member,\xa0\n\xa0\nPlease\xa0be\xa0informed\xa0that\xa0below\xa0updates\xa0have\xa0been\xa0made\xa0for\xa0SAE/AESI\xa0in\xa0R4018‐ONC‐1721.\xa0\n\xa0\nCountry\xa0:\xa0World\xa0\nSite\xa0Number\xa0:\xa01721840005\xa0\nSite\xa0Name\xa0:\xa0840005\xa0‐\xa0Liu\xa0‐\xa0USA\xa0\nSubject\xa0number\xa0:\xa0840005025\xa0\nAdverse\xa0event\xa0number\xa0:\xa012\xa0\nAdverse\xa0event\xa0term\xa0:\xa0DECREASE\xa0IN\xa0EJECTION\xa0FRACTION\xa0Adverse\xa0Start\xa0Date\xa0:\xa029\xa0JUN\xa02021\xa0Specify\xa0Rationale\xa0for\xa0Causality\xa0\nto\xa0cemiplimab\xa0‐\xa0Specify\xa0the\xa0Rationale\xa0for\xa0Causality\xa0to\xa0REGN4018\xa0‐\xa0TEMPORAL\xa0Specify\xa0the\xa0Rationale\xa0for\xa0Causality\xa0to\xa0Study\xa0\nConduct\xa0‐\xa0SAE/AESI\xa0Narrative\xa0Text\xa0‐\xa0Event\xa0Description\xa0(Split\xa00‐200)\xa0‐\xa0Event\xa0Description\xa0(Split\xa0201‐400)\xa0‐\xa0Event\xa0Description\xa0\n(Split\xa0401‐600)\xa0‐\xa0Event\xa0Description\xa0(Split\xa0601‐800)\xa0‐\xa0Event\xa0Description\xa0(Split\xa0801‐1000)\xa0‐\xa0Event\xa0Description\xa0(Split\xa01001‐\n1200)\xa0‐\xa0Event\xa0Description\xa0(Split\xa01201‐1400)\xa0‐\xa0Event\xa0Description\xa0(Split\xa01401‐1600)\xa0‐\xa0Event\xa0Description\xa0(Split\xa01601‐1800)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa01801‐1999)\xa0‐\xa0SAE/AESI\xa0Narrative\xa0Text\xa0‐\xa0PATIENT\xa0840005025\xa0ON\xa0REGN4018\xa0PRESENTED\xa0TO\xa0\nCLINIC\xa0TODAY\xa06/29/2021\xa0PRIOR\xa0TO\xa0ADMISSION\xa0FOR\xa0C1D22\xa0FULL\xa0DOSE\xa0250MG.\xa0HER\xa0ECHO\xa0PERFORMED\xa0TODAY\xa0SHOWED\xa0\nGRADE\xa0TWO\xa0DECREASE\xa0IN\xa0EJECTION\xa0FRACTION.\xa0BASELINE\xa0EF\xa060%,\xa0TODAY’S\xa0ECHO\xa0REPORTED\xa050%.\xa0LABS\xa0REVEALED\xa0\nGRADE\xa0ONE\xa0TROPONIN\xa0INCREASE.\xa0SHE\xa0REPORTS\xa0NO\xa0CARDIOPULMONARY\xa0SYMPTOMS.\xa0TREATMENT\xa0WILL\xa0BE\xa0HELD\xa0THIS\xa0\nWEEK\xa0AND\xa0SHE\xa0WILL\xa0BE\xa0ADMITTED\xa0FOR\xa0FURTHER\xa0WORK\xa0UP\xa0OF\xa0HER\xa0CARDIAC\xa0FINDINGS.\xa0A\xa0FOLLOW\xa0UP\xa0WITH\xa0BE\xa0\nREPORTED\xa0WHEN\xa0MORE\xa0INFORMATION\xa0BECOMES\xa0AVAILABLE.\xa0THESE\xa0EVENTS\xa0AS\xa0POSSIBLY\xa0RELATED\xa0TO\xa0REGN4018.\xa0\nEvent\xa0Description\xa0(Split\xa00‐200)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa0201‐400)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa0401‐600)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa0601‐800)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa0801‐1000)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa01001‐1200)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa01201‐1400)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa01401‐1600)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa01601‐1800)\xa0‐\xa0\nEvent\xa0Description\xa0(Split\xa01801‐1999)\xa0‐\xa0\xa0\n\xa0\nWWRD\xa0(GMT):\xa029\xa0Jun\xa02021\xa007:57\xa0\n\xa0\nThank\xa0you,\xa0\nSyneos\xa0Health\xa0Data\xa0Management\xa0\n\xa0\n\xa0\nCreated\xa0by\xa0:\xa0Alexis\xa0Rabbitt\xa0[alexism_rabbitt@dfci.harvard.edu]\xa0\nFor\xa0further\xa0details,\xa0please\xa0log\xa0on\xa0to\xa0Medidata\xa0Rave\xa0using\xa0the\xa0following\xa0link\xa0:\xa0\n1 https://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?Page=CRFPage.aspx&DP=9\n7299239__;!!OR9aRoiw!Yi9Dz74bZ_ZTRuua‐ARW4qeD9Cgj8AOuc2NuMoxFE9n1yKZhltR4xuEG1I5dYYjLOtm2tv8$\xa0\xa0\n\xa0\n\xa0\n\xa0***********This\xa0is\xa0a\xa0system\xa0generated\xa0message,\xa0Please\xa0do\xa0not\xa0respond\xa0to\xa0this\xa0e‐mail.***********\xa0\n2']
apiLogger::2021-10-05 04:25:36,933::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 04:25:36,933::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:25:37,012::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:25:37,014::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:25:37,014::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpjn1xbxs9 
apiLogger::2021-10-05 04:25:37,015::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:25:37,015::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:25:37,028::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:25:37,028::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpjn1xbxs9
apiLogger::2021-10-05 04:25:37,134::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:25:37,135::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:25:37,135::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:25:37,135::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:25:37,139::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:37,139::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:25:37,139::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:25:37,140::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:25:37,143::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:37,143::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:25:37,143::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 04:25:37,143::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 05-Oct-2021 04:23:41 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Initial/R4018-ONC-1721/Subject: 840005-025/SAE Term: Neutropenia/ MFR date 06-\nAug-2021\nFrom: Saini, Agamdeep <agamdeep.saini@syneoshealth.com> Sent: Friday, August 6, 2021\n3:35 PM To: Regeneron Medical Safety <Medical.Safety@regeneron.com> Cc: Paul Curtis\n<paul.curtis@regeneron.com>; Maryan Hussein <maryan.hussein@regeneron.com>; Tracey\nRowlands <tracey.rowlands@regeneron.com>; Priscila Goncalves\n<priscila.goncalves@regeneron.com>; Tamara Schmidt <tamara.schmidt@regeneron.com>;\nThomas Uldrick <thomas.uldrick@regeneron.com>; Elizabeth Miller\n<elizabeth.miller@regeneron.com>; Quasheeda Fields <quasheeda.fields@regeneron.com>;\nSaleem Shariff <saleem.shariff@regeneron.com>; Jevtovic, Jelena\n<jelena.jevtovic@syneoshealth.com>; IRT BCP Regeneron_Safety\n<Regeneron_Safety@syneoshealth.com> Subject: <External> Initial/R4018-ONC-1721/Subject:\n840005-025/SAE Term: Neutropenia/ MFR date 06-Aug-2021 \n \nEXTERNAL MESSAGE\n \n \nDear Regeneron Colleagues, \n \nPlease find attached initial information for R4018-ONC-1721/Subject: 840009-008. \n \nProtocol: R4018-ONC-1721\nDay 0: 06-Aug-2021\nCountry: USA\nSite # /Investigator: 840005/ Liu\nSubject ID: 840005-025\nStudy Drug(s): REGN4018\nEvent Term: Neutropenia\nOnset date: 6 AUG 2021\nSeverity/Grade: Grade 4 - Life threatening\nSAE Criteria and/or AESI Criteria: Life-threatening /AESI: No\nInvestigator Relationship to Study Drug: Related to REGN4018\nInvestigator Relationship to Study Conduct (if applicable): Not Related\nList of issued urgent queries: N/A\nREGN Argus number: Initial\n \n******** Updated Items ********   \nBest Regards, \nAgamdeep Saini \nSr. Safety &PV Specialist \nSyneos Health, Canada \nDirect: +1 984 459 5521 \nagamdeep.saini@syneoshealth.com \n \nwww.syneoshealth.com  ']
apiLogger::2021-10-05 04:25:37,143::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 04:25:37,143::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:25:37,414::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:25:37,415::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:25:37,416::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmprk6aop5a 
apiLogger::2021-10-05 04:25:37,416::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:25:37,416::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:25:37,429::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:25:37,430::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmprk6aop5a
apiLogger::2021-10-05 04:25:37,588::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:25:37,588::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:25:37,588::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:25:37,588::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:25:37,593::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:37,593::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:25:37,593::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:25:37,593::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:25:37,597::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:25:37,597::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:25:37,597::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 04:25:37,597::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 05-Oct-2021 04:25:00 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Initial/R4018-ONC-1721/Subject: 840005-025/SAE Terms: DECREASE IN EJECTION\nFRACTION, TROPONIN INCREASE/ MFR date 29-Jun-2021\nFrom: Mandal, Mukesh <mukesh.mandal@syneoshealth.com> Sent: Wednesday, June 30, 2021\n4:01 AM To: Regeneron Medical Safety <Medical.Safety@regeneron.com> Cc: Paul Curtis\n<paul.curtis@regeneron.com>; Maryan Hussein-External <maryan.hussein@regeneron.com>;\nTracey Rowlands <tracey.rowlands@regeneron.com>; Priscila Goncalves\n<priscila.goncalves@regeneron.com>; Tamara Schmidt <tamara.schmidt@regeneron.com>;\nQuasheeda Fields <quasheeda.fields@regeneron.com>; Saleem Shariff\n<saleem.shariff@regeneron.com>; Jevtovic, Jelena <jelena.jevtovic@syneoshealth.com>; IRT\nBCP Regeneron_Safety <Regeneron_Safety@syneoshealth.com> Subject: <External>\nInitial/R4018-ONC-1721/Subject: 840005-025/SAE Terms: DECREASE IN EJECTION\nFRACTION, TROPONIN INCREASE/ MFR date 29-Jun-2021 \n \nEXTERNAL MESSAGE\n \n \nDear Regeneron Colleagues, \n \nPlease find attached an Initial information for R4018-ONC-1721/Subject: 840005-025. \n \nProtocol: R4018-ONC-1721\nDay 0: 29-Jun-2021\nCountry: USA\nSite # /Investigator: 840005/ Liu\nSubject ID: 840005-025\nStudy Drug(s): REGN4018\nEvent Term: DECREASE IN EJECTION FRACTION\nOnset date: 29-JUN-2021\nSeverity/Grade: Grade 2- Moderate\nSAE Criteria and/or AESI Criteria:  Hospitalization/AESI: No\nInvestigator Relationship to Study Drug: Related to REGN4018\nInvestigator Relationship to Study Conduct (if applicable): Not related\nList of issued urgent queries: N/A\nREGN Argus number: Initial\n \n******** Updated Items ******** \n  Event Term: TROPONIN INCREASE\nOnset date: 29-JUN-2021\nSeverity/Grade: Grade 1 - Mild\nSAE Criteria and/or AESI Criteria: Hospitalization/AESI: No\nInvestigator Relationship to Study Drug: Related to REGN4018\nInvestigator Relationship to Study Conduct (if applicable): Not related\nList of issued urgent queries: N/A\nREGN Argus number: Initial\n \n******** Updated Items ******** \nThank you. \n \nKind Regards \nMukesh Mandal \nM.S. Pharma (Pharmacology &Toxicology) \nSafety &PV Specialist I \nDrug Safety &Pharmacovigilanc \nSyneos Health|14th Flr,Tower-B, Building#14,DLF Cyber City,Gurgaon| INDIA| \nMobile: +91 7903174994 \nmukesh.mandal@syneoshealth.com I syneoshealth.com I \n \nEMAIL DISCLAIMER NOTICE: Syneos Health, (the “Company”). This email and any files\ntransmitted may contain information that is privileged, confidential and exempt from disclosure and\nis intended solely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct transactions by\nelectronic means nor creates any legally binding contract or enforceable obligation in the absence\nof a fully signed written contract. Any views or opinions expressed are solely those of the author\nand do not necessarily represent those of the Company. Although the Company has taken\nreasonable precautions to ensure no viruses are present in this email, the Company cannot accept\nresponsibility for any loss or damage arising from the use of this email or attachments. ']
apiLogger::2021-10-05 04:25:37,597::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 04:25:37,597::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:29:18,866::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:29:18,891::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:29:18,891::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpippmrmzq 
apiLogger::2021-10-05 04:29:18,893::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:29:18,893::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:29:23,019::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:29:23,019::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpippmrmzq
apiLogger::2021-10-05 04:29:33,393::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:29:33,393::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:29:33,393::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:29:33,393::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:29:33,398::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:29:33,398::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:29:33,398::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:29:33,398::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:29:33,402::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:29:33,402::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:29:33,402::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 04:29:33,403::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 04:29:33,407::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:29:33,407::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 04:29:33,407::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 04:29:33,407::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 04:29:33,411::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:29:33,411::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 04:29:33,411::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 04:29:33,411::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 04:29:33,416::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:29:33,416::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 04:29:33,416::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 04:29:33,416::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '6/24/2021 CRF\n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Agamdeep Saini (Safety)\nR4018-ONC-1721 840004 - O\'Malley - USA 840004020 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS Subject ID: 840004020\nAdverse Events Yes/No\nAdverse Event Subject: 840004020\nPage: Adverse Event - ADVERSE EVENTS\nCRF History   CCulicrrke hnetlyre v tioe wreintugr nlin teo  2"C0 oomf 2p0le.te View". Apply to Record\n840004020 - Adverse\nEvent Main Adverse Event Description (Term) NEUTROPHIL COUNT DECREASED\n   \n840004020 - Adverse\nEvents Yes/No SOC 10022891Investigations\nHLGT10018851Haematology investigations (incl blood groups)\n840004020 - Serious\nAdverse Event/AESI # 20 HLT 10047938White blood cell analyses\nPT 10029366Neutrophil count decreased\n840004020 - Serious\nLLT 10029366Neutrophil count decreased\nAdverse Event/AESI # 02\n840004020 - Serious Start date (dd-mon-yyyy) 16 JUN 2021\nAdverse Event/AESI # 01\nIf event occurred on study day 1, did the event occur prior to first study drug\nNot Applicable\nadministration\nIf the event is part of an Infusion Related Reaction or Cytokine Release Syndrome,\nplease check the box and complete Immune Related Response/Cytokine Release\nSyndrome CRF\nIs this AE related to the immune-mediated mechanism of action of\nREGN4018/Cemiplimab?\n(Please complete associated CRFs for time frame, symptoms and signs, and\nvital sign changes. On the corresponding CRFs for this AE, please enter\ninterventions for management (eg. Medications, rate reduction))\nSelect if AE is intermittent No\nCAUSALITY\nAE suspected to be caused by REGN4018? Yes\nAE suspected to be caused by cemiplimab?\nStart date is present; however, response to \'AE suspected to be caused by\ncemiplimab?\' is missing. Please review data entered and update as appropriate.\nOpened To Site from System (24 Jun 2021)\nAE suspected to be caused by study conduct?\nStart date is present; however, response to \'AE suspected to be caused by study\nconduct?\' is missing. Please review data entered and update as appropriate.\nOpened To Site from System (24 Jun 2021)\n---If Yes, specify\nACTION TAKEN\nAction taken with REGN4018 Dose Reduced\nAction taken with cemiplimab\nStart date is present; however, response to \'Action taken with cemiplimab\' is\nmissing. Please review data entered and update as appropriate.\nOpened To Site from System (24 Jun 2021)\nData is required. Please complete.\nClick Here for COusptoemneerd S Tuopp Soritt eIn ffroormma tSioynstem (24 Jun 2021) Medidata Classic Rave® 2020.3.2 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(k4kf03qf0kedjt3eelgn2efp))/Modules/EDC/CRFPage.aspx?DP=95593582 1/4 6/24/2021 CRF\nIf Other, specify\n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Agamdeep Saini (Safety)\nIf the Event is not study drug related but belongs to the sponsor list of immune related\neveRnt4, 0p1le8a-OseN pCr-o1v7id2e1 the e8t4io0lo0g0y4 - O\'Malley - USA 840004020 ADVERSE EVENTS Adverse Event\nIf Other, specify\nADVERSE EVENTS\nAdverse Events Yes/No\nOutcome of AE Not recovered/Not resolved\nAdverse Event\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nCRF History\n840004020 - Adverse Resolution date (dd-mon-yyyy)\nEvent\n840004020 - Adverse AE initial severity CTCAE grade Grade 4 - Life threatening\nEvents Yes/No\n840004020 - Serious AE most extreme severity CTCAE grade Grade 4 - Life threatening\nAdverse Event/AESI # 20\n840004020 - Serious Date Event Became Grade 3 or higher - if applicable (dd-mon-yyyy)\nAdverse Event/AESI # 02 AE most extreme severity CTCAE grade is Grade 3 or higher, but \'Date Event\n840004020 - Serious Became Grade 3 or higher - if applicable\' is blank. Please review data entered\nAdverse Event/AESI # 01 and update as appropriate.\nOpened To Site from System (24 Jun 2021)\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nTreatment for AE (select all that apply except when NONE is noted): for drug\ntherapy or medication please enter into concomitant medications eCRF; If\nprocedure or surgery please enter into the on-study procedure/surgery eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nClick Here for Customer Support Information Medidata Classic Rave® 2020.3.2 \nConcomitant procedure/surgery #3 Copyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(k4kf03qf0kedjt3eelgn2efp))/Modules/EDC/CRFPage.aspx?DP=95593582 2/4 6/24/2021 CRF\n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Agamdeep Saini (Safety)\nConcomitant procedure/surgery #4\nR4018-ONC-1721 840004 - O\'Malley - USA 840004020 ADVERSE EVENTS Adverse Event\nConcomitant procedure/surgery #5\nADVERSE EVENTS\nAdverse Events Yes/No Other\nAdverse Event\nIf Other, specify\nCRF History\n840004020 - Adverse Does this AE qualify as Serious? (If YES, complete SAE/AESI Form) No\nEvent\nComplete the following fields ONLY if Adverse Event qualifies as either serious\n840004020 - Adverse or as an event of special interest (AESI) per protocol. If AE does not meet criteria\nEvents Yes/No for either SAE or AESI then STOP here.\n840004020 - Serious\nAdverse Event/AESI # 20 FOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \n840004020 - Serious CHECK ALL THAT APPLY\nAdverse Event/AESI # 02\n840004020 - Serious It resulted in death\nAdverse Event/AESI # 01\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious\ncriteria, but may jeopardize the subject, and may require medical or surgical\nintervention to prevent one of the outcomes listed above).\nIf Other, specify\nIs this an AE of Special Interest (AESI)? (If YES, complete SAE/AESI Form)\nIs this an AE of Special interest (AESI)? is Yes, yet AESI criteria is not selected.\nYes\nPlease select all that apply.\nOpened To Site from System (24 Jun 2021)\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nAny AE that meets DLT criteria at any time while on treatment\nGrade 2 or greater Infusion-Related Reactions associated with study drug infusions\nGrade 2 or greater pain syndrome temporally related to study drug infusion in the\nopinion of the investigator\nGrade 2 or greater Cytokine Release Syndrome\nGrade 2 or greater allergic/hypersensitivity reactions\nAn irAE of any grade in a patient previously treated with a PI 3-K inhibitor\nPericardial effusions of any size\nGrade ≥2 treatment-emergent pleural effusion (clinically significant new effusion and/or\nClick Hae rec lfoinr Cicuastlolym esr iSgunppifoicrt aInnfotr mcahtiaonnge in size of an existing effusion) Medidata Classic Rave® 2020.3.2 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(k4kf03qf0kedjt3eelgn2efp))/Modules/EDC/CRFPage.aspx?DP=95593582 3/4 6/24/2021 CRF\nGrade ≥2 Treatment-emergent ascites (clinically significant new ascite and/or a\n iMedidata   Messages   My Profile   Help   Home   Logout\nclinically significant change in size of existing ascites)\nUser: Agamdeep Saini (Safety)\nNote: An irAE can occur shortly after the first dose or several months after the last\ndosRe 4o0f 1tr8e-aOtNmCen-1t.7 A21ll AEs 8o4f 0u0n0k4n o- wOn\'M eatiloleloyg -y U aSssAociate8d4 w00it0h4 d0r2u0g expoAsDuVreE sRhSoEu lEdVENTS Adverse Event\nbe evaluated to determine possible immune etiology. If an irAE is suspected, efforts\nADVERSE EVENTS should be made to rule out neoplastic, infectious, metabolic, toxin or other etiologic\nAdverse Events Yes/No causes prior to labeling an AE as an irAE.\nAdverse Event Date Time 24 JUN 2021 08:21:26\n \nCRF History\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n840004020 - Adverse CRF Version 9193 - Page Generated: 24 Jun 2021 12:09:51 Eastern Daylight Time\nEvent\n840004020 - Adverse\nEvents Yes/No\n840004020 - Serious\nAdverse Event/AESI # 20\n840004020 - Serious\nAdverse Event/AESI # 02\n840004020 - Serious\nAdverse Event/AESI # 01\nClick Here for Customer Support Information Medidata Classic Rave® 2020.3.2 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(k4kf03qf0kedjt3eelgn2efp))/Modules/EDC/CRFPage.aspx?DP=95593582 4/4 6/24/2021 CRF\n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Agamdeep Saini (Safety)\nR4018-ONC-1721 840004 - O\'Malley - USA 840004020 SERIOUS ADVERSE EVENTS/AESI (1) Serious Adverse Event/AESI # 20\nSERIOUS ADVERSE Subject ID: 840004020\nEVENTS/AESI (1)\nSerious Adverse Subject: 840004020\nEvent/AESI # 01\nPage: Serious Adverse Event/AESI # 20 - SERIOUS ADVERSE EVENTS/AESI (1)\nSerious Adverse\nEvent/AESI # 02 AE number 20\nSerious Adverse\nEvent/AESI # 20 Adverse Event Description (Term) NEUTROPHIL COUNT DECREASED\n   \nCRF History SOC 10022891Investigations\n840004020 - Serious HLGT10018851Haematology investigations (incl blood groups)\nAdverse Event/AESI # 20 HLT 10047938White blood cell analyses\nPT 10029366Neutrophil count decreased\n840004020 - Serious\nLLT 10029366Neutrophil count decreased\nAdverse Event/AESI # 02\n840004020 - Serious Start Date (dd-mon-yyyy) 16 JUN 2021\nAdverse Event/AESI # 01\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN4018 INVESTIGATORS REVIEWED AS "PROBABLY-RELATED" TO\nREGN4018 THERAPY, TEMPORALLY RELATED TO REGN4018\nINFUSION\nSpecify Rationale for Causality to cemiplimab\nSpecify the Rationale for Causality to Study Conduct\nSAE/AESI NARRATIVE\n#  SAE/AESI Narrative Text\nSUBJECT 840004-020 DEVELOPED GRADE 4 NEUTROPENIA (0.34 K/UL) THE DAY FOLLOWING FIRST COMBINATION DOSE - CYCLE 2 DAY 1:\nREGN4018 @ 60 MG + CEMIPLIMAB @ 350 MG – ON 16-JUN-2021. PATIENT WAS ASYMPTOMATIC AND AFEBRILE AT OCCURRENCE WITH\nNEUTROPHIL COUNT RE-CHECKED BEFORE END OF 24 HOUR OBSERVATION PERIOD ON 16-JUN-2021 WHICH CONTINUED TO\nDEMONSTRATE ONGOING GRADE 4 NEUTROPENIA (0.18 K/UL). PATIENT COMPLETED 48 HOUR (17-JUN-2021 - 0.14 K/UL) AND 72 HOUR (18-\nJUN-2021 - 0.05 K/UL) SAFETY LAB CHECKS THAT CONTINUED TO DEMONSTRATE ONGOING GRADE 4 NEUTROPENIA - PATIENT STILL\nREMAINED ASYMPTOMATIC AND AFEBRILE AND REFUSED STARTING ANY PROPHYLACTIC ANTIBIOTICS. PATIENT WAS PLANNED FOR\nCYCLE 2 DAY 8 REGN4018 @ 60 MG DOSE THE FOLLOWING WEEK WITH PRE-TREATMENT HEMATOLOGY LAB CHECKED ON 21-JUN-2021\n1 THAT SHOWED ONGOING GRADE 4 NEUTROPENIA (0.15 K/UL). SITE PI REVIEWED PATIENT’S GRADE 4 NEUTROPENIA DID NOT MEET SAE\nREPORTING CRITERIA (I.E., “OTHER MEDICALLY SERIOUS IMPORTANT EVENT”) AFTER EXTENSIVE DISCUSSION ON 21-JUN-2021\nCONFERENCE CALL AND CONFIRMED PLAN TO DELAY UNTIL NEUTROPHIL COUNTS RECOVERED TO >/= 1.0 K/UL (GRADE 2). PATIENT\'S\nTREATMENT WAS DELAYED WITH PLAN TO RE-CHECK NEUTROPHIL RECOVERY ON 23-JUN-2021 WHICH CONFIRMED ONGOING GRADE 4\nNEUTROPENIA (0.13 K/UL). SITE INVESTIGATORS MADE AWARE OF PERSISTENT GRADE 4 NEUTROPENIA AND INDICATED AE AS\nPROBABLY-RELATED TO REGN4018 THERAPY. SPONSOR MADE AWARE OF PERSISTENT GRADE 4 NEUTROPENIA AND CONFIRMED\nPATIENT MEETS DOSE LIMITING TOXICITY REQUIRING PATIENT TO DOSE REDUCE TO NEXT LOWEST DOSE LEVEL - DLC4A (NOW TO DOSE\nWITH REGN4018 @ 20 MG + CEMIPLIMAB @ 350 MG).\nNO OTHER DIAGNOSTIC TESTS/LABS WERE USED TO EVALUATE AE. PATIENT IS PLANNED FOR HEMATOLOGY LAB CHECK TODAY TO\n2\nCHECK NEUTROPHIL COUNT STATUS. WILL CONTINUE TO UPDATE REPORT WITH ANY NEW INFORMATION AS IT BECOMES AVAILABLE.\n   \nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 9193 - Page Generated: 24 Jun 2021 12:09:21 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.3.2 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(k4kf03qf0kedjt3eelgn2efp))/Modules/EDC/CRFPage.aspx?DP=97248195 1/1']
apiLogger::2021-10-05 04:29:33,416::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 04:29:33,416::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:29:33,812::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:29:33,817::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:29:33,817::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp46hby2ze 
apiLogger::2021-10-05 04:29:33,818::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:29:33,818::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:29:33,915::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:29:33,916::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp46hby2ze
apiLogger::2021-10-05 04:29:34,467::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:29:34,468::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:29:34,468::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:29:34,468::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:29:34,472::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:29:34,473::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:29:34,473::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:29:34,473::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:29:34,477::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:29:34,478::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:29:34,478::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 04:29:34,478::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 04:29:34,481::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:29:34,481::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 04:29:34,482::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 04:29:34,482::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 04:29:34,486::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:29:34,486::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 04:29:34,486::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 04:29:34,486::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 04:29:34,490::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:29:34,490::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 04:29:34,490::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 04:29:34,490::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From: noreply@mdsol.com\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 AESI Alert: An adverse event of special interest has been reported\nfor the Site : 1721840004, Subject : 840004020, AE Number : 20\nDate: Thursday, June 24, 2021 8:22:33 AM\nDear Project Member,\nPlease be informed that a new AESI has been reported for Study R4018-ONC-1721.\nCountry : World\nSite Number : 1721840004\nSite Name : 840004 - O\'Malley - USA\nSubject number : 840004020\nAdverse event number : 20\nMain Adverse Event Description (Term) - NEUTROPHIL COUNT DECREASED\nStart date (dd-mon-yyyy) - 16 JUN 2021\nAE suspected to be caused by REGN4018? - Yes\nAE suspected to be caused by cemiplimab? -\nAE suspected to be caused by study conduct? -\nAny AE that meets DLT criteria at any time while on treatment - Checked\nGrade 2 or greater Infusion-Related Reactions associated with study drug infusions - Not Checked\nGrade 2 or greater pain syndrome temporally related to study drug infusion in the opinion of the investigator - Not\nChecked\nGrade 2 or greater Cytokine Release Syndrome - Not Checked\nGrade 2 or greater allergic/hypersensitivity reactions - Not Checked\nAn irAE of any grade in a patient previously treated with a PI 3-K inhibitor - Not Checked\nPericardial effusions of any size - Not Checked\nGrade ≥2 treatment-emergent pleural effusion (clinically significant new effusion and/or a clinically significant\nchange in size of an existing effusion) - Not Checked\nGrade ≥2 Treatment-emergent ascites (clinically significant new ascite\nand/or a clinically significant change in size of existing ascites) - Not Checked\nWWRD (GMT): 24 Jun 2021 12:22\nThank you,\nSyneoa Health Data Management\nCreated by : Ridge Archer [ridge.archer@osumc.edu]\nFor further details, please log on to Medidata Rave using the following link :\nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?\nPage=CRFPage.aspx&DP=95593582__;!!OR9aRoiw!byymHzh-\ndPncgkRYGzcqmzyXVt3A9byeKpIVOGZiV4Dh1v34kOWjB-s4_0WPcrCtq_0el9s$\n***********This is a system generated message, Please do not respond to this e-mail.*********** From: noreply@mdsol.com\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 SAE/AESI form has been updated for Site : 1721840004, Subject : 840004020,\nAE number : 20\nDate: Thursday, June 24, 2021 9:02:05 AM\nDear Project Member,\nPlease be informed that below updates have been made for SAE/AESI in R4018-ONC-1721.\nCountry : World\nSite Number : 1721840004\nSite Name : 840004 - O\'Malley - USA\nSubject number : 840004020\nAdverse event number : 20\nAdverse event term : NEUTROPHIL COUNT DECREASED\nAdverse Start Date : 16 JUN 2021\nSpecify Rationale for Causality to cemiplimab -\nSpecify the Rationale for Causality to REGN4018 - INVESTIGATORS REVIEWED AS "PROBABLY-RELATED" TO\nREGN4018 THERAPY, TEMPORALLY RELATED TO REGN4018 INFUSION\nSpecify the Rationale for Causality to Study Conduct -\nSAE/AESI Narrative Text - SUBJECT 840004-020 DEVELOPED GRADE 4 NEUTROPENIA (0.34 K/UL) THE DAY\nFOLLOWING FIRST COMBINATION DOSE - CYCLE 2 DAY 1: REGN4018 @ 60 MG + CEMIPLIMAB @ 350 MG –\nON 16-JUN-2021. PATIENT WAS ASYMPTOMATIC AND AFEBRILE AT OCCURRENCE WITH NEUTROPHIL\nCOUNT RE-CHECKED BEFORE END OF 24 HOUR OBSERVATION PERIOD ON 16-JUN-2021 WHICH CONTINUED\nTO DEMONSTRATE ONGOING GRADE 4 NEUTROPENIA (0.18 K/UL). PATIENT COMPLETED 48 HOUR (17-JUN-\n2021 - 0.14 K/UL) AND 72 HOUR (18-JUN-2021 - 0.05 K/UL) SAFETY LAB CHECKS THAT CONTINUED TO\nDEMONSTRATE ONGOING GRADE 4 NEUTROPENIA - PATIENT STILL REMAINED ASYMPTOMATIC AND\nAFEBRILE AND REFUSED STARTING ANY PROPHYLACTIC ANTIBIOTICS. PATIENT WAS PLANNED FOR\nCYCLE 2 DAY 8 REGN4018 @ 60 MG DOSE THE FOLLOWING WEEK WITH PRE-TREATMENT HEMATOLOGY\nLAB CHECKED ON 21-JUN-2021 THAT SHOWED ONGOING GRADE 4 NEUTROPENIA (0.15 K/UL). SITE PI\nREVIEWED PATIENT’S GRADE 4 NEUTROPENIA DID NOT MEET SAE REPORTING CRITERIA (I.E., “OTHER\nMEDICALLY SERI!\n OUS IMPORTANT EVENT”) AFTER EXTENSIVE DISCUSSION ON 21-JUN-2021 CONFERENCE CALL AND\nCONFIRMED PLAN TO DELAY UNTIL NEUTROPHIL COUNTS RECOVERED TO >/= 1.0 K/UL (GRADE 2).\nPATIENT\'S TREATMENT WAS DELAYED WITH PLAN TO RE-CHECK NEUTROPHIL RECOVERY ON 23-JUN-2021\nWHICH CONFIRMED ONGOING GRADE 4 NEUTROPENIA (0.13 K/UL).  SITE INVESTIGATORS MADE AWARE OF\nPERSISTENT GRADE 4 NEUTROPENIA AND INDICATED AE AS PROBABLY-RELATED TO REGN4018 THERAPY.\nSPONSOR MADE AWARE OF PERSISTENT GRADE 4 NEUTROPENIA AND CONFIRMED PATIENT MEETS DOSE\nLIMITING TOXICITY REQUIRING PATIENT TO DOSE REDUCE TO NEXT LOWEST DOSE LEVEL - DLC4A (NOW\nTO DOSE WITH REGN4018 @ 20 MG + CEMIPLIMAB @ 350 MG).\nEvent Description (Split 0-200) -\nEvent Description (Split 201-400) -\nEvent Description (Split 401-600) -\nEvent Description (Split 601-800) -\nEvent Description (Split 801-1000) -\nEvent Description (Split 1001-1200) -\nEvent Description (Split 1201-1400) -\nEvent Description (Split 1401-1600) -\nEvent Description (Split 1601-1800) -\nEvent Description (Split 1801-1999) -\nWWRD (GMT): 24 Jun 2021 01:01\nThank you,\nSyneos Health Data Management\nCreated by : Ridge Archer [ridge.archer@osumc.edu]\nFor further details, please log on to Medidata Rave using the following link :\nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx? Page=CRFPage.aspx&DP=97248195__;!!OR9aRoiw!ZO2X4N_Ys2heO9hqYDuo7FLJ5GRgk_iwh80RyYMoOpFDaOAOumb-\nHpptdOM8j5OaUau6UCY$\n ***********This is a system generated message, Please do not respond to this e-mail.*********** From: noreply@mdsol.com\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 SAE/AESI form has been updated for Site : 1721840004, Subject :\n840004020, AE number : 20\nDate: Thursday, June 24, 2021 9:18:34 AM\nDear Project Member,\nPlease be informed that below updates have been made for SAE/AESI in R4018-ONC-1721.\nCountry : World\nSite Number : 1721840004\nSite Name : 840004 - O\'Malley - USA\nSubject number : 840004020\nAdverse event number : 20\nAdverse event term : NEUTROPHIL COUNT DECREASED\nAdverse Start Date : 16 JUN 2021\nSpecify Rationale for Causality to cemiplimab -\nSpecify the Rationale for Causality to REGN4018 - INVESTIGATORS REVIEWED AS "PROBABLY-\nRELATED" TO REGN4018 THERAPY, TEMPORALLY RELATED TO REGN4018 INFUSION\nSpecify the Rationale for Causality to Study Conduct -\nSAE/AESI Narrative Text - SUBJECT 840004-020 DEVELOPED GRADE 4 NEUTROPENIA (0.34 K/UL) THE\nDAY FOLLOWING FIRST COMBINATION DOSE - CYCLE 2 DAY 1: REGN4018 @ 60 MG + CEMIPLIMAB\n@ 350 MG – ON 16-JUN-2021. PATIENT WAS ASYMPTOMATIC AND AFEBRILE AT OCCURRENCE\nWITH NEUTROPHIL COUNT RE-CHECKED BEFORE END OF 24 HOUR OBSERVATION PERIOD ON 16-\nJUN-2021 WHICH CONTINUED TO DEMONSTRATE ONGOING GRADE 4 NEUTROPENIA (0.18 K/UL).\nPATIENT COMPLETED 48 HOUR (17-JUN-2021 - 0.14 K/UL) AND 72 HOUR (18-JUN-2021 - 0.05 K/UL)\nSAFETY LAB CHECKS THAT CONTINUED TO DEMONSTRATE ONGOING GRADE 4 NEUTROPENIA -\nPATIENT STILL REMAINED ASYMPTOMATIC AND AFEBRILE AND REFUSED STARTING ANY\nPROPHYLACTIC ANTIBIOTICS. PATIENT WAS PLANNED FOR CYCLE 2 DAY 8 REGN4018 @ 60 MG\nDOSE THE FOLLOWING WEEK WITH PRE-TREATMENT HEMATOLOGY LAB CHECKED ON 21-JUN-\n2021 THAT SHOWED ONGOING GRADE 4 NEUTROPENIA (0.15 K/UL). SITE PI REVIEWED PATIENT’S\nGRADE 4 NEUTROPENIA DID NOT MEET SAE REPORTING CRITERIA (I.E., “OTHER MEDICALLY\nSERI!\n OUS IMPORTANT EVENT”) AFTER EXTENSIVE DISCUSSION ON 21-JUN-2021 CONFERENCE CALL\nAND CONFIRMED PLAN TO DELAY UNTIL NEUTROPHIL COUNTS RECOVERED TO >/= 1.0 K/UL\n(GRADE 2). PATIENT\'S TREATMENT WAS DELAYED WITH PLAN TO RE-CHECK NEUTROPHIL\nRECOVERY ON 23-JUN-2021 WHICH CONFIRMED ONGOING GRADE 4 NEUTROPENIA (0.13 K/UL). \nSITE INVESTIGATORS MADE AWARE OF PERSISTENT GRADE 4 NEUTROPENIA AND INDICATED AE\nAS PROBABLY-RELATED TO REGN4018 THERAPY. SPONSOR MADE AWARE OF PERSISTENT GRADE\n4 NEUTROPENIA AND CONFIRMED PATIENT MEETS DOSE LIMITING TOXICITY REQUIRING\nPATIENT TO DOSE REDUCE TO NEXT LOWEST DOSE LEVEL - DLC4A (NOW TO DOSE WITH\nREGN4018 @ 20 MG + CEMIPLIMAB @ 350 MG).\nEvent Description (Split 0-200) -\nEvent Description (Split 201-400) -\nEvent Description (Split 401-600) -\nEvent Description (Split 601-800) -\nEvent Description (Split 801-1000) -\nEvent Description (Split 1001-1200) -\nEvent Description (Split 1201-1400) -\nEvent Description (Split 1401-1600) -\nEvent Description (Split 1601-1800) -\nEvent Description (Split 1801-1999) -\nSAE/AESI Narrative Text -\nEvent Description (Split 0-200) - Event Description (Split 201-400) -\nEvent Description (Split 401-600) -\nEvent Description (Split 601-800) -\nEvent Description (Split 801-1000) -\nEvent Description (Split 1001-1200) -\nEvent Description (Split 1201-1400) -\nEvent Description (Split 1401-1600) -\nEvent Description (Split 1601-1800) -\nEvent Description (Split 1801-1999) -\nWWRD (GMT): 24 Jun 2021 01:18\nThank you,\nSyneos Health Data Management\nCreated by : Ridge Archer [ridge.archer@osumc.edu]\nFor further details, please log on to Medidata Rave using the following link :\nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?\nPage=CRFPage.aspx&DP=97248195__;!!OR9aRoiw!eDCq1Uv8xPDNVNIP8cbF8jHCdnWmtF_uVEK-\nPakjd41_1IGjJzq9cbwN8F0IFMMwD7TtFRM$\n ***********This is a system generated message, Please do not respond to this e-mail.***********']
apiLogger::2021-10-05 04:29:34,491::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 04:29:34,491::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:29:34,947::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:29:34,948::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:29:34,949::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpt86hc2ws 
apiLogger::2021-10-05 04:29:34,949::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:29:34,949::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:29:34,962::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:29:34,962::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpt86hc2ws
apiLogger::2021-10-05 04:29:35,073::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:29:35,073::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:29:35,073::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:29:35,073::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:29:35,078::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:29:35,078::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:29:35,078::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:29:35,078::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:29:35,082::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:29:35,082::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:29:35,082::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 04:29:35,082::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 05-Oct-2021 04:27:35 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Initial /R4018-ONC-1721/Subject: 840004-020/SAE Terms: NEUTROPHIL COUNT\nDECREASED/ MFR date 24-Jun-2021\nFrom: Saini, Agamdeep <agamdeep.saini@syneoshealth.com> Sent: Thursday, June 24, 2021\n12:52 PM To: Regeneron Medical Safety <Medical.Safety@regeneron.com> Cc: Paul Curtis\n<paul.curtis@regeneron.com>; Maryan Hussein-External <maryan.hussein@regeneron.com>;\nTracey Rowlands <tracey.rowlands@regeneron.com>; Priscila Goncalves\n<priscila.goncalves@regeneron.com>; Tamara Schmidt <tamara.schmidt@regeneron.com>;\nQuasheeda Fields <quasheeda.fields@regeneron.com>; Saleem Shariff\n<saleem.shariff@regeneron.com>; IRT BCP Regeneron_Safety\n<Regeneron_Safety@syneoshealth.com>; Jevtovic, Jelena <jelena.jevtovic@syneoshealth.com>\nSubject: <External> Initial /R4018-ONC-1721/Subject: 840004-020/SAE Terms: NEUTROPHIL\nCOUNT DECREASED/ MFR date 24-Jun-2021 \n \nEXTERNAL MESSAGE\n \n \nDear Regeneron Colleagues, \n \nPlease find attached an Initial information for R4018-ONC-1721/Subject: 840004-020. \n \nProtocol: R4018-ONC-1721\nDay 0: 24-Jun-2021\nCountry: USA\nSite # /Investigator: 840004/ O\'Malley\nSubject ID: 840004-020\nStudy Drug(s): REGN4018\nEvent Term: NEUTROPHIL COUNT DECREASED\nOnset date: 16 JUN 2021\nSeverity/Grade: Grade 4 - Life threatening\nSAE Criteria and/or AESI Criteria: Non Serious/AESI: Yes, Any AE that meets DLT criteria at any\ntime while on treatment\nInvestigator Relationship to Study Drug: Related to REGN4018\nInvestigator Relationship to Study Conduct (if applicable): Not reported\nList of issued urgent queries: For the event of NEUTROPHIL COUNT DECREASED (onset date:\n16-Jun-2021), It was reported the event is considered as Grade 4 - Life threatening, however no\nseriousness criteria is selected for the event. Could you please review and update appropriately.\nREGN Argus number: Initial  \n******** Updated Items ******** \n \n \nBest Regards, \nAgamdeep Saini \nSr. Safety &PV Specialist \nSyneos Health \nDirect: +1 984 459 5521 \nagamdeep.saini@syneoshealth.com \n \nwww.syneoshealth.com  ']
apiLogger::2021-10-05 04:29:35,082::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 04:29:35,082::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:31:18,854::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:31:18,862::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:31:18,862::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp2hqaor98 
apiLogger::2021-10-05 04:31:18,863::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:31:18,863::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:31:18,893::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:31:18,893::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp2hqaor98
apiLogger::2021-10-05 04:31:19,410::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:31:19,410::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:31:19,411::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:31:19,411::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:31:19,415::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:31:19,415::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:31:19,415::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:31:19,415::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:31:19,419::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:31:19,420::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:31:19,420::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 04:31:19,420::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 04:31:19,423::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:31:19,423::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 04:31:19,424::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 04:31:19,424::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 04:31:19,427::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:31:19,428::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 04:31:19,428::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 04:31:19,428::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 04:31:19,431::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:31:19,431::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 04:31:19,431::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 04:31:19,432::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Bock, Kendra\nFrom: noreply@mdsol.com\nSent: Friday, May 28, 2021 10:16 AM\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 SAE Alert: A new SAE has been reported for the Site : 1721840009, Subject : \n840009013, AE Number : 1\nCategories: Kendra\nDear Project Member, \n \nPlease be informed that a new SAE has been reported for Study R4018-ONC-1721. \n \nCountry : World \nSite Number : 1721840009 \nSite Name : 840009 - O\'cearbhail - USA \nSubject number : 840009013 \nAdverse event number : 1 \nMain Adverse Event Description (Term) - NON-CARDIAC CHEST PAIN Start date (dd-mon-yyyy) - 26 MAY 2021 AE suspected to be caused by REGN4018? - Yes AE \nsuspected to be caused by cemiplimab? - Not Applicable AE suspected to be caused by study conduct? - No It resulted in death - Not Checked It was life-\nthreatening - Not Checked It required or prolonged inpatient hospitalization - Checked Persistent or significant disability / incapacity - Not Checked It is a \ncongenital anomaly/birth defect in offspring of study subject - Not Checked Other medically serious important event - Not Checked If Other, specify -  \n \nWWRD (GMT): 28 May 2021 03:15 \n \nThank you, \nSyneos Health Data Management \n \n \nCreated by : Pooja Shah [shahp@mskcc.org] For further details, please log on to Medidata Rave using the following link : \nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?Page=CRFPage.aspx&DP=95824021__;!!OR9aRoiw!ZlOGY5gaHP4sIx\n3zL3clRLgHwwDlbdTKrA8nDg6hmyvsg0sQ_AbQG9DbrGuGJQPngCWziCI$  \n \n***********This is a system generated message, Please do not respond to this e-mail.*********** \n1 Bock, Kendra\nFrom: noreply@mdsol.com\nSent: Friday, May 28, 2021 10:18 AM\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 SAE Alert: SAE has been updated for the Site : 1721840009, Subject : 840009013, AE \nnumber : 1\nCategories: Kendra\nDear Project Member, \n \nPlease be informed that updates have been made for below SAE. \n \nCountry : World \nSite Number : 1721840009 \nSite Name : 840009 - O\'cearbhail - USA \nSubject number : 840009013 \nAdverse event number : 1 \nAdverse Event Description (Term) : NON-CARDIAC CHEST PAIN Start date : 26 MAY 2021 \n \n******** Updated Items ******** \nSelect if AE is intermittent : has been changed to "No" from "_____". \n \n*Please note "_____" denotes - saved blank. \n \nWWRD (GMT): 28 May 2021 03:18 \n \nThank you, \nSyneos Health Data Management \n \n \nCreated by : Pooja Shah [shahp@mskcc.org] For further details, please log on to Medidata Rave using the following link : \nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?Page=CRFPage.aspx&DP=95824021__;!!OR9aRoiw!b2D9qetAjAur4r\nLxFf_qqb7d25leKYhpl8W224hY_5-PeNI73phnIsfbHm89zD4Z38s1dhc$  \n \n \n1  ***********This is a system generated message, Please do not respond to this e-mail.*********** \n2 Bock, Kendra\nFrom: noreply@mdsol.com\nSent: Friday, May 28, 2021 10:23 AM\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 SAE Alert: SAE has been updated for the Site : 1721840009, Subject : 840009013, AE \nnumber : 1\nFollow Up Flag: Follow up\nFlag Status: Flagged\nCategories: Kendra\nDear Project Member, \n \nPlease be informed that updates have been made for below SAE. \n \nCountry : World \nSite Number : 1721840009 \nSite Name : 840009 - O\'cearbhail - USA \nSubject number : 840009013 \nAdverse event number : 1 \nAdverse Event Description (Term) : NON-CARDIAC CHEST PAIN Start date : 26 MAY 2021 \n \n******** Updated Items ******** \nConcomitant Medication #1 : has been changed to "1_LIDOCAINE_26 MAY 2021" from "_____". \nConcomitant Medication #2 : has been changed to "2_TRAMADOL_26 MAR 2021" from "_____". \n \n*Please note "_____" denotes - saved blank. \n \nWWRD (GMT): 28 May 2021 03:23 \n \nThank you, \nSyneos Health Data Management \n \n \nCreated by : Pooja Shah [shahp@mskcc.org] For further details, please log on to Medidata Rave using the following link : \n1 https://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?Page=CRFPage.aspx&DP=95824021__;!!OR9aRoiw!bsS5soUq34uQ2\n0N0_5t7uxCN_IOGFKQsT_F97nkiI-00FakvOOq61OqJwCUDOT62eA5iyX0$  \n \n \n ***********This is a system generated message, Please do not respond to this e-mail.*********** \n2']
apiLogger::2021-10-05 04:31:19,432::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 04:31:19,432::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:31:19,655::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:31:19,669::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:31:19,670::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp9kcp6qsm 
apiLogger::2021-10-05 04:31:19,670::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:31:19,670::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:31:20,039::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:31:20,039::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp9kcp6qsm
apiLogger::2021-10-05 04:31:22,071::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:31:22,071::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:31:22,071::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:31:22,071::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:31:22,076::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:31:22,076::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:31:22,076::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:31:22,076::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:31:22,081::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:31:22,081::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:31:22,081::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 04:31:22,081::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 04:31:22,086::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:31:22,086::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 04:31:22,086::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 04:31:22,086::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 04:31:22,091::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:31:22,091::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 04:31:22,091::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 04:31:22,091::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 04:31:22,095::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:31:22,096::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 04:31:22,096::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 04:31:22,096::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'CRF Page 1 of 3\niMedidata Messages My Profile Help Home Logout\nUser: Kendra Bock Safety Specialist(Safety)\nR4018-ONC-1721 840009 - O\'cearbhail- USA 840009013 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS Subject ID:840009013\nAdverse Events Yes/No\nAdverse Event Subject:840009013\nPage: Adverse Event - ADVERSE EVENTS\nCRF History\nCurrently viewing line 1 of 1.\n840009013- Adverse Event Click here to return to "Complete View". Apply to Record\n840009013- Adverse Events \nMain Adverse Event Description (Term) NON-CARDIAC CHEST PAIN\nYes/No\n056001007- Concomitant \nSOC 10018065General disorders and administration site conditions\nMedications\nHLGT10018073General system disorders NEC\n056001007- Concomitant  HLT 10033372Pain and discomfort NEC\nMedications Yes/No PT 10062501Non-cardiac chest pain\n056001007- SAE / AESI #1 LLT 10062501Non-cardiac chest pain\n056001007- Adverse Event\nStart date (dd-mon-yyyy) 26 MAY 2021\n056001007- Adverse Events \nYes/No\nIf event occurred on study day 1, did the event occur prior to first study drug administration Not Applicable\n056001006- SAE / AESI #4\n056001006- SAE / AESI #1 If the event is part of an Infusion Related Reaction or Cytokine Release Syndrome, please\n056001006- Adverse Event check the box and complete Immune Related Response/Cytokine Release Syndrome CRF\n056001006- Adverse Events Is this AE related to the immune-mediated mechanism of action of REGN4018/Cemiplimab?\nYes/No\n(Please complete associated CRFs for time frame, symptoms and signs, and vital sign\nchanges. On the corresponding CRFs for this AE, please enter interventions for \nmanagement (eg. Medications, rate reduction))\nSelect if AE is intermittent No\nCAUSALITY\nAE suspected to be caused by REGN4018? Yes\nAE suspected to be caused by cemiplimab? Not Applicable\nAE suspected to be caused by study conduct? No\n---If Yes, specify\nACTION TAKEN\nAction taken with REGN4018 Dose Not Changed\nAction taken with cemiplimab Dose Not Changed\nIf Other, specify\nIf the Event is not study drug related but belongs to the sponsor list of immune related event, \nplease provide the etiology\nIf Other, specify\nOutcome of AE Recovered/Resolved\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nClick HReree fsoro Cluusttioomne r dSauptpeo r(t dIndfo-rmmaotionn-yyyy) 27 MAY 202C1opyright © 19M9e9d-i2d0a2ta0  CMleadssidica tRa aSvoel®ut i2o0n2s0, .I3n.c2.\nhttps://regeneron.mdsol.com/MedidataRave/(S(stor1kane1ups3snihlgm31u))/Modules/EDC/CRFPage.aspx?DP=95824021 5/30/2021 CRF Page 2 of 3\niMedidata Messages My Profile Help Home Logout\nUser: Kendra Bock Safety Specialist(Safety)\nR4018-ONC-1721 840009 - O\'cearbhail- USA 840009013 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS\nAdverse Events Yes/No\nAdverse Event Date Event Became Grade 3 or higher - if applicable (dd-mon-yyyy)\nCRF History Date Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\n840009013- Adverse Event\n840009013- Adverse Events  Treatment for AE (select all that apply except when NONE is noted): for drug therapy \nYes/No or medication please enter into concomitant medications eCRF; If procedure or \nsurgery please enter into the on-study procedure/surgery eCRF \n056001007- Concomitant \nMedications None\n056001007- Concomitant \nMedications Yes/No\nDrug therapy/ Medication\n056001007- SAE / AESI #1\n056001007- Adverse Event Concomitant Medication #1 1_LIDOCAINE_26 MAY 2021\n056001007- Adverse Events \nYes/No Concomitant Medication #2 2_TRAMADOL_26 MAR 2021\n056001006- SAE / AESI #4\n056001006- SAE / AESI #1 Concomitant Medication #3\n056001006- Adverse Event\n056001006- Adverse Events Concomitant Medication #4\nYes/No\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nConcomitant procedure/surgery #3\nConcomitant procedure/surgery #4\nConcomitant procedure/surgery #5\nOther\nIf Other, specify\nDoes this AE qualify as Serious? (If YES, complete SAE/AESI Form) Yes\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as \nan event of special interest (AESI) per protocol. If AE does not meet criteria for either \nClick HSereA foEr  Courst oAmEer SSuI ptphoret Innf oSrmTaOtionP here. Copyright © 19M9e9d-i2d0a2ta0  CMleadssidica tRa aSvoel®ut i2o0n2s0, .I3n.c2.\nFORSAE IDENTIFYSERIOUSNESSCRITERION/CRITERIA\nhttps://regeneron.mdsol.com/MedidataRave/(S(stor1kane1ups3snihlgm31u))/Modules/EDC/CRFPage.aspx?DP=95824021 5/30/2021 CRF Page 3 of 3\niMedidata Messages My Profile Help Home Logout\nUser: Kendra Bock Safety Specialist(Safety)\nR4018-ONC-1721 840009 - O\'cearbhail- USA 840009013 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS It resulted in death\nAdverse Events Yes/No\nAdverse Event It was life-threatening\nCRF History It required or prolonged inpatient hospitalization\n840009013- Adverse Event\n840009013- Adverse Events  Persistent or significant disability / incapacity\nYes/No\n056001007- Concomitant  It is a congenital anomaly/birth defect in offspring of study subject\nMedications\n056001007- Concomitant  Other medically serious important event (It does not meet any of the above serious \nMedications Yes/No criteria, but may jeopardize the subject, and may require medical or surgical intervention \n056001007- SAE / AESI #1 to prevent one of the outcomes listed above).\n056001007- Adverse Event If Other, specify\n056001007- Adverse Events \nYes/No Is this an AE of Special Interest (AESI)? (If YES, complete SAE/AESI Form) No\n056001006- SAE / AESI #4\n056001006- SAE / AESI #1 The AE fulfills the following AE of special interest (AESI)\n056001006- Adverse Event\nCHECK ALL THAT APPLY\n056001006- Adverse Events\nYes/No Any AE that meets DLT criteria at any time while on treatment\nGrade 2 or greater Infusion-Related Reactions associated with study drug infusions\nGrade 2 or greater pain syndrome temporally related to study drug infusion in the opinion of\nthe investigator\nGrade 2 or greater Cytokine Release Syndrome\nGrade 2 or greater allergic/hypersensitivity reactions\nAn irAE of any grade in a patient previously treated with a PI 3-K inhibitor\nPericardial effusions of any size\nGrade ≥2 treatment-emergent pleural effusion (clinically significant new effusion and/or a\nclinically significant change in size of an existing effusion)\nGrade ≥2 Treatment-emergent ascites (clinically significant new ascite and/or a clinically\nsignificant change in size of existing ascites)\nNote: An irAE can occur shortly after the first dose or several months after the last dose of\ntreatment. All AEs of unknown etiology associated with drug exposure should be evaluated \nto determine possible immune etiology. If an irAE is suspected, efforts should be made to\nrule out neoplastic, infectious, metabolic, toxin or other etiologic causes prior to labeling an \nAE as an irAE.\nDate Time 28 MAY 2021 11:22:24 \ue008\nPrintable Version View PDF Icon Key Save Cancel\nCRF Version 9193 - Page Generated: 30 May 2021 19:11:00 Central America Standard Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.3.2\nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(stor1kane1ups3snihlgm31u))/Modules/EDC/CRFPage.aspx?DP=95824021 5/30/2021 CRF Page 1 of 1\niMedidata Messages My Profile Help Home Logout\nUser: Kendra Bock Safety Specialist(Safety)\nR4018-ONC-1721 840009 - O\'cearbhail- USA 840009013 SERIOUS ADVERSE EVENTS/AESI (1) Serious Adverse Event/AESI # 01\nSERIOUS ADVERSE Subject ID:840009013\nEVENTS/AESI (1)\nSerious Adverse  Subject:840009013\nEvent/AESI # 01\nPage: Serious Adverse Event/AESI # 01 - SERIOUS ADVERSE EVENTS/AESI (1)\nCRF History\n840009013- Serious Adverse AE number 1\nEvent/AESI # 01\n840009013- Adverse Event Adverse Event Description (Term) NON-CARDIAC CHEST PAIN\n840009013- Adverse Events \nYes/No SOC 10018065General disorders and administration site conditions\nHLGT10018073General system disorders NEC\n056001007- Concomitant \nHLT 10033372Pain and discomfort NEC\nMedications\nPT 10062501Non-cardiac chest pain\n056001007- Concomitant  LLT 10062501Non-cardiac chest pain\nMedications Yes/No\n056001007- SAE / AESI #1 Start Date (dd-mon-yyyy) 26 MAY 2021\n056001007- Adverse Event\nRATIONALE FOR CAUSALITY ASSESSMENT\n056001007- Adverse Events \nYes/No Specify the Rationale for Causality to REGN4018 TEMPORAL\n056001006- SAE / AESI #4\n056001006- SAE / AESI #1 Specify Rationale for Causality to cemiplimab\n056001006- Adverse Event\n056001006- Adverse Events Specify the Rationale for Causality to Study Conduct\nYes/No\nSAE/AESI NARRATIVE\n# SAE/AESI Narrative Text\nPATIENT (STUDY ID 840009-013) IS A 55-YEAR OLD FEMALE WITH HIGH GRADE SEROUS OVARIAN CANCER WHO CONSENTED TO PROTOCOL MSK IRB #20-190/R4018-\nONC-1721 ON 11MAY2021. SHE WAS ADMITTED ON 24MAY2021 TO RECEIVE CYCLE 1 DAY 1 ON 25MAY2021. PATIENT RECEIVED REGN4018 1MG IV OVER 4 HOURS AS \nPLANNED ON 25MAY2021, INFUSION ENDED AT 15:09 WITHOUT INCIDENT. AT APPROXIMATELY 2200, PATIENT REPORTED ABDOMINAL PAIN. KETOROLAC 15MG IV\n1 PUSH AND ACETAMINOPHEN 650MG ORALLY WERE GIVEN INTERMITTENTLY WITH ADEQUATE RELIEF. ON 26MAY2021, PATIENT ENDORSED CHEST PAIN WHEN \nTAKING A DEEP BREATH. AN ECG WAS PERFORMED AND SHOWED NORMAL SINUS RHYTHM. TOPICAL LIDOCAINE PATCH AND TRAMADOL 50 MG BY MOUTH WERE \nADMINISTERED FOR PAIN. PATIENT REMAINED HOSPITALIZED FOR OPTIMAL PAIN MANAGEMENT. STUDY TEAM BECAME AWARE OF PROLONGED HOSPITALIZATION \nON 27MAY2021. AS OF 27MAY2021, PATIENT REPORTED IMPROVEMENT OF PAIN AND WAS DISCHARGED TO HOME IN STABLE CONDITION.\nPrintable Version View PDF Icon Key Save Cancel\nCRF Version 9193 - Page Generated: 30 May 2021 19:12:08 Central America Standard Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.3.2\nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(stor1kane1ups3snihlgm31u))/Modules/EDC/CRFPage.aspx?DP=95824068 5/30/2021 CRF Page 1 of 1\niMedidata Messages My Profile Help Home Logout\nUser: Kendra Bock Safety Specialist(Safety)\nR4018-ONC-1721 840009 - O\'cearbhail- USA 840009013 CONCOMITANT MEDICATIONS Concomitant Medications\nCONCOMITANT Subject ID:840009013\nMEDICATIONS\nConcomitant MedicationSubject:840009013\nYes/No\nPage: Concomitant Medications - CONCOMITANT MEDICATIONS\nConcomitant Medication\nDrug Name\nIf Prophylaxis Or MHx  Adverse Event record  Dose  Other,  If Other  If Other,  Start  Unknown  Stop \nCRF History # List only one Indication Dose Frequency Route Ongoing\nOther, specify Specify # Unit specify Specify specify date Start Date date\n840009013- Concomitant  medication per line\nMedications Adverse  1_NON-CARDIAC  26  26 \n1 LIDOCAINE _ _ CHEST PAIN_26  1 Patch _ Other ONCE Topical_ MAY  MAY \n840009013- Concomitant  Event MAY 2021 2021 2021\nMedications Yes/No 1_NON-CARDIAC  26 \nAdverse \n840009013- Serious Adverse 2 TRAMADOL _ _ CHEST PAIN_26  50 mg _ q6h _ Oral _ MAR  _\nEvent\nEvent/AESI # 01 MAY 2021 2021\n840009013- Adverse Event\n840009013- Adverse Events Printable Version View PDF Icon Key Save Cancel\nCRF Version 9193 -Page Generated: 30 May 2021 19:12:39 Central America Standard Time\nYes/No\n056001007- Concomitant \nMedications\n056001007- Concomitant \nMedications Yes/No\n056001007- SAE / AESI #1\n056001007- Adverse Event\n056001007- Adverse Events \nYes/No\n056001006- SAE / AESI #4\n056001006- SAE / AESI #1\n056001006- Adverse Event\n056001006- Adverse Events\nYes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2020.3.2\nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(stor1kane1ups3snihlgm31u))/Modules/EDC/CRFPage.aspx?DP=95824069 5/30/2021']
apiLogger::2021-10-05 04:31:22,099::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 04:31:22,099::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:31:22,663::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:31:22,665::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:31:22,665::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqvjjpl2b 
apiLogger::2021-10-05 04:31:22,665::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:31:22,665::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:31:22,677::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:31:22,677::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqvjjpl2b
apiLogger::2021-10-05 04:31:22,796::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:31:22,796::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:31:22,796::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:31:22,797::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:31:22,801::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:31:22,801::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:31:22,801::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:31:22,801::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:31:22,805::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:31:22,805::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:31:22,806::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 04:31:22,806::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 05-Oct-2021 04:29:26 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Initial/R4018-ONC-1721/Subject: 840009-013/SAE Term: Non-Cardiac Chest Pain/ MFR\ndate 28-May-2021\nFrom: Bock, Kendra <kendra.bock@syneoshealth.com> Sent: Sunday, May 30, 2021 9:18 PM\nTo: Regeneron Medical Safety <Medical.Safety@regeneron.com> Cc: Paul Curtis\n<paul.curtis@regeneron.com>; Maryan Hussein-External <maryan.hussein@regeneron.com>;\nTracey Rowlands <tracey.rowlands@regeneron.com>; Priscila Goncalves\n<priscila.goncalves@regeneron.com>; Tamara Schmidt <tamara.schmidt@regeneron.com>;\nQuasheeda Fields <quasheeda.fields@regeneron.com>; Saleem Shariff\n<saleem.shariff@regeneron.com>; Blount, Nate <nate.blount@syneoshealth.com>; IRT BCP\nRegeneron_Safety <Regeneron_Safety@syneoshealth.com> Subject: <External> Initial/R4018-\nONC-1721/Subject: 840009-013/SAE Term: Non-Cardiac Chest Pain/ MFR date 28-May-2021 \n \nEXTERNAL MESSAGE\n \n \nDear Regeneron Colleagues, \n \nPlease find attached an Initial information for R4018-ONC-1721/Subject: 840009-013. \n \nProtocol: R4018-ONC-1721\nDay 0: 28-May-2021\nCountry: USA\nSite # /Investigator: 840009/O’cearbhail\nSubject ID: 840009-013\nStudy Drug(s): REGN4018\nEvent Term: Non-Cardiac Chest Pain\nOnset date: 26-May-2021\nSeverity/Grade: Grade 2 Moderate\nSAE Criteria and/or AESI Criteria: Hospitalization/AESI: No\nInvestigator Relationship to Study Drug: Related to REGN4018\nInvestigator Relationship to Study Conduct (if applicable): Not Related\nList of issued urgent queries: N/A\nREGN Argus number: Initial\n \n \n******** Updated Items ******** \nSelect if AE is intermittent : has been changed to "No" from "_____".   \n*Please note "_____" denotes - saved blank. \n \n \n******** Updated Items ******** \nConcomitant Medication #1 : has been changed to "1_LIDOCAINE_26 MAY 2021" from "_____". \nConcomitant Medication #2 : has been changed to "2_TRAMADOL_26 MAR 2021" from "_____". \n \n*Please note "_____" denotes - saved blank. \n \n \nPlease let me know if anyone has any questions. \n \n \nSincerely, Kendra Bock, MS, BS \nSenior Safety Specialist, Global Clinical Safety and Pharmacovigilance Syneos Health \nUS Regional | Kansas \nPhone: 919.257.6813 \nMobile: 910.584.7103 \nE-mail: kendra.bock@syneoshealth.com\nwww.syneoshealth.com ']
apiLogger::2021-10-05 04:31:22,806::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 04:31:22,806::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:35:18,998::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:35:19,006::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:35:19,007::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxik9oah_ 
apiLogger::2021-10-05 04:35:19,007::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:35:19,007::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:35:19,123::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:35:19,123::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxik9oah_
apiLogger::2021-10-05 04:35:20,321::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:35:20,321::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:35:20,321::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:35:20,321::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:35:20,325::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:35:20,326::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:35:20,326::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:35:20,326::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:35:20,330::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:35:20,330::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:35:20,330::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 04:35:20,330::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 04:35:20,334::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-05 04:35:20,334::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 04:35:20,334::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 04:35:20,334::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-05 04:35:20,334::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 076001-ANIMI\nEnvironment Prod\nSubject Details\nStudy Site Number 76,001\nPatient ID 76,001,001\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1960\nAge 60\nSex Male\nEthnicity Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 08 JUN 2020\nR2810-ONC-1788_SAE REPORT_30-JUL-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 15 MAY 2020\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 15 MAY 2020 Amendment 1\n2 05 JAN 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_30-JUL-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_30-JUL-2021']
apiLogger::2021-10-05 04:35:20,334::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 04:35:20,334::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-05 04:35:20,334::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 04:35:20,334::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 04:35:20,335::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 04:35:37,866::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 04:35:37,866::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:35:37,960::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:35:38,000::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:35:38,000::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmplpntj_q_ 
apiLogger::2021-10-05 04:35:38,002::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:35:38,002::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:35:38,633::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:35:38,634::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmplpntj_q_
apiLogger::2021-10-05 04:35:40,144::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:35:40,144::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:35:40,144::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:35:40,144::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:35:40,149::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-05 04:35:40,149::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:35:40,149::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 04:35:40,149::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 04:35:40,149::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410002 - Cho - South Korea@KOR\nSite Number 1625410002\nSubject ID: 410002002\nScreening Date 10 FEB 2020 REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nGlobal\nR1979-ONC-1625 Original ICF\n1 No 24 JUL 2019 10 FEB 2020 Main consent 24 JUL 2019 10 FEB 2020\nProtocol Version\n1.0\nR1979-ONC-1625\n2 09 JUN 2020 Main consent 28 MAY 2020 10 FEB 2020\nAmendment 1 Global\nR1979-ONC-1625 Original Genomics Sub-Study\n3 10 FEB 2020 24 JUL 2019 10 FEB 2020\nProtocol consent\nFuture Biomedical\nR1979-ONC-1625 Original\n4 10 FEB 2020 Research Sub-Study 24 JUL 2019 10 FEB 2020\nProtocol\nconsent\nR1979-ONC-1625 Genomics Sub-Study\n5 09 JUN 2020 28 MAY 2020 10 FEB 2020\nAmendment 1 Global consent\nFuture Biomedical\nR1979-ONC-1625\n6 09 JUN 2020 Research Sub-Study 28 MAY 2020 10 FEB 2020\nAmendment 1 Global\nconsent\nR1979-ONC-1625\n7 12 JAN 2021 Main consent 30 DEC 2020 10 FEB 2020\nAmendment 2 Global\nR1979-ONC-1625\n8 06 APR 2021 Main consent 02 MAR 2021 10 FEB 2020\nAmendment 3 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410002002 1959 61 Female Asian -\nor Latino\nDisease-Specific Cohort REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) Follicular Lymphoma Grade 1-3a REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1    HEPATITIS B CARRIER      checked Ongoing Grade 1 - unchecked REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nMedical 1_HEPATIT 20 JAN unchecke\n1 ENTECAVIR History - IS B - 0.5 mg - QD - Oral - 2012 d - checked\nCARRIER_\nDEXAMETH Premedicatio Intraveno 11 FEB unchecke 19 FEB\n2 ASONE n for - - - 20 mg - PRN - us - 2020 d 2020 unchecked\nREGN1979\nCHLORPHE Premedicatio Intraveno 11 FEB unchecke 12 FEB\n3 NIRAMINE n for - - - 4 mg - QD - us - 2020 d 2020 unchecked\nREGN1979\nACETAMINO Premedicatio 11 FEB unchecke 12 FEB\n4 PHEN n for - - - 600 mg - Qid - Oral - 2020 d 2020 unchecked\nREGN1979\nALOPURINO PROPHYLA 11 FEB unchecke\n5 L Prophylaxis XIS FOR - - 100 mg - PRN - Oral - 2020 d - checked\nTLS\nPROPHYLA 11 FEB unchecke\n6 MOSAPRIDE Prophylaxis XIS FOR - - 5 mg - PRN - Oral - 2020 d - checked\nINDIGESTIO\nDIMENHYD Premedicatio 11 FEB unchecke 12 FEB\n7 RINATE n for - - - 50 mg - QD - Oral - 2020 d 2020 unchecked\nREGN1979\nSODIUM Premedicatio Intraveno 11 FEB unchecke 12 FEB\n8 BICARBONA n for - - - 80 mEq - QD - us - 2020 d 2020 unchecked\nTE REGN1979\nNEUTROPE Subcutan 11 FEB unchecke 11 FEB\n9 FILGRASTIM Prophylaxis NIC - - 300 mcg - QD - eous - 2020 d 2020 unchecked\nPROPHYLA\nPACKED PROPHYLA Intraveno 11 FEB unchecke 11 FEB\n10 RBC Prophylaxis XIS FOR - - 2 Unit - QD - us - 2020 d 2020 unchecked\nANEMIA\nPROPHYLA Intraveno 11 FEB unchecke 11 FEB\n11 PLATELETS Prophylaxis XIS FOR - - 1 Unit - QD - us - 2020 d 2020 unchecked\nBLEEDING\nPROPHYLA Intraveno 13 FEB unchecke 13 FEB\n12 PLATELETS Prophylaxis XIS FOR - - 1 Unit - QD - us - 2020 d 2020 unchecked\nBLEEDING']
apiLogger::2021-10-05 04:35:40,149::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 04:35:40,149::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-05 04:35:40,149::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 04:35:40,149::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 04:35:40,149::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 04:36:43,871::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 04:36:43,871::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:37:19,007::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:37:19,012::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:37:19,013::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmplk4nrqrk 
apiLogger::2021-10-05 04:37:19,013::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:37:19,013::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:37:19,111::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:37:19,111::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmplk4nrqrk
apiLogger::2021-10-05 04:37:20,016::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:37:20,016::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:37:20,016::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:37:20,016::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:37:20,021::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:37:20,021::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:37:20,021::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:37:20,021::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:37:20,025::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-05 04:37:20,025::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:37:20,025::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 04:37:20,025::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-05 04:37:20,025::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036019-Calvary Mater Newcastle\nEnvironment Prod\nSubject Details\nStudy Site Number 36,019\nPatient ID 36,019,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1937\nAge 83\nSex Female\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential? No\nIf No, please specify reason: Post-menopausal status\nRandomization Details\nRandomization Date 8/SEP/2020\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 8/SEP/2020\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25/AUG/2020\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25/AUG/2020 Amendment 1\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_08-JAN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_08-JAN-2021']
apiLogger::2021-10-05 04:37:20,025::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 04:37:20,025::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-05 04:37:20,025::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 04:37:20,025::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 04:37:20,025::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 04:37:37,252::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 04:37:37,252::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:37:37,343::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:37:37,350::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:37:37,350::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfp2fm61n 
apiLogger::2021-10-05 04:37:37,350::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:37:37,351::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:37:37,463::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:37:37,463::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfp2fm61n
apiLogger::2021-10-05 04:37:38,273::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:37:38,274::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:37:38,274::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:37:38,274::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:37:38,278::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:37:38,278::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:37:38,278::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:37:38,278::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:37:38,282::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:37:38,282::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:37:38,282::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 04:37:38,282::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 04:37:38,285::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-05 04:37:38,286::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 04:37:38,286::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 04:37:38,286::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 2
apiLogger::2021-10-05 04:37:38,286::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID 36,018,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained?\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained?\nDate patient signed Future Biomedical\nResearch Informed Consent\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_24-AUG-2021']
apiLogger::2021-10-05 04:37:38,286::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 04:37:38,286::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-05 04:37:38,286::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 04:37:38,286::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 04:37:38,286::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 04:37:52,857::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 04:37:52,857::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:41:20,538::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:41:20,544::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:41:20,545::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp0qhorsa_ 
apiLogger::2021-10-05 04:41:20,545::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:41:20,545::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:41:20,627::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:41:20,627::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp0qhorsa_
apiLogger::2021-10-05 04:41:23,614::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:41:23,614::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:41:23,614::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:41:23,614::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:41:23,618::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:41:23,619::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:41:23,619::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:41:23,619::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:41:23,623::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:41:23,623::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:41:23,623::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 04:41:23,623::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 04:41:23,627::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:41:23,627::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 04:41:23,627::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 04:41:23,627::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 04:41:23,632::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:41:23,632::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 04:41:23,632::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 04:41:23,632::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 04:41:23,637::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:41:23,637::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 04:41:23,637::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 04:41:23,637::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', "Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Tuesday, June 1, 2021 6:13 PM\nTo: .STUDY-PVSS-DL-0456-0085\nSubject: [EXTERNAL] ATTENTION! A SAE has been entered from Study R3767-ONC-1613. Please \nreview ASAP at https://protect-eu.mimecast.com/s/EBA9CN9DJS0xzBnWum0bSr?\ndomain=login.imedidata.com\n*** IMPORTANT: The current Cyber threat landscape has increased within Healthcare with the Irish Health \nSystem falling victim to the Conti Ransomware group. Please be diligent when you receive an email from a \nperson outside of our organization. Do not open an attachment or click on any links if you are suspicious of the \nemail. Note that an external sender may impersonate themselves as being someone within our organization. If \nyou need assistance, please contact the IT Service Desk. ***  \n \n \nAn SAE of COLITIS has been reported for Subject Number 840113024 with  \nStart date (dd-mon-yyyy) : 30 MAY 2021 \nwith AE suspected to be caused by REGN2810? : BLANK \nand with AE suspected to be caused by REGN3767? : BLANK \nand It required or prolonged inpatient hospitalization : CHECKED \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject Details\nProtocol\nProject Name R3767-ONC-1613\nICON Study code 0456/0085\nSite Name 840113- The Angeles Clinic\nEnvironment Prod\nSubject Details\nSubject Number 24\nSubject ID 840113024\nHas the patient been\nNo\nrescreened?\nIf Yes, previous\nscreening ID?\nDemographic Details\nDate of Birth (dd-\n18 FEB 1940\nmon-yyyy)\nAge (Derived) (All\nEXCEPT German 80\nSites)\nAge (German Sites\nOnly)\nSex Male\nRace (choose only\nWhite\none primary race)\nIf Other, specify\nEthnicity Not Hispanic or Latino\nInformed Consent Details\nDate Subject Signed\nthe First Informed\n13 JAN 2021\nConsent (dd-mon-\nyyyy)\nHas the subject\nconsented to\nparticipate in the Yes\ngenomics sub\nstudy?\nDate of Genomics\nConsent (dd-mon- 13 JAN 2021\nyyyy)\nInformed Consent\nVersion 11\nVersion\nSmoking History Details\nSmoking Status Never Smoked\nNumber of Years\nSmoked\nNumber of\nCigarettes Per Day\nCohort Details\nMalignancy type Solid Tumor\nStudy Phase Dose Expansion\nDL1 (1 mg/kg REGN\nNot Checked\n3767)\nDL2 (3.0 mg/kg\nNot Checked\nREGN3767)\nDL4 (10 mg/kg\nNot Checked\nREGN3767)\nDL-1m (0.3 mg/kg\nNot Checked\nREGN3767)\nDL3 (1.0 mg/kg\nREGN3767 and 3.0 Not Checked\nmg/kg REGN2810)\nDL5 (3.0 mg/kg\nREGN3767 and 3.0 Not Checked\nmg/kg REGN2810)\nDL6 (10.0 mg/kg\nREGN3767 and 3.0 Not Checked\nmg/kg REGN2810)\nDL-1c (0.3 mg/kg\nREGN3767 and 3.0 Not Checked\nmg/kg REGN2810)\nDL7 (20 mg/kg\nNot Checked\nREGN3767)\nDL8 (10 mg/kg\nREGN3767 and 350 Not Checked\nmg REGN2810)\nDose Expansion\n6- Melanoma - Anti-PD-1/PD-L1Naïve REGN3767/2810 Combo\nCohort\nCohort SOLID TUMOR-DOSE EXPANSION-6- MELANOMA \nCohort Code 1B16\nR3767-ONC-1613_SAE Report_02-JUN-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking\nProtocol IRB Date Subject Signed\nInformed Consent Approval\nRecord Position Protocol Version Approval date (dd- Informed Consent\ndate from IRB (dd-mon-yyyy)\nmon-yyyy) (dd-mon-yyyy)\n1 R3767-ONC-1613 31 JAN 2020 13 JAN 2021 08 JUL 2019\n2 R3767-ONC-1613 31 JAN 2020 13 JAN 2021 08 JUL 2019\n3 R3767-ONC-1613 31 JAN 2020 13 JAN 2021 08 JUL 2019\nR3767-ONC-1613_SAE Report_02-JUN-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History\nMedical History /Finding Start Date (dd-mon- Check for unknown If Ongoing Specify CTCAE Date resolved (End date)\nRecord Position Ongoing at study entry? Check for unknown end date\n(Abnormality) yyyy) start date Grade (dd-mon-yyyy)\n1 BILATERAL CATARACT  UN UNK 2010 Not Checked Resolved UN NOV 2020 Not Checked\nRIGHT EYE CATARACT\n2 UN OCT 2020 Not Checked Resolved UN OCT 2020 Not Checked\nSURGERY \n3 LEFT EYE CATARACT  UN NOV 2020 Not Checked Resolved UN NOV 2020 Not Checked\n4 AMAUROSIS FUGAX UN UNK 2003 Not Checked Resolved UN UNK 2019 Not Checked\n5 HYPERTENSION  UN UNK 2010 Not Checked Ongoing Grade 2 - Moderate Not Checked\n6 HYPERLIPIDEMIA  UN UNK 2005 Not Checked Ongoing Grade 2 - Moderate Not Checked\nBENIGN PROSTATIC\n7 UN UNK 2005 Not Checked Ongoing Grade 2 - Moderate Not Checked\nHYPERTROPHY\nFLEXOR HALLUCIS LONGUS\n8 UN UNK 1963 Not Checked Resolved UN DEC 1963 Not Checked\nTENDON INJURY \nGASTROESOPHAGEAL\n9 UN UNK 2000 Not Checked Ongoing Grade 2 - Moderate Not Checked\nREFLUX DISEASE \nBASEL CELL CARCINOMA\n10 UN UNK 1995 Not Checked Resolved UN UNK 2018 Not Checked\nINTERMITTENT  \n11 MUMPS  UN UNK 1951 Not Checked Resolved UN UNK 1951 Not Checked\n12 CHICKEN POX UN UNK 1948 Not Checked Resolved UN UNK 1948 Not Checked\nSUPERFICIAL BLADDER\n13 UN UNK 1990 Not Checked Resolved UN UNK 1990 Not Checked\nCARCINOMA \nTRANSURETHRAL RESECTION\n14 OF SUPERFICIAL BLADDER UN UNK 1990 Not Checked Resolved UN UNK 1990 Not Checked\nCARCINOMA\nMITRAL VALVE REPAIR\n15 UN UNK 2003 Not Checked Ongoing Grade 2 - Moderate Not Checked\nSURGERY \nTRANSCATHETER AORTIC\n16 UN DEC 2019 Not Checked Resolved UN DEC 2019 Not Checked\nVALVE REPLACEMENT \n17 AORTIC STENOSIS  UN DEC 2019 Not Checked Ongoing Grade 1 - Mild Not Checked\nHISTORY OF BLADDER\n18 UN UNK 1998 Not Checked Resolved UN UNK 2000 Not Checked\nCARCINOMA \nHISTORY OF BCG INJECTION\n19 UN UNK 2000 Not Checked Resolved UN UNK 2000 Not Checked\nINTO BLADDER\n20 PARKINSON'S DISEASE UN UNK 2019 Not Checked Ongoing Grade 2 - Moderate Not Checked\nRIGHT SUPRAORBITAL\nPARALYSIS SECONDARY TO\n21 UN UNK 2019 Not Checked Ongoing Grade 1 - Mild Not Checked\nWIDE EXCISION OF RIGHT\nFOREARM MELANOMA LESION\n22 BACK ITCHING  UN NOV 2020 Not Checked Ongoing Grade 1 - Mild Not Checked\n23 XERODERMA UN UNK 2000 Not Checked Ongoing Grade 1 - Mild Not Checked\n24 ARTHRITIS UN UNK 2000 Not Checked Ongoing Grade 1 - Mild Not Checked\n25 COUGH UN UNK 2018 Not Checked Ongoing Grade 1 - Mild Not Checked\n26 FATIGUE  UN UNK 2019 Not Checked Ongoing Grade 1 - Mild Not Checked\n27 ANXIETY  UN UNK 2019 Not Checked Ongoing Grade 2 - Moderate Not Checked\n28 IRON DEFICIENCY ANEMIA  UN UNK 2018 Not Checked Ongoing Grade 1 - Mild Not Checked\n29 HISTORY OF HEMOPTYSIS  UN DEC 2020 Not Checked Resolved UN DEC 2020 Not Checked\nMILD RIGHT VENTRICULAR\n30 UN DEC 2020 Not Checked Ongoing Grade 1 - Mild Not Checked\nBILATERAL ENLARGEMENT \nPULMONARY ARTERIAL\n31 UN DEC 2020 Not Checked Ongoing Grade 1 - Mild Not Checked\nHYPERTENSION \n32 MEASLES UN UNK 1950 Not Checked Resolved UN UNK 1950 Not Checked\n WIDE EXCISION OF RIGHT\n33 UN UNK 2019 Not Checked Resolved UN UNK 2019 Not Checked\nFOREARM MELANOMA LESION\nHISTORY OF ATRIAL\n34 UN UNK 2000 Not Checked Ongoing Grade 2 - Moderate Not Checked\nFIBRILLATION INTERMITTENT \nR3767-ONC-1613_SAE Report_02-JUN-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute(If no\nIf If appropriate\nIndicatio Indicatio term can be\nn is n is found in the\nmedical adverse pick list, then\nhistory, event, please select\nDrug Please Please 'Other' from\nName select the select the the pick list\nList only appropria appropria and specify\none te te the\nmedicati Medical Adverse corresponding Start date Start Stop date\nRecord on per Indicatio If Other, History Event Dose Other, Frequenc If Other term in the If Other, (dd-mon- Date (dd-mon-\nPosition line n specify record. record. Dose Unit specify y Specify next line.) specify yyyy) Unknown yyyy) Ongoing\n1_RIGHT\nTEMPOR\nAL\nMANDIBU\nLAR\nJOINT\nAdverse PAIN_27 27 JAN Not\n1 TYLENOL Event JAN 2021 500 mg PRN Oral 2021 Checked Checked\n1_RIGHT\nTEMPOR\nAL\nMANDIBU\nLAR\nJOINT\nAdverse PAIN_27 27 JAN Not\n2 ALEVE  Event JAN 2021 220 mg PRN Oral 2021 Checked Checked\n9_GASTR\nOESOPH\nAGEAL\nREFLUX\nDISEASE\nMedical _UN UNK UN UNK Not\n3 PEPCID History 2000 20 mg QD Oral 2018 Checked Checked\nFOLIC SUPPLE UN UNK Not\n4 ACID Other MENT  1000 mg QD Oral 2019 Checked Checked\nSUPPLE UN UNK Not\n5 CALCIUM Other MENT  600 mg BID Oral 2000 Checked Checked\nZINC\nFLUCON SUPPLE UN UNK Not\n6 ATE Other MENT  50 mg BID Oral 2003 Checked Checked\nMAGNESI\nUM SUPPLE UN UNK Not\n7 OXIDE  Other MENT  400 mg BID Oral 2003 Checked Checked\nMAGNESI\nUM SUPPLE UN UNK Not\n8 OXIDE   Other MENT  400 mg BID Sublingual 2003 Checked Checked\nB 100\nCOMPLE SUPPLE UN UNK Not\n9 X  Other MENT  1 Tablet QD Oral 2000 Checked Checked\nVITAMIN SUPPLE UN UNK Not\n10 C Other MENT  1000 mg QD Oral 2020 Checked Checked\nVITAMIN SUPPLE UN UNK Not\n11 D Other MENT  1000 mg QD Oral 2000 Checked Checked\nSUPPLE UN UNK Not\n12 FISH OIL  Other MENT  1000 mg QD Oral 2000 Checked Checked\nPFIZER PROPHY\nCOVID 19 LAXIS TO 06 JAN Not 06 JAN Not\n13 VACCINE Other COVID 19 1 Unknown OTO Intramuscular 2021 Checked 2021 Checked\nPFIZER PROPHY\nCOVID-19 LAXIS TO 27 JAN Not 27 JAN Not\n14 VACCINE Other COVID 19 1 Unknown OTO Intramuscular 2021 Checked 2021 Checked\n1_RIGHT\nTEMPOR\nAL\nMANDIBU\nLAR\nJOINT\nAdverse PAIN_27 27 JAN Not\n15 ALEVE Event JAN 2021 220 mg PRN Oral 2021 Checked Checked\n3_PRURI\nTRIAMCI Adverse TUS_24 24 FEB Not\n16 NOLONE  Event FEB 2021 1 g PRN Oral 2021 Checked Checked\nBAKING Adverse 21 APR Not\n17 SODA  Event 100 mL TID Oral 2021 Checked Checked\n5_THRUS\nNYSTATI Adverse H_20 10 MAY Not\n18 N  Event APR 2021 5 mL qid Oral 2021 Checked Checked\n24_ARTH\nMedical RITIS_UN UN UNK Not\n19 ADVIL History UNK 2000 600 mg PRN Oral 2000 Checked Checked\n27_ANXI\nMedical ETY_UN UN APR Not\n20 XANAX History UNK 2019 0.25 mg PRN Oral 2000 Checked Checked\n28_IRON\nDEFICIE\nNCY\nANEMIA_\nMedical UN UNK UN UNK Not\n21 IRON History 2018 325 mg QD Oral 2019 Checked Checked\n34_HIST\nORY OF\nATRIAL\nFIBRILLA\nTION\nINTERMI\nTTENT_U\nMETOPR Medical N UNK UN APR Not\n22 OLOL History 2000 25 mg BID Oral 2020 Checked Checked\nCARBIDO\nPA/ 20_PARK\nLEVIDOP INSON'S\nA DISEASE\n(SINEME Medical _UN UNK UN AUG Not\n23 T) History 2019 25/100 mg TID Oral 2000 Checked Checked\n34_HIST\nORY OF\nATRIAL\nFIBRILLA\nTION\nINTERMI\nTTENT_U\nBABY Medical N UNK UN UNK Not\n24 ASPIRIN History 2000 81 mg QD Oral 2003 Checked Checked\nPROPHY\nLAXIS\nBLOOD\nTHINNIN UN UNK Not\n25 PLAVIX  Other G  75 mg QD Oral 2003 Checked Checked\n7_BENIG\nN\nPROSTA\nTIC\nHYPERT\nROPHY_\nPROSCA Medical UN UNK UN UNK Not\n26 R  History 2005 5 mg QD Oral 2003 Checked Checked\n5_HYPER\nLOSART TENSION\nAN Medical _UN UNK UN APR Not\n27 COZAAR History 2010 100 mg TID Oral 2000 Checked Checked\n5_HYPER\nHYDROC TENSION\nHLOROT Medical _UN UNK UN UNK Not\n28 HIAZIDE  History 2010 50 mg QD Oral 2019 Checked Checked\n6_HYPER\nLIPIDEMI\nMedical A_UN UN UNK Not\n29 ZOCOR History UNK 2005 20 mg QD Oral 2010 Checked Checked\n7_BENIG\nN\nPROSTA\nTIC\nHYPERT\nROPHY_\nMedical UN UNK UN UNK Not\n30 FLOMAX History 2005 0.4 mg QD Oral 2003 Checked Checked\nR3767-ONC-1613_SAE Report_02-JUN-2021"]
apiLogger::2021-10-05 04:41:23,637::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 04:41:23,637::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:41:23,729::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:41:23,745::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:41:23,745::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpj7w6vds1 
apiLogger::2021-10-05 04:41:23,746::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:41:23,746::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:41:23,952::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:41:23,952::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpj7w6vds1
apiLogger::2021-10-05 04:41:24,391::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:41:24,391::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:41:24,392::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:41:24,392::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:41:24,396::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:41:24,396::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:41:24,396::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:41:24,396::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:41:24,400::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:41:24,400::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:41:24,400::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 04:41:24,400::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 04:41:24,404::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:41:24,404::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 04:41:24,404::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 04:41:24,404::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 04:41:24,408::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:41:24,408::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 04:41:24,408::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 04:41:24,408::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 04:41:24,411::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:41:24,412::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 04:41:24,412::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 04:41:24,412::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Wednesday, April 28, 2021 8:47 AM\nTo: .STUDY-PVSS-DL-0456-0085\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R3767-ONC-1613. \nPlease review ASAP at https://protect-eu.mimecast.com/s/8QguCOylKipmXjDZuEr2yQ?\ndomain=login.imedidata.com\nAn AESI of COLITIS has been reported for Subject Number 840108008 With Start date (dd-mon-yyyy) : 17 MAR \n2021  with AE suspected to be caused by REGN2810? : NO  and with AE suspected to be caused by REGN3767? \n: YES \n \n1 Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Wednesday, April 28, 2021 8:49 AM\nTo: .STUDY-PVSS-DL-0456-0085\nSubject: [EXTERNAL] ATTENTION! An AESI has been updated from Study R3767-ONC-1613. \nPlease review ASAP at https://protect-eu.mimecast.com/s/29LKCnrQ1S7NL22ot9tUrM?\ndomain=login.imedidata.com\nAE suspected to be caused by study procedure? :  has been updated from BLANK to NO, for AE COLITIS for \nSubject Number 840108008 \n \n1 Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Wednesday, April 28, 2021 8:53 AM\nTo: .STUDY-PVSS-DL-0456-0085\nSubject: [EXTERNAL] ATTENTION! An AESI has been updated from Study R3767-ONC-1613. \nPlease review ASAP at https://protect-eu.mimecast.com/s/uCe-CRoYNSvql6XXc9Dm0x?\ndomain=login.imedidata.com\nAE initial severity CTCAE grade :  has been updated from GRADE 3 to GRADE 2, AE most extreme severity \nCTCAE grade :  has been updated from GRADE 3 to GRADE 2, for AE COLITIS for Subject Number 840108008 \n \n1 Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Wednesday, April 28, 2021 9:35 AM\nTo: .STUDY-PVSS-DL-0456-0085\nSubject: [EXTERNAL] ATTENTION! An AESI has been updated from Study R3767-ONC-1613. \nPlease review ASAP at https://protect-eu.mimecast.com/s/lSp-CYvp8fL2vLlEc0o7Jh?\ndomain=login.imedidata.com\nConcomitant procedure/surgery #1 :  has been updated from BLANK to 1_TERMINAL ILEUM BIOPSY_17 MAR \n2021, Concomitant procedure/surgery #2 :  has been updated from BLANK to 2_COLON BIOPSY_17 MAR \n2021, Concomitant procedure/surgery #3 :  has been updated from BLANK to 3_RECTUM BIOPSY_17 MAR \n2021, for AE COLITIS for Subject Number 840108008 \n \n1 Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Wednesday, April 28, 2021 9:37 AM\nTo: .STUDY-PVSS-DL-0456-0085\nSubject: [EXTERNAL] ATTENTION! An AESI has been updated from Study R3767-ONC-1613. \nPlease review ASAP at https://protect-eu.mimecast.com/s/NletCW7OVH5mQj5ls6IEB_?\ndomain=login.imedidata.com\nConcomitant Medication #1 :  has been updated from BLANK to 5_PREDNISONE_26 MAR 2021, for AE \nCOLITIS for Subject Number 840108008 \n \n1']
apiLogger::2021-10-05 04:41:24,412::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 04:41:24,412::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:41:24,491::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:41:24,492::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:41:24,493::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpv197gdjw 
apiLogger::2021-10-05 04:41:24,493::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:41:24,493::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:41:24,505::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:41:24,505::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpv197gdjw
apiLogger::2021-10-05 04:41:24,644::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:41:24,644::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:41:24,644::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:41:24,644::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:41:24,649::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:41:24,649::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:41:24,649::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:41:24,649::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:41:24,653::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:41:24,653::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:41:24,653::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 04:41:24,653::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 05-Oct-2021 04:39:43 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : R3767-ONC-1613_Initial_840113024_Colitis\nFrom: .STUDY-PVSS-0456-0085 <STUDY-PVSS-0456-0085@iconplc.com> Sent: Wednesday,\nJune 2, 2021 1:32 PM To: Regeneron Medical Safety <Medical.Safety@regeneron.com>;\nGiuseppe Gullo <giuseppe.gullo@regeneron.com>; Tasha Sims <Tasha.Sims@regeneron.com>;\nQuasheeda Fields <quasheeda.fields@regeneron.com>; Emmanuel Okoye\n<emmanuel.okoye@regeneron.com>; Jayakumar Mani <jayakumar.mani@regeneron.com>;\nZachary Piracha <zachary.piracha@regeneron.com>; Charlotte Fisher\n<charlotte.fisher@regeneron.com>; JuAn Wang <juan.wang@regeneron.com>; Nimraj, Lekhraj\n<Lekhraj.Nimraj@iconplc.com>; Jaikumar, Rama <Rama.Jaikumar@iconplc.com>; Shauna Byrne\n<shauna.byrne@regeneron.com> Cc: .STUDY-PVSS-DL-0456-0085 <STUDY-PVSS-DL-0456-\n0085@iconplc.com>; Bell, James Andrew <JamesAndrew.Bell@iconplc.com> Subject:\n<External> R3767-ONC-1613_Initial_840113024_Colitis \n \nEXTERNAL MESSAGE\n \n \nDear All,\n \nPlease find enclosed the Initial SAE Package for above named event of patient 840113024, received on 01Jun2021,\napplicable for study R3767-ONC-1613 (ICON # 0456-0085). \n \nProtocol: R3767-ONC-1613\nSite # / Investigator: 840113\nSubject #: 024\nSAE Term: Colitis\nOnset date: 30May2021\nSAE Criteria Hospitalization\nRelationship to study drug: Not Related\nCountry: United States\nPI Name and mail address: Hamid, Omid      ohamid@theangelesclinic.org\nDay 0 01Jun2021\n \n \n \n \n \n \n \n   \n \n \n \n \nKind Regards !\n \nLucia Flores \nDrug Safety Associate ICON Clinical Research Internal Tel: 7240 4787 External Tel: +52 55 5063 4787 Email:\nLucia.Flores@iconplc.com Web: www.iconplc.com \n \nICON plc made the following annotations. --------------------------------------------------------------------------\n---- This e-mail transmission may contain confidential or legally privileged information that is\nintended only for the individual or entity named in the e-mail address. If you are not the intended\nrecipient, you are hereby notified that any disclosure, copying, distribution, or reliance upon the\ncontents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error,\nplease reply to the sender, so that ICON plc can arrange for proper delivery, and then please\ndelete the message. Thank You, ICON plc South County Business Park Leopardstown Dublin 18\nIreland Registered number: 145835 ']
apiLogger::2021-10-05 04:41:24,653::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 04:41:24,653::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 04:41:24,849::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 04:41:24,850::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 04:41:24,850::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmptmfoqna8 
apiLogger::2021-10-05 04:41:24,851::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 04:41:24,851::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 04:41:24,863::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 04:41:24,863::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmptmfoqna8
apiLogger::2021-10-05 04:41:24,997::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 04:41:24,997::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 04:41:24,997::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 04:41:24,997::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 04:41:25,002::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:41:25,002::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 04:41:25,002::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 04:41:25,002::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 04:41:25,006::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 04:41:25,006::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 04:41:25,006::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 04:41:25,006::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 05-Oct-2021 04:41:08 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : R3767-ONC-1613_Initial_840108008_Colitis\nFrom: .STUDY-PVSS-0456-0085 <STUDY-PVSS-0456-0085@iconplc.com> Sent: Wednesday,\nApril 28, 2021 12:50 PM To: Regeneron Medical Safety <Medical.Safety@regeneron.com>;\nGiuseppe Gullo <giuseppe.gullo@regeneron.com>; Tasha Sims <Tasha.Sims@regeneron.com>;\nQuasheeda Fields <quasheeda.fields@regeneron.com>; Emmanuel Okoye\n<emmanuel.okoye@regeneron.com>; Jayakumar Mani <jayakumar.mani@regeneron.com>;\nZachary Piracha <zachary.piracha@regeneron.com>; Charlotte Fisher\n<charlotte.fisher@regeneron.com>; Ibrahim Adiguzel <ibrahim.adiguzel@regeneron.com>; JuAn\nWang <juan.wang@regeneron.com>; Nimraj, Lekhraj <Lekhraj.Nimraj@iconplc.com>; Jaikumar,\nRama <Rama.Jaikumar@iconplc.com> Cc: .STUDY-PVSS-DL-0456-0085 <STUDY-PVSS-DL-\n0456-0085@iconplc.com>; McCormick, Lisa <Lisa.McCormick@iconplc.com> Subject:\n<External> R3767-ONC-1613_Initial_840108008_Colitis \n \nEXTERNAL MESSAGE\n \n \nDear All,\n \nPlease find enclosed the Initial AESI Package for above named event of patient 840108008, received on 28Apr2021,\napplicable for study R3767-ONC-1613 (ICON # 0456-0085). \n \nProtocol: R3767-ONC-1613\nSite # / Investigator: 840108\nSubject #: 008\nSAE Term: Colitis\nOnset date: 17Mar2021\nSAE Criteria Not Applicable\nRelationship to study drug: Related\nCountry: United States\nPI Name and mail address: Groisberg Roman       roman.groisberg@rutgers.edu\nDay 0 28Apr2021\n \n \n \n \n \n \n \n   \n \n \n \n \nKind Regards !\n \nLucia Flores \nDrug Safety Associate ICON Clinical Research Internal Tel: 7240 4787 External Tel: +52 55 5063 4787 Email:\nLucia.Flores@iconplc.com Web: www.iconplc.com \n \nICON plc made the following annotations. --------------------------------------------------------------------------\n---- This e-mail transmission may contain confidential or legally privileged information that is\nintended only for the individual or entity named in the e-mail address. If you are not the intended\nrecipient, you are hereby notified that any disclosure, copying, distribution, or reliance upon the\ncontents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error,\nplease reply to the sender, so that ICON plc can arrange for proper delivery, and then please\ndelete the message. Thank You, ICON plc South County Business Park Leopardstown Dublin 18\nIreland Registered number: 145835 ']
apiLogger::2021-10-05 04:41:25,007::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 04:41:25,007::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 05:23:18,840::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 05:23:18,881::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 05:23:18,881::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpztevoy9z 
apiLogger::2021-10-05 05:23:18,883::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 05:23:18,883::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 05:23:20,071::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 05:23:20,071::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpztevoy9z
apiLogger::2021-10-05 05:23:22,498::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 05:23:22,498::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 05:23:22,498::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 05:23:22,498::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 05:23:22,503::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-05 05:23:22,503::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 05:23:22,503::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 05:23:22,503::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 05:23:22,503::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM']
apiLogger::2021-10-05 05:23:22,503::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 05:23:22,503::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-05 05:23:22,503::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 05:23:22,503::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 05:23:22,503::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 05:23:47,409::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 05:23:47,409::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 05:23:48,024::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 05:23:48,025::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 05:23:48,025::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpdev7csun 
apiLogger::2021-10-05 05:23:48,025::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 05:23:48,025::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 05:23:48,030::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 05:23:48,030::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpdev7csun
apiLogger::2021-10-05 05:23:48,042::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 05:23:48,042::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 05:23:48,042::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 05:23:48,042::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 05:23:48,046::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 05:23:48,046::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 05:23:48,046::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 05:23:48,046::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Ritu Sharma-External <ritu.sharma@regeneron.com>\nReceived Date : 05-Oct-2021 05:22:10 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : 1625 - fup\n ']
apiLogger::2021-10-05 05:23:48,046::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 05:23:48,046::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 05:33:21,629::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 05:33:21,672::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 05:33:21,673::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpsyyeew9a 
apiLogger::2021-10-05 05:33:21,674::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 05:33:21,674::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 05:33:22,872::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 05:33:22,872::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpsyyeew9a
apiLogger::2021-10-05 05:33:25,288::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 05:33:25,288::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 05:33:25,288::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 05:33:25,288::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 05:33:25,293::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-05 05:33:25,293::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 05:33:25,293::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 05:33:25,293::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 05:33:25,293::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 840027002\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS\n21 SEASONAL ALLERGIES 22 MAY 2020 unchecked Ongoing Grade 1 - unchecked REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke 21 SEP\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d 2021 unchecked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 24SEP2021 SC 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM']
apiLogger::2021-10-05 05:33:25,293::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 05:33:25,293::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-05 05:33:25,293::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 05:33:25,293::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 05:33:25,293::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 05:33:50,075::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 05:33:50,075::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 06:13:18,949::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 06:13:19,013::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 06:13:19,013::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpm997ei2c 
apiLogger::2021-10-05 06:13:19,016::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 06:13:19,016::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 06:13:21,037::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 06:13:21,037::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpm997ei2c
apiLogger::2021-10-05 06:13:23,627::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 06:13:23,627::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 06:13:23,627::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 06:13:23,627::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 06:13:23,637::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 06:13:23,637::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 06:13:23,637::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 06:13:23,637::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 06:13:23,641::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 06:13:23,641::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 06:13:23,641::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 06:13:23,641::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 06:13:23,645::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 06:13:23,645::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 06:13:23,645::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 06:13:23,645::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 06:13:23,649::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 06:13:23,649::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 06:13:23,649::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 06:13:23,649::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 06:13:23,653::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 06:13:23,654::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 06:13:23,654::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 06:13:23,654::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '\x00\x01\x02D\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x07\x08\t\n\x0b\x01 \x0c\r\x0e\x0f\x0e\x10\x11\x12\x13\x10\r\x14\x15\x16ÿ\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x12ÿ\x11\x1b\x1c\x12\x10\x1d\x1a\x1e\x1c\x1dÿ\x1f !"#ÿ \x11ÿ\x1a\x1f\x1f\x1c\x1f\x1fÿ $\x1cÿ\x1a\x12 %\x10 !&\x11\x0cÿ\x1a\x13 %\'% #ÿ\x1a\x12"\n\x1f\x1a(\x1c #ÿ\x11(ÿ\x0c\x1c)\x12\r\x0e\x0f\x0e*ÿ\x1a\x12ÿ\x1a\x12 %\x10\x13"\x15+ÿ,ÿ\x1a\x12 %\x10\x13"-ÿ\x1e%\x1f\x1b\x1c\x13%(%\x13\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x18\x19\x03\x05\x0b\n\x1a\x12 %\x1e\x11"#*ÿ%\x12ÿ\x1b\x1a %\x1c\x12 \x1fÿ.% $ÿ\x0c\x1c\x1d\x1a\x1b\x1f\x1c"ÿ\x11\x0cÿ\x0c\x1c(\x0c\x1a\x13 \x11\x0c#ÿ\x1e\x10\x13\x1c\x1d\x1d\n\x12\x11\x12\x10$\x11")/%\x12ÿ\x1d#&\x1b$\x11&\x1a\n\x1901\x0b0\x03\x192ÿ3\x0b4\x05\x035ÿ6\x03\x0878ÿ9\x027\x0b \r\x0f\x0c)\x1b\x10+++:\n9\x02\t;\x02\x0807 \x0c\x1c)\x12\r\x0e\x0f\x0e\n6\x08\nD\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n6\x19\x03\x0bÿ\x074\t\x0b \x15\x0f\x14++\rÿ\x10ÿ"<=>>ÿ\x10ÿ)=?@ABC\n6\x19\x03\x0bÿ\x07\x08\t\n\x0b\x01 \r\x14\x15\x16\x15\x0f\x14++\r\n6\x08\nD\x0b\x04\x03ÿEFG \x15\x0f\x14++\r++-\n6\x04\x01\x0b\x0b0\x190HÿF4\x03\x0b +\x15ÿ\x1f\x1c\x1bÿ\x15+\x15\r \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06ÿ\t\x16=ÿ?\x0c\r\x06\r\x05\r;ÿ\x12\n\x04\x16=\n\x04\x16\x06ÿ@\x0c\t\x05A\x10\x16\x13\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 :\t\x06\x04ÿ<\x01\x02\x03\x04\x05\x06ÿ<\x10\x13\x16\x04=\nF\x04\x0c\x04ÿ\x06\x11\x04\x0c\x04ÿ\t\x16\x17 :\t\x06\x04ÿ\x00\x01\x02\x03\x04\x05\x06ÿ\x00\x10\x13\x16\x04=\nC;\r\x02\t;ÿ?\x0c\r\x06\r\x05\r;ÿD ÿ\x12\n\x04\x16=\n\x04\x16\x06 ?\x0c\r\x06\r\x05\r;ÿ\x1a\x18\x0fÿ\x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04 \x1a>L \x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04ÿ\x0e\x0c\r\n ;\r\x05\t;ÿ\x1a\x16\x0e\r\x0c\n\x04=\nB ;\r\x05\t; \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 >\r\x16<\x04\x16\x06ÿ@\x17\x1d\x04\n\x12\n\x04\x16=\n\x04\x16\x06ÿE\x04\x0c<\x10\r\x16 E\x04\x0c<\x10\r\x16ÿHI\r\x05\t;Jÿ H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J E\x04\x0c<\x10\r\x16 \x15>M\x1a\x18\x0fÿH==\x1c\n\r\x16\x1c >\r\x16<\x04\x16\x06ÿH==\x1c\n\r\x16\x1c\n\t\n\x04\x16=\n\x04\x16\x06<G H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J\n\x17\x17\x17\x17J \x17\x17\x17\x17J\x19ÿ\x10\x0eÿ\t\x1d\x1d;\x10\x05\t\x02;\x04\nN"$\x1f$9O+P9" \x1e&\n" "$ÿQWUÿ\x1e!\x1e" \'(03ÿ4,31*3- "#ÿ\'QXÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V()\nN"$\x1f$9O+P9" \x1e& U*3,R041ÿYZV9Y-ZS[\n\x1e "$ÿQWUÿ\x1e!\x1e" ""ÿ\\]^ÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V() 4,31*3-\n:\x04\n\r\x13\x0c\t\x1d\x11\x17ÿ:\x04\x06\t\x10;<\n\x18\t\x05\x04\x19ÿ\x1a\x0eÿ\x1b\x06\x11\x04\x0c\x1c\n\x00\x01\x02\x03\x04\x05\x06ÿ\x08\t\n\x04 \x0b\x04\t\x0cÿ\r\x0eÿ\x0f\x10\x0c\x06\x11 \x12\x13\x04 \x00\x04\x14 \x15\x06\x11\x16\x10\x05\x10\x06\x17 \x18\t\x05\x04\n+,-ÿ/012(304 \x00\x1d\x04\x05\x10\x0e\x17\n\x1e\x1f !!"!!# "$#  %& \'()* 780-* 9\n,5ÿ6(-03,\n:\x10<\x04\t<\x04\x1c\x00\x1d\x04\x05\x10\x0e\x10\x05ÿ>\r\x11\r\x0c\x06\n:\x10<\x04\t<\x04ÿ<\x1d\x04\x05\x10\x0e\x10\x05ÿ\x05\r\x11\r\x0c\x06M\x13\x0c\r\x01\x1dÿH\x10\x16\x06\x04\x13\x0c\t\x06\x04=J _6^P6ÿY*)*4-*SÿN*`0R*3 \x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0e\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x19\x06\x0b\x02\n#\x1eÿ\x0c\x11\x12\x0c\x04\x11\x12\n\x18\x0b\x06\r\x0bÿ\x19\x06\x0b\x02 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r \r\x02\n\x0c\x07(\x02\x03 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r\n\x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0eÿ\x0f\x10\x04\x11\x03\x04\x11\x12 !\x11\x12\x0c\x04\x11\x12ÿ\x06\x0b \n$\x02\x05\x04\x1e\x0e\n\x00 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x1f\x11\x1d\x11\x0c \x11ÿ\n\x0b\x06\r\x0b \x13&\x11\x03ÿ\x03\x06\x0b\x02\x17 \x1f\x11\x1d\x11\x0c \x11ÿ\x02\x11\x03\n\x13\x14\x15\x11\x0c\r\x16\x06\x07\x04\x0b\x0e\x17 \n\x0b\x1f\x03\x0eÿ\x02\x11\x0b\r\x0e" \x1b%\x1b\x14&\n\x0e\x0e\x0e\x0e\x17 \x03\x06\x0b\x02 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x03\x06\x0b\x02\n\'\r\x06\x03\x02\n\x0e\x0e\x0e\x0e\x17\n) *+,-./.0ÿ2.33+/40ÿ/56ÿ++ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nG7H7I,H5ÿJ.,H/\nF \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n*+0.,0.\nK ,/H+,3ÿL+-H+33,/+7I \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nM 0+<2,*+N.H/+G4370+0 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nO G,H*+,3ÿ+I04LL+G+.IG5ÿ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\nP ,G.ÿ+IJ+-+/7Hÿ,33.H<5 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nQ J+6ÿH.63.,0.2.I/ÿH+<J/ 4Iÿ,6HÿFR)M B8CD@CE@? H@S:TU@? A 4Iÿ,6HÿFR)M B8CD@CE@?\nV J+6ÿH.63.,0.2.I/ÿ3.L/ 4IÿW4IÿFR)P B8CD@CE@? H@S:TU@? A 4IÿW4IÿFR)P B8CD@CE@?\n3.Lÿ-4I*3.ÿ-H.IGJ\nX \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n-37GY\n)R 6H70/,/,J56.H63,0+. \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)) <</ÿ+IGH.,0.* )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n)F ,I.2+,ÿ )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n63,/.3./ÿG74I*\n)K )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n*.GH.,0.*\n)M +<ÿ<ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)O +<ÿ,ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)P +<ÿ2ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n<34/.,3ÿH.<+7Iÿ3.L/\n)Q \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\n6,+I \x00\x01\x02\x03\x01\x04\x05\x06\x07\x02\x06ÿ\t\n\x0b\x05\x03\x07\x06\x05\x01\x02\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x12\x13 \x12\x13\n\x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02\n\x05\x1aÿ\x04\n\x0b\x05\x03\x07\x18 \x05\x1aÿ\x07\x0b\x1f\n\x0e\x1a\n\n\x12\x13 \x16\x05\x1a\x06\x01\x0e\x17\x1c \n\x1f\n\x02\x06\x1c\n%\x06\x07\x0e\x06ÿ\x0b\x07\x06\n %\x06\x01\x15ÿ\x0b\x07\x06\n\n\x14\x0e\x01\x15\x16\x17\x18\x07\x19\x05\x1a \x14\x18\n\x07\x1a\n \x14\x18\n\x07\x1a\n \r\x01\x1a\n \x1b\x06\x16\n\x0e\x1c \x12\x13ÿ\x1b\x06\x16\n\x0e \x12\x13ÿ\x1b\x06\x16\n\x0e\x1c %\x06\x07\x0e\x06\n\x0c \r\x0e\x0f\x10ÿ\x11\x07\x04\n \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \r\x01\x1a\n #\x0e\n$\x0f\n\x02\x03\x17 &\x01\x0f\x06\n \'\x0b\x0b(\x04\x01\x02( \'\x0b\x0b(\x04\x01\x02( \x1b\x02\x10\x01\x05\x02\x10\n\x1b\x0eÿ\x1b\x06\x16\n\x0e\x1c \x1a\n\x18\n\x03\x06ÿ\x06\x16\n \x1a\n\x18\n\x03\x06ÿ\x06\x16\n "\x02\x05\x06 \x1a\x15\n\x03\x05\x13\x17 %\x15\n\x03\x05\x13\x17 \x1a\x15\n\x03\x05\x13\x17 \r\x07\x06\nÿ"\x02*\n\x17\x17\x17\x17) \x17\x17\x17\x17)\n\x1a\x15\n\x03\x05\x13\x17 \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n\n\t\n\x0b\x05\x03\x07\x18  \x0b\x1f\n\x0e\x1a\n\n\x1d\x05\x1a\x06\x01\x0e\x17 !\x1f\n\x02\x06\n\x0e\n\x03\x01\x0e\x0b\x1e \x0e\n\x03\x01\x0e\x0b\x1e\n@AB30C5A 2LMNLG<O FPÿ2A5 LON9HNSH FUÿ2A5\n+ ,-./0123-4 56789:;<=>? D D EFF CG9H6 I/ JK D D LON9HNSHT\n@-1 H7L? RFR+ T RFR+\n4HT>N<; WXY10K-1.\nR 3C012A4-K V>?G76: D -@2B,,-Y-A D +F \\] D ^-K D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n25-0C.C@1 4HT>N<; WXY10K-1.\nE Y3C@ V>?G76: D -@2B,,-Y-A D RW \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n3142B.C2- 4HT>N<; +FX50C23\n_ @ V>?G76: D 131VZ5A0 D F`_ \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n5.12-AXB@\n145VC4C0\nW 56789:;<=>? 4B[C2-3-2 D D +FF \\]a\\. D J>T D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@1.\n51@3C501 23C41YV\nb cC. 56789:;<=>? 50C3AY3-C D D _F \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@\n4HT>N<; EX130-1. 2LMNLG<O\nP A@Cd150-@ V>?G76: D ,-^0-..13- D UFF CG9H6 -A ^-K D H7L? D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@XB@[\n@Ce14-@2 4HT>N<; +PX/.B3A B@ÿ1B/ LON9HNSH\nU B.,C@ V>?G76: D 1.ÿ0A/-C@ D WFF \\] D 50@ D C6<; D RFR+ T D \x03\x16\n\x03*\n\x0b\n.A,3\nKAd14A3V 1TgH6?H +XY02X+_ -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\nf D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\nKAd14A3V 1TgH6?H RXY02X+b -OG6<gHO7 +bÿ2A5 LON9HNSH +bÿ2A5\n+F D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\n5101YA31 56H\\HT>N<G>7 +_ÿ2A5 LON9HNSH +Wÿ2A5\n++ 4C. Oÿh76 D D D + ] D JK D C6<; D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf\n56H\\HT>N<G>7 -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\n+R 31eA/-. Oÿh76 D D D R \\] D JK D L? D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf \n\x11 \n\x11\n\n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b\n\r\x18ÿ\x08\t\x0c\r\x0e\x07\x16 \r\x18ÿ\x07\x0c\x1e\t\x02\x18\t\n\n\x11 \x14\r\x18\x0f\x10\x02\x15\x1a \t\x1e\t\x0b\x0f\x1a\nREG-2021-00130 GSPV RECEIPT DATE 1$7\x0f\x07S\x02E\x0fÿ\x0cP\x072\x0f\t021 AKA 25 pages$\x0f\x10\x13ÿ\x0c\x07\x0f\t\n\x12\x02\x10\x13\x14\x15\x16\x07\x17\r\x18 \x12\x16\t\x07\x18\t \x12\x16\t\x07\x18\t \x01\x10\x18\t \x19\x0f\x14\t\x02\x1a \n\x11ÿ\x19\x0f\x14\t\x02 \n\x11ÿ\x19\x0f\x14\t\x02\x1a $\x0f\x07\x02\x0f\n\x00 \x01\x02\x03\x04ÿ\x06\x07\x08\t \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \x01\x10\x18\t "\x02\t#\x03\t\x0b\x0e\x15 %\x10\x03\x0f\t &\x0c\x0c\'\x08\x10\x0b\' &\x0c\x0c\'\x08\x10\x0b\' \x19\x0b\x04\x10\r\x0b\x04\n\x19\x02ÿ\x19\x0f\x14\t\x02\x1a \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t !\x0b\r\x0f \x18\x13\t\x0e\r\x11\x15 $\x13\t\x0e\r\x11\x15 \x18\x13\t\x0e\r\x11\x15 \x01\x07\x0f\tÿ!\x0b)\n\x15\x15\x15\x15( \x15\x15\x15\x15(\n\x18\x13\t\x0e\r\x11\x15 \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t\n\x1b\t\x0c\r\x0e\x07\x16 \x1f\x0c\x1e\t\x02\x18\t\n\x1c\r\x18\x0f\x10\x02\x15  \x1e\t\x0b\x0f\n\x02\t\x0e\x10\x02\x0c\x1d \x02\t\x0e\x10\x02\x0c\x1d\nHIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\n*+ ,-./01/23 456789:;<=> /?. @ @ ABC DE @ FG @ @ MIR8LRSLT\nM> PQP* T PQP*\nG2U-V2/W 45LDLT=R;J=6 HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Cÿ.24\n*N -.XY IÿZ65 @ @ @ PQ DE @ FG @ M> @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nW]G1XVX1 VLT=R;: *A^[?0/2 .M_RMJ;I *Nÿ.24 MIR8LRSL\n*C 4WXY W=>J659 @ -?ÿ12[HXY @ * DE @ 41Y @ L6M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nW]G1X3W? ?2,/\n4-1-32/- VLT=R;: *A^[?0/2 HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*` VX? W=>J659 @ -?ÿ12[HXY @ * E @ 41Y @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n?2,/\n3X/1HV +ÿ/HV2. *Cÿ.24 MIR8LRSL\n*A 456789:;<=> a-3/21H-? @ @ \\`Q DE @ XJ8L5 X5;: @ @ \x0e\x14\t\x0e)\t\x0c\n,X1/2 -ÿb22c PQP* T\n*ÿ@ÿPÿ@ÿ* *Cÿ.24 MIR8LRSL\n*d -3H3?XeH1 456789:;<=> eH1-? @ @ NQQ DE @ XJ8L5 /a?ÿ- X5;: @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nG-]ÿ\nY-/1H0V3W HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*\\ 456789:;<=> /?. @ @ PCQ D? @ 36IJ=IM6M> @ @ @ \x0e\x14\t\x0e)\t\x0c\n?X1HG M> PQP* T\n4H421-3H?H Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nPQ 456789:;<=> a-3/21H-? @ @ NB*A E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nYÿY-/1H0V -ÿG-] M> PQP* T\n/-fXa-3/- Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nP* 456789:;<=> a-3/21H-? @ @ QBC E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nVÿY-/1H0V -ÿG-] M> PQP* T\nG2U-V2/W 45LDLT=R;J=6 *+ÿ.24 MIR8LRSL *+ÿ.24\nPP -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W 45LDLT=R;J=6 *`ÿ.24 MIR8LRSL *`ÿ.24\nP+ -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W -TKL5>L *^31.^*N HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\nPN @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L P^31.^*` HIJ5;KLI6 *`ÿ.24 MIR8LRSL *`ÿ.24\nPC @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L N^2Y324W HIJ5;KLI6 *`ÿ.24 MIR8LRSL\nP` -.XY 2KLIJ @ @ -?X4-/W] *Q DE @ aHG @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n^*`ÿ.24']
apiLogger::2021-10-05 06:13:23,654::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 06:13:23,654::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 06:13:24,376::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 06:13:24,376::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 06:13:24,377::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpfk9eftwk 
apiLogger::2021-10-05 06:13:24,377::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 06:13:24,377::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 06:13:24,382::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 06:13:24,382::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpfk9eftwk
apiLogger::2021-10-05 06:13:24,395::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 06:13:24,395::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 06:13:24,395::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 06:13:24,395::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 06:13:24,399::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 06:13:24,399::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 06:13:24,399::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 06:13:24,399::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 05-Oct-2021 06:12:32 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario3 Reshabh Reshabh\nScenario 3 )5-10-2021 ']
apiLogger::2021-10-05 06:13:24,399::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 06:13:24,400::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 06:22:51,036::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 06:22:51,101::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 06:22:51,102::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpjx7199r_ 
apiLogger::2021-10-05 06:22:51,104::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 06:22:51,104::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 06:22:53,124::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 06:22:53,124::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpjx7199r_
apiLogger::2021-10-05 06:22:55,684::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 06:22:55,684::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 06:22:55,685::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 06:22:55,685::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 06:22:55,689::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 06:22:55,689::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 06:22:55,689::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 06:22:55,689::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 06:22:55,693::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 06:22:55,693::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 06:22:55,693::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 06:22:55,693::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 06:22:55,697::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 06:22:55,697::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 06:22:55,697::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 06:22:55,697::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 06:22:55,702::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 06:22:55,702::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 06:22:55,702::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 06:22:55,702::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 06:22:55,706::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 06:22:55,706::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 06:22:55,706::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 06:22:55,706::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '\x00\x01\x02D\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x07\x08\t\n\x0b\x01 \x0c\r\x0e\x0f\x0e\x10\x11\x12\x13\x10\r\x14\x15\x16ÿ\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x12ÿ\x11\x1b\x1c\x12\x10\x1d\x1a\x1e\x1c\x1dÿ\x1f !"#ÿ \x11ÿ\x1a\x1f\x1f\x1c\x1f\x1fÿ $\x1cÿ\x1a\x12 %\x10 !&\x11\x0cÿ\x1a\x13 %\'% #ÿ\x1a\x12"\n\x1f\x1a(\x1c #ÿ\x11(ÿ\x0c\x1c)\x12\r\x0e\x0f\x0e*ÿ\x1a\x12ÿ\x1a\x12 %\x10\x13"\x15+ÿ,ÿ\x1a\x12 %\x10\x13"-ÿ\x1e%\x1f\x1b\x1c\x13%(%\x13\n\x00\x01\x02\x03\x02\x04\x02\x05ÿ\x18\x19\x03\x05\x0b\n\x1a\x12 %\x1e\x11"#*ÿ%\x12ÿ\x1b\x1a %\x1c\x12 \x1fÿ.% $ÿ\x0c\x1c\x1d\x1a\x1b\x1f\x1c"ÿ\x11\x0cÿ\x0c\x1c(\x0c\x1a\x13 \x11\x0c#ÿ\x1e\x10\x13\x1c\x1d\x1d\n\x12\x11\x12\x10$\x11")/%\x12ÿ\x1d#&\x1b$\x11&\x1a\n\x1901\x0b0\x03\x192ÿ3\x0b4\x05\x035ÿ6\x03\x0878ÿ9\x027\x0b \r\x0f\x0c)\x1b\x10+++:\n9\x02\t;\x02\x0807 \x0c\x1c)\x12\r\x0e\x0f\x0e\n6\x08\nD\x0b\x04\x03ÿF\x0b\x034\x19\x05I\n6\x19\x03\x0bÿ\x074\t\x0b \x15\x0f\x14++\rÿ\x10ÿ"<=>>ÿ\x10ÿ)=?@ABC\n6\x19\x03\x0bÿ\x07\x08\t\n\x0b\x01 \r\x14\x15\x16\x15\x0f\x14++\r\n6\x08\nD\x0b\x04\x03ÿEFG \x15\x0f\x14++\r++-\n6\x04\x01\x0b\x0b0\x190HÿF4\x03\x0b +\x15ÿ\x1f\x1c\x1bÿ\x15+\x15\r \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06ÿ\t\x16=ÿ?\x0c\r\x06\r\x05\r;ÿ\x12\n\x04\x16=\n\x04\x16\x06ÿ@\x0c\t\x05A\x10\x16\x13\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 :\t\x06\x04ÿ<\x01\x02\x03\x04\x05\x06ÿ<\x10\x13\x16\x04=\nF\x04\x0c\x04ÿ\x06\x11\x04\x0c\x04ÿ\t\x16\x17 :\t\x06\x04ÿ\x00\x01\x02\x03\x04\x05\x06ÿ\x00\x10\x13\x16\x04=\nC;\r\x02\t;ÿ?\x0c\r\x06\r\x05\r;ÿD ÿ\x12\n\x04\x16=\n\x04\x16\x06 ?\x0c\r\x06\r\x05\r;ÿ\x1a\x18\x0fÿ\x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04 \x1a>L \x12\x1d\x1d\x0c\rK\t;ÿ=\t\x06\x04ÿ\x0e\x0c\r\n ;\r\x05\t;ÿ\x1a\x16\x0e\r\x0c\n\x04=\nB ;\r\x05\t; \x1a\x16\x0e\r\x0c\n\x04=ÿ>\r\x16<\x04\x16\x06 >\r\x16<\x04\x16\x06ÿ@\x17\x1d\x04\n\x12\n\x04\x16=\n\x04\x16\x06ÿE\x04\x0c<\x10\r\x16 E\x04\x0c<\x10\r\x16ÿHI\r\x05\t;Jÿ H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J E\x04\x0c<\x10\r\x16 \x15>M\x1a\x18\x0fÿH==\x1c\n\r\x16\x1c >\r\x16<\x04\x16\x06ÿH==\x1c\n\r\x16\x1c\n\t\n\x04\x16=\n\x04\x16\x06<G H==\x1c\n\r\x16\x1c\x17\x17\x17\x17J\n\x17\x17\x17\x17J \x17\x17\x17\x17J\x19ÿ\x10\x0eÿ\t\x1d\x1d;\x10\x05\t\x02;\x04\nN"$\x1f$9O+P9" \x1e&\n" "$ÿQWUÿ\x1e!\x1e" \'(03ÿ4,31*3- "#ÿ\'QXÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V()\nN"$\x1f$9O+P9" \x1e& U*3,R041ÿYZV9Y-ZS[\n\x1e "$ÿQWUÿ\x1e!\x1e" ""ÿ\\]^ÿ\x1e!\x1e" "$ÿQWUÿ\x1e!\x1e"\nQR*3SR*3-ÿTÿU),V() 4,31*3-\n:\x04\n\r\x13\x0c\t\x1d\x11\x17ÿ:\x04\x06\t\x10;<\n\x18\t\x05\x04\x19ÿ\x1a\x0eÿ\x1b\x06\x11\x04\x0c\x1c\n\x00\x01\x02\x03\x04\x05\x06ÿ\x08\t\n\x04 \x0b\x04\t\x0cÿ\r\x0eÿ\x0f\x10\x0c\x06\x11 \x12\x13\x04 \x00\x04\x14 \x15\x06\x11\x16\x10\x05\x10\x06\x17 \x18\t\x05\x04\n+,-ÿ/012(304 \x00\x1d\x04\x05\x10\x0e\x17\n\x1e\x1f !!"!!# "$#  %& \'()* 780-* 9\n,5ÿ6(-03,\n:\x10<\x04\t<\x04\x1c\x00\x1d\x04\x05\x10\x0e\x10\x05ÿ>\r\x11\r\x0c\x06\n:\x10<\x04\t<\x04ÿ<\x1d\x04\x05\x10\x0e\x10\x05ÿ\x05\r\x11\r\x0c\x06M\x13\x0c\r\x01\x1dÿH\x10\x16\x06\x04\x13\x0c\t\x06\x04=J _6^P6ÿY*)*4-*SÿN*`0R*3 \x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0e\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x19\x06\x0b\x02\n#\x1eÿ\x0c\x11\x12\x0c\x04\x11\x12\n\x18\x0b\x06\r\x0bÿ\x19\x06\x0b\x02 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r \r\x02\n\x0c\x07(\x02\x03 \x1b\x1c\x02\x05\x1dÿ\x1e\x0c\r\n\x01\x02\x03\x04\x05\x06\x07ÿ\t\x04\n\x0b\x0c\r\x0eÿ\x0f\x10\x04\x11\x03\x04\x11\x12 !\x11\x12\x0c\x04\x11\x12ÿ\x06\x0b \n$\x02\x05\x04\x1e\x0e\n\x00 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x1f\x11\x1d\x11\x0c \x11ÿ\n\x0b\x06\r\x0b \x13&\x11\x03ÿ\x03\x06\x0b\x02\x17 \x1f\x11\x1d\x11\x0c \x11ÿ\x02\x11\x03\n\x13\x14\x15\x11\x0c\r\x16\x06\x07\x04\x0b\x0e\x17 \n\x0b\x1f\x03\x0eÿ\x02\x11\x0b\r\x0e" \x1b%\x1b\x14&\n\x0e\x0e\x0e\x0e\x17 \x03\x06\x0b\x02 \x13\x03\x03\x1a\x16\x0c\x11\x1a \x03\x06\x0b\x02\n\'\r\x06\x03\x02\n\x0e\x0e\x0e\x0e\x17\n) *+,-./.0ÿ2.33+/40ÿ/56ÿ++ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nG7H7I,H5ÿJ.,H/\nF \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n*+0.,0.\nK ,/H+,3ÿL+-H+33,/+7I \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nM 0+<2,*+N.H/+G4370+0 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nO G,H*+,3ÿ+I04LL+G+.IG5ÿ \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\nP ,G.ÿ+IJ+-+/7Hÿ,33.H<5 \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\nQ J+6ÿH.63.,0.2.I/ÿH+<J/ 4Iÿ,6HÿFR)M B8CD@CE@? H@S:TU@? A 4Iÿ,6HÿFR)M B8CD@CE@?\nV J+6ÿH.63.,0.2.I/ÿ3.L/ 4IÿW4IÿFR)P B8CD@CE@? H@S:TU@? A 4IÿW4IÿFR)P B8CD@CE@?\n3.Lÿ-4I*3.ÿ-H.IGJ\nX \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n-37GY\n)R 6H70/,/,J56.H63,0+. \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)) <</ÿ+IGH.,0.* )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n)F ,I.2+,ÿ )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n63,/.3./ÿG74I*\n)K )Rÿ0.6ÿFRF) B8CD@CE@? 789:;89 <=>?@ÿF A B8CD@CE@?\n*.GH.,0.*\n)M +<ÿ<ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)O +<ÿ,ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n)P +<ÿ2ÿ*.GH.,0.* \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿ) A B8CD@CE@?\n<34/.,3ÿH.<+7Iÿ3.L/\n)Q \x05\x1c\x02\x05\x1d\x02\x03 789:;89 <=>?@ÿF A B8CD@CE@?\n6,+I \x00\x01\x02\x03\x01\x04\x05\x06\x07\x02\x06ÿ\t\n\x0b\x05\x03\x07\x06\x05\x01\x02\nREG-2021-00130 GSPV RECEIPT DATE 17SEP2021 AKA 25 pages\n\x12\x13 \x12\x13\n\x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02\n\x05\x1aÿ\x04\n\x0b\x05\x03\x07\x18 \x05\x1aÿ\x07\x0b\x1f\n\x0e\x1a\n\n\x12\x13 \x16\x05\x1a\x06\x01\x0e\x17\x1c \n\x1f\n\x02\x06\x1c\n%\x06\x07\x0e\x06ÿ\x0b\x07\x06\n %\x06\x01\x15ÿ\x0b\x07\x06\n\n\x14\x0e\x01\x15\x16\x17\x18\x07\x19\x05\x1a \x14\x18\n\x07\x1a\n \x14\x18\n\x07\x1a\n \r\x01\x1a\n \x1b\x06\x16\n\x0e\x1c \x12\x13ÿ\x1b\x06\x16\n\x0e \x12\x13ÿ\x1b\x06\x16\n\x0e\x1c %\x06\x07\x0e\x06\n\x0c \r\x0e\x0f\x10ÿ\x11\x07\x04\n \x12\x02\x0b\x05\x03\x07\x06\x05\x01\x02 \r\x01\x1a\n #\x0e\n$\x0f\n\x02\x03\x17 &\x01\x0f\x06\n \'\x0b\x0b(\x04\x01\x02( \'\x0b\x0b(\x04\x01\x02( \x1b\x02\x10\x01\x05\x02\x10\n\x1b\x0eÿ\x1b\x06\x16\n\x0e\x1c \x1a\n\x18\n\x03\x06ÿ\x06\x16\n \x1a\n\x18\n\x03\x06ÿ\x06\x16\n "\x02\x05\x06 \x1a\x15\n\x03\x05\x13\x17 %\x15\n\x03\x05\x13\x17 \x1a\x15\n\x03\x05\x13\x17 \r\x07\x06\nÿ"\x02*\n\x17\x17\x17\x17) \x17\x17\x17\x17)\n\x1a\x15\n\x03\x05\x13\x17 \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n \x07\x15\x15\x0e\x01\x15\x0e\x05\x07\x06\n\n\t\n\x0b\x05\x03\x07\x18  \x0b\x1f\n\x0e\x1a\n\n\x1d\x05\x1a\x06\x01\x0e\x17 !\x1f\n\x02\x06\n\x0e\n\x03\x01\x0e\x0b\x1e \x0e\n\x03\x01\x0e\x0b\x1e\n@AB30C5A 2LMNLG<O FPÿ2A5 LON9HNSH FUÿ2A5\n+ ,-./0123-4 56789:;<=>? D D EFF CG9H6 I/ JK D D LON9HNSHT\n@-1 H7L? RFR+ T RFR+\n4HT>N<; WXY10K-1.\nR 3C012A4-K V>?G76: D -@2B,,-Y-A D +F \\] D ^-K D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n25-0C.C@1 4HT>N<; WXY10K-1.\nE Y3C@ V>?G76: D -@2B,,-Y-A D RW \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@YZXB@[\n3142B.C2- 4HT>N<; +FX50C23\n_ @ V>?G76: D 131VZ5A0 D F`_ \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n5.12-AXB@\n145VC4C0\nW 56789:;<=>? 4B[C2-3-2 D D +FF \\]a\\. D J>T D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@1.\n51@3C501 23C41YV\nb cC. 56789:;<=>? 50C3AY3-C D D _F \\] D JK D C6<; D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\n@\n4HT>N<; EX130-1. 2LMNLG<O\nP A@Cd150-@ V>?G76: D ,-^0-..13- D UFF CG9H6 -A ^-K D H7L? D \x03\x16\n\x03*\n\x0b D \x03\x16\n\x03*\n\x0b\nC@XB@[\n@Ce14-@2 4HT>N<; +PX/.B3A B@ÿ1B/ LON9HNSH\nU B.,C@ V>?G76: D 1.ÿ0A/-C@ D WFF \\] D 50@ D C6<; D RFR+ T D \x03\x16\n\x03*\n\x0b\n.A,3\nKAd14A3V 1TgH6?H +XY02X+_ -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\nf D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\nKAd14A3V 1TgH6?H RXY02X+b -OG6<gHO7 +bÿ2A5 LON9HNSH +bÿ2A5\n+F D D +F \\] D JK D D LON9HNSHT\n12C@ AgHOG 2A5ÿRFR+ L? RFR+ T RFR+\n5101YA31 56H\\HT>N<G>7 +_ÿ2A5 LON9HNSH +Wÿ2A5\n++ 4C. Oÿh76 D D D + ] D JK D C6<; D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf\n56H\\HT>N<G>7 -OG6<gHO7 +_ÿ2A5 LON9HNSH +_ÿ2A5\n+R 31eA/-. Oÿh76 D D D R \\] D JK D L? D RFR+ T RFR+ LON9HNSHT\n0A/@+fPf \n\x11 \n\x11\n\n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b\n\r\x18ÿ\x08\t\x0c\r\x0e\x07\x16 \r\x18ÿ\x07\x0c\x1e\t\x02\x18\t\n\n\x11 \x14\r\x18\x0f\x10\x02\x15\x1a \t\x1e\t\x0b\x0f\x1a\nREG-2021-00130 GSPV RECEIPT DATE 1$7\x0f\x07S\x02E\x0fÿ\x0cP\x072\x0f\t021 AKA 25 pages$\x0f\x10\x13ÿ\x0c\x07\x0f\t\n\x12\x02\x10\x13\x14\x15\x16\x07\x17\r\x18 \x12\x16\t\x07\x18\t \x12\x16\t\x07\x18\t \x01\x10\x18\t \x19\x0f\x14\t\x02\x1a \n\x11ÿ\x19\x0f\x14\t\x02 \n\x11ÿ\x19\x0f\x14\t\x02\x1a $\x0f\x07\x02\x0f\n\x00 \x01\x02\x03\x04ÿ\x06\x07\x08\t \n\x0b\x0c\r\x0e\x07\x0f\r\x10\x0b \x01\x10\x18\t "\x02\t#\x03\t\x0b\x0e\x15 %\x10\x03\x0f\t &\x0c\x0c\'\x08\x10\x0b\' &\x0c\x0c\'\x08\x10\x0b\' \x19\x0b\x04\x10\r\x0b\x04\n\x19\x02ÿ\x19\x0f\x14\t\x02\x1a \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t \x18\t\x16\t\x0e\x0fÿ\x0f\x14\t !\x0b\r\x0f \x18\x13\t\x0e\r\x11\x15 $\x13\t\x0e\r\x11\x15 \x18\x13\t\x0e\r\x11\x15 \x01\x07\x0f\tÿ!\x0b)\n\x15\x15\x15\x15( \x15\x15\x15\x15(\n\x18\x13\t\x0e\r\x11\x15 \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t \x07\x13\x13\x02\x10\x13\x02\r\x07\x0f\t\n\x1b\t\x0c\r\x0e\x07\x16 \x1f\x0c\x1e\t\x02\x18\t\n\x1c\r\x18\x0f\x10\x02\x15  \x1e\t\x0b\x0f\n\x02\t\x0e\x10\x02\x0c\x1d \x02\t\x0e\x10\x02\x0c\x1d\nHIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\n*+ ,-./01/23 456789:;<=> /?. @ @ ABC DE @ FG @ @ MIR8LRSLT\nM> PQP* T PQP*\nG2U-V2/W 45LDLT=R;J=6 HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Cÿ.24\n*N -.XY IÿZ65 @ @ @ PQ DE @ FG @ M> @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nW]G1XVX1 VLT=R;: *A^[?0/2 .M_RMJ;I *Nÿ.24 MIR8LRSL\n*C 4WXY W=>J659 @ -?ÿ12[HXY @ * DE @ 41Y @ L6M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nW]G1X3W? ?2,/\n4-1-32/- VLT=R;: *A^[?0/2 HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*` VX? W=>J659 @ -?ÿ12[HXY @ * E @ 41Y @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n?2,/\n3X/1HV +ÿ/HV2. *Cÿ.24 MIR8LRSL\n*A 456789:;<=> a-3/21H-? @ @ \\`Q DE @ XJ8L5 X5;: @ @ \x0e\x14\t\x0e)\t\x0c\n,X1/2 -ÿb22c PQP* T\n*ÿ@ÿPÿ@ÿ* *Cÿ.24 MIR8LRSL\n*d -3H3?XeH1 456789:;<=> eH1-? @ @ NQQ DE @ XJ8L5 /a?ÿ- X5;: @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\nG-]ÿ\nY-/1H0V3W HIJ5;KLI6 *Nÿ.24 MIR8LRSL\n*\\ 456789:;<=> /?. @ @ PCQ D? @ 36IJ=IM6M> @ @ @ \x0e\x14\t\x0e)\t\x0c\n?X1HG M> PQP* T\n4H421-3H?H Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nPQ 456789:;<=> a-3/21H-? @ @ NB*A E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nYÿY-/1H0V -ÿG-] M> PQP* T\n/-fXa-3/- Nÿ/HV2. HIJ5;KLI6 *Cÿ.24 MIR8LRSL\nP* 456789:;<=> a-3/21H-? @ @ QBC E @ XJ8L5 @ @ \x0e\x14\t\x0e)\t\x0c\nVÿY-/1H0V -ÿG-] M> PQP* T\nG2U-V2/W 45LDLT=R;J=6 *+ÿ.24 MIR8LRSL *+ÿ.24\nPP -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W 45LDLT=R;J=6 *`ÿ.24 MIR8LRSL *`ÿ.24\nP+ -.XY IÿZ65 @ @ @ *Q DE @ FG @ X5;: @ PQP* T PQP* MIR8LRSLT\n12[Y*\\A\\\nG2U-V2/W -TKL5>L *^31.^*N HIJ5;KLI6 *Nÿ.24 MIR8LRSL *Nÿ.24\nPN @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L P^31.^*` HIJ5;KLI6 *`ÿ.24 MIR8LRSL *`ÿ.24\nPC @ @ *Q DE @ FG @ @ MIR8LRSLT\n-.XY 2KLIJ .24ÿPQP* M> PQP* T PQP*\nG2U-V2/W -TKL5>L N^2Y324W HIJ5;KLI6 *`ÿ.24 MIR8LRSL\nP` -.XY 2KLIJ @ @ -?X4-/W] *Q DE @ aHG @ M> @ PQP* T @ \x0e\x14\t\x0e)\t\x0c\n^*`ÿ.24']
apiLogger::2021-10-05 06:22:55,706::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 06:22:55,706::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 06:25:18,786::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 06:25:18,825::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 06:25:18,825::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp5h2tr5gq 
apiLogger::2021-10-05 06:25:18,826::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 06:25:18,827::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 06:25:20,070::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 06:25:20,070::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp5h2tr5gq
apiLogger::2021-10-05 06:25:23,678::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 06:25:23,678::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 06:25:23,678::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 06:25:23,678::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 06:25:23,683::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 06:25:23,683::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 06:25:23,683::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 06:25:23,683::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 06:25:23,687::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-05 06:25:23,687::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 06:25:23,687::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 06:25:23,687::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-05 06:25:23,687::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Please note that Syneos Health received initial information regarding the\nfollowing event.\n \nProtocol: R1979-ONC-1625\nDay 0: 19-JUN-2021\nCountry: South Korea\nSite # /Investigator: 1625410007/ Kim, Tae Min\nSubject ID: 410007013\nStudy Drug(s): REGN1979\nEvent Term: HYPOTENSION\nOnset date: 09-JUN-2021\nSeverity/Grade: Grade 3\nSAE Criteria and/or AESI Criteria: Hospitalization / No\nInvestigator Relationship to Study Drug: Not Related\nInvestigator Relationship to Study Conduct: No\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2021-00096\n \nKind regards,\n \n \nJessica McIntyre, RN, BSN, CPN\nSafety & PV Specialist I, Drug Safety & Pharmacovigilance\nSyneos Health\nUS Regional – Ohio\nDirect   +1 984 710 8965\nsyneoshealth.com  \nEMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. \x00\x01\x02\x03\x01\x02\x04\x02\x03 \x05\x06\x07 REG-2021-00096 GSPV RECEIPT DATE 19JUN2021 JM 48 pages\nÿwxyzwz{|{ÿ ÿxy}}{~y}ÿ ÿx\x7fÿ\x81\x82\x83\x84w\x85yÿ ÿ\x86y\x85\x87ÿ ÿ\x86\x83\x88yÿ ÿ\x89\x83~\x83\x8a|\n\x8b}y\x82\x8cÿ\x8dy}}w\x8e{ÿx\x8e\x8f\x90|\x7f\x82yÿ\x1b\x1c\x19\x1d\x0e\t9%\n\x06\x03-5-V02\x05V\x03\x00\x02# ,\x03\x04\x04\x045ÿVÿ\x91\x18\x13_ÿ1\x12ÿVÿ\x1c\x11\x1f\t\x08ÿ\x91\x11\r\x0e\x19\x92\x910\x06 ,\x03\x04\x04\x045\x04\x03< U\'6&\x06\x1c&ÿ&6&21\x1c U\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\nU\'6&\x06\x1c&ÿ&6&21\x1c\nU\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x0bÿ/\x0e\x0b\x012\x11 \x1c\x1f"=\x0e\x16\t\x0cÿ>?@@@A@?B\n(\x19\x0f\x0e\x0cÿCDEFGHFÿJEFKLÿMÿCNOJPQJÿJOJRSQ\nU\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\n\x05\x1f\r\r\x0e\x10\t\x159ÿ\x1a\x18\x0e\x1e\x18\x10\x0fÿ\x15\x18\x10\x0eÿ\x03<ÿ\x11\x1dÿ\x03<\x12\nÿ U\n\n\x159ÿ\t\x11ÿ\x06\x0e\x16\x11\r\x14\n\x05\x15\x18\x16$ÿ\x08\x0e\r\x0eÿ\t\x11ÿ\r\x0e\t\x1f\r\x10ÿ\t\x11ÿT\x05\x11\x13\n\x15\x0e\t\x0eÿ6\x18\x0e\x1eT\x12\n\x05\x06\x07ÿ.\x18\x0b\t\x11\r9\n,\x03\x04\x04\x045\x04\x03<ÿVÿU\x14\x1a\x0e\r\x0b\x0e \x17\x19\x18\x10ÿU\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\tÿ\'\x0e\x0b\x16\r\x18\n\t\x18\x11\x10ÿ\x1b1\x0e\r\x13% ./(01&2\x1c302\n&\x1a\x0e\x10\t ÿÿÿ\n\x1c0\x05 \x03\x04\x04,5\x04\x00#6\x19\x0b\x16\x1f\x15\x19\rÿ\x14\x18\x0b\x11\r\x14\x0e\r\x0b\n,\x03\x04\x04\x045\x04\x03<ÿVÿU\x14\x1a\x0e\r\x0b\x0e\n&\x1a\x0e\x10\t\x0bÿ/\x0e\x0b\x012\x11 .781\x03\x04\x04\x03\x03-#,\'\x0e\x16\r\x0e\x19\x0b\x0e\x14ÿ\x19\x10\x14ÿ\x10\x11\x10\x0b\n\x0e\x16\x18\x1d\x18\x16ÿ"\x15\x11\x11\x14\n\n\r\x0e\x0b\x0b\x1f\r\x0eÿ\x14\x18\x0b\x11\r\x14\x0e\r\x0bÿ\x19\x10\x14ÿ\x0b\x08\x11\x16$\n,\x03\x04\x04\x045\x04\x03<ÿVÿ\x1c\x0e\r\x18\x11\x1f\x0b .71 \x03\x04\x04#5\x03+\x036\x19\x0b\x16\x1f\x15\x19\rÿ\x089\n\x11\t\x0e\x10\x0b\x18\x1a\x0eÿ\x14\x18\x0b\x11\r\x14\x0e\r\x0b\nU\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x01U&\x1c3ÿt, (1 \x03\x04\x04\x02\x03\x04-5.9\n\x11\t\x0e\x10\x0b\x18\x11\x10\n,\x03\x04\x04\x045\x04\x03<ÿVÿ\x1c\x0e\r\x18\x11\x1f\x0b 771 \x03\x04\x04\x02\x03\x04-5.9\n\x11\t\x0e\x10\x0b\x18\x11\x10\nU\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x01U&\x1c3ÿt\x03\n,\x03\x04\x04\x045\x04\x03<ÿVÿ\x1c\x0e\r\x18\x11\x1f\x0b \x1c\t\x19\r\tÿ\x14\x19\t\x0eÿ\x1b\x14\x14V\x13\x11\x10V9999% -ÿ:;2ÿ\x02\x04\x02\x03\nU\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x01U&\x1c3ÿt\x02\n(\x15\x0e\x19\x0b\x0eÿ\x16\x11\x13\n\x15\x0e\t\x0eÿWKXYÿ\x18\x1dÿ\x0e\x1a\x0e\x10\tÿ\x11\x10\x0b\x0e\tÿ\x11\x10ÿZFF[ÿ?ÿN\\Yÿ?ÿ\x0c\n\'\x18\x14ÿ\t\x08\x18\x0bÿ\x0e\x1a\x0e\x10\tÿ\x0b\t\x19\r\tÿ]G^WGÿ\t\x11ÿ\t\x08\x0eÿ\x0b\t\x19\r\tÿ\x11\x1dÿ\x0b\t\x1f\x149ÿ\x14\r\x1f\x0f\n\x19\x14\x13\x18\x10\x18\x0b\t\r\x19\t\x18\x11\x10)\n3\x1dÿ\t\x08\x18\x0bÿ\x0e\x1a\x0e\x10\tÿ\x18\x0bÿ\x19\x10ÿ3\x10\x1d\x1f\x0b\x18\x11\x10ÿ\x06\x0e\x15\x19\t\x0e\x14ÿ\x06\x0e\x19\x16\t\x18\x11\x10ÿ\x11\rÿ\x169\t\x11$\x18\x10\x0e\n\r\x0e\x15\x0e\x19\x0b\x0eÿ\x0b9\x10\x14\r\x11\x13\x0e_ÿ\n\x15\x0e\x19\x0b\x0eÿ\x16\x08\x0e\x16$ÿ\t\x08\x0eÿ"\x11 ÿ\x19\x10\x14ÿ\x16\x11\x13\n\x15\x0e\t\x0e\n\t\x08\x0eÿ\x19\n\n\r\x11\n\r\x18\x19\t\x0eÿ3\x06\x06\x01\x05\x06\x1cÿ\x1d\x11\r\x13\n\'\x18\x14ÿ\t\x08\x0eÿ\x0e\x1a\x0e\x10\tÿ\x11\x16\x16\x1f\rÿ\x1e\x18\t\x08ÿ\x19\x10ÿ\x11\x1a\x0e\r\x14\x11\x0b\x0e) 2\x11\n\x1c\x0e\x15\x0e\x16\tÿ\x18\x1dÿU&ÿ\x18\x0bÿ\x18\x10\t\x0e\r\x13\x18\t\t\x0e\x10\t /\x0e\x0b\nU&ÿ\x0b\x1f\x0b\n\x0e\x16\t\x0e\x14ÿ\t\x11ÿ"\x0eÿ\x16\x19\x1f\x0b\x0e\x14ÿ"9ÿ\x06&82\x03-5-) 2\x11\nU&ÿ\x0b\x1f\x0b\n\x0e\x16\t\x0e\x14ÿ\t\x11ÿ"\x0eÿ\x16\x19\x1f\x0b\x0e\x14ÿ"9ÿ\x0b\t\x1f\x149ÿ\x16\x11\x10\x14\x1f\x16\t) 2\x11\n3\x1dÿ9\x0e\x0b_ÿ\x0b\n\x0e\x16\x18\x1d9ÿ\x0b\t\x1f\x149ÿ\x16\x11\x10\x14\x1f\x16\t\n0\x1f\t\x16\x11\x13\x0eÿ\x11\x1dÿU& \x06\x0e\x16\x11\x1a\x0e\r\x18\x10\x0f\x01\x06\x0e\x0b\x11\x15\x1a\x18\x10\x0f\n3\x1dÿ\x11\x1f\t\x16\x11\x13\x0eÿ\x18\x0bÿ\x06\x0e\x16\x11\x1a\x0e\r\x0e\x14\x01\x06\x0e\x0b\x11\x15\x1a\x0e\x14ÿ\x1e\x18\t\x08ÿ\x1c\x0e`\x1f\x0e\x15\x19\x0ea\n\x1c\n\x0e\x16\x18\x1d9ÿ\t\x08\x0eÿ\x0b\x0e`\x1f\x0e\x15\x19\x0e\x12\n\x06\x0e\x0b\x11\x15\x1f\t\x18\x11\x10ÿ\x14\x19\t\x0eÿ\x1b\x14\x14V\x13\x11\x10V9999%\nU&ÿ\x18\x10\x18\t\x18\x19\x15ÿ\x0b\x0e\x1a\x0e\r\x18\t9ÿ\x0f\r\x19\x14\x0e 8\r\x19\x14\x0eÿ\x02\nU&ÿ\x13\x11\x0b\tÿ\x0e \t\r\x0e\x13\x0eÿ\x0b\x0e\x1a\x0e\r\x18\t9ÿ\x0f\r\x19\x14\x0e 8\r\x19\x14\x0eÿ<\n\'\x19\t\x0eÿ\x0e\x1a\x0e\x10\tÿb\x0e\x16\x19\x13\x0eÿ8\r\x19\x14\x0eÿ<ÿ\x11\rÿ\x08\x18\x0f\x08\x0e\rÿVÿ\x18\x1dÿ\x19\n\n\x15\x18\x16\x19"\x15\x0eÿ\x1b\x14\x14V\n\x03+ÿ:;2ÿ\x02\x04\x02\x03\n\x13\x11\x10V9999%\n\'\x19\t\x0eÿ\x0e\x1a\x0e\x10\tÿ"\x0e\x16\x19\x13\x0eÿ\x08\x18\x0f\x08\x0e\rÿ\t\x08\x19\x10ÿ8\r\x19\x14\x0eÿ<ÿVÿ2\x11\tÿ\x19\n\n\x15\x18\x16\x19"\x15\x0e\n\'\x19\t\x0eÿ&\x1a\x0e\x10\tÿb\x0e\x16\x19\x13\x0eÿ7\x0e\x0b\x0bÿ\t\x08\x19\x10ÿ8\r\x19\x14\x0eÿ<ÿVÿ\x18\x1dÿ\x19\n\n\x15\x18\x16\x19"\x15\x0eÿ\x1b\x14\x14V\n\x13\x11\x10V9999%\n\'\x19\t\x0eÿ\x0e\x1a\x0e\x10\tÿ"\x0e\x16\x19\x13\x0eÿ\x15\x0e\x0b\x0b\x0e\rÿ\t\x08\x19\x10ÿ8\r\x19\x14\x0eÿ<ÿVÿ2\x11\tÿ\x19\n\n\x15\x18\x16\x19"\x15\x0e\nSGF\\LcFKLÿdWGÿCJÿeHFXFfLÿ\\XXÿLg\\Lÿ\\]]XYÿFhfF]LÿigFK\nRjRJÿ^HÿKWLFDklÿdWGÿDGmnÿLgFG\\]YÿWGÿcFD^f\\L^WK\n]XF\\HFÿFKLFGÿ^KLWÿfWKfWc^L\\KLÿcFD^f\\L^WKHÿFoPpqÿrd\n]GWfFDmGFÿWGÿHmGnFGYÿ]XF\\HFÿFKLFGÿ^KLWÿLgF\noWKfWc^L\\KLÿ]GWfFDmGFHsHmGnFG^FHÿFoPp\n2\x11\x10\x0e\n\'\r\x1f\x0fÿ\t\x08\x0e\r\x19\n9\x01ÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt\x03\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt\x02\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt<\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt,\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt#\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt\x00\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt5\n\x05\x15\x18\x16$ÿ.\x0e\r\x0eÿ\x1d\x05\x11\rÿ\x11\x05\x10\x1f\x0b\x16\t\x11\x11\x13\x13\x0e\r\x18ÿ\x1c\t\x19\x1f\n\x10\n\t\x11ÿ\r\x17\tÿ3\x10\x0e\x1d\x11\x14\r\x13\x18\x16\x19\x19\t\x18\x11\t\x18\x10\x11\x10ÿt+ \x17\x0e\x14\x18\x14\x19\t\x19ÿ\x05\x15\x19\x0b\x0b\x18\x16ÿ\x06\x19\x1a\x0euÿ\x02\x04\x02\x04\x12<\x12\x02ÿ\n\x05\x11\n9\r\x18\x0f\x08\tÿvÿ\x03---V\x02\x04\x02\x04ÿ\x17\x0e\x14\x18\x14\x19\t\x19ÿ\x1c\x11\x15\x1f\t\x18\x11\x10\x0b_ÿ3\x10\x16\x12\n\x08\t\t\n\x0b\x0c\x01\x01\r\x0e\x0f\x0e\x10\x0e\r\x11\x10\x12\x13\x14\x0b\x11\x15\x12\x16\x11\x13\x01\x17\x0e\x14\x18\x14\x19\t\x19\x06\x19\x1a\x0e\x01\x1b\x1c\x1b\t\x15\x13\x1d\x1e\x1f\x0e \x10\x18\x15!\x03"\x19#\x08\x16\x0b\x0b\x1f\x08$\x1d%%\x01\x17\x11\x14\x1f\x15\x0e\x0b\x01&\'\x05\x01\x05\x06\x07(\x19\x0f\x0e\x12\x19\x0b\n )\'(*+#,\x04\x03-+\x03 \x03\x01\x02 \x00\x01\x02\x03\x01\x02\x04\x02\x03 \x05\x06\x07 REG-2021-00096 GSPV RECEIPT DATE 19JUN2021 JM 48 pages\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿ2- ÿstuvsvwxwÿ ÿtuyywzuyÿ ÿt{ÿ}~\x7f\x80s\x81uÿ ÿ\x82u\x81\x83ÿ ÿ\x82\x7f\x84uÿ ÿ\x85\x7fz\x7f\x86x\n\x87yu~\x88ÿ\x89uyys\x8awÿt\x8a\x8b\x8cx{~uÿ\x1b\x1c\x19\x1d\x0e\t3%\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿ2\x03\x04\n\x06\x03-9-g5.\x05g\x03\x00\x02# ,\x03\x04\x04\x049ÿgÿo\x18\x137ÿj\x12ÿgÿ\x1c\x11\x1f\t\x08ÿo\x11\r\x0e\x19\x8do5\x06 ,\x03\x04\x04\x049\x04\x034 0\'n&\x06\x1c&ÿ&n&.j\x1c 0\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\n0\'n&\x06\x1c&ÿ&n&.j\x1c \x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ(\r\x11\x16\x0e\x14\x1f\r\x0e\x01\x0b\x1f\r\x0f\x0e\r3\n0\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x0bÿ1\x0e\x0b\x01.\x11\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\n\r\x11\x16\x0e\x14\x1f\r\x0e\x01\x0b\x1f\r\x0f\x0e\r3ÿ2\x03\n0\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\n\r\x11\x16\x0e\x14\x1f\r\x0e\x01\x0b\x1f\r\x0f\x0e\r3ÿ2\x02\n\x05\x06\x07ÿl\x18\x0b\t\x11\r3\n,\x03\x04\x04\x049\x04\x034ÿgÿ0\x14\x1a\x0e\r\x0b\x0e \x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\n\r\x11\x16\x0e\x14\x1f\r\x0e\x01\x0b\x1f\r\x0f\x0e\r3ÿ24\n&\x1a\x0e\x10\t\n,\x03\x04\x04\x049\x04\x034ÿgÿ0\x14\x1a\x0e\r\x0b\x0e \x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\n\r\x11\x16\x0e\x14\x1f\r\x0e\x01\x0b\x1f\r\x0f\x0e\r3ÿ2,\n&\x1a\x0e\x10\t\x0bÿ1\x0e\x0b\x01.\x11\n,\x03\x04\x04\x049\x04\x034ÿgÿ\x1c\x0e\r\x18\x11\x1f\x0b \x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\n\r\x11\x16\x0e\x14\x1f\r\x0e\x01\x0b\x1f\r\x0f\x0e\r3ÿ2#\n0\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x010&\x1c6ÿ2,\n,\x03\x04\x04\x049\x04\x034ÿgÿ\x1c\x0e\r\x18\x11\x1f\x0b 5\t\x08\x0e\r\n0\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x010&\x1c6ÿ2\x03\n,\x03\x04\x04\x049\x04\x034ÿgÿ\x1c\x0e\r\x18\x11\x1f\x0b 6\x1dÿ5\t\x08\x0e\r7ÿ\x0b\n\x0e\x16\x18\x1d3\n0\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x010&\x1c6ÿ2\x02\n0\x16\t\x18\x11\x10ÿ\t\x19$\x0e\x10ÿ\x1e\x18\t\x08ÿ\x06&8.\x03-9- .\x11\tÿ0\n\n\x15\x18\x16\x19"\x15\x0e\n\'\x11\x0e\x0bÿ\t\x08\x18\x0bÿ0&ÿ:\x1f\x19\x15\x18\x1d3ÿ\x19\x0bÿ\x1c\x0e\r\x18\x11\x1f\x0b) 1\x0e\x0b\n6\x0bÿ\t\x08\x18\x0bÿ\x19\x10ÿ0&ÿ\x11\x1dÿ\x1c\n\x0e\x16\x18\x19\x15ÿ\x18\x10\t\x0e\r\x0e\x0b\tÿ\x1b0&\x1c6%) .\x11\n;<=>?@A@ÿAC@ÿD<??<EFGHÿDF@?IJÿKLMNÿFDÿOIP@QJ@ÿRP@GA\nSTU?FDF@JÿUJÿ@FAC@QÿJ@QF<TJÿ<QÿUJÿUGÿ@P@GAÿ<DÿJ>@VFU?\nFGA@Q@JAÿWORXYZÿ>@Qÿ>Q<A<V<?[ÿYDÿORÿI<@JÿG<Aÿ=@@A\nVQFA@QFUÿD<Qÿ@FAC@QÿXORÿ<QÿORXYÿAC@GÿX\\K]ÿC@Q@[\n^K_ÿXORÿ`ÿYaRL\\Y^NÿXR_YKbXLRXX\n;_Y\\R_YKLc;_Y\\R_YOdÿ\n;eR;fÿOMMÿ\\eO\\ÿO]]MN\n6\tÿ\r\x0e\x0b\x1f\x15\t\x0e\x14ÿ\x18\x10ÿ\x14\x0e\x19\t\x08\n6\tÿ\x1e\x19\x0bÿ\x15\x18\x1d\x0eg\t\x08\r\x0e\x19\t\x0e\x10\x18\x10\x0f\n6\tÿ\r\x0e:\x1f\x18\r\x0e\x14ÿ\x11\rÿ\n\r\x11\x15\x11\x10\x0f\x0e\x14ÿ\x18\x10\n\x19\t\x18\x0e\x10\tÿ\x08\x11\x0b\n\x18\t\x19\x15\x18!\x19\t\x18\x11\x10\n(\x0e\r\x0b\x18\x0b\t\x0e\x10\tÿ\x11\rÿ\x0b\x18\x0f\x10\x18\x1d\x18\x16\x19\x10\tÿ\x14\x18\x0b\x19"\x18\x15\x18\t3ÿ\x01ÿ\x18\x10\x16\x19\n\x19\x16\x18\t3\n6\tÿ\x18\x0bÿ\x19ÿ\x16\x11\x10\x0f\x0e\x10\x18\t\x19\x15ÿ\x19\x10\x11\x13\x19\x153\x01"\x18\r\t\x08ÿ\x14\x0e\x1d\x0e\x16\tÿ\x18\x10ÿ\x11\x1d\x1d\x0b\n\r\x18\x10\x0fÿ\x11\x1d\n\x0b\t\x1f\x143ÿ\x0b\x1f"h\x0e\x16\t\n5\t\x08\x0e\rÿ\x13\x0e\x14\x18\x16\x19\x15\x153ÿ\x0b\x0e\r\x18\x11\x1f\x0bÿ\x18\x13\n\x11\r\t\x19\x10\tÿ\x0e\x1a\x0e\x10\tÿ\x1b6\tÿ\x14\x11\x0e\x0bÿ\x10\x11\t\n\x13\x0e\x0e\tÿ\x19\x103ÿ\x11\x1dÿ\t\x08\x0eÿ\x19"\x11\x1a\x0eÿ\x0b\x0e\r\x18\x11\x1f\x0bÿ\x16\r\x18\t\x0e\r\x18\x197ÿ"\x1f\tÿ\x13\x193\nh\x0e\x11\n\x19\r\x14\x18!\x0eÿ\t\x08\x0eÿ\x0b\x1f"h\x0e\x16\t7ÿ\x19\x10\x14ÿ\x13\x193ÿ\r\x0e:\x1f\x18\r\x0eÿ\x13\x0e\x14\x18\x16\x19\x15ÿ\x11\r\n\x0b\x1f\r\x0f\x18\x16\x19\x15ÿ\x18\x10\t\x0e\r\x1a\x0e\x10\t\x18\x11\x10ÿ\t\x11ÿ\n\r\x0e\x1a\x0e\x10\tÿ\x11\x10\x0eÿ\x11\x1dÿ\t\x08\x0eÿ\x11\x1f\t\x16\x11\x13\x0e\x0b\n\x15\x18\x0b\t\x0e\x14ÿ\x19"\x11\x1a\x0e%\x12\nKLMNÿ^YMMÿKb\\ÿY^ÿORÿiRR\\Xÿ;_Y\\R_YOÿ^K_ÿORXY\n\\C@ÿORÿDT?DF??JÿAC@ÿD<??<EFGHÿORÿ<DÿJ>@VFU?ÿFGA@Q@JA\nWORXYZ\n;eR;fÿOMMÿ\\eO\\ÿO]]MN\n8\r\x19\x14\x0eÿ4ÿ\x11\rÿ\x0f\r\x0e\x19\t\x0e\rÿ6\x06\x06\n8\r\x19\x14\x0eÿ4ÿ\x11\rÿ\x08\x18\x0f\x08\x0e\rÿjk\x1c\n8\r\x19\x14\x0eÿ\x02ÿ\x11\rÿ\x0f\r\x0e\x19\t\x0e\rÿ\x05\x06\x1cÿ\x1bk\x0e\x0e7\x02\x04\x03-%\n8\r\x19\x14\x0eÿ4ÿ\x11\rÿ\x0f\r\x0e\x19\t\x0e\rÿ\x19\x15\x15\x0e\r\x0f\x18\x16ÿ\r\x0e\x19\x16\t\x18\x11\x10\x0b\n8\r\x19\x14\x0eÿ4ÿ\x11\rÿ\x0f\r\x0e\x19\t\x0e\rÿ\x18\x10\x1d\x0e\x16\t\x18\x11\x10\x0b\n8\r\x19\x14\x0eÿ\x02ÿ\x11\rÿ\x0f\r\x0e\x19\t\x0e\rÿ\x05.\x1cÿ\x0e\x1a\x0e\x10\t\x0b\nl\x0e\n\x19\t\x18\t\x18\x0bÿmÿ\r\x0eg\x19\x16\t\x18\x1a\x19\t\x18\x11\x10\nÿ\n(\r\x18\x10\t\x19"\x15\x0eÿn\x0e\r\x0b\x18\x11\x10ÿÿn\x18\x0e\x1eÿ(\'\x07ÿÿÿ6\x16\x11\x10ÿo\x0e3 \x1c\x19\x1a\x0eÿ\x05\x19\x10\x16\x0e\x15\n\x05\x06\x07ÿn\x0e\r\x0b\x18\x11\x10ÿ-49+ÿgÿ(\x19\x0f\x0eÿ8\x0e\x10\x0e\r\x19\t\x0e\x14\x0cÿ\x02\x03ÿp\x1f\x10ÿ\x02\x04\x02\x03ÿ\x04+\x0c,\x02\x0c\x02,ÿ&\x19\x0b\t\x0e\r\x10ÿ\'\x193\x15\x18\x0f\x08\tÿj\x18\x13\x0e\n\x05\x15\x18\x16$ÿl\x0e\r\x0eÿ\x1d\x11\rÿ\x05\x1f\x0b\t\x11\x13\x0e\rÿ\x1c\x1f\n\n\x11\r\tÿ6\x10\x1d\x11\r\x13\x19\t\x18\x11\x10 \x17\x0e\x14\x18\x14\x19\t\x19ÿ\x05\x15\x19\x0b\x0b\x18\x16ÿ\x06\x19\x1a\x0eqÿ\x02\x04\x02\x04\x124\x12\x02ÿ\n\x05\x11\n3\r\x18\x0f\x08\tÿrÿ\x03---g\x02\x04\x02\x04ÿ\x17\x0e\x14\x18\x14\x19\t\x19ÿ\x1c\x11\x15\x1f\t\x18\x11\x10\x0b7ÿ6\x10\x16\x12\n\x08\t\t\n\x0b\x0c\x01\x01\r\x0e\x0f\x0e\x10\x0e\r\x11\x10\x12\x13\x14\x0b\x11\x15\x12\x16\x11\x13\x01\x17\x0e\x14\x18\x14\x19\t\x19\x06\x19\x1a\x0e\x01\x1b\x1c\x1b\t\x15\x13\x1d\x1e\x1f\x0e \x10\x18\x15!\x03"\x19#\x08\x16\x0b\x0b\x1f\x08$\x1d%%\x01\x17\x11\x14\x1f\x15\x0e\x0b\x01&\'\x05\x01\x05\x06\x07(\x19\x0f\x0e\x12\x19\x0b\n )\'(*+#,\x04\x03-+\x03 \x02\x01\x02']
apiLogger::2021-10-05 06:25:23,688::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 06:25:23,688::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-05 06:25:23,688::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 06:25:23,688::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 06:25:23,688::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 06:25:56,442::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 06:25:56,443::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 06:27:19,001::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 06:27:19,039::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 06:27:19,039::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpi6yr5kag 
apiLogger::2021-10-05 06:27:19,041::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 06:27:19,041::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 06:27:20,282::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 06:27:20,282::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpi6yr5kag
apiLogger::2021-10-05 06:27:23,824::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 06:27:23,825::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 06:27:23,825::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 06:27:23,825::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 06:27:23,829::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 06:27:23,829::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 06:27:23,830::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 06:27:23,830::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 06:27:23,834::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-05 06:27:23,834::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 06:27:23,834::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 06:27:23,834::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-05 06:27:23,834::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Please note that Syneos Health received initial information regarding the\nfollowing event.\n \nProtocol: R1979-ONC-1625\nDay 0: 19-JUN-2021\nCountry: South Korea\nSite # /Investigator: 1625410007/ Kim, Tae Min\nSubject ID: 410007013\nStudy Drug(s): REGN1979\nEvent Term: HYPOTENSION\nOnset date: 09-JUN-2021\nSeverity/Grade: Grade 3\nSAE Criteria and/or AESI Criteria: Hospitalization / No\nInvestigator Relationship to Study Drug: Not Related\nInvestigator Relationship to Study Conduct: No\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2021-00096\n \nKind regards,\n \n \nJessica McIntyre, RN, BSN, CPN\nSafety & PV Specialist I, Drug Safety & Pharmacovigilance\nSyneos Health\nUS Regional – Ohio\nDirect   +1 984 710 8965\nsyneoshealth.com  \nEMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. \x00\x01\x02\x03\x01\x02\x04\x02\x03 \x05\x06\x07 REG-2021-00096 GSPV RECEIPT DATE 19JUN2021 JM 48 pages\nÿwxyzwz{|{ÿ ÿxy}}{~y}ÿ ÿx\x7fÿ\x81\x82\x83\x84w\x85yÿ ÿ\x86y\x85\x87ÿ ÿ\x86\x83\x88yÿ ÿ\x89\x83~\x83\x8a|\n\x8b}y\x82\x8cÿ\x8dy}}w\x8e{ÿx\x8e\x8f\x90|\x7f\x82yÿ\x1b\x1c\x19\x1d\x0e\t9%\n\x06\x03-5-V02\x05V\x03\x00\x02# ,\x03\x04\x04\x045ÿVÿ\x91\x18\x13_ÿ1\x12ÿVÿ\x1c\x11\x1f\t\x08ÿ\x91\x11\r\x0e\x19\x92\x910\x06 ,\x03\x04\x04\x045\x04\x03< U\'6&\x06\x1c&ÿ&6&21\x1c U\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\nU\'6&\x06\x1c&ÿ&6&21\x1c\nU\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x0bÿ/\x0e\x0b\x012\x11 \x1c\x1f"=\x0e\x16\t\x0cÿ>?@@@A@?B\n(\x19\x0f\x0e\x0cÿCDEFGHFÿJEFKLÿMÿCNOJPQJÿJOJRSQ\nU\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\n\x05\x1f\r\r\x0e\x10\t\x159ÿ\x1a\x18\x0e\x1e\x18\x10\x0fÿ\x15\x18\x10\x0eÿ\x03<ÿ\x11\x1dÿ\x03<\x12\nÿ U\n\n\x159ÿ\t\x11ÿ\x06\x0e\x16\x11\r\x14\n\x05\x15\x18\x16$ÿ\x08\x0e\r\x0eÿ\t\x11ÿ\r\x0e\t\x1f\r\x10ÿ\t\x11ÿT\x05\x11\x13\n\x15\x0e\t\x0eÿ6\x18\x0e\x1eT\x12\n\x05\x06\x07ÿ.\x18\x0b\t\x11\r9\n,\x03\x04\x04\x045\x04\x03<ÿVÿU\x14\x1a\x0e\r\x0b\x0e \x17\x19\x18\x10ÿU\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\tÿ\'\x0e\x0b\x16\r\x18\n\t\x18\x11\x10ÿ\x1b1\x0e\r\x13% ./(01&2\x1c302\n&\x1a\x0e\x10\t ÿÿÿ\n\x1c0\x05 \x03\x04\x04,5\x04\x00#6\x19\x0b\x16\x1f\x15\x19\rÿ\x14\x18\x0b\x11\r\x14\x0e\r\x0b\n,\x03\x04\x04\x045\x04\x03<ÿVÿU\x14\x1a\x0e\r\x0b\x0e\n&\x1a\x0e\x10\t\x0bÿ/\x0e\x0b\x012\x11 .781\x03\x04\x04\x03\x03-#,\'\x0e\x16\r\x0e\x19\x0b\x0e\x14ÿ\x19\x10\x14ÿ\x10\x11\x10\x0b\n\x0e\x16\x18\x1d\x18\x16ÿ"\x15\x11\x11\x14\n\n\r\x0e\x0b\x0b\x1f\r\x0eÿ\x14\x18\x0b\x11\r\x14\x0e\r\x0bÿ\x19\x10\x14ÿ\x0b\x08\x11\x16$\n,\x03\x04\x04\x045\x04\x03<ÿVÿ\x1c\x0e\r\x18\x11\x1f\x0b .71 \x03\x04\x04#5\x03+\x036\x19\x0b\x16\x1f\x15\x19\rÿ\x089\n\x11\t\x0e\x10\x0b\x18\x1a\x0eÿ\x14\x18\x0b\x11\r\x14\x0e\r\x0b\nU\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x01U&\x1c3ÿt, (1 \x03\x04\x04\x02\x03\x04-5.9\n\x11\t\x0e\x10\x0b\x18\x11\x10\n,\x03\x04\x04\x045\x04\x03<ÿVÿ\x1c\x0e\r\x18\x11\x1f\x0b 771 \x03\x04\x04\x02\x03\x04-5.9\n\x11\t\x0e\x10\x0b\x18\x11\x10\nU\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x01U&\x1c3ÿt\x03\n,\x03\x04\x04\x045\x04\x03<ÿVÿ\x1c\x0e\r\x18\x11\x1f\x0b \x1c\t\x19\r\tÿ\x14\x19\t\x0eÿ\x1b\x14\x14V\x13\x11\x10V9999% -ÿ:;2ÿ\x02\x04\x02\x03\nU\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x01U&\x1c3ÿt\x02\n(\x15\x0e\x19\x0b\x0eÿ\x16\x11\x13\n\x15\x0e\t\x0eÿWKXYÿ\x18\x1dÿ\x0e\x1a\x0e\x10\tÿ\x11\x10\x0b\x0e\tÿ\x11\x10ÿZFF[ÿ?ÿN\\Yÿ?ÿ\x0c\n\'\x18\x14ÿ\t\x08\x18\x0bÿ\x0e\x1a\x0e\x10\tÿ\x0b\t\x19\r\tÿ]G^WGÿ\t\x11ÿ\t\x08\x0eÿ\x0b\t\x19\r\tÿ\x11\x1dÿ\x0b\t\x1f\x149ÿ\x14\r\x1f\x0f\n\x19\x14\x13\x18\x10\x18\x0b\t\r\x19\t\x18\x11\x10)\n3\x1dÿ\t\x08\x18\x0bÿ\x0e\x1a\x0e\x10\tÿ\x18\x0bÿ\x19\x10ÿ3\x10\x1d\x1f\x0b\x18\x11\x10ÿ\x06\x0e\x15\x19\t\x0e\x14ÿ\x06\x0e\x19\x16\t\x18\x11\x10ÿ\x11\rÿ\x169\t\x11$\x18\x10\x0e\n\r\x0e\x15\x0e\x19\x0b\x0eÿ\x0b9\x10\x14\r\x11\x13\x0e_ÿ\n\x15\x0e\x19\x0b\x0eÿ\x16\x08\x0e\x16$ÿ\t\x08\x0eÿ"\x11 ÿ\x19\x10\x14ÿ\x16\x11\x13\n\x15\x0e\t\x0e\n\t\x08\x0eÿ\x19\n\n\r\x11\n\r\x18\x19\t\x0eÿ3\x06\x06\x01\x05\x06\x1cÿ\x1d\x11\r\x13\n\'\x18\x14ÿ\t\x08\x0eÿ\x0e\x1a\x0e\x10\tÿ\x11\x16\x16\x1f\rÿ\x1e\x18\t\x08ÿ\x19\x10ÿ\x11\x1a\x0e\r\x14\x11\x0b\x0e) 2\x11\n\x1c\x0e\x15\x0e\x16\tÿ\x18\x1dÿU&ÿ\x18\x0bÿ\x18\x10\t\x0e\r\x13\x18\t\t\x0e\x10\t /\x0e\x0b\nU&ÿ\x0b\x1f\x0b\n\x0e\x16\t\x0e\x14ÿ\t\x11ÿ"\x0eÿ\x16\x19\x1f\x0b\x0e\x14ÿ"9ÿ\x06&82\x03-5-) 2\x11\nU&ÿ\x0b\x1f\x0b\n\x0e\x16\t\x0e\x14ÿ\t\x11ÿ"\x0eÿ\x16\x19\x1f\x0b\x0e\x14ÿ"9ÿ\x0b\t\x1f\x149ÿ\x16\x11\x10\x14\x1f\x16\t) 2\x11\n3\x1dÿ9\x0e\x0b_ÿ\x0b\n\x0e\x16\x18\x1d9ÿ\x0b\t\x1f\x149ÿ\x16\x11\x10\x14\x1f\x16\t\n0\x1f\t\x16\x11\x13\x0eÿ\x11\x1dÿU& \x06\x0e\x16\x11\x1a\x0e\r\x18\x10\x0f\x01\x06\x0e\x0b\x11\x15\x1a\x18\x10\x0f\n3\x1dÿ\x11\x1f\t\x16\x11\x13\x0eÿ\x18\x0bÿ\x06\x0e\x16\x11\x1a\x0e\r\x0e\x14\x01\x06\x0e\x0b\x11\x15\x1a\x0e\x14ÿ\x1e\x18\t\x08ÿ\x1c\x0e`\x1f\x0e\x15\x19\x0ea\n\x1c\n\x0e\x16\x18\x1d9ÿ\t\x08\x0eÿ\x0b\x0e`\x1f\x0e\x15\x19\x0e\x12\n\x06\x0e\x0b\x11\x15\x1f\t\x18\x11\x10ÿ\x14\x19\t\x0eÿ\x1b\x14\x14V\x13\x11\x10V9999%\nU&ÿ\x18\x10\x18\t\x18\x19\x15ÿ\x0b\x0e\x1a\x0e\r\x18\t9ÿ\x0f\r\x19\x14\x0e 8\r\x19\x14\x0eÿ\x02\nU&ÿ\x13\x11\x0b\tÿ\x0e \t\r\x0e\x13\x0eÿ\x0b\x0e\x1a\x0e\r\x18\t9ÿ\x0f\r\x19\x14\x0e 8\r\x19\x14\x0eÿ<\n\'\x19\t\x0eÿ\x0e\x1a\x0e\x10\tÿb\x0e\x16\x19\x13\x0eÿ8\r\x19\x14\x0eÿ<ÿ\x11\rÿ\x08\x18\x0f\x08\x0e\rÿVÿ\x18\x1dÿ\x19\n\n\x15\x18\x16\x19"\x15\x0eÿ\x1b\x14\x14V\n\x03+ÿ:;2ÿ\x02\x04\x02\x03\n\x13\x11\x10V9999%\n\'\x19\t\x0eÿ\x0e\x1a\x0e\x10\tÿ"\x0e\x16\x19\x13\x0eÿ\x08\x18\x0f\x08\x0e\rÿ\t\x08\x19\x10ÿ8\r\x19\x14\x0eÿ<ÿVÿ2\x11\tÿ\x19\n\n\x15\x18\x16\x19"\x15\x0e\n\'\x19\t\x0eÿ&\x1a\x0e\x10\tÿb\x0e\x16\x19\x13\x0eÿ7\x0e\x0b\x0bÿ\t\x08\x19\x10ÿ8\r\x19\x14\x0eÿ<ÿVÿ\x18\x1dÿ\x19\n\n\x15\x18\x16\x19"\x15\x0eÿ\x1b\x14\x14V\n\x13\x11\x10V9999%\n\'\x19\t\x0eÿ\x0e\x1a\x0e\x10\tÿ"\x0e\x16\x19\x13\x0eÿ\x15\x0e\x0b\x0b\x0e\rÿ\t\x08\x19\x10ÿ8\r\x19\x14\x0eÿ<ÿVÿ2\x11\tÿ\x19\n\n\x15\x18\x16\x19"\x15\x0e\nSGF\\LcFKLÿdWGÿCJÿeHFXFfLÿ\\XXÿLg\\Lÿ\\]]XYÿFhfF]LÿigFK\nRjRJÿ^HÿKWLFDklÿdWGÿDGmnÿLgFG\\]YÿWGÿcFD^f\\L^WK\n]XF\\HFÿFKLFGÿ^KLWÿfWKfWc^L\\KLÿcFD^f\\L^WKHÿFoPpqÿrd\n]GWfFDmGFÿWGÿHmGnFGYÿ]XF\\HFÿFKLFGÿ^KLWÿLgF\noWKfWc^L\\KLÿ]GWfFDmGFHsHmGnFG^FHÿFoPp\n2\x11\x10\x0e\n\'\r\x1f\x0fÿ\t\x08\x0e\r\x19\n9\x01ÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt\x03\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt\x02\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt<\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt,\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt#\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt\x00\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt5\n\x05\x15\x18\x16$ÿ.\x0e\r\x0eÿ\x1d\x05\x11\rÿ\x11\x05\x10\x1f\x0b\x16\t\x11\x11\x13\x13\x0e\r\x18ÿ\x1c\t\x19\x1f\n\x10\n\t\x11ÿ\r\x17\tÿ3\x10\x0e\x1d\x11\x14\r\x13\x18\x16\x19\x19\t\x18\x11\t\x18\x10\x11\x10ÿt+ \x17\x0e\x14\x18\x14\x19\t\x19ÿ\x05\x15\x19\x0b\x0b\x18\x16ÿ\x06\x19\x1a\x0euÿ\x02\x04\x02\x04\x12<\x12\x02ÿ\n\x05\x11\n9\r\x18\x0f\x08\tÿvÿ\x03---V\x02\x04\x02\x04ÿ\x17\x0e\x14\x18\x14\x19\t\x19ÿ\x1c\x11\x15\x1f\t\x18\x11\x10\x0b_ÿ3\x10\x16\x12\n\x08\t\t\n\x0b\x0c\x01\x01\r\x0e\x0f\x0e\x10\x0e\r\x11\x10\x12\x13\x14\x0b\x11\x15\x12\x16\x11\x13\x01\x17\x0e\x14\x18\x14\x19\t\x19\x06\x19\x1a\x0e\x01\x1b\x1c\x1b\t\x15\x13\x1d\x1e\x1f\x0e \x10\x18\x15!\x03"\x19#\x08\x16\x0b\x0b\x1f\x08$\x1d%%\x01\x17\x11\x14\x1f\x15\x0e\x0b\x01&\'\x05\x01\x05\x06\x07(\x19\x0f\x0e\x12\x19\x0b\n )\'(*+#,\x04\x03-+\x03 \x03\x01\x02 \x00\x01\x02\x03\x01\x02\x04\x02\x03 \x05\x06\x07 REG-2021-00096 GSPV RECEIPT DATE 19JUN2021 JM 48 pages\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿ2- ÿstuvsvwxwÿ ÿtuyywzuyÿ ÿt{ÿ}~\x7f\x80s\x81uÿ ÿ\x82u\x81\x83ÿ ÿ\x82\x7f\x84uÿ ÿ\x85\x7fz\x7f\x86x\n\x87yu~\x88ÿ\x89uyys\x8awÿt\x8a\x8b\x8cx{~uÿ\x1b\x1c\x19\x1d\x0e\t3%\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿ2\x03\x04\n\x06\x03-9-g5.\x05g\x03\x00\x02# ,\x03\x04\x04\x049ÿgÿo\x18\x137ÿj\x12ÿgÿ\x1c\x11\x1f\t\x08ÿo\x11\r\x0e\x19\x8do5\x06 ,\x03\x04\x04\x049\x04\x034 0\'n&\x06\x1c&ÿ&n&.j\x1c 0\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\n0\'n&\x06\x1c&ÿ&n&.j\x1c \x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ(\r\x11\x16\x0e\x14\x1f\r\x0e\x01\x0b\x1f\r\x0f\x0e\r3\n0\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x0bÿ1\x0e\x0b\x01.\x11\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\n\r\x11\x16\x0e\x14\x1f\r\x0e\x01\x0b\x1f\r\x0f\x0e\r3ÿ2\x03\n0\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\n\r\x11\x16\x0e\x14\x1f\r\x0e\x01\x0b\x1f\r\x0f\x0e\r3ÿ2\x02\n\x05\x06\x07ÿl\x18\x0b\t\x11\r3\n,\x03\x04\x04\x049\x04\x034ÿgÿ0\x14\x1a\x0e\r\x0b\x0e \x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\n\r\x11\x16\x0e\x14\x1f\r\x0e\x01\x0b\x1f\r\x0f\x0e\r3ÿ24\n&\x1a\x0e\x10\t\n,\x03\x04\x04\x049\x04\x034ÿgÿ0\x14\x1a\x0e\r\x0b\x0e \x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\n\r\x11\x16\x0e\x14\x1f\r\x0e\x01\x0b\x1f\r\x0f\x0e\r3ÿ2,\n&\x1a\x0e\x10\t\x0bÿ1\x0e\x0b\x01.\x11\n,\x03\x04\x04\x049\x04\x034ÿgÿ\x1c\x0e\r\x18\x11\x1f\x0b \x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\n\r\x11\x16\x0e\x14\x1f\r\x0e\x01\x0b\x1f\r\x0f\x0e\r3ÿ2#\n0\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x010&\x1c6ÿ2,\n,\x03\x04\x04\x049\x04\x034ÿgÿ\x1c\x0e\r\x18\x11\x1f\x0b 5\t\x08\x0e\r\n0\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x010&\x1c6ÿ2\x03\n,\x03\x04\x04\x049\x04\x034ÿgÿ\x1c\x0e\r\x18\x11\x1f\x0b 6\x1dÿ5\t\x08\x0e\r7ÿ\x0b\n\x0e\x16\x18\x1d3\n0\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x010&\x1c6ÿ2\x02\n0\x16\t\x18\x11\x10ÿ\t\x19$\x0e\x10ÿ\x1e\x18\t\x08ÿ\x06&8.\x03-9- .\x11\tÿ0\n\n\x15\x18\x16\x19"\x15\x0e\n\'\x11\x0e\x0bÿ\t\x08\x18\x0bÿ0&ÿ:\x1f\x19\x15\x18\x1d3ÿ\x19\x0bÿ\x1c\x0e\r\x18\x11\x1f\x0b) 1\x0e\x0b\n6\x0bÿ\t\x08\x18\x0bÿ\x19\x10ÿ0&ÿ\x11\x1dÿ\x1c\n\x0e\x16\x18\x19\x15ÿ\x18\x10\t\x0e\r\x0e\x0b\tÿ\x1b0&\x1c6%) .\x11\n;<=>?@A@ÿAC@ÿD<??<EFGHÿDF@?IJÿKLMNÿFDÿOIP@QJ@ÿRP@GA\nSTU?FDF@JÿUJÿ@FAC@QÿJ@QF<TJÿ<QÿUJÿUGÿ@P@GAÿ<DÿJ>@VFU?\nFGA@Q@JAÿWORXYZÿ>@Qÿ>Q<A<V<?[ÿYDÿORÿI<@JÿG<Aÿ=@@A\nVQFA@QFUÿD<Qÿ@FAC@QÿXORÿ<QÿORXYÿAC@GÿX\\K]ÿC@Q@[\n^K_ÿXORÿ`ÿYaRL\\Y^NÿXR_YKbXLRXX\n;_Y\\R_YKLc;_Y\\R_YOdÿ\n;eR;fÿOMMÿ\\eO\\ÿO]]MN\n6\tÿ\r\x0e\x0b\x1f\x15\t\x0e\x14ÿ\x18\x10ÿ\x14\x0e\x19\t\x08\n6\tÿ\x1e\x19\x0bÿ\x15\x18\x1d\x0eg\t\x08\r\x0e\x19\t\x0e\x10\x18\x10\x0f\n6\tÿ\r\x0e:\x1f\x18\r\x0e\x14ÿ\x11\rÿ\n\r\x11\x15\x11\x10\x0f\x0e\x14ÿ\x18\x10\n\x19\t\x18\x0e\x10\tÿ\x08\x11\x0b\n\x18\t\x19\x15\x18!\x19\t\x18\x11\x10\n(\x0e\r\x0b\x18\x0b\t\x0e\x10\tÿ\x11\rÿ\x0b\x18\x0f\x10\x18\x1d\x18\x16\x19\x10\tÿ\x14\x18\x0b\x19"\x18\x15\x18\t3ÿ\x01ÿ\x18\x10\x16\x19\n\x19\x16\x18\t3\n6\tÿ\x18\x0bÿ\x19ÿ\x16\x11\x10\x0f\x0e\x10\x18\t\x19\x15ÿ\x19\x10\x11\x13\x19\x153\x01"\x18\r\t\x08ÿ\x14\x0e\x1d\x0e\x16\tÿ\x18\x10ÿ\x11\x1d\x1d\x0b\n\r\x18\x10\x0fÿ\x11\x1d\n\x0b\t\x1f\x143ÿ\x0b\x1f"h\x0e\x16\t\n5\t\x08\x0e\rÿ\x13\x0e\x14\x18\x16\x19\x15\x153ÿ\x0b\x0e\r\x18\x11\x1f\x0bÿ\x18\x13\n\x11\r\t\x19\x10\tÿ\x0e\x1a\x0e\x10\tÿ\x1b6\tÿ\x14\x11\x0e\x0bÿ\x10\x11\t\n\x13\x0e\x0e\tÿ\x19\x103ÿ\x11\x1dÿ\t\x08\x0eÿ\x19"\x11\x1a\x0eÿ\x0b\x0e\r\x18\x11\x1f\x0bÿ\x16\r\x18\t\x0e\r\x18\x197ÿ"\x1f\tÿ\x13\x193\nh\x0e\x11\n\x19\r\x14\x18!\x0eÿ\t\x08\x0eÿ\x0b\x1f"h\x0e\x16\t7ÿ\x19\x10\x14ÿ\x13\x193ÿ\r\x0e:\x1f\x18\r\x0eÿ\x13\x0e\x14\x18\x16\x19\x15ÿ\x11\r\n\x0b\x1f\r\x0f\x18\x16\x19\x15ÿ\x18\x10\t\x0e\r\x1a\x0e\x10\t\x18\x11\x10ÿ\t\x11ÿ\n\r\x0e\x1a\x0e\x10\tÿ\x11\x10\x0eÿ\x11\x1dÿ\t\x08\x0eÿ\x11\x1f\t\x16\x11\x13\x0e\x0b\n\x15\x18\x0b\t\x0e\x14ÿ\x19"\x11\x1a\x0e%\x12\nKLMNÿ^YMMÿKb\\ÿY^ÿORÿiRR\\Xÿ;_Y\\R_YOÿ^K_ÿORXY\n\\C@ÿORÿDT?DF??JÿAC@ÿD<??<EFGHÿORÿ<DÿJ>@VFU?ÿFGA@Q@JA\nWORXYZ\n;eR;fÿOMMÿ\\eO\\ÿO]]MN\n8\r\x19\x14\x0eÿ4ÿ\x11\rÿ\x0f\r\x0e\x19\t\x0e\rÿ6\x06\x06\n8\r\x19\x14\x0eÿ4ÿ\x11\rÿ\x08\x18\x0f\x08\x0e\rÿjk\x1c\n8\r\x19\x14\x0eÿ\x02ÿ\x11\rÿ\x0f\r\x0e\x19\t\x0e\rÿ\x05\x06\x1cÿ\x1bk\x0e\x0e7\x02\x04\x03-%\n8\r\x19\x14\x0eÿ4ÿ\x11\rÿ\x0f\r\x0e\x19\t\x0e\rÿ\x19\x15\x15\x0e\r\x0f\x18\x16ÿ\r\x0e\x19\x16\t\x18\x11\x10\x0b\n8\r\x19\x14\x0eÿ4ÿ\x11\rÿ\x0f\r\x0e\x19\t\x0e\rÿ\x18\x10\x1d\x0e\x16\t\x18\x11\x10\x0b\n8\r\x19\x14\x0eÿ\x02ÿ\x11\rÿ\x0f\r\x0e\x19\t\x0e\rÿ\x05.\x1cÿ\x0e\x1a\x0e\x10\t\x0b\nl\x0e\n\x19\t\x18\t\x18\x0bÿmÿ\r\x0eg\x19\x16\t\x18\x1a\x19\t\x18\x11\x10\nÿ\n(\r\x18\x10\t\x19"\x15\x0eÿn\x0e\r\x0b\x18\x11\x10ÿÿn\x18\x0e\x1eÿ(\'\x07ÿÿÿ6\x16\x11\x10ÿo\x0e3 \x1c\x19\x1a\x0eÿ\x05\x19\x10\x16\x0e\x15\n\x05\x06\x07ÿn\x0e\r\x0b\x18\x11\x10ÿ-49+ÿgÿ(\x19\x0f\x0eÿ8\x0e\x10\x0e\r\x19\t\x0e\x14\x0cÿ\x02\x03ÿp\x1f\x10ÿ\x02\x04\x02\x03ÿ\x04+\x0c,\x02\x0c\x02,ÿ&\x19\x0b\t\x0e\r\x10ÿ\'\x193\x15\x18\x0f\x08\tÿj\x18\x13\x0e\n\x05\x15\x18\x16$ÿl\x0e\r\x0eÿ\x1d\x11\rÿ\x05\x1f\x0b\t\x11\x13\x0e\rÿ\x1c\x1f\n\n\x11\r\tÿ6\x10\x1d\x11\r\x13\x19\t\x18\x11\x10 \x17\x0e\x14\x18\x14\x19\t\x19ÿ\x05\x15\x19\x0b\x0b\x18\x16ÿ\x06\x19\x1a\x0eqÿ\x02\x04\x02\x04\x124\x12\x02ÿ\n\x05\x11\n3\r\x18\x0f\x08\tÿrÿ\x03---g\x02\x04\x02\x04ÿ\x17\x0e\x14\x18\x14\x19\t\x19ÿ\x1c\x11\x15\x1f\t\x18\x11\x10\x0b7ÿ6\x10\x16\x12\n\x08\t\t\n\x0b\x0c\x01\x01\r\x0e\x0f\x0e\x10\x0e\r\x11\x10\x12\x13\x14\x0b\x11\x15\x12\x16\x11\x13\x01\x17\x0e\x14\x18\x14\x19\t\x19\x06\x19\x1a\x0e\x01\x1b\x1c\x1b\t\x15\x13\x1d\x1e\x1f\x0e \x10\x18\x15!\x03"\x19#\x08\x16\x0b\x0b\x1f\x08$\x1d%%\x01\x17\x11\x14\x1f\x15\x0e\x0b\x01&\'\x05\x01\x05\x06\x07(\x19\x0f\x0e\x12\x19\x0b\n )\'(*+#,\x04\x03-+\x03 \x02\x01\x02']
apiLogger::2021-10-05 06:27:23,834::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 06:27:23,835::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-05 06:27:23,835::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 06:27:23,835::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 06:27:23,835::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 06:27:56,272::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 06:27:56,272::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 06:29:18,987::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 06:29:19,026::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 06:29:19,027::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqdm5802z 
apiLogger::2021-10-05 06:29:19,028::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 06:29:19,028::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 06:29:20,269::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 06:29:20,269::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqdm5802z
apiLogger::2021-10-05 06:29:23,807::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 06:29:23,807::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 06:29:23,807::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 06:29:23,808::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 06:29:23,812::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 06:29:23,812::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 06:29:23,812::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 06:29:23,812::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 06:29:23,816::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-05 06:29:23,817::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 06:29:23,817::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 06:29:23,817::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-10-05 06:29:23,817::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'Please note that Syneos Health received initial information regarding the\nfollowing event.\n \nProtocol: R1979-ONC-1625\nDay 0: 19-JUN-2021\nCountry: South Korea\nSite # /Investigator: 1625410007/ Kim, Tae Min\nSubject ID: 410007013\nStudy Drug(s): REGN1979\nEvent Term: HYPOTENSION\nOnset date: 09-JUN-2021\nSeverity/Grade: Grade 3\nSAE Criteria and/or AESI Criteria: Hospitalization / No\nInvestigator Relationship to Study Drug: Not Related\nInvestigator Relationship to Study Conduct: No\nList of issued urgent queries: N/A\nREGN Argus number: N/A\nSyneos Health Tracking #: REG-2021-00096\n \nKind regards,\n \n \nJessica McIntyre, RN, BSN, CPN\nSafety & PV Specialist I, Drug Safety & Pharmacovigilance\nSyneos Health\nUS Regional – Ohio\nDirect   +1 984 710 8965\nsyneoshealth.com  \nEMAIL DISCLAIMER NOTICE:\nSyneos Health, (the “Company”). This email and any files transmitted may contain\ninformation that is privileged, confidential and exempt from disclosure and is intended\nsolely for the intended recipient. If you received this email in error, please inform the\nsender and delete it. This email neither constitutes an agreement to conduct\ntransactions by electronic means nor creates any legally binding contract or\nenforceable obligation in the absence of a fully signed written contract. Any views or\nopinions expressed are solely those of the author and do not necessarily represent those\nof the Company. Although the Company has taken reasonable precautions to ensure no\nviruses are present in this email, the Company cannot accept responsibility for any loss\nor damage arising from the use of this email or attachments. \x00\x01\x02\x03\x01\x02\x04\x02\x03 \x05\x06\x07 REG-2021-00096 GSPV RECEIPT DATE 19JUN2021 JM 48 pages\nÿwxyzwz{|{ÿ ÿxy}}{~y}ÿ ÿx\x7fÿ\x81\x82\x83\x84w\x85yÿ ÿ\x86y\x85\x87ÿ ÿ\x86\x83\x88yÿ ÿ\x89\x83~\x83\x8a|\n\x8b}y\x82\x8cÿ\x8dy}}w\x8e{ÿx\x8e\x8f\x90|\x7f\x82yÿ\x1b\x1c\x19\x1d\x0e\t9%\n\x06\x03-5-V02\x05V\x03\x00\x02# ,\x03\x04\x04\x045ÿVÿ\x91\x18\x13_ÿ1\x12ÿVÿ\x1c\x11\x1f\t\x08ÿ\x91\x11\r\x0e\x19\x92\x910\x06 ,\x03\x04\x04\x045\x04\x03< U\'6&\x06\x1c&ÿ&6&21\x1c U\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\nU\'6&\x06\x1c&ÿ&6&21\x1c\nU\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x0bÿ/\x0e\x0b\x012\x11 \x1c\x1f"=\x0e\x16\t\x0cÿ>?@@@A@?B\n(\x19\x0f\x0e\x0cÿCDEFGHFÿJEFKLÿMÿCNOJPQJÿJOJRSQ\nU\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\n\x05\x1f\r\r\x0e\x10\t\x159ÿ\x1a\x18\x0e\x1e\x18\x10\x0fÿ\x15\x18\x10\x0eÿ\x03<ÿ\x11\x1dÿ\x03<\x12\nÿ U\n\n\x159ÿ\t\x11ÿ\x06\x0e\x16\x11\r\x14\n\x05\x15\x18\x16$ÿ\x08\x0e\r\x0eÿ\t\x11ÿ\r\x0e\t\x1f\r\x10ÿ\t\x11ÿT\x05\x11\x13\n\x15\x0e\t\x0eÿ6\x18\x0e\x1eT\x12\n\x05\x06\x07ÿ.\x18\x0b\t\x11\r9\n,\x03\x04\x04\x045\x04\x03<ÿVÿU\x14\x1a\x0e\r\x0b\x0e \x17\x19\x18\x10ÿU\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\tÿ\'\x0e\x0b\x16\r\x18\n\t\x18\x11\x10ÿ\x1b1\x0e\r\x13% ./(01&2\x1c302\n&\x1a\x0e\x10\t ÿÿÿ\n\x1c0\x05 \x03\x04\x04,5\x04\x00#6\x19\x0b\x16\x1f\x15\x19\rÿ\x14\x18\x0b\x11\r\x14\x0e\r\x0b\n,\x03\x04\x04\x045\x04\x03<ÿVÿU\x14\x1a\x0e\r\x0b\x0e\n&\x1a\x0e\x10\t\x0bÿ/\x0e\x0b\x012\x11 .781\x03\x04\x04\x03\x03-#,\'\x0e\x16\r\x0e\x19\x0b\x0e\x14ÿ\x19\x10\x14ÿ\x10\x11\x10\x0b\n\x0e\x16\x18\x1d\x18\x16ÿ"\x15\x11\x11\x14\n\n\r\x0e\x0b\x0b\x1f\r\x0eÿ\x14\x18\x0b\x11\r\x14\x0e\r\x0bÿ\x19\x10\x14ÿ\x0b\x08\x11\x16$\n,\x03\x04\x04\x045\x04\x03<ÿVÿ\x1c\x0e\r\x18\x11\x1f\x0b .71 \x03\x04\x04#5\x03+\x036\x19\x0b\x16\x1f\x15\x19\rÿ\x089\n\x11\t\x0e\x10\x0b\x18\x1a\x0eÿ\x14\x18\x0b\x11\r\x14\x0e\r\x0b\nU\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x01U&\x1c3ÿt, (1 \x03\x04\x04\x02\x03\x04-5.9\n\x11\t\x0e\x10\x0b\x18\x11\x10\n,\x03\x04\x04\x045\x04\x03<ÿVÿ\x1c\x0e\r\x18\x11\x1f\x0b 771 \x03\x04\x04\x02\x03\x04-5.9\n\x11\t\x0e\x10\x0b\x18\x11\x10\nU\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x01U&\x1c3ÿt\x03\n,\x03\x04\x04\x045\x04\x03<ÿVÿ\x1c\x0e\r\x18\x11\x1f\x0b \x1c\t\x19\r\tÿ\x14\x19\t\x0eÿ\x1b\x14\x14V\x13\x11\x10V9999% -ÿ:;2ÿ\x02\x04\x02\x03\nU\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x01U&\x1c3ÿt\x02\n(\x15\x0e\x19\x0b\x0eÿ\x16\x11\x13\n\x15\x0e\t\x0eÿWKXYÿ\x18\x1dÿ\x0e\x1a\x0e\x10\tÿ\x11\x10\x0b\x0e\tÿ\x11\x10ÿZFF[ÿ?ÿN\\Yÿ?ÿ\x0c\n\'\x18\x14ÿ\t\x08\x18\x0bÿ\x0e\x1a\x0e\x10\tÿ\x0b\t\x19\r\tÿ]G^WGÿ\t\x11ÿ\t\x08\x0eÿ\x0b\t\x19\r\tÿ\x11\x1dÿ\x0b\t\x1f\x149ÿ\x14\r\x1f\x0f\n\x19\x14\x13\x18\x10\x18\x0b\t\r\x19\t\x18\x11\x10)\n3\x1dÿ\t\x08\x18\x0bÿ\x0e\x1a\x0e\x10\tÿ\x18\x0bÿ\x19\x10ÿ3\x10\x1d\x1f\x0b\x18\x11\x10ÿ\x06\x0e\x15\x19\t\x0e\x14ÿ\x06\x0e\x19\x16\t\x18\x11\x10ÿ\x11\rÿ\x169\t\x11$\x18\x10\x0e\n\r\x0e\x15\x0e\x19\x0b\x0eÿ\x0b9\x10\x14\r\x11\x13\x0e_ÿ\n\x15\x0e\x19\x0b\x0eÿ\x16\x08\x0e\x16$ÿ\t\x08\x0eÿ"\x11 ÿ\x19\x10\x14ÿ\x16\x11\x13\n\x15\x0e\t\x0e\n\t\x08\x0eÿ\x19\n\n\r\x11\n\r\x18\x19\t\x0eÿ3\x06\x06\x01\x05\x06\x1cÿ\x1d\x11\r\x13\n\'\x18\x14ÿ\t\x08\x0eÿ\x0e\x1a\x0e\x10\tÿ\x11\x16\x16\x1f\rÿ\x1e\x18\t\x08ÿ\x19\x10ÿ\x11\x1a\x0e\r\x14\x11\x0b\x0e) 2\x11\n\x1c\x0e\x15\x0e\x16\tÿ\x18\x1dÿU&ÿ\x18\x0bÿ\x18\x10\t\x0e\r\x13\x18\t\t\x0e\x10\t /\x0e\x0b\nU&ÿ\x0b\x1f\x0b\n\x0e\x16\t\x0e\x14ÿ\t\x11ÿ"\x0eÿ\x16\x19\x1f\x0b\x0e\x14ÿ"9ÿ\x06&82\x03-5-) 2\x11\nU&ÿ\x0b\x1f\x0b\n\x0e\x16\t\x0e\x14ÿ\t\x11ÿ"\x0eÿ\x16\x19\x1f\x0b\x0e\x14ÿ"9ÿ\x0b\t\x1f\x149ÿ\x16\x11\x10\x14\x1f\x16\t) 2\x11\n3\x1dÿ9\x0e\x0b_ÿ\x0b\n\x0e\x16\x18\x1d9ÿ\x0b\t\x1f\x149ÿ\x16\x11\x10\x14\x1f\x16\t\n0\x1f\t\x16\x11\x13\x0eÿ\x11\x1dÿU& \x06\x0e\x16\x11\x1a\x0e\r\x18\x10\x0f\x01\x06\x0e\x0b\x11\x15\x1a\x18\x10\x0f\n3\x1dÿ\x11\x1f\t\x16\x11\x13\x0eÿ\x18\x0bÿ\x06\x0e\x16\x11\x1a\x0e\r\x0e\x14\x01\x06\x0e\x0b\x11\x15\x1a\x0e\x14ÿ\x1e\x18\t\x08ÿ\x1c\x0e`\x1f\x0e\x15\x19\x0ea\n\x1c\n\x0e\x16\x18\x1d9ÿ\t\x08\x0eÿ\x0b\x0e`\x1f\x0e\x15\x19\x0e\x12\n\x06\x0e\x0b\x11\x15\x1f\t\x18\x11\x10ÿ\x14\x19\t\x0eÿ\x1b\x14\x14V\x13\x11\x10V9999%\nU&ÿ\x18\x10\x18\t\x18\x19\x15ÿ\x0b\x0e\x1a\x0e\r\x18\t9ÿ\x0f\r\x19\x14\x0e 8\r\x19\x14\x0eÿ\x02\nU&ÿ\x13\x11\x0b\tÿ\x0e \t\r\x0e\x13\x0eÿ\x0b\x0e\x1a\x0e\r\x18\t9ÿ\x0f\r\x19\x14\x0e 8\r\x19\x14\x0eÿ<\n\'\x19\t\x0eÿ\x0e\x1a\x0e\x10\tÿb\x0e\x16\x19\x13\x0eÿ8\r\x19\x14\x0eÿ<ÿ\x11\rÿ\x08\x18\x0f\x08\x0e\rÿVÿ\x18\x1dÿ\x19\n\n\x15\x18\x16\x19"\x15\x0eÿ\x1b\x14\x14V\n\x03+ÿ:;2ÿ\x02\x04\x02\x03\n\x13\x11\x10V9999%\n\'\x19\t\x0eÿ\x0e\x1a\x0e\x10\tÿ"\x0e\x16\x19\x13\x0eÿ\x08\x18\x0f\x08\x0e\rÿ\t\x08\x19\x10ÿ8\r\x19\x14\x0eÿ<ÿVÿ2\x11\tÿ\x19\n\n\x15\x18\x16\x19"\x15\x0e\n\'\x19\t\x0eÿ&\x1a\x0e\x10\tÿb\x0e\x16\x19\x13\x0eÿ7\x0e\x0b\x0bÿ\t\x08\x19\x10ÿ8\r\x19\x14\x0eÿ<ÿVÿ\x18\x1dÿ\x19\n\n\x15\x18\x16\x19"\x15\x0eÿ\x1b\x14\x14V\n\x13\x11\x10V9999%\n\'\x19\t\x0eÿ\x0e\x1a\x0e\x10\tÿ"\x0e\x16\x19\x13\x0eÿ\x15\x0e\x0b\x0b\x0e\rÿ\t\x08\x19\x10ÿ8\r\x19\x14\x0eÿ<ÿVÿ2\x11\tÿ\x19\n\n\x15\x18\x16\x19"\x15\x0e\nSGF\\LcFKLÿdWGÿCJÿeHFXFfLÿ\\XXÿLg\\Lÿ\\]]XYÿFhfF]LÿigFK\nRjRJÿ^HÿKWLFDklÿdWGÿDGmnÿLgFG\\]YÿWGÿcFD^f\\L^WK\n]XF\\HFÿFKLFGÿ^KLWÿfWKfWc^L\\KLÿcFD^f\\L^WKHÿFoPpqÿrd\n]GWfFDmGFÿWGÿHmGnFGYÿ]XF\\HFÿFKLFGÿ^KLWÿLgF\noWKfWc^L\\KLÿ]GWfFDmGFHsHmGnFG^FHÿFoPp\n2\x11\x10\x0e\n\'\r\x1f\x0fÿ\t\x08\x0e\r\x19\n9\x01ÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt\x03\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt\x02\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt<\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt,\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt#\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt\x00\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿt5\n\x05\x15\x18\x16$ÿ.\x0e\r\x0eÿ\x1d\x05\x11\rÿ\x11\x05\x10\x1f\x0b\x16\t\x11\x11\x13\x13\x0e\r\x18ÿ\x1c\t\x19\x1f\n\x10\n\t\x11ÿ\r\x17\tÿ3\x10\x0e\x1d\x11\x14\r\x13\x18\x16\x19\x19\t\x18\x11\t\x18\x10\x11\x10ÿt+ \x17\x0e\x14\x18\x14\x19\t\x19ÿ\x05\x15\x19\x0b\x0b\x18\x16ÿ\x06\x19\x1a\x0euÿ\x02\x04\x02\x04\x12<\x12\x02ÿ\n\x05\x11\n9\r\x18\x0f\x08\tÿvÿ\x03---V\x02\x04\x02\x04ÿ\x17\x0e\x14\x18\x14\x19\t\x19ÿ\x1c\x11\x15\x1f\t\x18\x11\x10\x0b_ÿ3\x10\x16\x12\n\x08\t\t\n\x0b\x0c\x01\x01\r\x0e\x0f\x0e\x10\x0e\r\x11\x10\x12\x13\x14\x0b\x11\x15\x12\x16\x11\x13\x01\x17\x0e\x14\x18\x14\x19\t\x19\x06\x19\x1a\x0e\x01\x1b\x1c\x1b\t\x15\x13\x1d\x1e\x1f\x0e \x10\x18\x15!\x03"\x19#\x08\x16\x0b\x0b\x1f\x08$\x1d%%\x01\x17\x11\x14\x1f\x15\x0e\x0b\x01&\'\x05\x01\x05\x06\x07(\x19\x0f\x0e\x12\x19\x0b\n )\'(*+#,\x04\x03-+\x03 \x03\x01\x02 \x00\x01\x02\x03\x01\x02\x04\x02\x03 \x05\x06\x07 REG-2021-00096 GSPV RECEIPT DATE 19JUN2021 JM 48 pages\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿ2- ÿstuvsvwxwÿ ÿtuyywzuyÿ ÿt{ÿ}~\x7f\x80s\x81uÿ ÿ\x82u\x81\x83ÿ ÿ\x82\x7f\x84uÿ ÿ\x85\x7fz\x7f\x86x\n\x87yu~\x88ÿ\x89uyys\x8awÿt\x8a\x8b\x8cx{~uÿ\x1b\x1c\x19\x1d\x0e\t3%\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\x17\x0e\x14\x18\x16\x19\t\x18\x11\x10ÿ2\x03\x04\n\x06\x03-9-g5.\x05g\x03\x00\x02# ,\x03\x04\x04\x049ÿgÿo\x18\x137ÿj\x12ÿgÿ\x1c\x11\x1f\t\x08ÿo\x11\r\x0e\x19\x8do5\x06 ,\x03\x04\x04\x049\x04\x034 0\'n&\x06\x1c&ÿ&n&.j\x1c 0\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\n0\'n&\x06\x1c&ÿ&n&.j\x1c \x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ(\r\x11\x16\x0e\x14\x1f\r\x0e\x01\x0b\x1f\r\x0f\x0e\r3\n0\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x0bÿ1\x0e\x0b\x01.\x11\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\n\r\x11\x16\x0e\x14\x1f\r\x0e\x01\x0b\x1f\r\x0f\x0e\r3ÿ2\x03\n0\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\n\x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\n\r\x11\x16\x0e\x14\x1f\r\x0e\x01\x0b\x1f\r\x0f\x0e\r3ÿ2\x02\n\x05\x06\x07ÿl\x18\x0b\t\x11\r3\n,\x03\x04\x04\x049\x04\x034ÿgÿ0\x14\x1a\x0e\r\x0b\x0e \x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\n\r\x11\x16\x0e\x14\x1f\r\x0e\x01\x0b\x1f\r\x0f\x0e\r3ÿ24\n&\x1a\x0e\x10\t\n,\x03\x04\x04\x049\x04\x034ÿgÿ0\x14\x1a\x0e\r\x0b\x0e \x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\n\r\x11\x16\x0e\x14\x1f\r\x0e\x01\x0b\x1f\r\x0f\x0e\r3ÿ2,\n&\x1a\x0e\x10\t\x0bÿ1\x0e\x0b\x01.\x11\n,\x03\x04\x04\x049\x04\x034ÿgÿ\x1c\x0e\r\x18\x11\x1f\x0b \x05\x11\x10\x16\x11\x13\x18\t\x19\x10\tÿ\n\r\x11\x16\x0e\x14\x1f\r\x0e\x01\x0b\x1f\r\x0f\x0e\r3ÿ2#\n0\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x010&\x1c6ÿ2,\n,\x03\x04\x04\x049\x04\x034ÿgÿ\x1c\x0e\r\x18\x11\x1f\x0b 5\t\x08\x0e\r\n0\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x010&\x1c6ÿ2\x03\n,\x03\x04\x04\x049\x04\x034ÿgÿ\x1c\x0e\r\x18\x11\x1f\x0b 6\x1dÿ5\t\x08\x0e\r7ÿ\x0b\n\x0e\x16\x18\x1d3\n0\x14\x1a\x0e\r\x0b\x0eÿ&\x1a\x0e\x10\t\x010&\x1c6ÿ2\x02\n0\x16\t\x18\x11\x10ÿ\t\x19$\x0e\x10ÿ\x1e\x18\t\x08ÿ\x06&8.\x03-9- .\x11\tÿ0\n\n\x15\x18\x16\x19"\x15\x0e\n\'\x11\x0e\x0bÿ\t\x08\x18\x0bÿ0&ÿ:\x1f\x19\x15\x18\x1d3ÿ\x19\x0bÿ\x1c\x0e\r\x18\x11\x1f\x0b) 1\x0e\x0b\n6\x0bÿ\t\x08\x18\x0bÿ\x19\x10ÿ0&ÿ\x11\x1dÿ\x1c\n\x0e\x16\x18\x19\x15ÿ\x18\x10\t\x0e\r\x0e\x0b\tÿ\x1b0&\x1c6%) .\x11\n;<=>?@A@ÿAC@ÿD<??<EFGHÿDF@?IJÿKLMNÿFDÿOIP@QJ@ÿRP@GA\nSTU?FDF@JÿUJÿ@FAC@QÿJ@QF<TJÿ<QÿUJÿUGÿ@P@GAÿ<DÿJ>@VFU?\nFGA@Q@JAÿWORXYZÿ>@Qÿ>Q<A<V<?[ÿYDÿORÿI<@JÿG<Aÿ=@@A\nVQFA@QFUÿD<Qÿ@FAC@QÿXORÿ<QÿORXYÿAC@GÿX\\K]ÿC@Q@[\n^K_ÿXORÿ`ÿYaRL\\Y^NÿXR_YKbXLRXX\n;_Y\\R_YKLc;_Y\\R_YOdÿ\n;eR;fÿOMMÿ\\eO\\ÿO]]MN\n6\tÿ\r\x0e\x0b\x1f\x15\t\x0e\x14ÿ\x18\x10ÿ\x14\x0e\x19\t\x08\n6\tÿ\x1e\x19\x0bÿ\x15\x18\x1d\x0eg\t\x08\r\x0e\x19\t\x0e\x10\x18\x10\x0f\n6\tÿ\r\x0e:\x1f\x18\r\x0e\x14ÿ\x11\rÿ\n\r\x11\x15\x11\x10\x0f\x0e\x14ÿ\x18\x10\n\x19\t\x18\x0e\x10\tÿ\x08\x11\x0b\n\x18\t\x19\x15\x18!\x19\t\x18\x11\x10\n(\x0e\r\x0b\x18\x0b\t\x0e\x10\tÿ\x11\rÿ\x0b\x18\x0f\x10\x18\x1d\x18\x16\x19\x10\tÿ\x14\x18\x0b\x19"\x18\x15\x18\t3ÿ\x01ÿ\x18\x10\x16\x19\n\x19\x16\x18\t3\n6\tÿ\x18\x0bÿ\x19ÿ\x16\x11\x10\x0f\x0e\x10\x18\t\x19\x15ÿ\x19\x10\x11\x13\x19\x153\x01"\x18\r\t\x08ÿ\x14\x0e\x1d\x0e\x16\tÿ\x18\x10ÿ\x11\x1d\x1d\x0b\n\r\x18\x10\x0fÿ\x11\x1d\n\x0b\t\x1f\x143ÿ\x0b\x1f"h\x0e\x16\t\n5\t\x08\x0e\rÿ\x13\x0e\x14\x18\x16\x19\x15\x153ÿ\x0b\x0e\r\x18\x11\x1f\x0bÿ\x18\x13\n\x11\r\t\x19\x10\tÿ\x0e\x1a\x0e\x10\tÿ\x1b6\tÿ\x14\x11\x0e\x0bÿ\x10\x11\t\n\x13\x0e\x0e\tÿ\x19\x103ÿ\x11\x1dÿ\t\x08\x0eÿ\x19"\x11\x1a\x0eÿ\x0b\x0e\r\x18\x11\x1f\x0bÿ\x16\r\x18\t\x0e\r\x18\x197ÿ"\x1f\tÿ\x13\x193\nh\x0e\x11\n\x19\r\x14\x18!\x0eÿ\t\x08\x0eÿ\x0b\x1f"h\x0e\x16\t7ÿ\x19\x10\x14ÿ\x13\x193ÿ\r\x0e:\x1f\x18\r\x0eÿ\x13\x0e\x14\x18\x16\x19\x15ÿ\x11\r\n\x0b\x1f\r\x0f\x18\x16\x19\x15ÿ\x18\x10\t\x0e\r\x1a\x0e\x10\t\x18\x11\x10ÿ\t\x11ÿ\n\r\x0e\x1a\x0e\x10\tÿ\x11\x10\x0eÿ\x11\x1dÿ\t\x08\x0eÿ\x11\x1f\t\x16\x11\x13\x0e\x0b\n\x15\x18\x0b\t\x0e\x14ÿ\x19"\x11\x1a\x0e%\x12\nKLMNÿ^YMMÿKb\\ÿY^ÿORÿiRR\\Xÿ;_Y\\R_YOÿ^K_ÿORXY\n\\C@ÿORÿDT?DF??JÿAC@ÿD<??<EFGHÿORÿ<DÿJ>@VFU?ÿFGA@Q@JA\nWORXYZ\n;eR;fÿOMMÿ\\eO\\ÿO]]MN\n8\r\x19\x14\x0eÿ4ÿ\x11\rÿ\x0f\r\x0e\x19\t\x0e\rÿ6\x06\x06\n8\r\x19\x14\x0eÿ4ÿ\x11\rÿ\x08\x18\x0f\x08\x0e\rÿjk\x1c\n8\r\x19\x14\x0eÿ\x02ÿ\x11\rÿ\x0f\r\x0e\x19\t\x0e\rÿ\x05\x06\x1cÿ\x1bk\x0e\x0e7\x02\x04\x03-%\n8\r\x19\x14\x0eÿ4ÿ\x11\rÿ\x0f\r\x0e\x19\t\x0e\rÿ\x19\x15\x15\x0e\r\x0f\x18\x16ÿ\r\x0e\x19\x16\t\x18\x11\x10\x0b\n8\r\x19\x14\x0eÿ4ÿ\x11\rÿ\x0f\r\x0e\x19\t\x0e\rÿ\x18\x10\x1d\x0e\x16\t\x18\x11\x10\x0b\n8\r\x19\x14\x0eÿ\x02ÿ\x11\rÿ\x0f\r\x0e\x19\t\x0e\rÿ\x05.\x1cÿ\x0e\x1a\x0e\x10\t\x0b\nl\x0e\n\x19\t\x18\t\x18\x0bÿmÿ\r\x0eg\x19\x16\t\x18\x1a\x19\t\x18\x11\x10\nÿ\n(\r\x18\x10\t\x19"\x15\x0eÿn\x0e\r\x0b\x18\x11\x10ÿÿn\x18\x0e\x1eÿ(\'\x07ÿÿÿ6\x16\x11\x10ÿo\x0e3 \x1c\x19\x1a\x0eÿ\x05\x19\x10\x16\x0e\x15\n\x05\x06\x07ÿn\x0e\r\x0b\x18\x11\x10ÿ-49+ÿgÿ(\x19\x0f\x0eÿ8\x0e\x10\x0e\r\x19\t\x0e\x14\x0cÿ\x02\x03ÿp\x1f\x10ÿ\x02\x04\x02\x03ÿ\x04+\x0c,\x02\x0c\x02,ÿ&\x19\x0b\t\x0e\r\x10ÿ\'\x193\x15\x18\x0f\x08\tÿj\x18\x13\x0e\n\x05\x15\x18\x16$ÿl\x0e\r\x0eÿ\x1d\x11\rÿ\x05\x1f\x0b\t\x11\x13\x0e\rÿ\x1c\x1f\n\n\x11\r\tÿ6\x10\x1d\x11\r\x13\x19\t\x18\x11\x10 \x17\x0e\x14\x18\x14\x19\t\x19ÿ\x05\x15\x19\x0b\x0b\x18\x16ÿ\x06\x19\x1a\x0eqÿ\x02\x04\x02\x04\x124\x12\x02ÿ\n\x05\x11\n3\r\x18\x0f\x08\tÿrÿ\x03---g\x02\x04\x02\x04ÿ\x17\x0e\x14\x18\x14\x19\t\x19ÿ\x1c\x11\x15\x1f\t\x18\x11\x10\x0b7ÿ6\x10\x16\x12\n\x08\t\t\n\x0b\x0c\x01\x01\r\x0e\x0f\x0e\x10\x0e\r\x11\x10\x12\x13\x14\x0b\x11\x15\x12\x16\x11\x13\x01\x17\x0e\x14\x18\x14\x19\t\x19\x06\x19\x1a\x0e\x01\x1b\x1c\x1b\t\x15\x13\x1d\x1e\x1f\x0e \x10\x18\x15!\x03"\x19#\x08\x16\x0b\x0b\x1f\x08$\x1d%%\x01\x17\x11\x14\x1f\x15\x0e\x0b\x01&\'\x05\x01\x05\x06\x07(\x19\x0f\x0e\x12\x19\x0b\n )\'(*+#,\x04\x03-+\x03 \x02\x01\x02']
apiLogger::2021-10-05 06:29:23,817::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 06:29:23,817::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-05 06:29:23,817::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 06:29:23,817::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 06:29:23,817::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 06:29:55,895::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 06:29:55,896::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 06:35:18,684::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 06:35:18,706::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 06:35:18,706::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpb9ly0t42 
apiLogger::2021-10-05 06:35:18,707::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 06:35:18,707::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 06:35:18,913::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 06:35:18,913::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpb9ly0t42
apiLogger::2021-10-05 06:35:20,255::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 06:35:20,255::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 06:35:20,255::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 06:35:20,255::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 06:35:20,260::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-05 06:35:20,260::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 06:35:20,260::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 06:35:20,260::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 06:35:20,260::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410005 - Kim, W. - South Korea@KOR\nSite Number 1625410005\nSubject ID: 410005014\nScreening Date 29 JUL 2020 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 28 JUL 2020 Main consent 20 JAN 2020 28 JUL 2020\nAmendment 1 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410005014 1970 50 Female Asian -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Arm 1 REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 TUBERCULOSIS   Resolved - -  \n2 HEMORRHOID   Resolved - -  \n3 BACK PAIN 02 MAY 2020 - Ongoing Grade 1 - -\n4 DYSPEPSIA   Ongoing Grade 2 - -\n5 CONSTIPATION   Ongoing Grade 1 - - REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n1 ITOPRIDE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - TID\n2 FAMOTIDINE Medical History - 4_DYSPEPSIA_UNK - 1 Tablet - BID\n3_BACK PAIN_02\n3 CETAMADOL Medical History - - 1 Tablet - BID\nMAY 2020\nPremedication for\n4 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n5 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\nCHLORPHENIRAMI\n6 REGN1979 study - - - 4 mg - QD\nNE\ndrug administration\n5_CONSTIPATION_\n7 MG.OXIDE Medical History - - 1 Capsule - TID\nUNK\n5_CONSTIPATION_\n8 LACTULOSE Medical History - - 15 mL - TID\nUNK\n1_CYTOKINE\nRELEASE\n9 TOCILIZUMAB Adverse Event - - 545 mg - QD\nSYNDROME_14\nAUG 2020\n1_CYTOKINE\nRELEASE\n10 NOREPINEPHRINE Adverse Event - - 30 mg - QD\nSYNDROME_14\nAUG 2020\nPremedication for\n11 ACETAMINOPHEN REGN1979 study - - - 650 mg - QD\ndrug administration\nPremedication for\n12 DEXAMETHASONE REGN1979 study - - - 20 mg - QD\ndrug administration REG-2020-00320 GSPV RECEIPT DATE 12OCT2020 AKA 26 pages\nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nTID - Oral - 12 JUN 2019 - -  \nBID - Oral - 11 OCT 2019 - -  \nBID - Oral - 02 MAY 2020 - -  \nQD - Oral - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 05 AUG 2020 - 06 AUG 2020 -\nTID - Oral - 06 AUG 2020 - -  \nTID - Oral - 06 AUG 2020 - 06 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 14 AUG 2020 -\nQD - Intravenous - 14 AUG 2020 - 15 AUG 2020 -\nQD - Oral - 12 AUG 2020 - 13 AUG 2020 -\nQD - Intravenous - 12 AUG 2020 - 13 AUG 2020 -']
apiLogger::2021-10-05 06:35:20,260::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 06:35:20,260::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-05 06:35:20,260::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 06:35:20,260::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 06:35:20,260::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 06:35:39,465::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 06:35:39,465::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 07:25:18,709::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 07:25:18,712::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 07:25:18,712::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpctz0ngu8 
apiLogger::2021-10-05 07:25:18,712::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 07:25:18,712::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 07:25:18,744::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 07:25:18,744::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpctz0ngu8
apiLogger::2021-10-05 07:25:19,330::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 07:25:19,331::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 07:25:19,331::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 07:25:19,331::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 07:25:19,336::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 07:25:19,336::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 07:25:19,336::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 07:25:19,336::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 07:25:19,340::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 07:25:19,340::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 07:25:19,340::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 07:25:19,340::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88286 (v.1)\nA. GENERAL INFORMATION\nCase Number: REGEMC-88286 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Edwyn Lee, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB. CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Kurtis McGee Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 180-048-62668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC. ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter:    \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD. ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction: \nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE. PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88286 (v.1)\nF. SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial  \nF. CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nF. HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nG. OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH. RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES \nI. PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\n \n \nVersion 16Nov2020']
apiLogger::2021-10-05 07:25:19,340::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 07:25:19,340::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 07:25:19,651::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 07:25:19,652::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 07:25:19,652::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp45qwd9e9 
apiLogger::2021-10-05 07:25:19,652::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 07:25:19,652::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 07:25:19,657::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 07:25:19,657::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp45qwd9e9
apiLogger::2021-10-05 07:25:19,669::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 07:25:19,669::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 07:25:19,669::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 07:25:19,669::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 07:25:19,674::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 07:25:19,674::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 07:25:19,674::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 07:25:19,674::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 05-Oct-2021 07:24:38 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 1 iniital\n ']
apiLogger::2021-10-05 07:25:19,674::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 07:25:19,674::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 08:05:19,010::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 08:05:19,104::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 08:05:19,104::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp87xx6eqs 
apiLogger::2021-10-05 08:05:19,108::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 08:05:19,109::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 08:05:19,809::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 08:05:19,809::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp87xx6eqs
apiLogger::2021-10-05 08:05:20,768::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 08:05:20,768::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 08:05:20,769::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 08:05:20,769::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 08:05:20,773::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-05 08:05:20,773::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 08:05:20,773::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 08:05:20,773::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 08:05:20,773::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012005\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021']
apiLogger::2021-10-05 08:05:20,773::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 08:05:20,773::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-05 08:05:20,773::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 08:05:20,773::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 08:05:20,774::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 08:05:53,444::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 08:05:53,444::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 08:17:18,725::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 08:17:18,728::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 08:17:18,728::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpnwmraz8q 
apiLogger::2021-10-05 08:17:18,729::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 08:17:18,729::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 08:17:18,762::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 08:17:18,762::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpnwmraz8q
apiLogger::2021-10-05 08:17:19,374::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 08:17:19,374::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 08:17:19,374::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 08:17:19,374::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 08:17:19,379::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 08:17:19,379::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 08:17:19,379::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 08:17:19,379::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 08:17:19,383::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 08:17:19,383::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 08:17:19,383::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 08:17:19,383::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 08:17:19,387::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 08:17:19,387::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 08:17:19,387::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 08:17:19,387::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', "Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 3\nCase ID: REGEMC-88286 (v.2)\nA. GENERAL INFORMATION\nCase Number: REGEMC-88286 Report Version: 2\nEVERSANA Received Date: 16-Sep-2021 04:42, Version 2 Source: Fax\nEVERSANA Staff: Edwyn Lee, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB. CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Kurtis McGee Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 180-048-62668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC. ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter:    \nReceived date: : 16-Sep-2021, Version 2\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD. ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction: \nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nVersion 2 (16-Sep-2021, ELee): Information regarding this event was provided by the physician's office to Medical Information via fax on 16-Sep-\n2021.  Please refer to the source document for additional information.  No additional information was provided at the time of this report.\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 3\nCase ID: REGEMC-88286 (v.2)\nE. PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nF. SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial  \nF. CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nF. HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nG. OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH. RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES \nI. PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\n \n \nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 3\nCase ID: REGEMC-88286 (v.2)\nVersion 16Nov2020"]
apiLogger::2021-10-05 08:17:19,387::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 08:17:19,387::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 08:17:19,698::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 08:17:19,699::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 08:17:19,699::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpyq9e7th7 
apiLogger::2021-10-05 08:17:19,699::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 08:17:19,699::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 08:17:19,704::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 08:17:19,704::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpyq9e7th7
apiLogger::2021-10-05 08:17:19,716::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 08:17:19,717::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 08:17:19,717::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 08:17:19,717::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 08:17:19,721::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 08:17:19,721::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 08:17:19,721::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 08:17:19,721::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 05-Oct-2021 08:16:31 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 1 follow up\n ']
apiLogger::2021-10-05 08:17:19,721::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 08:17:19,721::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 08:27:18,695::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 08:27:18,696::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 08:27:18,696::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpytktix1c 
apiLogger::2021-10-05 08:27:18,697::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 08:27:18,697::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 08:27:18,721::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 08:27:18,721::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpytktix1c
apiLogger::2021-10-05 08:27:19,056::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 08:27:19,056::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 08:27:19,056::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 08:27:19,056::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 08:27:19,060::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-05 08:27:19,060::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 08:27:19,061::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 08:27:19,061::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 08:27:19,061::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site bruising]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n10-JUN-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n16-JUN-2021\xa0\nINITIAL FOLLOWUP:\n16-Jun-2021 07:52 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n16-Jun-2021 07:52']
apiLogger::2021-10-05 08:27:19,061::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 08:27:19,061::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-05 08:27:19,061::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 08:27:19,061::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 08:27:19,061::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 08:27:27,933::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 08:27:27,933::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 08:57:18,733::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 08:57:18,735::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 08:57:18,735::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpnc1erutc 
apiLogger::2021-10-05 08:57:18,736::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 08:57:18,736::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 08:57:18,739::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 08:57:18,739::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpnc1erutc
apiLogger::2021-10-05 08:57:20,105::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 08:57:20,105::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 08:57:20,105::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 08:57:20,105::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 08:57:20,111::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-05 08:57:20,111::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 08:57:20,111::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 08:57:20,111::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 08:57:20,111::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', 'CIOMS FORM(cid:1)\nSUSPECT ADVERSE REACTION REPORT(cid:1)\n Mfr. Control No. :2021ZIOP000001(0)(cid:1)\nI.REACTION INFORMATION(cid:1)\n1.PATIENT INITIALS(cid:1) 1a.COUNTRY(cid:1) 2.DATE OF BIRTH(cid:1) 2a. AGE(cid:1) 3. SEX(cid:1) 4-6 REACTION ONSET(cid:1) 8-12 CHECK ALL(cid:1)\n11-(19-fi13r-s. t , 4cl a ms tK(cid:1)) (cid:1)g (cid:1)          (cid:1) USA(cid:1) 0D4ay(cid:1)(cid:1) MMAoRn(cid:1)th(cid:1) 19Y9ea2r(cid:1)(cid:1)28(cid:1)Years(cid:1) M     (cid:1) 2D2ay(cid:1)(cid:1) FMEoBn(cid:1)th(cid:1) 2Y0ea2r(cid:1)1(cid:1) ATROEPPA ARCDOTVPIOERRNIAS(cid:1)TEE(cid:1)(cid:1)\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)(cid:1)\n  (cid:1)(cid:1)PATIENT DIED(cid:1)\nSEIZURE (Seizure) [v.23.1](cid:1)\nX (cid:1)(cid:1)INVOLVED OR(cid:1)\nDRAFTPROLONGED INPATIENT(cid:1)\nStudy Protocol: ATI001-204(cid:1) HOSPITALIZATION(cid:1)\nSubject ID: 468-041(cid:1)   (cid:1)(cid:1)INVO(cid:1)LVED PERSISTENCE OR(cid:1)\nEvent: Seizure(cid:1) SIGNIFICANT DISABILITY OR(cid:1)\nCase ID: 2021ZIOP000001(cid:1) INCAPACITY(cid:1)\nA serious adverse event report of seizure (Grade 3)  was received from site 468 (cid:1)   (cid:1)(cid:1)LIFE THREATENING(cid:1)\nin the United States on 23 February 2021 concerning a 28 year old male subject (cid:1)\n(468-041) enrolled in study ATI001-204, A Phase II Study of Ad-RTS-hIL-12 + (cid:1)\nVeledimex in Combination with Cemiplimab‐rwlc (Libtayo®) in Subjects with (cid:1)   (cid:1)(cid:1)CONGENITAL ANOMALY(cid:1)\nRecurrent or Progressive Glioblastoma. Serious criteria included: Hospitalization(cid:1)\n(Initial).(cid:1)\n  (cid:1)(cid:1)OTHER MEDICALLY IMPORTANT (cid:1)\nThe subject received the first dose of cemiplimab (250 milligrams [mg] (cid:1) CONDITION(cid:1)\nintravenously [IV]) on 09 June 2020 (Day -7). The subject received the single (cid:1)\nCont...(cid:1)\nII.SUSPECT DRUG(S) INFORMATION(cid:1)\n14. SUSPECT DRUG(S) (include generic name)(cid:1) Treatment Unblinded : (cid:1)Not Applicable(cid:1) 20.DID REACTION ABATE(cid:1)\nVELEDIMEX(VELEDIMEX)(cid:1) AFTER STOPPING DRUG?(cid:1)\nCont...(cid:1)   (cid:1)(cid:1)YES(cid:1)   (cid:1)(cid:1)NO(cid:1) X (cid:1)(cid:1)NA(cid:1)\n15. DAILY DOSE(S)(cid:1) 16. ROUTE(S) OF ADMINISTRATION(cid:1) 21.DID REACTION(cid:1)\n20 mg (20 mg,1 in 1 D)(cid:1) Oral(cid:1) RREEAINPTPREOADR UACFTTEIORN(cid:1)?(cid:1)\n17. INDICATION(S) FOR USE(cid:1)\nGlioblastoma [v.23.1](cid:1)\n  (cid:1)(cid:1)YES(cid:1)   (cid:1)(cid:1)NO(cid:1) X (cid:1)(cid:1)NA(cid:1)\n18. THERAPY DATES(from/to)(cid:1) 19. THERAPY DURATION(cid:1)\n16/JUN/2020 - 29/JUN/2020(cid:1) 14 Days(cid:1)\nDRAFT\nIII.CONCOMITANT DRUG(S) AND HISTORY(cid:1)\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)(cid:1) (cid:1)\nNone(cid:1)\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)(cid:1)\nIV.MANUFACTURER INFORMATION(cid:1)\n                                                                                                     \n24a. NAME AND ADDRESS OF MANUFACTURER(cid:1) Initial Reporter:                                                                                    \nZIOPHARM Oncology, Inc.                                 (cid:1) Dr. Sylvia Kurz                                                                                      \n1 First Avenue, Parris Building, #34, Navy Yard Plaza   (cid:1) NYU Langone Health                                                                                   \n240 E. 38th Street                                                                                   \nBoston, MA 02129 United States of America               (cid:1) 19th floor                                                                                           \nNew York, NY 10019                                                                                   \nEudraCT no : (cid:1) 24b. MFR. CONTROL NO.(cid:1) United States of America                                                                             \nStudy no  : ATI001-204(cid:1) 2021ZIOP000001(0)             (cid:1)Tel: 212-731-6267                                                                                    \nCenter no : 468(cid:1)\nCont...(cid:1)\n24c. DATE RECEIVED(cid:1) 24d. REPORT SOURCE(cid:1)\nBY MANUFACTURER(cid:1) X (cid:1)(cid:1)STUDY(cid:1)   (cid:1)(cid:1)LITERATURE(cid:1)   (cid:1)(cid:1)AUTHORITY(cid:1)\n23/FEB/2021(cid:1) X (cid:1)(cid:1) HEALTH PROFESSIONAL(cid:1)  (cid:1)(cid:1)OTHER (cid:1)\nDATE OF THIS REPORT(cid:1) 25a. REPORT TYPE(cid:1)\n08/MAR/2021(cid:1) X (cid:1)(cid:1)INITIAL(cid:1)   (cid:1)(cid:1)FOLLOW U  P(cid:1)(cid:1)(cid:1)\nCont...(cid:1) = Continuation attached sheet(s)(cid:1)  Date :08/MAR/2021(cid:1)\n Page : 2(cid:1) / (cid:1)3(cid:1)\n Continuation Sheet for CIOMS report(cid:1)  Mfr. Control No. :2021ZIOP000001(0)(cid:1)\n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)(cid:1)\ndose of Ad-RTS-hIL-12 (0.1 milliliters [mL] intratumoral; (location not reported)) and the first dose of (cid:1)\nveledimex (20 mg oral, daily) on 16 June 2020 (Day 0). The most recent dose of veledimex administered prior to (cid:1)\nthe onset of the SAE was received on 29 June 2020 (Day 13). The most recent dose of cemiplimab administered (cid:1)\nprior to the onset of the SAE was received on 16 February 2021 (Day 245).(cid:1)\nThe subject had no relevant medical history  or concomitant medications reported.  The subject’s cancer (cid:1)\ndiagnosis date was not reported.(cid:1)\nOn 22 February 2021 (Day 251), the subject presented to the hospital with seizure, Grade 3 and was admitted on (cid:1)\n (cid:1)\nthe same day. The event was considered serious due to the initial hospitalization. The subject woke up after a (cid:1)\nmedical event that he could not remember and noted his right (R) side was weak and he essentially was unable to(cid:1)\nmove. He could not recall the event, which he assumed was a seizure and called 911. There was n o (cid:1)tongue bite or(cid:1)\nDincontinence, and noR other trauma or injuAry reported. The subjecFt had an episode Tof nausea/vomiting at the (cid:1)\nhospital. A non-contrast helical computerized tomography (NCHCT) scan was negative for bleed or infarct and (cid:1)\nreading was consistent with known Glioblastoma (GBM) and prior surgeries. Laboratory test revea le(cid:1)d h(cid:1)igh lactate(cid:1)\nlevels but no other abnormalities. The subject was administered levetiracetam (Keppra) 1000 mg IV once for (cid:1)\npossible seizure episode, hydrocortisone 100 mg and intravenous fluid (IVF) bolus.  The subject was transferred(cid:1)\nto another hospital and subsequently admitted. He is currently able to walk stably and has had no recurrent (cid:1)\nevents reported. The subject provided a CT scan from the outside hospital. A continuous video (cid:1) (cid:1)\nelectroencephalogram (VEEG) monitoring was without electrographic seizures or epileptiform activity. The (cid:1)\nsubject’s caregiver informed that his pill box still contained Keppra and dexamethasone doses for the two (cid:1)\ndays prior to the hospitalization; therefore, the most likely diagnosis was noted as seizure du e (cid:1)to missed (cid:1)\ndoses of seizure medications and/or steroids. The plan was to resume Keppra at home dose and to discharge home (cid:1)\nonce recovered to baseline.(cid:1)\nOn 23 February 2021, Keppra dose was increased to 1000 mg twice daily (BID) orally.(cid:1)  (cid:1)\nNo action was taken with veledimex in response to the event seizure.(cid:1)\nAction taken with Ad-RTS-hIL-12 and cemiplimab was not applicable. The administration of Ad-RTS-hIL-12 was (cid:1)\ncompleted prior to the onset of the event.(cid:1)\nAt the time reporting (Day 252) the event of seizure (Grade 3) was not recovered/not resolved.(cid:1)\nThe investigator assessed the event of seizure to be unrelated to Ad-RTS-hIL-12 and veledimex, and unlikely (cid:1)\nrelated to cemiplimab. Alternative causality included other medical condition (pending confirmation )(cid:1).(cid:1)  (cid:1)  (cid:1)\nThe PPD Medical Monitor assessed the event of seizure to be not related to Ad-RTS-hIL-12 and veledimex, and (cid:1)\nunlikely to be related to cemiplimab.(cid:1)\nThe Sponsor assessed the event of seizure to be unrelated to Ad-RTS-hIL-12 and veledimex, and unlikely related (cid:1)\nto cemiplimab.(cid:1)\n (cid:1)  (cid:1)  (cid:1)\nThe event of seizure is unexpected for Ad-RTS-hIL-12 and veledimex.(cid:1)\nThe event of seizure is unexpected for cemiplimab.(cid:1)\n Suspect Products (Cont...)(cid:1)\nDRAFT\n Product-Reaction level(cid:1)\n(cid:1)\n Seq.No.(cid:1) :(cid:1) 1(cid:1)\n Drug(cid:1) :(cid:1) VELEDIMEX(VELEDIMEX)(cid:1)\n Causality(cid:1)\n1)(cid:1)SEIZURE (Seizure) [v.23.1](cid:1)\n Action(s) taken with drug(cid:1)  : (cid:1) Dosage maintained(cid:1)\n Causality as per reporter (Drug/Vaccine)(cid:1)  : (cid:1) Unrelated(cid:1)\n Causality as per Mfr.(Drug/Vaccine)(cid:1)  : (cid:1) Unrelated(cid:1)\n Dechallenge(cid:1)  : (cid:1) N/A(cid:1)\n Rechallenge(cid:1)  : (cid:1) N/A(cid:1)\n Seq.No.(cid:1) :(cid:1) 2(cid:1)\n Drug(cid:1) :(cid:1) Ad-RTS-hIL-12(Ad-RTS-hIL-12)(cid:1)\n Daily Dose(cid:1) :(cid:1) 1)(cid:1)2.0 x 10 ^11 (0.1 ml,2.0 x 10^11)(cid:1)\n Route of Admin(cid:1) :(cid:1) 1)(cid:1)Intratumor(cid:1)\n Indication for use(cid:1) :(cid:1) 1)(cid:1)Glioblastoma [v.23.1](cid:1)\n Therapy Dates/Duration(cid:1) :(cid:1) 1) 1(cid:1)6/JUN/2020 - 16/JUN/2020 (1 Days)(cid:1)\n Causality(cid:1)\n1)(cid:1)SEIZURE (Seizure) [v.23.1](cid:1)\n Action(s) taken with drug(cid:1)  : (cid:1) Not Applicable(cid:1)\n Causality as per reporter (Drug/Vaccine)(cid:1)  : (cid:1) Unrelated(cid:1)\n Causality as per Mfr.(Drug/Vaccine)(cid:1)  : (cid:1) Unrelated(cid:1)\n Dechallenge(cid:1)  : (cid:1) N/A(cid:1)\n Rechallenge(cid:1)  (cid:1)  (cid:1)  : (cid:1) N/A(cid:1) (cid:1)\n (cid:1)  (cid:1)\n Seq.No.(cid:1)  :(cid:1)(cid:1) 3(cid:1)  (cid:1)  (cid:1)\n Drug(cid:1) :(cid:1) LIBTAYO(CEMIPLIMAB-rwlc)(cid:1)\n Daily Dose(cid:1) :(cid:1) 1)(cid:1)11.9048 mg (250 mg,1 in 3 wk)(cid:1)\n Route of Admin(cid:1) :(cid:1) 1)(cid:1)Intravenous(cid:1)\n Indication for use(cid:1) :(cid:1) 1)(cid:1)Glioblastoma [v.23.1](cid:1)\n Therapy Dates/Duration(cid:1) :(cid:1) 1) 0(cid:1)9/JUN/2020 - 16/FEB/2021 (253 Days)(cid:1)  Date :08/MAR/2021(cid:1)\n Page : 3(cid:1) / (cid:1)3(cid:1)\n Continuation Sheet for CIOMS report(cid:1)  Mfr. Control No. :2021ZIOP000001(0)(cid:1)\n Causality(cid:1)\n1)(cid:1)SEIZURE (Seizure) [v.23.1](cid:1)\n Action(s) taken with drug(cid:1)  : (cid:1) Not Applicable(cid:1)\n Causality as per reporter (Drug/Vaccine)(cid:1)  : (cid:1) Unlikely(cid:1)\n Causality as per Mfr.(Drug/Vaccine)(cid:1)  : (cid:1) Unlikely(cid:1)\n Dechallenge(cid:1)  : (cid:1) N/A(cid:1)\n Rechallenge(cid:1)  : (cid:1) N/A(cid:1)\n Clinical Trial Identification ( Cont...)(cid:1)\n  (cid:1)(cid:1)\n Patient no : 468-041(cid:1)\n Study identification for EudraCT: PH II Study of Ad-RTS-hIL-12 + Veledimex in Combo w/ Cemipli  ma(cid:1)(cid:1)b-rwlc in rGBM(cid:1)\nDRAFT\n Additional information (continuation)(cid:1)   (cid:1)(cid:1) (cid:1)\n Lab Result  :(cid:1)\n  (cid:1)(cid:1)\nTest name(cid:1) Test date(cid:1) Test result(cid:1) Normal value(cid:1) Classification(cid:1)\nCT SCAN(cid:1) Results not (cid:1)   (cid:1)(cid:1)\nprovided(cid:1)\nLACTATE(cid:1) 22/Feb/2021(cid:1) High(cid:1)\n  (cid:1)(cid:1)\nNCHCT(cid:1) 22/Feb/2021(cid:1)\nnegative for bleed or infarct and reading consistent with known Glioblastoma (GBM) and prior surgeries(cid:1)\nVEEG(cid:1) 22/Feb/2021(cid:1) without (cid:1)\nelectrographic (cid:1)\nseizures or (cid:1)\nepileptiform (cid:1)\nactivity(cid:1)\n  (cid:1)(cid:1)   (cid:1)(cid:1)   (cid:1)(cid:1)\n  (cid:1)(cid:1)   (cid:1)(cid:1)   (cid:1)(cid:1)\nDRAFT\n(cid:1)\n  (cid:1)(cid:1)   (cid:1)(cid:1)   (cid:1)(cid:1)\n  (cid:1)(cid:1)   (cid:1)(cid:1)\n  (cid:1)(cid:1)   (cid:1)(cid:1)   (cid:1)(cid:1)']
apiLogger::2021-10-05 08:57:20,111::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 08:57:20,111::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-05 08:57:20,111::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 08:57:20,111::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 08:57:20,111::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 08:57:32,762::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 08:57:32,763::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 08:59:18,734::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 08:59:18,736::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 08:59:18,736::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp0kmcuvkz 
apiLogger::2021-10-05 08:59:18,736::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 08:59:18,736::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 08:59:18,740::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 08:59:18,740::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp0kmcuvkz
apiLogger::2021-10-05 08:59:19,627::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 08:59:19,627::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 08:59:19,627::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 08:59:19,627::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 08:59:19,631::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-05 08:59:19,632::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 08:59:19,632::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 08:59:19,632::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 08:59:19,632::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(0)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received HOSPITALIZATION\nfrom Spain on 22-Jun-2021, referring to a 81-year old White male subject with     INVOLVED PERSISTENCE OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain. The subject SIGNIFICANT DISABILITY OR\n102-3407-0001, was enrolled in RPL-002-18: A randomized, controlled, Open-Label,  INCAPACITY\nPhase 2 Study of Cemiplimab as Single Agent in Combination with RP1 in Patients \nwith advanced cutaneous squamous cell carcinoma.     LIFE THREATENING\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to     CONGENITAL ANOMALY\n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol \n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral     OTHER MEDICALLY IMPORTANT \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for  CONDITION\nES-RPL-21-00044); subcutaneous Hibor (bemiparin sodium), 7500 international units\nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 15/JUN/2021 20 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00054(0)            \nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n22/JUN/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n30/JUN/2021 X  INITIAL    FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :30/JUN/2021\nReplimune Inc.  Page : 2 /  3\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(0)\n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n daily, since 26-May-2021, for auricular fibrillation (taken for ES-RPL-21-00044); oral morphine, 15 mg every \n12 hours, since 26-May-2021 for tumour pain (taken from ES-RPL-21-00044); subcutaneous heparin, 7500 units once\ndaily, since 26-May-2021 for auricular fibrillation; oral MST (morphine sulphate), 30 mg twice daily, since \n15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg twice daily, since 15-Jun-2021, for tumour pain and oral \nNolotil (metamizole), 2 g as needed, since 15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\n \nmg and on 15-Jun-2021, the subject received the last dose of cemiplimab, at a dose of 350 mg prior to the event\nonset.\n \nOn 21-Jun-2021, the subject was admitted to the referral hospital due to tumour pain. Additional information \nhas been requested. \n \nAt the time of this report, the outcome of the event of tumour pain was reported as 'resolving'. The subject \nremained hospitalized. \nAction taken with cemiplimab due to the event was reported as 'dose not changed'.   \nThe Investigator assessed the event of tumour pain as Grade 3 (severe) and not related to cemiplimab, but \nrather related to the primary condition (disease under study).  \n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain is an unexpected adverse event for cemiplimab. Considering the sub ject's \nunderlying malignancy and previous history of tumour pain, the Company assessed the reported event as not \nrelated to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n     \n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A      \n Rechallenge  :  N/A\n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2\n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)\n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n   \n     \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]  Date :30/JUN/2021\nReplimune Inc.  Page : 3 /  3\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(0)\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)   \n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]   \n Therapy Dates/Duration : 1) 26/MAY/2021 - \n  \n  \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral   \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n  \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -          \n Other relevant history (Cont...)\n        \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0] ( Continuing: Yes)\nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n        \n     \n        "]
apiLogger::2021-10-05 08:59:19,632::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 08:59:19,632::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-05 08:59:19,632::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 08:59:19,632::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 08:59:19,632::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 08:59:29,629::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 08:59:29,629::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 09:53:18,725::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 09:53:18,726::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 09:53:18,726::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpuq2owfrb 
apiLogger::2021-10-05 09:53:18,727::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 09:53:18,727::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 09:53:18,750::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 09:53:18,750::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpuq2owfrb
apiLogger::2021-10-05 09:53:19,152::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 09:53:19,152::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 09:53:19,152::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 09:53:19,152::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 09:53:19,156::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-05 09:53:19,156::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 09:53:19,156::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 09:53:19,156::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 09:53:19,156::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site reaction]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n27-AUG-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n09-SEP-2021\xa0\nINITIAL FOLLOWUP: 1\n09-Sep-2021 06:51 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nOn 28-JUN-2021, a non-significant case correction of the version received on 10-JUN-2021 was performed to recode the event of \n"Injection site reaction- localised bruising" to Injection site reaction (previously coded as Injection site bruising). \nCompany Comment [28-JUN-2021]: Based on the non-significant case correction, there is no change in the Sponsor’s assessment.\nADDITIONAL INFORMATION WAS RECEIVED ON 27-AUG-2021.\n \nInformation provided included additional details regarding previously reported event and updated causality assessment.\n \nIt was stated that the localised bruising and tenderness symptoms were resolved spontaneously, without specific treatment.\nAdditional information has been requested.\n \nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was related (previously, not related) to “ALN-CC5 (cemdisiran) versus placebo”. Other \nalternative explanation for the event was not reported.\n \nCompany Comment [27-AUG-2021]: The event of Injection site reaction is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). Severe or serious ISRs are considered AECIs per the clinical study protocol, \nhowever this event was deemed by the investigator as mild and not serious. A query has been issued to clarify whether it meets AECI \ncriteria. Given the spatial relationship to the injection site in addition to the suggested potential temporal relationship to dosing, the \nSponsor considers the event of Injection site reaction as  related to “ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n09-Sep-2021 06:51']
apiLogger::2021-10-05 09:53:19,156::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 09:53:19,156::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-05 09:53:19,156::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 09:53:19,156::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 09:53:19,156::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 09:53:29,343::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 09:53:29,343::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 11:19:18,865::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 11:19:18,898::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 11:19:18,899::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpmid4d6y3 
apiLogger::2021-10-05 11:19:18,900::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 11:19:18,900::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 11:19:19,390::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 11:19:19,391::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpmid4d6y3
apiLogger::2021-10-05 11:19:20,478::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 11:19:20,479::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 11:19:20,479::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 11:19:20,479::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 11:19:20,483::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-05 11:19:20,483::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 11:19:20,483::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 11:19:20,483::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 11:19:20,484::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00101 GSPV RECEIPT DATE 09JUL2021 AKA 29 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 616003 - Walewski - Poland\nSite Number 1625616003\nSubject ID: 616003003\nScreening Date 11 SEP 2020 REG-2021-00101 GSPV RECEIPT DATE 09JUL2021 AKA 29 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625 Genomics Sub-Study\n1 08 SEP 2020 8 APR 2020 08 SEP 2020\nAmendment 3 EU consent\nR1979-ONC-1625\n2 08 SEP 2020 Main consent 8 APR 2020 08 SEP 2020\nAmendment 3 EU\nFuture Biomedical\nR1979-ONC-1625\n3 08 SEP 2020 Research Sub-Study 8 APR 2020 08 SEP 2020\nAmendment 3 EU\nconsent\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n616003003 1992 27 Male White -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) Other B-NHL REG-2021-00101 GSPV RECEIPT DATE 09JUL2021 AKA 29 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 ANEMIA 11 SEP 2020 unchecked Ongoing Grade 2 - unchecked\n2 TROMBOCYTOPENIA 11 SEP 2020 unchecked Ongoing Grade 2 - unchecked REG-2021-00101 GSPV RECEIPT DATE 09JUL2021 AKA 29 pages\nConcomitant Medication\nIf Indication is medical If Indication is adverse\nhistory, Please select event, Please select\nIf Prophylaxis Or\n# Drug Name Indication the the Dose Dose Unit Other, specify Frequency\nOther, specify\nappropriate Medical appropriate Adverse\nHistory record. Event record.\nPremedication for\n1 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n2 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n3 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\nPremedication for\n4 DEXAVEN REGN1979 study - - - 20 mg - QD\ndrug administration\n5 FILGRASTIM Other NEUTROPENIA  - - 48 IU - QD REG-2021-00101 GSPV RECEIPT DATE 09JUL2021 AKA 29 pages\nStart date Stop date\nIf Other If Other, Start Date\nFrequency Route (dd-mon- (dd-mon- Ongoing\nSpecify specify Unk\nyyyy) yyyy)\n24 SEP 24 SEP\nQD - Intravenous - unchecked unchecked\n2020 2020\n25 SEP 25 SEP\nQD - Intravenous - unchecked unchecked\n2020 2020\n30 SEP 30 SEP\nQD - Intravenous - unchecked unchecked\n2020 2020\n01 OCT 01 OCT\nQD - Intravenous - unchecked unchecked\n2020 2020\nSubcutaneo 23 SEP 23 SEP\nQD - - unchecked unchecked\nus 2020 2020']
apiLogger::2021-10-05 11:19:20,484::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 11:19:20,484::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-05 11:19:20,484::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 11:19:20,484::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 11:19:20,484::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 11:19:41,304::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 11:19:41,304::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 11:21:18,875::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 11:21:18,929::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 11:21:18,930::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpqbtax3j3 
apiLogger::2021-10-05 11:21:18,932::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 11:21:18,932::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 11:21:33,178::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 11:21:33,178::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpqbtax3j3
apiLogger::2021-10-05 11:21:43,881::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 11:21:43,881::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 11:21:43,881::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 11:21:43,881::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 11:21:43,886::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:21:43,887::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 11:21:43,887::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 11:21:43,887::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 11:21:43,891::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:21:43,892::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 11:21:43,892::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 11:21:43,892::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 11:21:43,896::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:21:43,896::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 11:21:43,897::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 11:21:43,897::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 11:21:43,901::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:21:43,901::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 11:21:43,901::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 11:21:43,901::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 11:21:43,906::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:21:43,906::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 11:21:43,906::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 11:21:43,906::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '9/27/2021 CRF\n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Agamdeep Saini (Safety)\nR4018-ONC-1721 840005 - Liu - USA 840005027 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS Subject ID: 840005027\nAdverse Events Yes/No\nAdverse Event Subject: 840005027\nPage: Adverse Event - ADVERSE EVENTS\nCRF History   CCulicrrke hnetlyre v tioe wreintugr nlin teo  1"C oof m5.plete View". Apply to Record\n840005027 - Adverse\nEvent Main Adverse Event Description (Term) NAUSEA\n   \n840005027 - Adverse\nEvents Yes/No SOC 10017947Gastrointestinal disorders\nHLGT10018012Gastrointestinal signs and symptoms\n840005027 - Concomitant\nMedications Yes/No HLT 10028817Nausea and vomiting symptoms\nPT 10028813Nausea\n840005027 - Serious\nLLT 10028813Nausea\nAdverse Event/AESI # 05\n840005027 - Serious Start date (dd-mon-yyyy) 25 SEP 2021\nAdverse Event/AESI # 04\n840005027 - Serious If event occurred on study day 1, did the event occur prior to first study Not Applicable\nAdverse Event/AESI # 03 drug administration\n840005027 - Serious If the event is part of an Infusion Related Reaction or Cytokine Release\nAdverse Event/AESI # 02 Syndrome, please check the box and complete Immune Related\n840005027 - Serious Response/Cytokine Release Syndrome CRF\nAdverse Event/AESI # 01\nIs this AE related to the immune-mediated mechanism of action of\n840002033 - Medical REGN4018/Cemiplimab?\nHistory Yes/No\n(Please complete associated CRFs for time frame, symptoms and\n840002033 - Medical\nsigns, and vital sign changes. On the corresponding CRFs for this AE,\nHistory\nplease enter interventions for management (eg. Medications, rate\n840002033 - Visit Date reduction))\nInformation\n840002033 - SAE / AESI Select if AE is intermittent No\n#1\nCAUSALITY\n840009026 - Pregnancy\nTest\n840009026 - Visit Date AE suspected to be caused by REGN4018? Not Applicable\nInformation\n840008005 - Adverse AE suspected to be caused by cemiplimab? Not Applicable\nEvent\n840008005 - Adverse AE suspected to be caused by study conduct? No\nEvents Yes/No\n840008005 - SAE / AESI ---If Yes, specify\n#2\n840008005 - SAE / AESI ACTION TAKEN\n#3\n840008005 - SAE / AESI Action taken with REGN4018 Not Applicable\n#1\n840008005 - Study Drug Action taken with cemiplimab Not Applicable\nAdministration\nIf Other, specify\nClick Here for Customer Support Information Medidata Classic Rave® 2021.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(jpqerbl3sef2skigokfxw3om))/Modules/EDC/CRFPage.aspx?DP=100290614 1/4 9/27/2021 CRF\nIf the Event is not study drug related but belongs to the sponsor list of\n iMedidata   Messages   My Profile   Help   Home   Logout\nimmune related event, please provide the etiology\nUser: Agamdeep Saini (Safety)\nIf Other, specify\nR4018-ONC-1721 840005 - Liu - USA 840005027 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS Outcome of AE Not recovered/Not resolved\nAdverse Events Yes/No\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nAdverse Event\nResolution date (dd-mon-yyyy)\nCRF History\n840005027 - Adverse AE initial severity CTCAE grade Grade 3 - Severe\nEvent\n840005027 - Adverse AE most extreme severity CTCAE grade Grade 3 - Severe\nEvents Yes/No\n840005027 - Concomitant Date Event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 25 SEP 2021\nMedications Yes/No\n840005027 - Serious Date Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nAdverse Event/AESI # 05\n840005027 - Serious Treatment for AE (select all that apply except when NONE is noted): for\nAdverse Event/AESI # 04 drug therapy or medication please enter into concomitant medications\n840005027 - Serious eCRF; If procedure or surgery please enter into the on-study\nAdverse Event/AESI # 03 procedure/surgery eCRF\n840005027 - Serious None\nAdverse Event/AESI # 02\n840005027 - Serious Drug therapy/ Medication\nAdverse Event/AESI # 01\n840002033 - Medical Concomitant Medication #1\nHistory Yes/No\n840002033 - Medical Concomitant Medication #2\nHistory\n840002033 - Visit Date\nConcomitant Medication #3\nInformation\n840002033 - SAE / AESI\nConcomitant Medication #4\n#1\n840009026 - Pregnancy\nConcomitant Medication #5\nTest\n840009026 - Visit Date\nConcomitant Medication #6\nInformation\n840008005 - Adverse\nEvent Concomitant Medication #7\n840008005 - Adverse\nEvents Yes/No Concomitant Medication #8\n840008005 - SAE / AESI\n#2 Concomitant Medication #9\n840008005 - SAE / AESI\n#3 Concomitant Medication #10\n840008005 - SAE / AESI\n#1 Concomitant Procedure/surgery\n840008005 - Study Drug\nAdministration Concomitant procedure/surgery #1\nClick Here fCor oCnusctoommeri Staupnpto prt rInofocremdatuionre/surgery #2 Medidata Classic Rave® 2021.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(jpqerbl3sef2skigokfxw3om))/Modules/EDC/CRFPage.aspx?DP=100290614 2/4 9/27/2021 CRF\nConcomitant procedure/surgery #3  iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Agamdeep Saini (Safety)\nConcomitant procedure/surgery #4\nR4018-ONC-1721 840005 - Liu - USA 840005027 ADVERSE EVENTS Adverse Event\nADVERSE EVENTS Concomitant procedure/surgery #5\nAdverse Events Yes/No\nOther\nAdverse Event\nIf Other, specify\nCRF History\n840005027 - Adverse Does this AE qualify as Serious? (If YES, complete SAE/AESI Form) Yes\nEvent\n840005027 - Adverse Complete the following fields ONLY if Adverse Event qualifies as either\nEvents Yes/No serious or as an event of special interest (AESI) per protocol. If AE\ndoes not meet criteria for either SAE or AESI then STOP here.\n840005027 - Concomitant\nMedications Yes/No FOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \n840005027 - Serious\nAdverse Event/AESI # 05 CHECK ALL THAT APPLY\n840005027 - Serious It resulted in death\nAdverse Event/AESI # 04\n840005027 - Serious It was life-threatening\nAdverse Event/AESI # 03\n840005027 - Serious\nIt required or prolonged inpatient hospitalization\nAdverse Event/AESI # 02\n840005027 - Serious\nPersistent or significant disability / incapacity\nAdverse Event/AESI # 01\n840002033 - Medical\nIt is a congenital anomaly/birth defect in offspring of study subject\nHistory Yes/No\n840002033 - Medical\nOther medically serious important event (It does not meet any of the\nHistory\nabove serious criteria, but may jeopardize the subject, and may require\n840002033 - Visit Date medical or surgical intervention to prevent one of the outcomes listed\nInformation above).\n840002033 - SAE / AESI\nIf Other, specify\n#1\n840009026 - Pregnancy\nTest Is this an AE of Special Interest (AESI)? (If YES, complete SAE/AESI Form) No\n840009026 - Visit Date\nInformation The AE fulfills the following AE of special interest (AESI)\n840008005 - Adverse CHECK ALL THAT APPLY\nEvent\n840008005 - Adverse Any AE that meets DLT criteria at any time while on treatment\nEvents Yes/No\n840008005 - SAE / AESI Grade 2 or greater Infusion-Related Reactions associated with study drug\n#2 infusions\n840008005 - SAE / AESI Grade 2 or greater pain syndrome temporally related to study drug infusion in\n#3 the opinion of the investigator\n840008005 - SAE / AESI\nGrade 2 or greater Cytokine Release Syndrome\n#1\n840008005 - Study Drug\nAdministration Grade 2 or greater allergic/hypersensitivity reactions\nAn irAE of any grade in a patient previously treated with a PI 3-K inhibitor\nClick Here for Customer Support Information Medidata Classic Rave® 2021.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(jpqerbl3sef2skigokfxw3om))/Modules/EDC/CRFPage.aspx?DP=100290614 3/4 9/27/2021 CRF\nPericardial effusions of any size\n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Agamdeep Saini (Safety)\nGrade ≥2 treatment-emergent pleural effusion (clinically significant new\neffuRsi4o0n1 a8n-Od/NorC a-1 c7li2n1ically 8si4g0n0if0ic5a -n tL ciuh a- nUgSeA in size8 4o0f 0a0n5 e0x2i7sting eAffDuVsiEonR)SE EVENTS Adverse Event\nADVERSE EVENTS Grade ≥2 Treatment-emergent ascites (clinically significant new ascite and/or\na clinically significant change in size of existing ascites)\nAdverse Events Yes/No\nNote: An irAE can occur shortly after the first dose or several months after\nAdverse Event\nthe last dose of treatment. All AEs of unknown etiology associated with drug\nexposure should be evaluated to determine possible immune etiology. If an\nirAE is suspected, efforts should be made to rule out neoplastic, infectious,\nCRF History\nmetabolic, toxin or other etiologic causes prior to labeling an AE as an irAE.\n840005027 - Adverse\nEvent Date Time 27 SEP 2021 01:55:43\n840005027 - Adverse\nEvents Yes/No  \nPrintable Version  View PDF   Icon Key\n840005027 - Concomitant Save   Cancel\nCRF Version 9443 - Page Generated: 27 Sep 2021 14:50:23 Eastern Daylight Time\nMedications Yes/No\n840005027 - Serious\nAdverse Event/AESI # 05\n840005027 - Serious\nAdverse Event/AESI # 04\n840005027 - Serious\nAdverse Event/AESI # 03\n840005027 - Serious\nAdverse Event/AESI # 02\n840005027 - Serious\nAdverse Event/AESI # 01\n840002033 - Medical\nHistory Yes/No\n840002033 - Medical\nHistory\n840002033 - Visit Date\nInformation\n840002033 - SAE / AESI\n#1\n840009026 - Pregnancy\nTest\n840009026 - Visit Date\nInformation\n840008005 - Adverse\nEvent\n840008005 - Adverse\nEvents Yes/No\n840008005 - SAE / AESI\n#2\n840008005 - SAE / AESI\n#3\n840008005 - SAE / AESI\n#1\n840008005 - Study Drug\nAdministration\nClick Here for Customer Support Information Medidata Classic Rave® 2021.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(jpqerbl3sef2skigokfxw3om))/Modules/EDC/CRFPage.aspx?DP=100290614 4/4 9/27/2021 CRF\n iMedidata   Messages   My Profile   Help   Home   Logout\nUser: Agamdeep Saini (Safety)\nR4018-ONC-1721 840005 - Liu - USA 840005027 SERIOUS ADVERSE EVENTS/AESI (1) Serious Adverse Event/AESI # 01\nSERIOUS ADVERSE Subject ID: 840005027\nEVENTS/AESI (1)\nSerious Adverse Subject: 840005027\nEvent/AESI # 01\nPage: Serious Adverse Event/AESI # 01 - SERIOUS ADVERSE EVENTS/AESI (1)\nSerious Adverse\nEvent/AESI # 02 AE number 1\nSerious Adverse\nEvent/AESI # 03 Adverse Event Description (Term) NAUSEA\nSerious Adverse    \nEvent/AESI # 04\nSOC 10017947Gastrointestinal disorders\nSerious Adverse HLGT10018012Gastrointestinal signs and symptoms\nEvent/AESI # 05 HLT 10028817Nausea and vomiting symptoms\nPT 10028813Nausea\nLLT 10028813Nausea\nCRF History\n840005027 - Serious Start Date (dd-mon-yyyy) 25 SEP 2021\nAdverse Event/AESI # 01\n840002033 - Medical RATIONALE FOR CAUSALITY ASSESSMENT\nHistory Yes/No\nSpecify the Rationale for Causality to REGN4018\n840002033 - Medical\nHistory\nSpecify Rationale for Causality to cemiplimab\n840002033 - Visit Date\nInformation\nSpecify the Rationale for Causality to Study Conduct\n840002033 - SAE / AESI\n#1\nSAE/AESI NARRATIVE\n840009026 - Pregnancy\nTest #  SAE/AESI Narrative Text\n840009026 - Visit Date ON 9/25/21, PATIENT 840005027 PRESENTED TO THE ED WITH G3 NAUSEA, G3 VOMITING, G2 DIARRHEA, AND G2 ABDOMINAL PAIN. CT SCAN REVEALED G2\nInformation GASTRIC OUTLET OBSTRUCTION. HEAD CT REVEALS SEVERAL AREAS OF BRAIN METS.\n1\nSHE IS ADMITTED FOR FURTHER EVALUATION AND WILL HAVE A CONSULT WITH RADIATION ONCOLOGY FOR TREATMENT OF NEWLY IDENTIFIED BRAIN\n840008005 - Adverse\nMETS. ALL ARE UNRELATED TO STUDY DRUG.\nEvent\n   \n840008005 - Adverse\nPrintable Version  View PDF   Icon Key\nEvents Yes/No Save   Cancel\nCRF Version 9443 - Page Generated: 27 Sep 2021 14:49:16 Eastern Daylight Time\n840008005 - SAE / AESI\n#2\n840008005 - SAE / AESI\n#3\n840008005 - SAE / AESI\n#1\n840008005 - Study Drug\nAdministration\n840009019 - Monotherapy\npatients – administration of\nREGN4018\n840005003 - Serious\nAdverse Event/AESI # 01\n840005026 - Medical\nHistory Yes/No\n840005026 - Medical\nHistory\n840005026 - Visit\n840003019 - Study\nCompletion/Discontinuation\nClick Here for Customer Support Information Medidata Classic Rave® 2021.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(jpqerbl3sef2skigokfxw3om))/Modules/EDC/CRFPage.aspx?DP=100290677 1/1']
apiLogger::2021-10-05 11:21:43,906::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 11:21:43,907::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 11:21:44,796::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 11:21:44,797::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 11:21:44,797::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp864dufo4 
apiLogger::2021-10-05 11:21:44,798::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 11:21:44,798::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 11:21:44,803::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 11:21:44,803::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp864dufo4
apiLogger::2021-10-05 11:21:44,815::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 11:21:44,815::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 11:21:44,815::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 11:21:44,815::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 11:21:44,819::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:21:44,820::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 11:21:44,820::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 11:21:44,820::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 05-Oct-2021 11:19:59 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 2 Syneos\n ']
apiLogger::2021-10-05 11:21:44,820::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 11:21:44,820::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 11:23:18,738::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 11:23:18,746::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 11:23:18,747::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpuyq9ud8v 
apiLogger::2021-10-05 11:23:18,747::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 11:23:18,747::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 11:23:18,856::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 11:23:18,856::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpuyq9ud8v
apiLogger::2021-10-05 11:23:19,664::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 11:23:19,664::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 11:23:19,664::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 11:23:19,664::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 11:23:19,669::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:23:19,669::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 11:23:19,669::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 11:23:19,669::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 11:23:19,673::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:23:19,673::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 11:23:19,673::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 11:23:19,673::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 11:23:19,677::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:23:19,677::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 11:23:19,677::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 11:23:19,677::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 11:23:19,681::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:23:19,681::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 11:23:19,681::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 11:23:19,681::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 11:23:19,685::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:23:19,685::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 11:23:19,685::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 11:23:19,685::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Thursday, April 15, 2021 12:33 PM\nTo: .STUDY-PVSS-DL-0456-0145-Unblinded; .STUDY-DM-DL-0456-0145-DM\nSubject: [EXTERNAL] ATTENTION! A SAE has been entered from Study R2810-ONC-16111. \nPlease review ASAP at https://protect-eu.mimecast.com/s/M_vbC7L8RCA1Wq81H8TvXl?\ndomain=login.imedidata.com\nAn SAE of ENTEROCOLITIS has been reported for Subject Number 840024005 with Start Date (dd-mon-yyyy) : \n13 APR 2021  with AE suspected to be caused by REGN2810? : NOT APPLICABLE  and It required or prolonged \ninpatient hospitalization : CHECKED  with If Other, specify : BLANK \n \nWWRD (GMT): 15 Apr 2021 17:32:21 \n \n1 Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Thursday, April 15, 2021 12:37 PM\nTo: .STUDY-PVSS-DL-0456-0145-Unblinded; .STUDY-DM-DL-0456-0145-DM\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16111. Please review ASAP at https://protect-\neu.mimecast.com/s/NAlzCvoq1S7zyGMKSQQtap?domain=login.imedidata.com\n \nIs this an AE of Special interest (AESI)?  (If YES, complete SAE/AESI Form) :  has been updated from BLANK to \nNO,  for SAE ENTEROCOLITIS for Subject Number 840024005 WWRD (GMT): 15 Apr 2021 17:36:25 \n \n1 Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Thursday, April 15, 2021 12:43 PM\nTo: .STUDY-PVSS-DL-0456-0145-Unblinded; .STUDY-DM-DL-0456-0145-DM\nSubject: [EXTERNAL] ATTENTION! A Serious AE has been updated from Study R2810-\nONC-16111. Please review ASAP at https://protect-\neu.mimecast.com/s/Hhn3CVPpRHxoPDGQtGv-k1?domain=login.imedidata.com\n \nAction taken with REGN2810 :  has been updated from NOT APPLICABLE to BLANK,  for SAE ENTEROCOLITIS \nfor Subject Number 840024005 WWRD (GMT): 15 Apr 2021 17:41:57 \n \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16111\nICON Study code 0456/0145\nenvironmentName Prod\nSite 840024- Pinellas Hematology and Oncology\nSubject details\nSubject Number 5\nSubject ID 840024005\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nstudy? Yes\nDate Subject Signed the First Informed\nConsent (dd-mon-yyyy) 31 OCT 2018\nHas the subject consented to\nparticipate in the genomics sub study? Yes\nDate of Genomics Consent (dd-mon-yyyy) 31 OCT 2018\nInformed Consent Version Version 1\nDemographic details\nDate of Birth (dd-mon-yyyy) 1958\nAge 59\nSex Female\nRace (choose only one primary race) White\n If Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 42\nNumber of Cigarettes Per Day 15\nR2810-ONC-16111_SAE Report_11-JUN-2018 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking\nInformed\nDate subject Consent\nProtocol IRB signed Informed Approval Date\nProtocol version Approval Date Consent (dd- from IRB (dd-\nRecordPosition (Global) (dd-mon-yyyy) mon-yyyy) Consent Type mon-yyyy)\nR2810-ONC-16111_SAE Report_11-JUN-2018']
apiLogger::2021-10-05 11:23:19,685::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 11:23:19,685::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 11:23:20,029::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 11:23:20,030::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 11:23:20,030::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpkhopipzh 
apiLogger::2021-10-05 11:23:20,030::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 11:23:20,030::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 11:23:20,035::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 11:23:20,035::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpkhopipzh
apiLogger::2021-10-05 11:23:20,047::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 11:23:20,047::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 11:23:20,047::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 11:23:20,047::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 11:23:20,051::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:23:20,052::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 11:23:20,052::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 11:23:20,052::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 05-Oct-2021 11:21:27 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 2 b\n ']
apiLogger::2021-10-05 11:23:20,052::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 11:23:20,052::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 11:33:18,731::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 11:33:18,736::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 11:33:18,736::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp9fht5duw 
apiLogger::2021-10-05 11:33:18,737::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 11:33:18,737::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 11:33:18,808::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 11:33:18,808::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp9fht5duw
apiLogger::2021-10-05 11:33:19,231::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 11:33:19,231::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 11:33:19,231::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 11:33:19,231::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 11:33:19,235::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:33:19,236::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 11:33:19,236::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 11:33:19,236::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 11:33:19,240::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:33:19,240::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 11:33:19,240::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 11:33:19,240::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 11:33:19,244::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:33:19,244::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 11:33:19,244::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 11:33:19,244::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 11:33:19,248::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:33:19,248::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 11:33:19,248::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 11:33:19,248::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 11:33:19,252::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:33:19,252::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 11:33:19,252::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 11:33:19,252::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', "Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 10 September 2021 18:38\nTo: .STUDY-PVSS-DL-0456-0300; .STUDY-DM-DL-0456-0300-DM-Blinded\nSubject: [EXTERNAL] SAE from Study R668-ABPA-1923\nFollow Up Flag: Follow up\nFlag Status: Flagged\nCategories: Red Category\nAn SAE of LOWER RESPIRATORY TRACK INFECTION has been reported for Subject Number 348002001 with Relationship \nto investigational product : NOT RELATED and Required or prolongs hospitalization : CHECKED \n \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R668-ABPA-1923\nIcon Study Code 0456/0300\nEnvironment Prod\nSite Name 348002- Semmelweis Egyetem\nSubject Details\nSubject Name 348002001\nDemographic Details\nYear of Birth 1980\nAge 41\nSex Male\nEthnicity Not Hispanic or Latino\nRace White\nIf Other, specify\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent Details\nInformed Consent/Assent1\nProtocol version in effect at\nDate Informed consent/ Did the child's parents sign\ntime of informed consent/\nassent signed and date informed consent?\nassent\n02 SEP 2021 Amendment 2 Not applicable\nInformed Consent\nDate of Informed Consent\nProtocol Reconsented to\nFirst Visit Performed Under Adult\nConsent\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nSubject Eligibility Details\nIs the subject eligible to participate\nin this study?\nIf No, provide the date the subject\nscreen failed\nIf the subject was not eligible, please\nprovide primary reason\nIf reason is Adverse Event, specify\nthe AE line number\nIf reason is Sponsor Request,\nspecify\nIf reason is Subject Decision, specify\nIf reason is Death, enter date of\nDeath\nIf reason is Other, specify\nSpecify the criteria Criteria Number Comment\nProgrammatic SAE/AESI Output Report_13-SEP-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History\nMedical History Details\nDoes subject have any Medical\nHistory?\nHas the subject been currently\nsmoking, vaping or chewing tobacco\nor cessation of any of these within 6\nmonths prior to screening?\nDoes subject have a >10 Pack-\nyears smoking history?\nDisorder/Diagnosis Start Date Ongoing End date\nProgrammatic SAE/AESI Output Report_13-SEP-2021"]
apiLogger::2021-10-05 11:33:19,252::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 11:33:19,252::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 11:33:19,548::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 11:33:19,549::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 11:33:19,549::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmppr15ywte 
apiLogger::2021-10-05 11:33:19,549::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 11:33:19,550::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 11:33:19,554::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 11:33:19,555::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmppr15ywte
apiLogger::2021-10-05 11:33:19,566::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 11:33:19,566::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 11:33:19,566::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 11:33:19,566::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 11:33:19,571::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:33:19,571::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 11:33:19,571::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 11:33:19,571::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 05-Oct-2021 11:33:11 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 2 c\n ']
apiLogger::2021-10-05 11:33:19,571::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 11:33:19,571::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 11:37:19,040::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 11:37:19,047::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 11:37:19,047::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp2vio8tis 
apiLogger::2021-10-05 11:37:19,048::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 11:37:19,048::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 11:37:19,053::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 11:37:19,053::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp2vio8tis
apiLogger::2021-10-05 11:37:19,842::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 11:37:19,843::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 11:37:19,843::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 11:37:19,843::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 11:37:19,847::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:37:19,848::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 11:37:19,848::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 11:37:19,848::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 11:37:19,852::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:37:19,852::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 11:37:19,852::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 11:37:19,852::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 11:37:19,856::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:37:19,856::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 11:37:19,856::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 11:37:19,856::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 11:37:19,860::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:37:19,860::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 11:37:19,861::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 11:37:19,861::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 11:37:19,864::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-05 11:37:19,865::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 11:37:19,865::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 11:37:19,865::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 4
apiLogger::2021-10-05 11:37:19,865::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036019-Calvary Mater Newcastle\nEnvironment Prod\nSubject Details\nStudy Site Number 36,019\nPatient ID 36,019,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1937\nAge 83\nSex Female\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential? No\nIf No, please specify reason: Post-menopausal status\nRandomization Details\nRandomization Date 8/SEP/2020\nR2810-ONC-1788_SAE REPORT_08-JAN-2021']
apiLogger::2021-10-05 11:37:19,865::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 11:37:19,865::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-05 11:37:19,865::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 11:37:19,865::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 11:37:19,865::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 11:37:38,266::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 11:37:38,266::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 11:37:38,358::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 11:37:38,377::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 11:37:38,377::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp3clai79n 
apiLogger::2021-10-05 11:37:38,379::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 11:37:38,379::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 11:37:38,556::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 11:37:38,556::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp3clai79n
apiLogger::2021-10-05 11:37:39,672::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 11:37:39,672::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 11:37:39,672::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 11:37:39,672::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 11:37:39,677::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-05 11:37:39,677::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 11:37:39,677::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 11:37:39,677::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 11:37:39,677::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2020-00310 GSPV Date of Receipt 06 OCT 2020 AN 20 pages \nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 616003 - Walewski - Poland\nSite Number 1625616003\nSubject ID: 616003004\nScreening Date 10 SEP 2020 REG-2020-00310 GSPV Date of Receipt 06 OCT 2020 AN 20 pages \nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 09 SEP 2020 Main consent 04 FEB 2020 09 SEP 2020\nAmendment 1 EU\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n616003004 1945 75 Female White -\nor Latino\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) REG-2020-00310 GSPV Date of Receipt 06 OCT 2020 AN 20 pages \nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 DIABETES MELLITUS UN UNK 2008   Ongoing Not Available - -\n2 HYPOTHYREOSIS UN UNK 1994   Ongoing Not Available - -\nHYPERTENSION\n3   Ongoing Not Available - -\nARTERIALIS\n4 HEPATITIS B   Resolved Not Available -   REG-2020-00310 GSPV Date of Receipt 06 OCT 2020 AN 20 pages \nConcomitant Medication\nIf Indication is\nIf Indication is\nadverse event,\nmedical history,\nIf Prophylaxis Or Please select the\n# Drug Name Indication Please select the Dose Dose Unit Other, specify Frequency\nOther, specify appropriate\nappropriate Medical\nAdverse Event\nHistory record.\nrecord.\n2_HYPOTHYREOSI\n1 EUTHYROX Medical History - - 125  mg - Continuous\nS_UN UNK 1994\n1_DIABETES\n2 METFORMINA Medical History - MELLITUS_UN UNK - 850 mg - TID\n2008\n1_DIABETES\n3 APIDRA SOLOSTAR Medical History - MELLITUS_UN UNK - 8 Other UNIT BID\n2008\n1_DIABETES\n4 ABASAGLAR Medical History - MELLITUS_UN UNK - 14 Other UNIT Other\n2008\n3_HYPERTENSION\n5 VIVACE Medical History - - 5 mg - Other\nARTERIALIS_UNK\n3_HYPERTENSION\n6 DIURESIN SR Medical History - - 1.5 mg - Other\nARTERIALIS_UNK\n1_DIABETES\n7 CROSUVO Medical History - MELLITUS_UN UNK - 5 mg - Other\n2008\n1_DIABETES\n8 GROFIBRAT Medical History - MELLITUS_UN UNK - 100 mg - Other\n2008 REG-2020-00310 GSPV Date of Receipt 06 OCT 2020 AN 20 pages \nStart date (dd-mon- Stop date (dd-mon-\nFrequency If Other Specify Route If Other, specify Start Date Unk Ongoing\nyyyy) yyyy)\nContinuous - Oral - UN UNK 1994 - -  \nTID - Oral -   -  \nBID - Subcutaneous -   -  \nOther ONCE A DAY Subcutaneous -   -  \nOther ONCE A DAY Oral -   -  \nOther ONCE A DAY Oral -   -  \nOther ONCE A DAY Oral -   -  \nOther ONCE A DAY Oral -   -  ']
apiLogger::2021-10-05 11:37:39,677::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 11:37:39,677::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-05 11:37:39,677::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 11:37:39,677::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 11:37:39,677::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 11:37:51,791::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 11:37:51,791::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 11:37:51,876::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 11:37:51,883::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 11:37:51,884::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpw3dx31jt 
apiLogger::2021-10-05 11:37:51,884::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 11:37:51,884::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 11:37:51,890::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 11:37:51,890::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpw3dx31jt
apiLogger::2021-10-05 11:37:52,375::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 11:37:52,376::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 11:37:52,376::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 11:37:52,376::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 11:37:52,380::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:37:52,381::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 11:37:52,381::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 11:37:52,381::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 11:37:52,385::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:37:52,385::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 11:37:52,385::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 11:37:52,385::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 11:37:52,389::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:37:52,389::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 11:37:52,389::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 11:37:52,389::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 11:37:52,393::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:37:52,393::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 11:37:52,393::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 11:37:52,393::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 11:37:52,397::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:37:52,397::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 11:37:52,397::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 11:37:52,397::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Message Subject : External R2810-ONC-1788_Initial_036018003_Sepsis\nReceived Time : Tue Aug 24 20:02:32 EDT 2021\nSender Address : STUDY-PVSS-0456-0232@iconplc.com\nTo Address : Medical Safety - Contact (EXTERNAL)\n[Medical.Safety@regeneron.com]; [quasheeda.fields@regeneron.com];\n[emmanuel.okoye@regeneron.com]; [simon.eng@regeneron.com]; Hyunsil Han\nRegeneron (EXTERNAL) [hyunsil.han@regeneron.com];Matthew Fury - Regeneron\n(EXTERNAL) [matthew.fury@regeneron.com];Diana Horton - Regeneron\n(EXTERNAL) [diana.horton@regeneron.com]; Fionnuala Gallagher - Regeneron\n(EXTERNAL) [fionnuala.gallagher@regeneron.com];\n[Lukasz.Kubarek@iconplc.com];Ait Yakoub, Tassadit\n[Tassadit.AitYakoub@iconplc.com]; [laurel.monismith@regeneron.com];Priscila\nGoncalves - Regeneron (EXTERNAL) [priscila.goncalves@regeneron.com];\nCc Address : .STUDY-PVSS-DL-0456-0232 [STUDY-PVSS-DL-0456-\n0232@iconplc.com]; Breier, Ana [Ana.Breier@iconplc.com];\nNo. of Attachments : 1\nR2810-ONC-1788_036018003_Initial_SAE Package_Sepsis_23Aug2021.pdf\nMessage content follows :\nEXTERNAL MESSAGE\nDear All,\n \nPlease find enclosed the InitialSAE Package for above named event of patient 036018003, received on\n23Aug2021, applicable for study R810-ONC-1788 (ICON # 0456-0232).\n \n \nR2810-ONC-1788\nProtocol: \nSite # / Investigator: 036018\nSubject #: 003\nSAE Term: Sepsis\nOnset Date: 23Aug2021\nSAE Criteria Hospitalization\nRelationship to study drug: Not Related Country: Australia\nPI Name and mail address: Palmieri, David J.      dpalmieri@riverinacancercare.com.au\nDay 0 23Aug2021\n \n \n \nKind Regards !\n \nLucia Flores\nDrug Safety Associate\nICON Clinical Research\nInternal Tel: 7240 4787\nExternal Tel: +52 55 5063 4787\nEmail: Lucia.Flores@iconplc.com\nWeb: www.iconplc.com\nICON plc made the following annotations.\n------------------------------------------------------------------------------\nThis e-mail transmission may contain confidential or legally privileged information\nthat is intended only for the individual or entity named in the e-mail address. If you are\nnot the intended recipient, you are hereby notified that any disclosure, copying,\ndistribution, or reliance upon the contents of this e-mail is strictly prohibited. If you\nhave received this e-mail transmission in error, please reply to the sender, so that\nICON plc can arrange for proper delivery, and then please delete the message.\nThank You,\nICON plc\nSouth County Business Park\nLeopardstown Dublin 18\nIreland\nRegistered number: 145835 Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Monday, August 23, 2021 8:33 PM\nTo: .ICR - Biometrics - DM - Global - CDMS RAVE EmailAlerts; .STUDY-PVSS-DL-0456-0232; \n.STUDY-DM-DL-0456-0232-DM-Unblinded\nSubject: [EXTERNAL] ATTENTION! A SAE has been entered from Study R2810-ONC-1788. Please \nreview ASAP at https://protect-eu.mimecast.com/s/SqqBCmQR5CjXOXYWUGuJ9e?\ndomain=login.imedidata.com\nAn SAE of SEPSIS has been reported for Subject Number 036018003 \n \n1 Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Tuesday, August 24, 2021 3:29 PM\nTo: .ICR - Biometrics - DM - Global - CDMS RAVE EmailAlerts; .STUDY-PVSS-DL-0456-0232; \n.STUDY-DM-DL-0456-0232-DM-Unblinded\nSubject: [EXTERNAL] ATTENTION! A SAE has been entered from Study R2810-ONC-1788. Please \nreview ASAP at https://protect-eu.mimecast.com/s/8LCBC7L8RCAJxgYlH8fMLC?\ndomain=login.imedidata.com\nAn SAE of SEPSIS has been reported for Subject Number 036018003 \n \n1']
apiLogger::2021-10-05 11:37:52,397::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 11:37:52,397::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 11:37:52,717::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 11:37:52,718::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 11:37:52,718::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpr9y39uuy 
apiLogger::2021-10-05 11:37:52,718::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 11:37:52,718::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 11:37:52,723::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 11:37:52,723::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpr9y39uuy
apiLogger::2021-10-05 11:37:52,735::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 11:37:52,735::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 11:37:52,735::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 11:37:52,735::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 11:37:52,739::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:37:52,739::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 11:37:52,740::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 11:37:52,740::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 05-Oct-2021 11:35:51 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 4\n ']
apiLogger::2021-10-05 11:37:52,740::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 11:37:52,740::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 11:43:47,505::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 11:43:47,514::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 11:43:47,514::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmphexonv4a 
apiLogger::2021-10-05 11:43:47,515::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 11:43:47,515::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 11:43:47,520::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 11:43:47,520::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmphexonv4a
apiLogger::2021-10-05 11:43:47,999::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 11:43:47,999::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 11:43:47,999::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 11:43:47,999::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 11:43:48,004::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:43:48,004::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 11:43:48,004::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 11:43:48,004::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 11:43:48,009::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:43:48,009::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 11:43:48,009::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 11:43:48,009::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 11:43:48,013::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:43:48,013::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 11:43:48,013::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 11:43:48,013::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 11:43:48,017::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:43:48,017::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 11:43:48,017::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 11:43:48,017::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 11:43:48,021::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 11:43:48,021::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 11:43:48,021::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 11:43:48,021::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Message Subject : External R2810-ONC-1788_Initial_036018003_Sepsis\nReceived Time : Tue Aug 24 20:02:32 EDT 2021\nSender Address : STUDY-PVSS-0456-0232@iconplc.com\nTo Address : Medical Safety - Contact (EXTERNAL)\n[Medical.Safety@regeneron.com]; [quasheeda.fields@regeneron.com];\n[emmanuel.okoye@regeneron.com]; [simon.eng@regeneron.com]; Hyunsil Han\nRegeneron (EXTERNAL) [hyunsil.han@regeneron.com];Matthew Fury - Regeneron\n(EXTERNAL) [matthew.fury@regeneron.com];Diana Horton - Regeneron\n(EXTERNAL) [diana.horton@regeneron.com]; Fionnuala Gallagher - Regeneron\n(EXTERNAL) [fionnuala.gallagher@regeneron.com];\n[Lukasz.Kubarek@iconplc.com];Ait Yakoub, Tassadit\n[Tassadit.AitYakoub@iconplc.com]; [laurel.monismith@regeneron.com];Priscila\nGoncalves - Regeneron (EXTERNAL) [priscila.goncalves@regeneron.com];\nCc Address : .STUDY-PVSS-DL-0456-0232 [STUDY-PVSS-DL-0456-\n0232@iconplc.com]; Breier, Ana [Ana.Breier@iconplc.com];\nNo. of Attachments : 1\nR2810-ONC-1788_036018003_Initial_SAE Package_Sepsis_23Aug2021.pdf\nMessage content follows :\nEXTERNAL MESSAGE\nDear All,\n \nPlease find enclosed the InitialSAE Package for above named event of patient 036018003, received on\n23Aug2021, applicable for study R810-ONC-1788 (ICON # 0456-0232).\n \n \nR2810-ONC-1788\nProtocol: \nSite # / Investigator: 036018\nSubject #: 003\nSAE Term: Sepsis\nOnset Date: 23Aug2021\nSAE Criteria Hospitalization\nRelationship to study drug: Not Related Country: Australia\nPI Name and mail address: Palmieri, David J.      dpalmieri@riverinacancercare.com.au\nDay 0 23Aug2021\n \n \n \nKind Regards !\n \nLucia Flores\nDrug Safety Associate\nICON Clinical Research\nInternal Tel: 7240 4787\nExternal Tel: +52 55 5063 4787\nEmail: Lucia.Flores@iconplc.com\nWeb: www.iconplc.com\nICON plc made the following annotations.\n------------------------------------------------------------------------------\nThis e-mail transmission may contain confidential or legally privileged information\nthat is intended only for the individual or entity named in the e-mail address. If you are\nnot the intended recipient, you are hereby notified that any disclosure, copying,\ndistribution, or reliance upon the contents of this e-mail is strictly prohibited. If you\nhave received this e-mail transmission in error, please reply to the sender, so that\nICON plc can arrange for proper delivery, and then please delete the message.\nThank You,\nICON plc\nSouth County Business Park\nLeopardstown Dublin 18\nIreland\nRegistered number: 145835 Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Monday, August 23, 2021 8:33 PM\nTo: .ICR - Biometrics - DM - Global - CDMS RAVE EmailAlerts; .STUDY-PVSS-DL-0456-0232; \n.STUDY-DM-DL-0456-0232-DM-Unblinded\nSubject: [EXTERNAL] ATTENTION! A SAE has been entered from Study R2810-ONC-1788. Please \nreview ASAP at https://protect-eu.mimecast.com/s/SqqBCmQR5CjXOXYWUGuJ9e?\ndomain=login.imedidata.com\nAn SAE of SEPSIS has been reported for Subject Number 036018003 \n \n1 Flores, Lucia\nFrom: noreply@mdsol.com\nSent: Tuesday, August 24, 2021 3:29 PM\nTo: .ICR - Biometrics - DM - Global - CDMS RAVE EmailAlerts; .STUDY-PVSS-DL-0456-0232; \n.STUDY-DM-DL-0456-0232-DM-Unblinded\nSubject: [EXTERNAL] ATTENTION! A SAE has been entered from Study R2810-ONC-1788. Please \nreview ASAP at https://protect-eu.mimecast.com/s/8LCBC7L8RCAJxgYlH8fMLC?\ndomain=login.imedidata.com\nAn SAE of SEPSIS has been reported for Subject Number 036018003 \n \n1']
apiLogger::2021-10-05 11:43:48,021::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 11:43:48,021::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 12:01:18,725::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 12:01:18,731::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 12:01:18,732::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpox498ak9 
apiLogger::2021-10-05 12:01:18,732::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 12:01:18,732::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 12:01:18,737::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 12:01:18,738::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpox498ak9
apiLogger::2021-10-05 12:01:19,511::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 12:01:19,511::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 12:01:19,511::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 12:01:19,511::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 12:01:19,516::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 12:01:19,516::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 12:01:19,516::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 12:01:19,516::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 12:01:19,520::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 12:01:19,520::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 12:01:19,520::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 12:01:19,520::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 12:01:19,524::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 12:01:19,524::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 12:01:19,524::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 12:01:19,524::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 12:01:19,528::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 12:01:19,528::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 12:01:19,528::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 12:01:19,528::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 12:01:19,532::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-10-05 12:01:19,532::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 12:01:19,532::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 12:01:19,532::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 4
apiLogger::2021-10-05 12:01:19,532::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036019-Calvary Mater Newcastle\nEnvironment Prod\nSubject Details\nStudy Site Number 36,019\nPatient ID 36,019,003\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1937\nAge 83\nSex Female\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential? No\nIf No, please specify reason: Post-menopausal status\nRandomization Details\nRandomization Date 8/SEP/2020\nR2810-ONC-1788_SAE REPORT_08-JAN-2021']
apiLogger::2021-10-05 12:01:19,532::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 12:01:19,532::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-10-05 12:01:19,532::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 12:01:19,533::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 12:01:19,533::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 12:01:37,942::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 12:01:37,942::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 12:59:18,877::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 12:59:18,878::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 12:59:18,879::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpoxeu_grm 
apiLogger::2021-10-05 12:59:18,879::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 12:59:18,879::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 12:59:18,885::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 12:59:18,885::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpoxeu_grm
apiLogger::2021-10-05 12:59:18,931::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 12:59:18,931::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 12:59:18,931::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 12:59:18,931::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 12:59:18,936::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 12:59:18,936::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 12:59:18,936::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 12:59:18,937::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 05-Oct-2021 12:58:05 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Evkeeza Event \nFrom: Leah Fenley <leah.fenley@regeneron.com> Sent: Friday, September 3, 2021 5:03 PM To:\nRegeneron Medical Safety <Medical.Safety@regeneron.com> Cc: robert.rosenson@mssm.edu\nSubject: Evkeeza Event \n \nGood Afternoon, \n \nPlease see below for a note from Bob Rosenson cc’d. Reach out to him with further questions. \n \n“We had a patient with a large increase in blood pressure with the infusion. Subsequently, she had\na punctate retinal bleed. \nCan the medication be administered in half normal saline?” \n \nThank you, \n \nLeah Fenley | Manager, CMC Program Management REGENERON | 1 Global View, Troy NY 12180\nUSA Office: +1.518.407-8749| Mobile: +1.518.248-8906\n ']
apiLogger::2021-10-05 12:59:18,937::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 12:59:18,937::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 13:23:18,982::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 13:23:19,080::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 13:23:19,081::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp72uqh_yo 
apiLogger::2021-10-05 13:23:19,085::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 13:23:19,085::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 13:23:19,791::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 13:23:19,791::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp72uqh_yo
apiLogger::2021-10-05 13:23:20,733::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 13:23:20,733::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 13:23:20,733::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 13:23:20,733::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 13:23:20,738::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-05 13:23:20,738::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 13:23:20,738::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 13:23:20,738::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 13:23:20,738::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012005\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021']
apiLogger::2021-10-05 13:23:20,738::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 13:23:20,738::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-05 13:23:20,738::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 13:23:20,738::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 13:23:20,738::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 13:23:53,874::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 13:23:53,874::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 14:01:18,782::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 14:01:18,786::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 14:01:18,786::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp0dkbns29 
apiLogger::2021-10-05 14:01:18,786::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 14:01:18,787::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 14:01:18,818::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 14:01:18,818::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp0dkbns29
apiLogger::2021-10-05 14:01:19,387::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 14:01:19,387::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 14:01:19,387::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 14:01:19,387::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 14:01:19,393::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 14:01:19,393::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 14:01:19,393::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 14:01:19,393::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 14:01:19,397::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 14:01:19,397::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 14:01:19,397::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 14:01:19,397::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 2\nCase ID: REGEMC-88286 (v.1)\nA. GENERAL INFORMATION\nCase Number: REGEMC-88286 Report Version: 1\nEVERSANA Received Date: 08-Jul-2021 12:35, Version 1 Source: Fax\nEVERSANA Staff: Edwyn Lee, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB. CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Kurtis McGee Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 180-048-62668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC. ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter:    \nReceived date: : 08-Jul-2021, Version 1\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD. ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction: \nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nE. PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 2\nCase ID: REGEMC-88286 (v.1)\nF. SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial  \nF. CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nF. HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nG. OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH. RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES \nI. PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\n \n \nVersion 16Nov2020']
apiLogger::2021-10-05 14:01:19,397::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 14:01:19,397::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 14:01:19,737::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 14:01:19,738::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 14:01:19,738::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpdc7dk15p 
apiLogger::2021-10-05 14:01:19,738::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 14:01:19,738::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 14:01:19,743::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 14:01:19,743::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpdc7dk15p
apiLogger::2021-10-05 14:01:19,755::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 14:01:19,755::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 14:01:19,755::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 14:01:19,755::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 14:01:19,759::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 14:01:19,760::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 14:01:19,760::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 14:01:19,760::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 05-Oct-2021 14:00:28 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Initial\n ']
apiLogger::2021-10-05 14:01:19,760::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 14:01:19,760::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 14:11:18,742::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 14:11:18,745::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 14:11:18,745::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpazq70klp 
apiLogger::2021-10-05 14:11:18,746::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 14:11:18,746::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 14:11:18,779::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 14:11:18,779::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpazq70klp
apiLogger::2021-10-05 14:11:19,388::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 14:11:19,388::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 14:11:19,388::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 14:11:19,388::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 14:11:19,393::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 14:11:19,393::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 14:11:19,393::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 14:11:19,393::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 14:11:19,397::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 14:11:19,398::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 14:11:19,398::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 14:11:19,398::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 14:11:19,402::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 14:11:19,402::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 14:11:19,402::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 14:11:19,402::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', "Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 3\nCase ID: REGEMC-88286 (v.2)\nA. GENERAL INFORMATION\nCase Number: REGEMC-88286 Report Version: 2\nEVERSANA Received Date: 16-Sep-2021 04:42, Version 2 Source: Fax\nEVERSANA Staff: Edwyn Lee, PharmD Attachments Included: Other\nReference ID #: Per Source Doc: 37743184\nB. CONTACT/REPORTER INFORMATION\nReporter Name: Mr. Kurtis McGee Reporter Type: Other Health Professional\nTitle:\nAddress: Humana Specialty Pharmacy Phone: 180-048-62668\n111 Merchant Street Other Phone:\n Springdale, OH 45246 Fax:\nUNITED STATES Email:\nPrimary Reporter:  Yes     No\nC. ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter:    \nReceived date: : 16-Sep-2021, Version 2\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nD. ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction: \nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 8-Jul-2021, Regeneron Medical Information received an event report via fax from Humana Specialty Pharmacy.\nPer the source document:\npt reports redness and bleeding in eye after an injection of eylea.\nPlease refer to the enclosed source document for additional information. \nNo further information was available at the time of this report.\nVersion 2 (16-Sep-2021, ELee): Information regarding this event was provided by the physician's office to Medical Information via fax on 16-Sep-\n2021.  Please refer to the source document for additional information.  No additional information was provided at the time of this report.\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 3\nCase ID: REGEMC-88286 (v.2)\nE. PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nDB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nF. SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea Vial  \nF. CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nF. HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nG. OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH. RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES \nI. PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\n \n \nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 3\nCase ID: REGEMC-88286 (v.2)\nVersion 16Nov2020"]
apiLogger::2021-10-05 14:11:19,402::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 14:11:19,402::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 14:11:19,719::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 14:11:19,720::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 14:11:19,720::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp192cnzis 
apiLogger::2021-10-05 14:11:19,721::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 14:11:19,721::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 14:11:19,726::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 14:11:19,726::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp192cnzis
apiLogger::2021-10-05 14:11:19,737::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 14:11:19,738::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 14:11:19,738::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 14:11:19,738::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 14:11:19,742::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 14:11:19,742::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 14:11:19,742::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 14:11:19,742::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Reshabh Reshabh-External <reshabh.reshabh@regeneron.com>\nReceived Date : 05-Oct-2021 14:11:10 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : follow up\n ']
apiLogger::2021-10-05 14:11:19,742::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 14:11:19,742::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 16:15:18,649::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 16:15:18,650::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 16:15:18,650::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpuedvmblz 
apiLogger::2021-10-05 16:15:18,650::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 16:15:18,650::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 16:15:18,674::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 16:15:18,674::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpuedvmblz
apiLogger::2021-10-05 16:15:18,987::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 16:15:18,987::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 16:15:18,987::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 16:15:18,987::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 16:15:18,991::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-05 16:15:18,992::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 16:15:18,992::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 16:15:18,992::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 16:15:18,992::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site bruising]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n10-JUN-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n16-JUN-2021\xa0\nINITIAL FOLLOWUP:\n16-Jun-2021 07:52 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n16-Jun-2021 07:52']
apiLogger::2021-10-05 16:15:18,992::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 16:15:18,992::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-05 16:15:18,992::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 16:15:18,992::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 16:15:18,992::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 16:15:27,553::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 16:15:27,553::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 18:41:18,713::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 18:41:18,715::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 18:41:18,715::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp2aypnb9n 
apiLogger::2021-10-05 18:41:18,716::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 18:41:18,716::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 18:41:18,719::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 18:41:18,719::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp2aypnb9n
apiLogger::2021-10-05 18:41:19,593::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 18:41:19,593::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 18:41:19,593::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 18:41:19,593::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 18:41:19,598::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_2
apiLogger::2021-10-05 18:41:19,598::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 18:41:19,598::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 18:41:19,598::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 18:41:19,598::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_2', 'generic', "CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\n Mfr. Control No. :ES-RPL-21-00054(0)\nI.REACTION INFORMATION\n1.PATIENT INITIALS 1a.COUNTRY 2.DATE OF BIRTH 2a. AGE 3. SEX 4-6 REACTION ONSET 8-12 CHECK ALL\n(first, last) ES Day Month Year Years Day Month Year APPROPRIATE\nTO ADVERSE\n1940 81       M      21 JUN 2021 REACTION\n7+13 DESCRIBE REACTION(S) (including relevant tests/lab data)\n   PATIENT DIED\nTUMOR PAIN (Tumour pain) [v.24.0]\nX  INVOLVED OR\nPROLONGED INPATIENT\nCase reference number ES-RPL-21-00054 is a clinical trial case initially received HOSPITALIZATION\nfrom Spain on 22-Jun-2021, referring to a 81-year old White male subject with     INVOLVED PERSISTENCE OR\ncutaneous squamous cell carcinoma (CSCC) who experienced tumour pain. The subject SIGNIFICANT DISABILITY OR\n102-3407-0001, was enrolled in RPL-002-18: A randomized, controlled, Open-Label,  INCAPACITY\nPhase 2 Study of Cemiplimab as Single Agent in Combination with RP1 in Patients \nwith advanced cutaneous squamous cell carcinoma.     LIFE THREATENING\nBesides advanced cutaneous squamous cell carcinoma, the subject had relevant \nmedical history of previous hospitalization for tumour pain, from 01-Jun-2021 to     CONGENITAL ANOMALY\n07-Jun-2021 (see case ES-RPL-21-00044) and auricular fibrillation (see case \nES-RPL-21-00044). The subject's concomitant medications included oral Sevredol \n(morphine sulphate), 10 mg as needed, since 26-May-2021 for tumour pain; oral     OTHER MEDICALLY IMPORTANT \ngabapentin, 400 mg daily, since 26-May-2021 for tumour pain (taken for  CONDITION\nES-RPL-21-00044); subcutaneous Hibor (bemiparin sodium), 7500 international units\nCont...\nII.SUSPECT DRUG(S) INFORMATION\n14. SUSPECT DRUG(S) (include generic name) Treatment Unblinded : Yes 20.DID REACTION ABATE\nAFTER STOPPING DRUG?\ncemiplimab(cemiplimab)(cemiplimab),8241400105\n      X \nYES NO NA\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION 21.DID REACTION\n350 mg (350 mg,1 in 3 wk) Intravenous (not otherwise specified) REAPPEAR AFTER\nREINTRODUCTION?\n17. INDICATION(S) FOR USE\nSquamous cell carcinoma [v.24.0]\n       X\nYES NO NA\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n26/MAY/2021 - 15/JUN/2021 20 Days\nIII.CONCOMITANT DRUG(S) AND HISTORY\n22.CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\nMST(MORPHINE SULFATE)(MORPHINE  15/JUN/2021 -              60 mg (30 mg,1 in 12                     \nSULFATE)                                                   hr)                                      \n                                26/MAY/2021 -              30 mg (15 mg,1 in 12                     \n                                                           hr)                                      \nCont...\n23. OTHER RELEVANT HISTORY (e.g. diagnostics, allergics, pregnancy with last month of period, etc.)\n Past Disease: \nTumour pain [v.24.0] (01/Jun/2021 - 07/Jun/2021) ( Continuing: Yes): previous hospitalization \n(ES-RPL-21-00044)\nCont...\nIV.MANUFACTURER INFORMATION\n                                                             \n24a. NAME AND ADDRESS OF MANUFACTURER\nInitial Reporter:                                            \nReplimune Inc.                                           Dr Ignacio Melero-Bermejo                                    \nUnited States of America                                 NAVARRA                                                      \nSpain                                                        \nEudraCT no : 2018-003964-30 24b. MFR. CONTROL NO.\nStudy no  : RPL-002-18 ES-RPL-21-00054(0)            \nCenter no : 102-3407\nCont...\n24c. DATE RECEIVED 24d. REPORT SOURCE\nBY MANUFACTURER X  STUDY    LITERATURE    AUTHORITY\n22/JUN/2021 X  HEALTH PROFESSIONAL    OTHER \nDATE OF THIS REPORT 25a. REPORT TYPE\n30/JUN/2021 X  INITIAL    FOLLOW U  P\nCont... = Continuation attached sheet(s)  Date :30/JUN/2021\nReplimune Inc.  Page : 2 /  3\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(0)\n Describe Reaction(s)(Include relevant test/lab data) ( Cont...)\n daily, since 26-May-2021, for auricular fibrillation (taken for ES-RPL-21-00044); oral morphine, 15 mg every \n12 hours, since 26-May-2021 for tumour pain (taken from ES-RPL-21-00044); subcutaneous heparin, 7500 units once\ndaily, since 26-May-2021 for auricular fibrillation; oral MST (morphine sulphate), 30 mg twice daily, since \n15-Jun-2021, for tumour pain; oral ibuprofen, 600 mg twice daily, since 15-Jun-2021, for tumour pain and oral \nNolotil (metamizole), 2 g as needed, since 15-Jun-2021, for tumour pain.\nOn 26-May-2021, the subject initiated treatment with intravenous (IV) cemiplimab, administered at a dose of 350\n \nmg and on 15-Jun-2021, the subject received the last dose of cemiplimab, at a dose of 350 mg prior to the event\nonset.\n \nOn 21-Jun-2021, the subject was admitted to the referral hospital due to tumour pain. Additional information \nhas been requested. \n \nAt the time of this report, the outcome of the event of tumour pain was reported as 'resolving'. The subject \nremained hospitalized. \nAction taken with cemiplimab due to the event was reported as 'dose not changed'.   \nThe Investigator assessed the event of tumour pain as Grade 3 (severe) and not related to cemiplimab, but \nrather related to the primary condition (disease under study).  \n Company Remarks (Sender's comments)  (Cont...)\nCompany comment: Tumour pain is an unexpected adverse event for cemiplimab. Considering the sub ject's \nunderlying malignancy and previous history of tumour pain, the Company assessed the reported event as not \nrelated to cemiplimab.\n Suspect Drugs (Cont...)\n Product-Reaction level\n Seq.No. : 1\n Drug : cemiplimab(cemiplimab)(cemiplimab)\n     \n Causality\n1)TUMOR PAIN (Tumour pain) [v.24.0]\n Action(s) taken with drug  :  Dosage maintained\n Causality as per reporter (Drug/Vaccine)  :  Not Related\n Causality as per Mfr.(Drug/Vaccine)  :  Not Related\n Dechallenge  :  N/A      \n Rechallenge  :  N/A\n Concomitant drugs (Cont...)\n Seq.No. : 1\n Drug : MST(MORPHINE SULFATE)(MORPHINE SULFATE)\n Route of Admin : 1)Oral\n2)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Seq.No. : 2\n Drug : SEVREDOL(MORPHINE SULFATE)(MORPHINE SULFATE)\n Daily Dose : 1)10 mg as needed. (10 mg)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n Seq.No. : 3\n Drug : IBUPROFEN(IBUPROFEN)(IBUPROFEN)\n Daily Dose : 1)1200 mg (600 mg,1 in 12 hr)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n     \n   \n     \n Seq.No. : 4\n Drug : NOLOTIL(METAMIZOLE MAGNESIUM)(METAMIZOLE MAGNESIUM)\n Daily Dose : 1) (2 gm,As required)\n Route of Admin : 1)Oral\n Indication for use : 1)Tumour pain [v.24.0]  Date :30/JUN/2021\nReplimune Inc.  Page : 3 /  3\nUnited States of America\n Continuation Sheet for CIOMS report  Mfr. Control No. :ES-RPL-21-00054(0)\n Therapy Dates/Duration : 1) 15/JUN/2021 - \n Seq.No. : 5\n Drug : HEPARIN(HEPARIN)(HEPARIN)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)   \n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]   \n Therapy Dates/Duration : 1) 26/MAY/2021 - \n  \n  \n Seq.No. : 6\n Drug : GABAPENTIN(GABAPENTIN)(GABAPENTIN)\n Daily Dose : 1)400 mg (400 mg,1 in 1 D)\n Route of Admin : 1)Oral   \n Indication for use : 1)Tumour pain [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 - \n  \n Seq.No. : 7\n Drug : HIBOR(BEMIPARIN SODIUM)(BEMIPARIN SODIUM)\n Daily Dose : 1)7500 IU (7500 IU,1 in 1 D)\n Route of Admin : 1)Subcutaneous\n Indication for use : 1)Atrial fibrillation [v.24.0]\n Therapy Dates/Duration : 1) 26/MAY/2021 -          \n Other relevant history (Cont...)\n        \n Concurrent Disease: \nSquamous cell carcinoma [v.24.0] ( Continuing: Yes)\nAtrial fibrillation [v.24.0] ( Continuing: Yes)\n Clinical Trial Identification ( Cont...)\n Patient no : 0001\n Study identification for EudraCT: 2018-003964-30#Phase 2 Study of Cemiplimab as Single Agent in Combo w RP1 in\nPts w Adv cutaneous SCC\n        \n     \n        "]
apiLogger::2021-10-05 18:41:19,598::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 18:41:19,598::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_2
apiLogger::2021-10-05 18:41:19,598::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 18:41:19,598::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 18:41:19,598::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 18:41:29,637::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 18:41:29,637::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 19:11:20,047::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 19:11:20,106::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 19:11:20,106::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpw2dy17w9 
apiLogger::2021-10-05 19:11:20,109::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 19:11:20,109::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 19:11:23,781::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 19:11:23,781::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpw2dy17w9
apiLogger::2021-10-05 19:11:25,439::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 19:11:25,439::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 19:11:25,439::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 19:11:25,439::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 19:11:25,444::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-05 19:11:25,444::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 19:11:25,444::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 19:11:25,444::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 19:11:25,444::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410002 - Cho - South Korea@KOR\nSite Number 1625410002\nSubject ID: 410002003\nScreening Date 10 FEB 2020 REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nGlobal\nR1979-ONC-1625 Original ICF\n1 No 24 JUL 2019 10 FEB 2020 Main consent 24 JUL 2019 10 FEB 2020\nProtocol Version\n1.0\nR1979-ONC-1625\n2 09 JUN 2020 Main consent 28 MAY 2020 10 FEB 2020\nAmendment 1 Global\nR1979-ONC-1625 Original Genomics Sub-Study\n3 10 FEB 2020 24 JUL 2019 10 FEB 2020\nProtocol consent\nFuture Biomedical\nR1979-ONC-1625 Original\n4 10 FEB 2020 Research Sub-Study 24 JUL 2019 10 FEB 2020\nProtocol\nconsent\nR1979-ONC-1625 Genomics Sub-Study\n5 09 JUN 2020 28 MAY 2020 10 FEB 2020\nAmendment 1 Global consent\nFuture Biomedical\nR1979-ONC-1625\n6 09 JUN 2020 Research Sub-Study 28 MAY 2020 10 FEB 2020\nAmendment 1 Global\nconsent\nR1979-ONC-1625\n7 12 JAN 2021 Main consent 30 DEC 2020 10 FEB 2020\nAmendment 2 Global\nR1979-ONC-1625\n8 06 APR 2021 Main consent 02 MAR 2021 10 FEB 2020\nAmendment 3 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410002003 1959 61 Female Asian -\nor Latino\nDisease-Specific Cohort REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) Follicular Lymphoma Grade 1-3a REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1    HEPATITIS B CARRIER      checked Ongoing Grade 1 - unchecked REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nMedical 1_HEPATIT 20 JAN unchecke\n1 ENTECAVIR History - IS B - 0.5 mg - QD - Oral - 2012 d - checked\nCARRIER_\nDEXAMETH Premedicatio Intraveno 11 FEB unchecke 19 FEB\n2 ASONE n for - - - 20 mg - PRN - us - 2020 d 2020 unchecked\nREGN1979\nCHLORPHE Premedicatio Intraveno 11 FEB unchecke 12 FEB\n3 NIRAMINE n for - - - 4 mg - QD - us - 2020 d 2020 unchecked\nREGN1979\nACETAMINO Premedicatio 11 FEB unchecke 12 FEB\n4 PHEN n for - - - 600 mg - Qid - Oral - 2020 d 2020 unchecked\nREGN1979\nALOPURINO PROPHYLA 11 FEB unchecke\n5 L Prophylaxis XIS FOR - - 100 mg - PRN - Oral - 2020 d - checked\nTLS\nPROPHYLA 11 FEB unchecke\n6 MOSAPRIDE Prophylaxis XIS FOR - - 5 mg - PRN - Oral - 2020 d - checked\nINDIGESTIO\nDIMENHYD Premedicatio 11 FEB unchecke 12 FEB\n7 RINATE n for - - - 50 mg - QD - Oral - 2020 d 2020 unchecked\nREGN1979\nSODIUM Premedicatio Intraveno 11 FEB unchecke 12 FEB\n8 BICARBONA n for - - - 80 mEq - QD - us - 2020 d 2020 unchecked\nTE REGN1979\nNEUTROPE Subcutan 11 FEB unchecke 11 FEB\n9 FILGRASTIM Prophylaxis NIC - - 300 mcg - QD - eous - 2020 d 2020 unchecked\nPROPHYLA\nPACKED PROPHYLA Intraveno 11 FEB unchecke 11 FEB\n10 RBC Prophylaxis XIS FOR - - 2 Unit - QD - us - 2020 d 2020 unchecked\nANEMIA\nPROPHYLA Intraveno 11 FEB unchecke 11 FEB\n11 PLATELETS Prophylaxis XIS FOR - - 1 Unit - QD - us - 2020 d 2020 unchecked\nBLEEDING\nPROPHYLA Intraveno 13 FEB unchecke 13 FEB\n12 PLATELETS Prophylaxis XIS FOR - - 1 Unit - QD - us - 2020 d 2020 unchecked\nBLEEDING']
apiLogger::2021-10-05 19:11:25,444::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 19:11:25,445::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-05 19:11:25,445::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 19:11:25,445::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 19:11:25,445::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 19:12:38,733::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 19:12:38,733::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 19:12:38,835::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 19:12:38,895::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 19:12:38,895::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpic9rn07u 
apiLogger::2021-10-05 19:12:38,899::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 19:12:38,899::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 19:12:42,932::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 19:12:42,932::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpic9rn07u
apiLogger::2021-10-05 19:12:44,659::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 19:12:44,660::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 19:12:44,660::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 19:12:44,660::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 19:12:44,665::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-10-05 19:12:44,665::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 19:12:44,665::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 19:12:44,665::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 19:12:44,665::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 410002 - Cho - South Korea@KOR\nSite Number 1625410002\nSubject ID: 410002004\nScreening Date 10 FEB 2020 REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nGlobal\nR1979-ONC-1625 Original ICF\n1 No 24 JUL 2019 10 FEB 2020 Main consent 24 JUL 2019 10 FEB 2020\nProtocol Version\n1.0\nR1979-ONC-1625\n2 09 JUN 2020 Main consent 28 MAY 2020 10 FEB 2020\nAmendment 1 Global\nR1979-ONC-1625 Original Genomics Sub-Study\n3 10 FEB 2020 24 JUL 2019 10 FEB 2020\nProtocol consent\nFuture Biomedical\nR1979-ONC-1625 Original\n4 10 FEB 2020 Research Sub-Study 24 JUL 2019 10 FEB 2020\nProtocol\nconsent\nR1979-ONC-1625 Genomics Sub-Study\n5 09 JUN 2020 28 MAY 2020 10 FEB 2020\nAmendment 1 Global consent\nFuture Biomedical\nR1979-ONC-1625\n6 09 JUN 2020 Research Sub-Study 28 MAY 2020 10 FEB 2020\nAmendment 1 Global\nconsent\nR1979-ONC-1625\n7 12 JAN 2021 Main consent 30 DEC 2020 10 FEB 2020\nAmendment 2 Global\nR1979-ONC-1625\n8 06 APR 2021 Main consent 02 MAR 2021 10 FEB 2020\nAmendment 3 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\nNot Hispanic\n410002004 1959 61 Female Asian -\nor Latino\nDisease-Specific Cohort REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) Follicular Lymphoma Grade 1-3a REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1    HEPATITIS B CARRIER      checked Ongoing Grade 1 - unchecked REG-2021-00115 GSPV RECEIPT DATE 18AUG2021 AKA 61 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nMedical 1_HEPATIT 20 JAN unchecke\n1 ENTECAVIR History - IS B - 0.5 mg - QD - Oral - 2012 d - checked\nCARRIER_\nDEXAMETH Premedicatio Intraveno 11 FEB unchecke 19 FEB\n2 ASONE n for - - - 20 mg - PRN - us - 2020 d 2020 unchecked\nREGN1979\nCHLORPHE Premedicatio Intraveno 11 FEB unchecke 12 FEB\n3 NIRAMINE n for - - - 4 mg - QD - us - 2020 d 2020 unchecked\nREGN1979\nACETAMINO Premedicatio 11 FEB unchecke 12 FEB\n4 PHEN n for - - - 600 mg - Qid - Oral - 2020 d 2020 unchecked\nREGN1979\nALOPURINO PROPHYLA 11 FEB unchecke\n5 L Prophylaxis XIS FOR - - 100 mg - PRN - Oral - 2020 d - checked\nTLS\nPROPHYLA 11 FEB unchecke\n6 MOSAPRIDE Prophylaxis XIS FOR - - 5 mg - PRN - Oral - 2020 d - checked\nINDIGESTIO\nDIMENHYD Premedicatio 11 FEB unchecke 12 FEB\n7 RINATE n for - - - 50 mg - QD - Oral - 2020 d 2020 unchecked\nREGN1979\nSODIUM Premedicatio Intraveno 11 FEB unchecke 12 FEB\n8 BICARBONA n for - - - 80 mEq - QD - us - 2020 d 2020 unchecked\nTE REGN1979\nNEUTROPE Subcutan 11 FEB unchecke 11 FEB\n9 FILGRASTIM Prophylaxis NIC - - 300 mcg - QD - eous - 2020 d 2020 unchecked\nPROPHYLA\nPACKED PROPHYLA Intraveno 11 FEB unchecke 11 FEB\n10 RBC Prophylaxis XIS FOR - - 2 Unit - QD - us - 2020 d 2020 unchecked\nANEMIA\nPROPHYLA Intraveno 11 FEB unchecke 11 FEB\n11 PLATELETS Prophylaxis XIS FOR - - 1 Unit - QD - us - 2020 d 2020 unchecked\nBLEEDING\nPROPHYLA Intraveno 13 FEB unchecke 13 FEB\n12 PLATELETS Prophylaxis XIS FOR - - 1 Unit - QD - us - 2020 d 2020 unchecked\nBLEEDING']
apiLogger::2021-10-05 19:12:44,665::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 19:12:44,665::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-10-05 19:12:44,665::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 19:12:44,665::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 19:12:44,665::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 19:13:59,315::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 19:13:59,315::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 19:49:19,448::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 19:49:19,454::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 19:49:19,455::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpb5jktx1w 
apiLogger::2021-10-05 19:49:19,455::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 19:49:19,455::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 19:49:19,953::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 19:49:19,953::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpb5jktx1w
apiLogger::2021-10-05 19:49:20,655::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 19:49:20,656::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 19:49:20,656::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 19:49:20,656::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 19:49:20,661::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 19:49:20,661::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 19:49:20,661::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 19:49:20,661::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 19:49:20,666::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 19:49:20,666::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 19:49:20,666::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 19:49:20,666::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From: noreply@mdsol.com\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 SAE/AESI form has been updated for Site : 1721840005, Subject : 8400026, AE number : 16 \nDate: Friday, August 6, 2021 3:11:05 PM\nDear Project Member,\nPlease be informed that below updates have been made for SAE/AESI in R4018-ONC-1721.\nCountry : World\nSite Number : 1721840005\nSite Name : 840005 - Liu - USA\nSubject number : 8400026\nAdverse event number : 16\nAdverse event term : NEUTROPENIA\nAdverse Start Date : 6 AUG 2021\nSpecify Rationale for Causality to cemiplimab -\nSpecify the Rationale for Causality to REGN4018 - TEMPORAL\nSpecify the Rationale for Causality to Study Conduct -\nSAE/AESI Narrative Text - PATIENT 8400026 ON REGN4108 MONOTHERAPY CAME OFF OF STUDY ON JULY 16, 2021 FOLLOWING \nPROGRESSION OF DISEASE. SHE FOLLOWED UP IN OUR CLINIC TODAY AND LABS REVEALED REBOUND GRADE 4 NEUTROPENIA \n(270). IF YOU RECALL, THIS PATIENT HAD GR 4 NEUTROPENIA FROM 6/30/21-7/16/21 REQUIRING NEUPOGEN SUPPORT FOR \nRECOVERY. SHE WILL FOLLOW UP WITH OUTPATIENT HEMATOLOGY FOR ASSESSMENT AND POTENTIAL BONE MARROW BIOPSY \nLIKELY WITHIN THE WEEK. NO GROWTH STIMULATING FACTOR WAS GIVEN IN OUR CLINIC TODAY. SHE IS FEELING WELL AND \nAFEBRILE AT THIS TIME. WE WILL FOLLOW UP AS WE KNOW MORE ABOUT THIS UNDERLYING PROCESS AND MANAGEMENT \nGUIDANCE FROM HEMATOLOGY. OUT TREATING INVESTIGATOR FEELS THIS IS RELATED TO REGN4018.\nEvent Description (Split 0-200) -\nEvent Description (Split 201-400) -\nEvent Description (Split 401-600) -\nEvent Description (Split 601-800) -\nEvent Description (Split 801-1000) -\nEvent Description (Split 1001-1200) -\nEvent Description (Split 1201-1400) -\nEvent Description (Split 1401-1600) -\nEvent Description (Split 1601-1800) -\nEvent Description (Split 1801-1999) -\nWWRD (GMT): 06 Aug 2021 07:11\nThank you,\nSyneos Health Data Management\nCreated by : Alexis Rabbitt [alexism_rabbitt@dfci.harvard.edu]\nFor further details, please log on to Medidata Rave using the following link :\nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?\nPage=CRFPage.aspx&DP=98276730__;!!OR9aRoiw!Ypf8G7LoFHhfZsSKQhXJC5VbpNIHfJbqWi6WAEPiYQLPpDQKiMRehdjCA5SjppwwEUyHS3A$\n ***********This is a system generated message, Please do not respond to this e-mail.*********** From: noreply@mdsol.com\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 SAE Alert: A new SAE has been reported for the Site : 1721840005, Subject : 8400026, AE Number : 16 \nDate: Friday, August 6, 2021 2:58:00 PM\nDear Project Member,\nPlease be informed that a new SAE has been reported for Study R4018-ONC-1721.\nCountry : World\nSite Number : 1721840005\nSite Name : 840005 - Liu - USA\nSubject number : 8400026\nAdverse event number : 16\nMain Adverse Event Description (Term) - NEUTROPENIA\nStart date (dd-mon-yyyy) - 6 AUG 2021\nAE suspected to be caused by REGN4018? - Yes\nAE suspected to be caused by cemiplimab? - Not Applicable\nAE suspected to be caused by study conduct? - No\nIt resulted in death - Not Checked\nIt was life-threatening - Checked\nIt required or prolonged inpatient hospitalization - Not Checked\nPersistent or significant disability / incapacity - Not Checked\nIt is a congenital anomaly/birth defect in offspring of study subject - Not Checked\nOther medically serious important event - Not Checked\nIf Other, specify -\nWWRD (GMT): 06 Aug 2021 06:57\nThank you,\nSyneos Health Data Management\nCreated by : Alexis Rabbitt [alexism_rabbitt@dfci.harvard.edu]\nFor further details, please log on to Medidata Rave using the following link :\nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?\nPage=CRFPage.aspx&DP=96374520__;!!OR9aRoiw!Z236qziaiMmz7Ps89DG7dMxNaBsvrQzqmNK9_v5gtT_G9SQaxAR5PrvWnd3MROjATSk9Gds$\n***********This is a system generated message, Please do not respond to this e-mail.***********']
apiLogger::2021-10-05 19:49:20,666::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 19:49:20,666::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 19:49:22,094::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 19:49:22,150::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 19:49:22,151::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpwgdfyh4z 
apiLogger::2021-10-05 19:49:22,154::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 19:49:22,154::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 19:49:28,897::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 19:49:28,897::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpwgdfyh4z
apiLogger::2021-10-05 19:49:38,469::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 19:49:38,469::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 19:49:38,469::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 19:49:38,469::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 19:49:38,475::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 19:49:38,475::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 19:49:38,475::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 19:49:38,475::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 19:49:38,480::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 19:49:38,480::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 19:49:38,480::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 19:49:38,480::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 19:49:38,485::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 19:49:38,485::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 19:49:38,485::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 19:49:38,485::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 19:49:38,490::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 19:49:38,490::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 19:49:38,490::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 19:49:38,490::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 19:49:38,495::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 19:49:38,495::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 19:49:38,495::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 19:49:38,495::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '8/6/2021 CRF\niMedidata Messages My Profile Help Home Logout\nUser: Agamdeep Saini (Safety)\nR4018-ONC-1721 840005 - Liu - USA ADVERSE EVENTS Adverse Event\n840005026\nADVERSE EVENTS Subject ID: 840005026\nAdverse Events Yes/No\nAdverse Event Subject: 840005026\nPage: Adverse Event - ADVERSE EVENTS\nCRF History Currently viewing line 16 of 16.\nClick here to return to "Complete View". Apply to Record\n - Adverse\n8E4v0e0n0t5026 Main Adverse Event Description (Term) NEUTROPENIA\n - Adverse\n840005026\nEvents Yes/No SOC 10005329Blood and lymphatic system disorders\n - Serious HLGT10047954White blood cell disorders\n8A4d0v0e0rs5e0 2E6vent/AESI  # 16 HLT 10029355Neutropenias\nPT 10029354Neutropenia\n840005026 - Serious  LLT 10029354Neutropenia\nAdverse Event/AESI # 01\n840009008 - Concomitant Start date (dd-mon-yyyy) 6 AUG 2021\nMedications\n840009008 - Concomitant If event occurred on study day 1, did the event occur prior to first study drug administration Not Applicable\nMedications Yes/No\n840009008 - Combination If the event is part of an Infusion Related Reaction or Cytokine Release Syndrome, please check the box and\npatients – administration of complete Immune Related Response/Cytokine Release Syndrome CRF\nREGN4018\nIs this AE related to the immune-mediated mechanism of action of REGN4018/Cemiplimab?\n840009008 - Monotherapy\npatients – administration of\nREGN4018 (Please complete associated CRFs for time frame, symptoms and signs, and vital sign changes. On the\ncorresponding CRFs for this AE, please enter interventions for management (eg. Medications, rate\n840009008 - Serious reduction))\nAdverse Event/AESI # 02\n840009008 - Serious Select if AE is intermittent No\nAdverse Event/AESI # 01\n840009008 - Adverse CAUSALITY\nEvent\n840009008 - Adverse AE suspected to be caused by REGN4018? Yes\nEvents Yes/No\nAE suspected to be caused by cemiplimab? Not Applicable\nAE suspected to be caused by study conduct? No\n---If Yes, specify\nACTION TAKEN\nAction taken with REGN4018 Not Applicable\nAction taken with cemiplimab Not Applicable\nIf Other, specify\nIf the Event is not study drug related but belongs to the sponsor list of immune related event, please provide\nthe etiology\nIf Other, specify\nOutcome of AE Not recovered/Not resolved\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy)\nAE initial severity CTCAE grade Grade 4 - Life threatening\nAE most extreme severity CTCAE grade Grade 4 - Life threatening\nDate Event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 6 AUG 2021\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication\nClick Hperlee faors Ceu setonmteer Sr uipnptoort  Incfoormnactioonmitant medications eCRF; If procedure or surgery please enter into the on- Medidata Classic Rave® 2021.1.0 \nstudy procedure/surgery eCRF Copyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(3hie4rvsvtuy4qwchgyjqfhr))/Modules/EDC/CRFPage.aspx?DP=96374520 1/3 8/6/2021 CRF\nNone iMedidata Messages My Profile Help Home Logout\nUser: Agamdeep Saini (Safety)\nDrug therapy/ Medication\nR4018-ONC-1721 840005 - Liu - USA ADVERSE EVENTS Adverse Event\n840005026\nADVERSE EVENTS Concomitant Medication #1\nAdverse Events Yes/No\nAdverse Event Concomitant Medication #2\nConcomitant Medication #3\nCRF History\n840005026 - Adverse Concomitant Medication #4\nEvent\n840005026 - Adverse Concomitant Medication #5\nEvents Yes/No\n840005026 - Serious  Concomitant Medication #6\nAdverse Event/AESI # 16\n840005026 - Serious  Concomitant Medication #7\nAdverse Event/AESI # 01\n840009008 - Concomitant Concomitant Medication #8\nMedications\n840009008 - Concomitant Concomitant Medication #9\nMedications Yes/No\n840009008 - Combination\npatients – administration of Concomitant Medication #10\nREGN4018\n840009008 - Monotherapy Concomitant Procedure/surgery\npatients – administration of\nREGN4018 Concomitant procedure/surgery #1\n840009008 - Serious\nAdverse Event/AESI # 02 Concomitant procedure/surgery #2\n840009008 - Serious\nAdverse Event/AESI # 01 Concomitant procedure/surgery #3\n840009008 - Adverse\nEvent Concomitant procedure/surgery #4\n840009008 - Adverse\nEvents Yes/No Concomitant procedure/surgery #5\nOther\nIf Other, specify\nDoes this AE qualify as Serious? (If YES, complete SAE/AESI Form) Yes\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of\nspecial interest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may\njeopardize the subject, and may require medical or surgical intervention to prevent one of the outcomes\nlisted above).\nIf Other, specify\nIs this an AE of Special Interest (AESI)? (If YES, complete SAE/AESI Form) No\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nAny AE that meets DLT criteria at any time while on treatment\nClick Here for Customer Support Information Medidata Classic Rave® 2021.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(3hie4rvsvtuy4qwchgyjqfhr))/Modules/EDC/CRFPage.aspx?DP=96374520 2/3 8/6/2021 CRF\nGrade 2 or greater Infusion-Related Reactions associated with study drug infusions\niMedidata Messages My Profile Help Home Logout\nGrade 2 or greater pain syndrome temporally related to study drug infusion in the opinion of the investigator User: Agamdeep Saini (Safety)\nR4018-ONC-1721 840005 - Liu - USA ADVERSE EVENTS Adverse Event\n840005026\nGrade 2 or greater Cytokine Release Syndrome\nADVERSE EVENTS\nAdverse Events Yes/No Grade 2 or greater allergic/hypersensitivity reactions\nAdverse Event\nAn irAE of any grade in a patient previously treated with a PI 3-K inhibitor\nCRF History\nPericardial effusions of any size\n - Adverse\n840005026\nEvent\nGrade ≥2 treatment-emergent pleural effusion (clinically significant new effusion and/or a clinically significant\n840005026 - Adverse change in size of an existing effusion)\nEvents Yes/No\n - Serious Grade ≥2 Treatment-emergent ascites (clinically significant new ascite and/or a clinically significant change in\n8A4d0v0e0rs5e0 2E6vent/AESI  # 16 size of existing ascites)\n840005026 - Serious  Note: An irAE can occur shortly after the first dose or several months after the last dose of treatment. All AEs of\nAdverse Event/AESI # 01 unknown etiology associated with drug exposure should be evaluated to determine possible immune etiology. If\n840009008 - Concomitant an irAE is suspected, efforts should be made to rule out neoplastic, infectious, metabolic, toxin or other\nMedications etiologic causes prior to labeling an AE as an irAE.\n840009008 - Concomitant Date Time 06 AUG 2021 02:57:04\nMedications Yes/No\n840009008 - Combination\npatients – administration of Printable Version  View PDF   Icon Key Save   Cancel\nREGN4018 CRF Version 9443 - Page Generated: 06 Aug 2021 15:24:05 Eastern Daylight Time\n840009008 - Monotherapy\npatients – administration of\nREGN4018\n840009008 - Serious\nAdverse Event/AESI # 02\n840009008 - Serious\nAdverse Event/AESI # 01\n840009008 - Adverse\nEvent\n840009008 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2021.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(3hie4rvsvtuy4qwchgyjqfhr))/Modules/EDC/CRFPage.aspx?DP=96374520 3/3 8/6/2021 CRF\niMedidata Messages My Profile Help Home Logout\nUser: Agamdeep Saini (Safety)\nR4018-ONC-1721 840005 - Liu - USA SERIOUS ADVERSE EVENTS/AESI (1) Serious Adverse Event/AESI # 16\n840005026\nSERIOUS ADVERSE Subject ID: \n840005026\nEVENTS/AESI (1)\nSerious Adverse Subject: \nEvent/AESI # 01 840005026\nPage: Serious Adverse Event/AESI # 16 - SERIOUS ADVERSE EVENTS/AESI (1)\nSerious Adverse\nEvent/AESI # 02 AE number 16\nSerious Adverse\nEvent/AESI # 12 Adverse Event Description (Term) NEUTROPENIA\nSerious Adverse\nEvent/AESI # 13\nSOC 10005329Blood and lymphatic system disorders\nSerious Adverse HLGT10047954White blood cell disorders\nEvent/AESI # 14 HLT 10029355Neutropenias\nSerious Adverse PT 10029354Neutropenia\nEvent/AESI # 15 LLT 10029354Neutropenia\nSerious Adverse Start Date (dd-mon-yyyy) 6 AUG 2021\nEvent/AESI # 16\nRATIONALE FOR CAUSALITY ASSESSMENT\nCRF History\nSpecify the Rationale for Causality to REGN4018 TEMPORAL\n - Serious\n840005026  \nAdverse Event/AESI # 16\nSpecify Rationale for Causality to cemiplimab\n - Serious\n840005026  \nAdverse Event/AESI # 01\nSpecify the Rationale for Causality to Study Conduct\n - Adverse\n840005026  \nEvent\nSAE/AESI NARRATIVE\n - Adverse\n840005026  \nEvents Yes/No #  SAE/AESI Narrative Text\n840009008 - Concomitant PATIENT   ON REGN4108 MONOTHERAPY CAME OFF OF STUDY ON JULY 16, 2021 FOLLOWING PROGRESSION OF DISEASE.\n840005026  \nMedications SHE FOLLOWED UP IN OUR CLINIC TODAY AND LABS REVEALED REBOUND GRADE 4 NEUTROPENIA (270). IF YOU RECALL, THIS\n \nPATIENT HAD GR 4 NEUTROPENIA FROM 6/30/21-7/16/21 REQUIRING NEUPOGEN SUPPORT FOR RECOVERY. SHE WILL FOLLOW UP\n840009008 - Concomitant  \nWITH OUTPATIENT HEMATOLOGY FOR ASSESSMENT AND POTENTIAL BONE MARROW BIOPSY LIKELY WITHIN THE WEEK. NO\nMedications Yes/No 1  \nGROWTH STIMULATING FACTOR WAS GIVEN IN OUR CLINIC TODAY. SHE IS FEELING WELL AND AFEBRILE AT THIS TIME. WE WILL\n840009008 - Combination FOLLOW UP AS WE KNOW MORE ABOUT THIS UNDERLYING PROCESS AND MANAGEMENT GUIDANCE FROM HEMATOLOGY. OUT  \npatients – administration of TREATING INVESTIGATOR FEELS THIS IS RELATED TO REGN4018.  \nREGN4018\n840009008 - Monotherapy\npatients – administration of Printable Version  View PDF   Icon Key\nSave   Cancel\nREGN4018 CRF Version 9443 - Page Generated: 06 Aug 2021 15:27:50 Eastern Daylight Time\n840009008 - Serious\nAdverse Event/AESI # 02\n840009008 - Serious\nAdverse Event/AESI # 01\n840009008 - Adverse\nEvent\n840009008 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2021.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(3hie4rvsvtuy4qwchgyjqfhr))/Modules/EDC/CRFPage.aspx?DP=98276730 1/1 8/6/2021 CRF\niMedidata Messages My Profile Help Home Logout\nUser: Agamdeep Saini (Safety)\nR4018-ONC-1721 840005 - Liu - USA 840005026 TREATMENT (1) Monotherapy patients – administration of R...\nTREATMENT (1) Subject ID: 840005026\nMonotherapy patients –\naRdEmGiNni4s0tr1a8tion of SPuabgjee:c Mt: o8n4o0t0h0e5r0a2p6y patients – administration of REGN4018 - TREATMENT (1)\nCombination patients –\nCRFaRCac eddHEommmmiGsiiitbpNnnoiliir4nissmy0tatrra1taaibo8ttiinoo nnp  aootffients – # VSistuitdy  srsmDeutuecibddedj eyiitvchceaettion? PSrIeflp eaNeascoosi,efny HOIDADf doabYidmstsee pessi/sirT,utv saipbmailor jtefoenioocv/rnDtid  sipesteacrhyi oaindrg?e : A(yDdyddaym ytMe)is MosfiMon A(2T03di0m:m5:0e9is0 )os –ifon D(yDdyidsayc ytMeh) aMorfMge D(2T03ii0sm:5c:0eh90 a)o r-fge IP Lot #  I#OP tLhoetr DLPeolvasenelned pdmWloaosandesnifieedd? dmwpdinIfoloaaco psssrndeeelanifaineesnddee,dd? dmwpddIfoloeaao psscsndeerlaniefineaendsdee,dd? DAocstueal dispcbIsfpholo etlesxiahtces,eke ADdamtein oisftration TISnimftuaesrti oonf TISnimftuoespi oonf dAedlamyiendis?tration sIpf eyecisfy, inIntefurrsuiopnted? ILnetenrgruthp toiofn raiwirrnnIeaeffatf tstdeuieesnuursrfmrciuuoesepndidto?ionn, IRnteearrsuopnti ofonr: dsIpnueteec rtiorfuy A:ptEe,d dpOsIpnultaheteneec nrtirorf,euyd:p toerd\n8p4a0tie0n0t5s0 –2 6a d- mMionnisotrtahteioranp oyf 1C11 YDCALYEYes _ Yes 0280 2J1UN 15:47 1220 2J1UN 14:20 8227800006_ DL7a No _ _ 1 09 JUN 202112:13 16:04 No _ No _ _ _ _ _\nR8p4aE0tGie0Nn0t54s00 –21 68a d- mCionmisbtriantaiotino nof 2C18 YDCALYEYes _ Yes 1250 2J1UN 16:21 _ _ 8227800006_ DL7a No _ _ 10 16 JUN 202111:04 14:48 No _ No _ _ _ _ _\nc8pe4am0tie0ipn0lt5ism0 –2a 6ba d- mCionmisbtriantaiotino nof 3C19 YDCALYEYes _ Yes 1250 2J1UN 16:21 _ _ 8227800006_ DL7a No _ _ 10 17 JUN 202111:19 15:18 No _ No _ _ _ _ _\nR8A8A44ddE00vvG00eeN00rrss554ee000  22EE1668vv  ee--  nnSStt//eeAArrEEiiooSSuuIIss  ##  1061 45C11C11 5 6YYDDCCAALLYYEEYYeess __ YYeess 22222020 2 2JJ11UUNN 1166::5511 22225050 2 2JJ11UUNN 1155::0000 88226611990000000044__ DDLL77aa NNoo __ __ 52000 2234  JJUUNN  220022111122::0116 1166::0201 NNoo __ NNoo __ __ __ __ __\n8E4v0e0n0t5026 - Adverse Printable Version  View PDF   Icon Key Save Cancel\n8E4v0e0n0ts5 Y02e6s/ N- Aodverse CRF Version 9443 - Page Generated: 06 Aug 2021 15:28:26 Eastern Daylight Time\n840009008 - Concomitant\nMedications\n840009008 - Concomitant\nMedications Yes/No\n840009008 - Combination\npatients – administration of\nREGN4018\n840009008 - Monotherapy\npatients – administration of\nREGN4018\n840009008 - Serious\nAdverse Event/AESI # 02\n840009008 - Serious\nAdverse Event/AESI # 01\n840009008 - Adverse\nEvent\n840009008 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2021.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(3hie4rvsvtuy4qwchgyjqfhr))/Modules/EDC/CRFPage.aspx?DP=96856400 1/1']
apiLogger::2021-10-05 19:49:38,495::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 19:49:38,495::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 19:49:41,087::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 19:49:41,088::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 19:49:41,088::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxjtwj_62 
apiLogger::2021-10-05 19:49:41,089::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 19:49:41,089::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 19:49:41,102::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 19:49:41,102::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxjtwj_62
apiLogger::2021-10-05 19:49:41,208::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 19:49:41,209::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 19:49:41,209::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 19:49:41,209::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 19:49:41,214::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 19:49:41,214::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 19:49:41,214::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 19:49:41,214::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 19:49:41,218::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 19:49:41,218::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 19:49:41,218::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 19:49:41,218::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 05-Oct-2021 19:48:23 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Initial/R4018-ONC-1721/Subject: 840005-026/SAE Term: Neutropenia/ MFR date 06-\nAug-2021\nFrom: Saini, Agamdeep <agamdeep.saini@syneoshealth.com> Sent: Friday, August 6, 2021\n3:35 PM To: Regeneron Medical Safety <Medical.Safety@regeneron.com> Cc: Paul Curtis\n<paul.curtis@regeneron.com>; Maryan Hussein <maryan.hussein@regeneron.com>; Tracey\nRowlands <tracey.rowlands@regeneron.com>; Priscila Goncalves\n<priscila.goncalves@regeneron.com>; Tamara Schmidt <tamara.schmidt@regeneron.com>;\nThomas Uldrick <thomas.uldrick@regeneron.com>; Elizabeth Miller\n<elizabeth.miller@regeneron.com>; Quasheeda Fields <quasheeda.fields@regeneron.com>;\nSaleem Shariff <saleem.shariff@regeneron.com>; Jevtovic, Jelena\n<jelena.jevtovic@syneoshealth.com>; IRT BCP Regeneron_Safety\n<Regeneron_Safety@syneoshealth.com> Subject: <External> Initial/R4018-ONC-1721/Subject:\n840005-026/SAE Term: Neutropenia/ MFR date 06-Aug-2021 \n \nEXTERNAL MESSAGE\n \n \nDear Regeneron Colleagues, \n \nPlease find attached initial information for R4018-ONC-1721/Subject: 840009-008. \n \nProtocol: R4018-ONC-1721\nDay 0: 06-Aug-2021\nCountry: USA\nSite # /Investigator: 840005/ Liu\nSubject ID: 840005-026\nStudy Drug(s): REGN4018\nEvent Term: Neutropenia\nOnset date: 6 AUG 2021\nSeverity/Grade: Grade 4 - Life threatening\nSAE Criteria and/or AESI Criteria: Life-threatening /AESI: No\nInvestigator Relationship to Study Drug: Related to REGN4018\nInvestigator Relationship to Study Conduct (if applicable): Not Related\nList of issued urgent queries: N/A\nREGN Argus number: Initial\n \n******** Updated Items ********   \nBest Regards, \nAgamdeep Saini \nSr. Safety &PV Specialist \nSyneos Health, Canada \nDirect: +1 984 459 5521 \nagamdeep.saini@syneoshealth.com \n \nwww.syneoshealth.com  ']
apiLogger::2021-10-05 19:49:41,218::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 19:49:41,218::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 19:51:18,851::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 19:51:18,857::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 19:51:18,858::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpguucy79o 
apiLogger::2021-10-05 19:51:18,858::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 19:51:18,858::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 19:51:19,363::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 19:51:19,364::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpguucy79o
apiLogger::2021-10-05 19:51:20,044::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 19:51:20,045::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 19:51:20,045::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 19:51:20,045::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 19:51:20,050::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 19:51:20,050::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 19:51:20,050::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 19:51:20,050::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 19:51:20,055::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 19:51:20,055::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 19:51:20,055::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 19:51:20,055::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From: noreply@mdsol.com\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 SAE/AESI form has been updated for Site : 1721840005, Subject : 840005027, AE number : 16 \nDate: Friday, August 6, 2021 3:11:05 PM\nDear Project Member,\nPlease be informed that below updates have been made for SAE/AESI in R4018-ONC-1721.\nCountry : World\nSite Number : 1721840005\nSite Name : 840005 - Liu - USA\nSubject number : 840005027\nAdverse event number : 16\nAdverse event term : NEUTROPENIA\nAdverse Start Date : 6 AUG 2021\nSpecify Rationale for Causality to cemiplimab -\nSpecify the Rationale for Causality to REGN4018 - TEMPORAL\nSpecify the Rationale for Causality to Study Conduct -\nSAE/AESI Narrative Text - PATIENT 840005027 ON REGN4108 MONOTHERAPY CAME OFF OF STUDY ON JULY 16, 2021 FOLLOWING \nPROGRESSION OF DISEASE. SHE FOLLOWED UP IN OUR CLINIC TODAY AND LABS REVEALED REBOUND GRADE 4 NEUTROPENIA \n(270). IF YOU RECALL, THIS PATIENT HAD GR 4 NEUTROPENIA FROM 6/30/21-7/16/21 REQUIRING NEUPOGEN SUPPORT FOR \nRECOVERY. SHE WILL FOLLOW UP WITH OUTPATIENT HEMATOLOGY FOR ASSESSMENT AND POTENTIAL BONE MARROW BIOPSY \nLIKELY WITHIN THE WEEK. NO GROWTH STIMULATING FACTOR WAS GIVEN IN OUR CLINIC TODAY. SHE IS FEELING WELL AND \nAFEBRILE AT THIS TIME. WE WILL FOLLOW UP AS WE KNOW MORE ABOUT THIS UNDERLYING PROCESS AND MANAGEMENT \nGUIDANCE FROM HEMATOLOGY. OUT TREATING INVESTIGATOR FEELS THIS IS RELATED TO REGN4018.\nEvent Description (Split 0-200) -\nEvent Description (Split 201-400) -\nEvent Description (Split 401-600) -\nEvent Description (Split 601-800) -\nEvent Description (Split 801-1000) -\nEvent Description (Split 1001-1200) -\nEvent Description (Split 1201-1400) -\nEvent Description (Split 1401-1600) -\nEvent Description (Split 1601-1800) -\nEvent Description (Split 1801-1999) -\nWWRD (GMT): 06 Aug 2021 07:11\nThank you,\nSyneos Health Data Management\nCreated by : Alexis Rabbitt [alexism_rabbitt@dfci.harvard.edu]\nFor further details, please log on to Medidata Rave using the following link :\nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?\nPage=CRFPage.aspx&DP=98276730__;!!OR9aRoiw!Ypf8G7LoFHhfZsSKQhXJC5VbpNIHfJbqWi6WAEPiYQLPpDQKiMRehdjCA5SjppwwEUyHS3A$\n ***********This is a system generated message, Please do not respond to this e-mail.*********** From: noreply@mdsol.com\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 SAE Alert: A new SAE has been reported for the Site : 1721840005, Subject : 840005027, AE Number : 16 \nDate: Friday, August 6, 2021 2:58:00 PM\nDear Project Member,\nPlease be informed that a new SAE has been reported for Study R4018-ONC-1721.\nCountry : World\nSite Number : 1721840005\nSite Name : 840005 - Liu - USA\nSubject number : 840005027\nAdverse event number : 16\nMain Adverse Event Description (Term) - NEUTROPENIA\nStart date (dd-mon-yyyy) - 6 AUG 2021\nAE suspected to be caused by REGN4018? - Yes\nAE suspected to be caused by cemiplimab? - Not Applicable\nAE suspected to be caused by study conduct? - No\nIt resulted in death - Not Checked\nIt was life-threatening - Checked\nIt required or prolonged inpatient hospitalization - Not Checked\nPersistent or significant disability / incapacity - Not Checked\nIt is a congenital anomaly/birth defect in offspring of study subject - Not Checked\nOther medically serious important event - Not Checked\nIf Other, specify -\nWWRD (GMT): 06 Aug 2021 06:57\nThank you,\nSyneos Health Data Management\nCreated by : Alexis Rabbitt [alexism_rabbitt@dfci.harvard.edu]\nFor further details, please log on to Medidata Rave using the following link :\nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?\nPage=CRFPage.aspx&DP=96374520__;!!OR9aRoiw!Z236qziaiMmz7Ps89DG7dMxNaBsvrQzqmNK9_v5gtT_G9SQaxAR5PrvWnd3MROjATSk9Gds$\n***********This is a system generated message, Please do not respond to this e-mail.***********']
apiLogger::2021-10-05 19:51:20,055::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 19:51:20,055::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 19:51:20,445::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 19:51:20,502::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 19:51:20,503::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp_ks7eigd 
apiLogger::2021-10-05 19:51:20,506::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 19:51:20,506::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 19:51:27,456::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 19:51:27,456::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp_ks7eigd
apiLogger::2021-10-05 19:51:37,037::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 19:51:37,038::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 19:51:37,038::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 19:51:37,038::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 19:51:37,043::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 19:51:37,043::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 19:51:37,043::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 19:51:37,043::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 19:51:37,048::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 19:51:37,048::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 19:51:37,048::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 19:51:37,048::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 19:51:37,053::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 19:51:37,053::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 19:51:37,053::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 19:51:37,053::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 19:51:37,058::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 19:51:37,058::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 19:51:37,058::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 19:51:37,058::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 19:51:37,063::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 19:51:37,063::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 19:51:37,063::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 19:51:37,063::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '8/6/2021 CRF\niMedidata Messages My Profile Help Home Logout\nUser: Agamdeep Saini (Safety)\nR4018-ONC-1721 840005 - Liu - USA ADVERSE EVENTS Adverse Event\n840005027\nADVERSE EVENTS Subject ID: 840005027\nAdverse Events Yes/No\nAdverse Event Subject: 840005027\nPage: Adverse Event - ADVERSE EVENTS\nCRF History Currently viewing line 16 of 16.\nClick here to return to "Complete View". Apply to Record\n - Adverse\n8E4v0e0n0t5027 Main Adverse Event Description (Term) NEUTROPENIA\n - Adverse\n840005027\nEvents Yes/No SOC 10005329Blood and lymphatic system disorders\n - Serious HLGT10047954White blood cell disorders\n8A4d0v0e0rs5e0 2E7vent/AESI  #  16 HLT 10029355Neutropenias\nPT 10029354Neutropenia\n840005027 - Serious   LLT 10029354Neutropenia\nAdverse Event/AESI # 01\n840009008 - Concomitant Start date (dd-mon-yyyy) 6 AUG 2021\nMedications\n840009008 - Concomitant If event occurred on study day 1, did the event occur prior to first study drug administration Not Applicable\nMedications Yes/No\n840009008 - Combination If the event is part of an Infusion Related Reaction or Cytokine Release Syndrome, please check the box and\npatients – administration of complete Immune Related Response/Cytokine Release Syndrome CRF\nREGN4018\nIs this AE related to the immune-mediated mechanism of action of REGN4018/Cemiplimab?\n840009008 - Monotherapy\npatients – administration of\nREGN4018 (Please complete associated CRFs for time frame, symptoms and signs, and vital sign changes. On the\ncorresponding CRFs for this AE, please enter interventions for management (eg. Medications, rate\n840009008 - Serious reduction))\nAdverse Event/AESI # 02\n840009008 - Serious Select if AE is intermittent No\nAdverse Event/AESI # 01\n840009008 - Adverse CAUSALITY\nEvent\n840009008 - Adverse AE suspected to be caused by REGN4018? Yes\nEvents Yes/No\nAE suspected to be caused by cemiplimab? Not Applicable\nAE suspected to be caused by study conduct? No\n---If Yes, specify\nACTION TAKEN\nAction taken with REGN4018 Not Applicable\nAction taken with cemiplimab Not Applicable\nIf Other, specify\nIf the Event is not study drug related but belongs to the sponsor list of immune related event, please provide\nthe etiology\nIf Other, specify\nOutcome of AE Not recovered/Not resolved\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nResolution date (dd-mon-yyyy)\nAE initial severity CTCAE grade Grade 4 - Life threatening\nAE most extreme severity CTCAE grade Grade 4 - Life threatening\nDate Event Became Grade 3 or higher - if applicable (dd-mon-yyyy) 6 AUG 2021\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nTreatment for AE (select all that apply except when NONE is noted): for drug therapy or medication\nClick Hperlee faors Ceu setonmteer Sr uipnptoort  Incfoormnactioonmitant medications eCRF; If procedure or surgery please enter into the on- Medidata Classic Rave® 2021.1.0 \nstudy procedure/surgery eCRF Copyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(3hie4rvsvtuy4qwchgyjqfhr))/Modules/EDC/CRFPage.aspx?DP=96374520 1/3 8/6/2021 CRF\nNone iMedidata Messages My Profile Help Home Logout\nUser: Agamdeep Saini (Safety)\nDrug therapy/ Medication\nR4018-ONC-1721 840005 - Liu - USA ADVERSE EVENTS Adverse Event\n840005027\nADVERSE EVENTS Concomitant Medication #1\nAdverse Events Yes/No\nAdverse Event Concomitant Medication #2\nConcomitant Medication #3\nCRF History\n840005027 - Adverse Concomitant Medication #4\nEvent\n840005027 - Adverse Concomitant Medication #5\nEvents Yes/No\n840005027 - Serious   Concomitant Medication #6\nAdverse Event/AESI # 16\n840005027 - Serious   Concomitant Medication #7\nAdverse Event/AESI # 01\n840009008 - Concomitant Concomitant Medication #8\nMedications\n840009008 - Concomitant Concomitant Medication #9\nMedications Yes/No\n840009008 - Combination\npatients – administration of Concomitant Medication #10\nREGN4018\n840009008 - Monotherapy Concomitant Procedure/surgery\npatients – administration of\nREGN4018 Concomitant procedure/surgery #1\n840009008 - Serious\nAdverse Event/AESI # 02 Concomitant procedure/surgery #2\n840009008 - Serious\nAdverse Event/AESI # 01 Concomitant procedure/surgery #3\n840009008 - Adverse\nEvent Concomitant procedure/surgery #4\n840009008 - Adverse\nEvents Yes/No Concomitant procedure/surgery #5\nOther\nIf Other, specify\nDoes this AE qualify as Serious? (If YES, complete SAE/AESI Form) Yes\nComplete the following fields ONLY if Adverse Event qualifies as either serious or as an event of\nspecial interest (AESI) per protocol. If AE does not meet criteria for either SAE or AESI then STOP here.\nFOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \nCHECK ALL THAT APPLY\nIt resulted in death\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious criteria, but may\njeopardize the subject, and may require medical or surgical intervention to prevent one of the outcomes\nlisted above).\nIf Other, specify\nIs this an AE of Special Interest (AESI)? (If YES, complete SAE/AESI Form) No\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nAny AE that meets DLT criteria at any time while on treatment\nClick Here for Customer Support Information Medidata Classic Rave® 2021.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(3hie4rvsvtuy4qwchgyjqfhr))/Modules/EDC/CRFPage.aspx?DP=96374520 2/3 8/6/2021 CRF\nGrade 2 or greater Infusion-Related Reactions associated with study drug infusions\niMedidata Messages My Profile Help Home Logout\nGrade 2 or greater pain syndrome temporally related to study drug infusion in the opinion of the investigator User: Agamdeep Saini (Safety)\nR4018-ONC-1721 840005 - Liu - USA ADVERSE EVENTS Adverse Event\n840005027\nGrade 2 or greater Cytokine Release Syndrome\nADVERSE EVENTS\nAdverse Events Yes/No Grade 2 or greater allergic/hypersensitivity reactions\nAdverse Event\nAn irAE of any grade in a patient previously treated with a PI 3-K inhibitor\nCRF History\nPericardial effusions of any size\n - Adverse\n840005027\nEvent\nGrade ≥2 treatment-emergent pleural effusion (clinically significant new effusion and/or a clinically significant\n840005027 - Adverse change in size of an existing effusion)\nEvents Yes/No\n - Serious Grade ≥2 Treatment-emergent ascites (clinically significant new ascite and/or a clinically significant change in\n8A4d0v0e0rs5e0 2E7vent/AESI  #  16 size of existing ascites)\n840005027 - Serious   Note: An irAE can occur shortly after the first dose or several months after the last dose of treatment. All AEs of\nAdverse Event/AESI # 01 unknown etiology associated with drug exposure should be evaluated to determine possible immune etiology. If\n840009008 - Concomitant an irAE is suspected, efforts should be made to rule out neoplastic, infectious, metabolic, toxin or other\nMedications etiologic causes prior to labeling an AE as an irAE.\n840009008 - Concomitant Date Time 06 AUG 2021 02:57:04\nMedications Yes/No\n840009008 - Combination\npatients – administration of Printable Version  View PDF   Icon Key Save   Cancel\nREGN4018 CRF Version 9443 - Page Generated: 06 Aug 2021 15:24:05 Eastern Daylight Time\n840009008 - Monotherapy\npatients – administration of\nREGN4018\n840009008 - Serious\nAdverse Event/AESI # 02\n840009008 - Serious\nAdverse Event/AESI # 01\n840009008 - Adverse\nEvent\n840009008 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2021.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(3hie4rvsvtuy4qwchgyjqfhr))/Modules/EDC/CRFPage.aspx?DP=96374520 3/3 8/6/2021 CRF\niMedidata Messages My Profile Help Home Logout\nUser: Agamdeep Saini (Safety)\nR4018-ONC-1721 840005 - Liu - USA SERIOUS ADVERSE EVENTS/AESI (1) Serious Adverse Event/AESI # 16\n840005027\nSERIOUS ADVERSE Subject ID: \n840005027\nEVENTS/AESI (1)\nSerious Adverse Subject: \nEvent/AESI # 01 840005027\nPage: Serious Adverse Event/AESI # 16 - SERIOUS ADVERSE EVENTS/AESI (1)\nSerious Adverse\nEvent/AESI # 02 AE number 16\nSerious Adverse\nEvent/AESI # 12 Adverse Event Description (Term) NEUTROPENIA\nSerious Adverse\nEvent/AESI # 13\nSOC 10005329Blood and lymphatic system disorders\nSerious Adverse HLGT10047954White blood cell disorders\nEvent/AESI # 14 HLT 10029355Neutropenias\nSerious Adverse PT 10029354Neutropenia\nEvent/AESI # 15 LLT 10029354Neutropenia\nSerious Adverse Start Date (dd-mon-yyyy) 6 AUG 2021\nEvent/AESI # 16\nRATIONALE FOR CAUSALITY ASSESSMENT\nCRF History\nSpecify the Rationale for Causality to REGN4018 TEMPORAL\n - Serious\n840005027   \nAdverse Event/AESI # 16\nSpecify Rationale for Causality to cemiplimab\n - Serious\n840005027   \nAdverse Event/AESI # 01\nSpecify the Rationale for Causality to Study Conduct\n - Adverse\n840005027   \nEvent\nSAE/AESI NARRATIVE\n - Adverse\n840005027   \nEvents Yes/No #  SAE/AESI Narrative Text\n840009008 - Concomitant PATIENT   ON REGN4108 MONOTHERAPY CAME OFF OF STUDY ON JULY 16, 2021 FOLLOWING PROGRESSION OF DISEASE.\n840005027   \nMedications SHE FOLLOWED UP IN OUR CLINIC TODAY AND LABS REVEALED REBOUND GRADE 4 NEUTROPENIA (270). IF YOU RECALL, THIS\n  \nPATIENT HAD GR 4 NEUTROPENIA FROM 6/30/21-7/16/21 REQUIRING NEUPOGEN SUPPORT FOR RECOVERY. SHE WILL FOLLOW UP\n840009008 - Concomitant   \nWITH OUTPATIENT HEMATOLOGY FOR ASSESSMENT AND POTENTIAL BONE MARROW BIOPSY LIKELY WITHIN THE WEEK. NO\nMedications Yes/No 1   \nGROWTH STIMULATING FACTOR WAS GIVEN IN OUR CLINIC TODAY. SHE IS FEELING WELL AND AFEBRILE AT THIS TIME. WE WILL\n840009008 - Combination FOLLOW UP AS WE KNOW MORE ABOUT THIS UNDERLYING PROCESS AND MANAGEMENT GUIDANCE FROM HEMATOLOGY. OUT   \npatients – administration of TREATING INVESTIGATOR FEELS THIS IS RELATED TO REGN4018.   \nREGN4018\n840009008 - Monotherapy\npatients – administration of Printable Version  View PDF   Icon Key\nSave   Cancel\nREGN4018 CRF Version 9443 - Page Generated: 06 Aug 2021 15:27:50 Eastern Daylight Time\n840009008 - Serious\nAdverse Event/AESI # 02\n840009008 - Serious\nAdverse Event/AESI # 01\n840009008 - Adverse\nEvent\n840009008 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2021.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(3hie4rvsvtuy4qwchgyjqfhr))/Modules/EDC/CRFPage.aspx?DP=98276730 1/1 8/6/2021 CRF\niMedidata Messages My Profile Help Home Logout\nUser: Agamdeep Saini (Safety)\nR4018-ONC-1721 840005 - Liu - USA 840005027 TREATMENT (1) Monotherapy patients – administration of R...\nTREATMENT (1) Subject ID: 840005027\nMonotherapy patients –\naRdEmGiNni4s0tr1a8tion of SPuabgjee:c Mt: o8n4o0t0h0e5r0a2p7y patients – administration of REGN4018 - TREATMENT (1)\nCombination patients –\nCRFaRCac eddHEommmmiGsiiitbpNnnoiliir4nissmy0tatrra1taaibo8ttiinoo nnp  aootffients – # VSistuitdy  srsmDeutuecibddedj eyiitvchceaettion? PSrIeflp eaNeascoosi,efny HOIDADf doabYidmstsee pessi/sirT,utv saipbmailor jtefoenioocv/rnDtid  sipesteacrhyi oaindrg?e : A(yDdyddaym ytMe)is MosfiMon A(2T03di0m:m5:0e9is0 )os –ifon D(yDdyidsayc ytMeh) aMorfMge D(2T03ii0sm:5c:0eh90 a)o r-fge IP Lot #  I#OP tLhoetr DLPeolvasenelned pdmWloaosandesnifieedd? dmwpdinIfoloaaco psssrndeeelanifaineesnddee,dd? dmwpddIfoloeaao psscsndeerlaniefineaendsdee,dd? DAocstueal dispcbIsfpholo etlesxiahtces,eke ADdamtein oisftration TISnimftuaesrti oonf TISnimftuoespi oonf dAedlamyiendis?tration sIpf eyecisfy, inIntefurrsuiopnted? ILnetenrgruthp toiofn raiwirrnnIeaeffatf tstdeuieesnuursrfmrciuuoesepndidto?ionn, IRnteearrsuopnti ofonr: dsIpnueteec rtiorfuy A:ptEe,d dpOsIpnultaheteneec nrtirorf,euyd:p toerd\n8p4a0tie0n0t5s0 –2 7a d- mMionnisotrtahteioranp oyf 1C11 YDCALYEYes _ Yes 0280 2J1UN 15:47 1220 2J1UN 14:20 8227800006_ DL7a No _ _ 1 09 JUN 202112:13 16:04 No _ No _ _ _ _ _\nR8p4aE0tGie0Nn0t54s00 –21 78a d- mCionmisbtriantaiotino nof 2C18 YDCALYEYes _ Yes 1250 2J1UN 16:21 _ _ 8227800006_ DL7a No _ _ 10 16 JUN 202111:04 14:48 No _ No _ _ _ _ _\nc8pe4am0tie0ipn0lt5ism0 –2a 7ba d- mCionmisbtriantaiotino nof 3C19 YDCALYEYes _ Yes 1250 2J1UN 16:21 _ _ 8227800006_ DL7a No _ _ 10 17 JUN 202111:19 15:18 No _ No _ _ _ _ _\nR8A8A44ddE00vvG00eeN00rrss554ee000  22EE1778vv  ee--  nnSStt//eeAArrEEiiooSSuuIIss  ##  1061 45C11C11 5 6YYDDCCAALLYYEEYYeess __ YYeess 22222020 2 2JJ11UUNN 1166::5511 22225050 2 2JJ11UUNN 1155::0000 88226611990000000044__ DDLL77aa NNoo __ __ 52000 2234  JJUUNN  220022111122::0116 1166::0201 NNoo __ NNoo __ __ __ __ __\n8E4v0e0n0t5027 - Adverse Printable Version  View PDF   Icon Key Save Cancel\n8E4v0e0n0ts5 Y02e7s/ N- Aodverse CRF Version 9443 - Page Generated: 06 Aug 2021 15:28:26 Eastern Daylight Time\n840009008 - Concomitant\nMedications\n840009008 - Concomitant\nMedications Yes/No\n840009008 - Combination\npatients – administration of\nREGN4018\n840009008 - Monotherapy\npatients – administration of\nREGN4018\n840009008 - Serious\nAdverse Event/AESI # 02\n840009008 - Serious\nAdverse Event/AESI # 01\n840009008 - Adverse\nEvent\n840009008 - Adverse\nEvents Yes/No\nClick Here for Customer Support Information Medidata Classic Rave® 2021.1.0 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(3hie4rvsvtuy4qwchgyjqfhr))/Modules/EDC/CRFPage.aspx?DP=96856400 1/1']
apiLogger::2021-10-05 19:51:37,064::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 19:51:37,064::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 19:51:38,059::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 19:51:38,061::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 19:51:38,061::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp94zj966c 
apiLogger::2021-10-05 19:51:38,061::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 19:51:38,061::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 19:51:38,074::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 19:51:38,075::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp94zj966c
apiLogger::2021-10-05 19:51:38,174::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 19:51:38,174::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 19:51:38,174::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 19:51:38,174::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 19:51:38,179::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 19:51:38,179::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 19:51:38,179::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 19:51:38,179::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 19:51:38,183::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 19:51:38,183::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 19:51:38,183::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 19:51:38,183::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 05-Oct-2021 19:49:12 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Initial/R4018-ONC-1721/Subject: 840005-027/SAE Term: Neutropenia/ MFR date 06-\nAug-2021\nFrom: Saini, Agamdeep <agamdeep.saini@syneoshealth.com> Sent: Friday, August 6, 2021\n3:35 PM To: Regeneron Medical Safety <Medical.Safety@regeneron.com> Cc: Paul Curtis\n<paul.curtis@regeneron.com>; Maryan Hussein <maryan.hussein@regeneron.com>; Tracey\nRowlands <tracey.rowlands@regeneron.com>; Priscila Goncalves\n<priscila.goncalves@regeneron.com>; Tamara Schmidt <tamara.schmidt@regeneron.com>;\nThomas Uldrick <thomas.uldrick@regeneron.com>; Elizabeth Miller\n<elizabeth.miller@regeneron.com>; Quasheeda Fields <quasheeda.fields@regeneron.com>;\nSaleem Shariff <saleem.shariff@regeneron.com>; Jevtovic, Jelena\n<jelena.jevtovic@syneoshealth.com>; IRT BCP Regeneron_Safety\n<Regeneron_Safety@syneoshealth.com> Subject: <External> Initial/R4018-ONC-1721/Subject:\n840005-027/SAE Term: Neutropenia/ MFR date 06-Aug-2021 \n \nEXTERNAL MESSAGE\n \n \nDear Regeneron Colleagues, \n \nPlease find attached initial information for R4018-ONC-1721/Subject: 840009-008. \n \nProtocol: R4018-ONC-1721\nDay 0: 06-Aug-2021\nCountry: USA\nSite # /Investigator: 840005/ Liu\nSubject ID: 840005-027\nStudy Drug(s): REGN4018\nEvent Term: Neutropenia\nOnset date: 6 AUG 2021\nSeverity/Grade: Grade 4 - Life threatening\nSAE Criteria and/or AESI Criteria: Life-threatening /AESI: No\nInvestigator Relationship to Study Drug: Related to REGN4018\nInvestigator Relationship to Study Conduct (if applicable): Not Related\nList of issued urgent queries: N/A\nREGN Argus number: Initial\n \n******** Updated Items ********   \nBest Regards, \nAgamdeep Saini \nSr. Safety &PV Specialist \nSyneos Health, Canada \nDirect: +1 984 459 5521 \nagamdeep.saini@syneoshealth.com \n \nwww.syneoshealth.com  ']
apiLogger::2021-10-05 19:51:38,184::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 19:51:38,184::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 22:01:19,047::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 22:01:19,145::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 22:01:19,146::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpsd9bvpia 
apiLogger::2021-10-05 22:01:19,150::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 22:01:19,150::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 22:01:19,854::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 22:01:19,854::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpsd9bvpia
apiLogger::2021-10-05 22:01:20,792::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 22:01:20,792::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 22:01:20,793::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 22:01:20,793::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 22:01:20,797::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-05 22:01:20,797::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 22:01:20,798::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 22:01:20,798::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 22:01:20,798::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012005\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021']
apiLogger::2021-10-05 22:01:20,798::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 22:01:20,798::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-05 22:01:20,798::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 22:01:20,798::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 22:01:20,798::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 22:01:53,824::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 22:01:53,824::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 22:13:18,657::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 22:13:18,658::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 22:13:18,659::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpjfhu6a57 
apiLogger::2021-10-05 22:13:18,659::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 22:13:18,659::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 22:13:18,683::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 22:13:18,683::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpjfhu6a57
apiLogger::2021-10-05 22:13:19,086::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 22:13:19,087::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 22:13:19,087::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 22:13:19,087::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 22:13:19,091::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_CIOMS_1
apiLogger::2021-10-05 22:13:19,091::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 22:13:19,091::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 22:13:19,091::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 22:13:19,091::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_CIOMS_1', 'generic', 'CIOMS FORM\nSUSPECT ADVERSE REACTION REPORT\nI. REACTION INFORMATION\xa0\n1. PATIENT INITIALS 1a. COUNTRY 2. DATE OF BIRTH 2a. AGE 3. SEX 3a. WEIGHT 4-6 REACTION ONSET 8-12 CHECK ALL\nPR(firIsVt, AlasCt)Y\xa0 UNITED KINGDOM\xa0 Day PRMIoVntAhCYYear Unk Female\xa0 98.00 D1a1y MMoAntYh 2Y0e2ar1 AAPDPVREORSPER IRATEEA CTTOION\nkg\n7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)\nEvent Verbatim [PREFERRED TERM] (Related symptoms if any separated by commas) PATIENT DIED\nInjection site reaction- localised bruising [Injection site reaction]\nINVOLVED OR\nPROLONGED INPATIENT\nCase Description: This Clinical Trial report from United Kingdom was received on 10-JUN-2021 regarding a  HOSPITALISATION\nfemale patient (031-0002) of an unspecified age who was enrolled in study protocol ALN-CC5-005 entitled: “A \nPhase 2, Randomized, Double-blind, Placebo-controlled Study of Cemdisiran in Adult Patients with IgA  INVOLVED PERSISTENT\nOR SIGNIFICANT\nNephropathy”. DISABILITY OR\nINCAPACITY\nThe patient\'s medical history included IgA nephropathy.\nLIFE\n (Continued on Additional Information Page)\xa0 THREATENING\nII. SUSPECT DRUG(S) INFORMATION\xa0\n14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION\n#1 ) ALN-CC5 (Code not broken) Solution for Injection\xa0 ABATE AFTER STOPPING\nDRUG?\n15. DAILY DOSE(S) 16. ROUTE(S) OF ADMINISTRATION\n#1 ) 600 milligram, monthly\xa0 #1 ) Subcutaneous\xa0 YES NO NA\n17. INDICATION(S) FOR USE 21. DID REACTION\n#1 ) IgA Nephropathy (IgA nephropathy)\xa0 REAPPEAR AFTER\nREINTRODUCTION?\n18. THERAPY DATES(from/to) 19. THERAPY DURATION\n#1 ) Ongoing\xa0 #1 ) Unknown\xa0 YES NO NA\nIII. CONCOMITANT DRUG(S) AND HISTORY\xa0\n22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)\n23. OTHER RELEVANT HISTORY. (e.g. diagnostics, allergies, pregnancy with last month of period, etc.)\nFrom/To Dates Type of History / Notes Description\nUnknown to Ongoing Current Condition\xa0 IgA nephropathy (IgA nephropathy)\xa0\nIV. MANUFACTURER INFORMATION\xa0\n24a. NAME AND ADDRESS OF MANUFACTURER 26. REMARKS\nAlnylam Pharmaceuticals, Inc.\n300 Third Street\nCambridge, MA 02142  UNITED STATES\xa0\n24b. MFR CONTROL NO. 25b. NAME AND ADDRESS OF REPORTER\nNAME AND ADDRESS WITHHELD.\xa0\nALN-2021-001418\xa0\n24c. DATE RECEIVED 24d. REPORT SOURCE\n        BY MANUFACTURER STUDY LITERATURE\n27-AUG-2021\xa0\nHEALTH OTHER:\nPROFESSIONAL\nDATE OF THIS REPORT 25a. REPORT TYPE\n09-SEP-2021\xa0\nINITIAL FOLLOWUP: 1\n09-Sep-2021 06:51 Page 2 of 2\nMfr. Control Number: ALN-2021-001418\nADDITIONAL INFORMATION\n7+13. DESCRIBE REACTION(S) continued\nConcomitant medications were not reported.\nThe patient received the first dose of “ALN-CC5 (cemdisiran) versus placebo” on an unspecified date, administered subcutaneously, \nat a dose of 600 mg for the treatment of IgA nephropathy. On 11-MAY-2021, the patient received the most recent administration of \n“ALN-CC5 (cemdisiran) vs. placebo” at a dose of 600 mg prior to the onset of the event.\nThe dose administration setting, and the dose number were not reported.\nOn 11-MAY-2021, the patient experienced “injection site reaction - localised bruising”.\nPatient reported injection site reaction - localised bruising after administration of study drug versus placebo at week 60 visit on \n11-MAY-2021. The bruising appeared on the right upper abdominal quadrant injection site. Other symptoms included tenderness. \nPatient did not report this event straight away. The site was notified at the time of week 64 visit, on 08-JUN-2021. Advice was given to \ncontact the site if situation occurs in the future. \nIt was reported that no treatment was administrated, and skin appeared intact at week 64 visit.\nOn 16-MAY-2021, the event of "Injection site reaction- localised bruising” was recovered/resolved.\nThe action taken regarding the study drug versus placebo as a result of the event was reported as dose not changed.\nAdditional information has been requested.\nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was not related to “ALN-CC5 (cemdisiran) versus placebo”. Other alternative explanation for \nthe event was not reported.\nCompany Comment [10-JUN-2021]: The event Injection site bruising is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). The Sponsor considers the event of Injection site bruising not related  to \n“ALN-CC5 (cemdisiran) versus placebo”.\nOn 28-JUN-2021, a non-significant case correction of the version received on 10-JUN-2021 was performed to recode the event of \n"Injection site reaction- localised bruising" to Injection site reaction (previously coded as Injection site bruising). \nCompany Comment [28-JUN-2021]: Based on the non-significant case correction, there is no change in the Sponsor’s assessment.\nADDITIONAL INFORMATION WAS RECEIVED ON 27-AUG-2021.\n \nInformation provided included additional details regarding previously reported event and updated causality assessment.\n \nIt was stated that the localised bruising and tenderness symptoms were resolved spontaneously, without specific treatment.\nAdditional information has been requested.\n \nIt was the opinion of the Investigator that the non-serious event of “Injection site reaction- localised bruising” was mild in intensity, was \nan adverse event of clinical interest and was related (previously, not related) to “ALN-CC5 (cemdisiran) versus placebo”. Other \nalternative explanation for the event was not reported.\n \nCompany Comment [27-AUG-2021]: The event of Injection site reaction is unexpected per the current version of the “ALN-CC5 \n(cemdisiran) versus placebo” Investigator Brochure (IB). Severe or serious ISRs are considered AECIs per the clinical study protocol, \nhowever this event was deemed by the investigator as mild and not serious. A query has been issued to clarify whether it meets AECI \ncriteria. Given the spatial relationship to the injection site in addition to the suggested potential temporal relationship to dosing, the \nSponsor considers the event of Injection site reaction as  related to “ALN-CC5 (cemdisiran) versus placebo”.\nALN-2021-001418\xa0\n09-Sep-2021 06:51']
apiLogger::2021-10-05 22:13:19,091::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 22:13:19,091::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_CIOMS_1
apiLogger::2021-10-05 22:13:19,092::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 22:13:19,092::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 22:13:19,092::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 22:13:29,351::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 22:13:29,351::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 22:25:20,182::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 22:25:20,198::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 22:25:20,199::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpncocdv6a 
apiLogger::2021-10-05 22:25:20,200::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 22:25:20,200::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 22:25:20,504::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 22:25:20,504::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpncocdv6a
apiLogger::2021-10-05 22:25:22,213::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 22:25:22,214::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 22:25:22,214::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 22:25:22,214::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 22:25:22,218::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-05 22:25:22,219::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 22:25:22,219::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 22:25:22,219::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 22:25:22,219::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Johnson, Janlyn Jeba\nFrom: noreply@mdsol.com\nSent: 01 July 2021 16:09\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/YWqACW7OVH5KzlwmH6f0d1?domain=login.imedidata.com\n*** IMPORTANT: As we approach Day 1 of the ICON / PRA combined organization we ask that all staff \nremain vigilant, especially with unsolicited telephone calls, new email interactions or any emails which are \nsuspicious in nature. Please report any suspicious emails to Information Security using the "Report Phish" \nbutton in Outlook. ***  \n \n \nAn AESI of INFUSION REACTION has been reported for Subject Number 616008034 with  \nStart Date (dd-mon-yyyy) : 17 OCT 2019 \nwith AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 01 Jul 2021 10:38:17 \n1 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 616008-Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy\nSubject details\nSubject Number 34\nSubject ID 616008034\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n04 SEP 2019\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n4 SEP 2019\nyyyy)\nInformed Consent Version Version 5\nDemographic details\nDate of Birth (dd-mon-yyyy) 1964\nAge (Derived) (All EXCEPT German\n55\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Current Smoker\nNumber of Years Smoked 39\nNumber of Cigarettes Per Day 20\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nMedical History details\nMedical If Date\nHistory / Check for Ongoing Ongoing resolved Check for\nRecord Start Date (dd-\nFinding unknown start at study Specify (End date) unknown end\nPosition mon-yyyy)\n(Abnorm date entry? CTCAE (dd-mon- date\nality) Grade yyyy)\nSPINAL\nNot\n1 OSTEOA UN UNK 2004 UNCHECKED Ongoing UNCHECKED\nAvailable\nRTHRITIS\nPOSTTR\nAUMATIC UN UNK\n2 UN UNK 1972 UNCHECKED Resolved UNCHECKED\nSPLENE 1972\nCTOMY\nPAIN:\nSACRO-\nLUMBAR UN JUL\n3 UN JUL 2019 UNCHECKED Resolved UNCHECKED\nSPINE 2019\n(NEOPLA\nSTIC)\nR2810-ONC-16113_SAE Report_02-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nConcomitant Medications\nRoute (If no\nappropriate term can\nIf Indication is be found in the pick\nMedical History, list, then please select\nDrug Name Please select the If Indication is Adverse \'Other\' from the pick\nList only one appropriate Event, Please select the list and specify the Start Date Stop Date\nRecord medication If Other, Medical History appropriate Adverse Dose If Other, If Other, corresponding term in If Other, (dd-mon- (dd-mon-\nPosition per line Indication specify record. Event record. Dose Unit specify Frequency specify the next line.) specify yyyy) yyyy) Ongoing\nDEXAMETHA UNCHEC\n1 SONE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nOMEPRASOL UNCHEC\n2 E Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nUNCHEC\n3 CLEMASTINE Pre Med 20 mg QD Intravenous 27 SEP 2019 27 SEP 2019 KED\nHYDROCOR Adverse UNCHEC\n4 TISONE Event 2_INFUSION REACTION 100 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n5 CLEMASTINE Pre Med 2 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nOMEPRASOL UNCHEC\n6 E Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nDEXAMETHA UNCHEC\n7 SONE Pre Med 20 mg QD Intravenous 17 OCT 2019 17 OCT 2019 KED\nUNCHEC\n8 CLEMASTINE Pre Med 2 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nOMEPRASOL UNCHEC\n9 E Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nDEXAMETHA UNCHEC\n10 SONE Pre Med 20 mg QD Intravenous 7 NOV 2019 7 NOV 2019 KED\nUNCHEC\n11 CLEMASTINE Pre Med 2 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nOMEPRASOL UNCHEC\n12 E Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nDEXAMETHA UNCHEC\n13 SONE Pre Med 20 mg QD Intravenous 27 NOV 2019 27 NOV 2019 KED\nCOMIRNATY\n(PFIZER/\nUNCHEC\nBIONTECH)\n14 Pre Med 30 mcg OTO Intramuscular 30 MAR 2021 30 MAR 2021 KED\nMRNA\nNUROFEN\n(IBUPROFEN Adverse 4_WHOLE BODY UNCHEC\n15 UM) Event OSTEOARTICULAR PAIN 200 mg Intermittent Oral 30 SEP 2019 02 OCT 2019 KED\nVITAMIN B Adverse 6_SENSORY CHECKE\n16 COMPLEX Event NEUROPATHY 1 Capsule TID Oral 18 DEC 2019 D\nTRAMAL\n(TRAMADOLI\nAdverse 5_LOWER EXTREMITIES CHECKE\nHYDROCHLO\n17 Event OSTEOARTICULAR PAIN 100 mg Intermittent Oral 27 NOV 2019 D\nRIDUM)\nPROPRANOL\nOL\nAdverse CHECKE\n(PROPRANO\n18 Event 8_TACHYCARDIA 10 mg Intermittent Oral 18 DEC 2019 D\nLOLI\nR2810-ONC-16113_SAE Report_02-JUL-2021']
apiLogger::2021-10-05 22:25:22,219::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 22:25:22,219::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-05 22:25:22,219::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 22:25:22,219::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 22:25:22,219::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 22:25:44,611::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 22:25:44,611::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 23:51:19,086::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 23:51:19,179::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 23:51:19,179::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpsul4vvo6 
apiLogger::2021-10-05 23:51:19,183::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 23:51:19,183::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 23:51:19,885::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 23:51:19,885::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpsul4vvo6
apiLogger::2021-10-05 23:51:20,822::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 23:51:20,823::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 23:51:20,823::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 23:51:20,823::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 23:51:20,827::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_16113
apiLogger::2021-10-05 23:51:20,827::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 23:51:20,828::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-10-05 23:51:20,828::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-10-05 23:51:20,828::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_16113', 'generic', 'Joseph, Sheba Roshan\nFrom: noreply@mdsol.com\nSent: 28 July 2021 02:27\nTo: SAEALERT16113_PROD2; SAEALERT16113_PROD\nSubject: [EXTERNAL] ATTENTION! An AESI has been entered from Study R2810-ONC-16113. \nPlease review ASAP at https://protect-\neu.mimecast.com/s/qrbFC4RmOiBV03BWHOgdOW?domain=login.imedidata.com\nFollow Up Flag: Follow up\nFlag Status: Flagged\nAn AESI of TROMBOITOPENIA has been reported for Subject Number 792012005 with Start Date (dd-mon-yyyy) : 27 JUL \n2021  with AE suspected to be caused by blinded study drug? : NO \n \nWWRD (GMT): 27 Jul 2021 20:56:17 \n \n1 R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening\nForm: Informed Consent\nData signed: (Asezer1) 08 Feb 2021 09:27:49\nGenerated On: 28 Jul 2021 11:57:30\nProtocol: R2810-ONC-16113\nInformed Consent:  Main Study and Biopsy\nDate Subject Signed the First Informed Consent (dd-mon-yyyy) 03 JUL 2020\nInformed Consent Version Version 3\nIs the version of the Informed consent signed for Part1 or Part 2 of Part 2\nthe protocol?\nGenomics Consent\nHas the subject consented to participate in the genomics sub Yes\nstudy?\nDate of Genomics Consent (dd-mon-yyyy) 03 JUL 2020\nDid the subject consented for the Only partial sequencing of tumor Yes\ntissue and circulating tumor DNA samples?\nCPPC12 R2810-ONC-16113 0027 1 of 4\n(9074) R2810-ONC-16113: 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi: 792012005\nFolder: Screening >>  Prior Cancer Therapies (1)\nForm: Prior Cancer Related Therapies Yes/No\nData signed: (Asezer1) 08 Feb 2021 09:27:52\nGenerated On: 28 Jul 2021 11:56:06\nDid subject have any Prior Cancer Systemic Therapy? No\nDid subject have any Prior Cancer Radiotherapy? Yes\nDid subject have any Prior Cancer Related Surgery? No\nCPPC12 R2810-ONC-16113 0027 1 of 3\n(9074) Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nProject details\nproject R2810-ONC-16113\nICON Study code 0456/0146\nenvironmentName Prod\nSite 792012-Baskent Universitesi Tip Fakultesi Adana Hastanesi\nSubject details\nSubject Number 5\nSubject ID 792012005\nHas subject been rescreened? No\nIf Yes, previous screening ID:\nInformed Consent and Eligibility details\nIs subject eligible to participate in this\nYes\nstudy?\nDate Subject Signed the First Informed\n03 JUL 2020\nConsent (dd-mon-yyyy)\nHas the subject consented to\nYes\nparticipate in the genomics sub study?\nDate of Genomics Consent (dd-mon-\n03 JUL 2020\nyyyy)\nInformed Consent Version Version 3\nDemographic details\nDate of Birth (dd-mon-yyyy) 1960\nAge (Derived) (All EXCEPT German\n60\nSites)\nSex Male\nRace (choose only one primary race) White\nIf Other, specify\nEthnicity Not Hispanic or Latino\nSmoking History details\nSmoking Status Past Smoker\nNumber of Years Smoked 35\nNumber of Cigarettes Per Day 1\nR2810-ONC-16113_SAE Report_28-JUL-2021 Regeneron Pharmaceuticals Inc.\nSerious Adverse Events (SAE) Form\nInformed Consent and Protocol Amendment Tracking - Screening\nProtocol IRB Date subject\nApproval signed Informed Informed Consent\nRecord Protocol version Date (dd- Consent (dd-mon- Consent Approval Date from\nPosition (Global) mon-yyyy) yyyy) Type Other, specify IRB (dd-mon-yyyy)\nR2810-ONC-16113\n2 Amend 5 21 AUG 2020 07 SEP 2020 21 AUG 2020\nR2810-ONC-16113_SAE Report_28-JUL-2021']
apiLogger::2021-10-05 23:51:20,828::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-10-05 23:51:20,828::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_16113
apiLogger::2021-10-05 23:51:20,828::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-10-05 23:51:20,828::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-10-05 23:51:20,828::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7fe5c20bee48>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-10-05 23:51:53,894::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-10-05 23:51:53,894::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 23:57:19,317::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 23:57:19,385::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 23:57:19,385::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpv6wzvosv 
apiLogger::2021-10-05 23:57:19,389::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 23:57:19,389::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 23:57:29,884::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 23:57:29,885::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpv6wzvosv
apiLogger::2021-10-05 23:57:40,589::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 23:57:40,590::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 23:57:40,590::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 23:57:40,590::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 23:57:40,595::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:57:40,595::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 23:57:40,595::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 23:57:40,595::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 23:57:40,600::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:57:40,600::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 23:57:40,600::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 23:57:40,600::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 23:57:40,605::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:57:40,605::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 23:57:40,605::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 23:57:40,605::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 23:57:40,610::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:57:40,610::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 23:57:40,610::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 23:57:40,610::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 23:57:40,615::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:57:40,615::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 23:57:40,615::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 23:57:40,615::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '6/24/2021 CRF\niMedidata Messages My Profile Help Home Logout\nUser: Agamdeep Saini (Safety)\nR4018-ONC-1721 840004 - O\'Malley - USA ADVERSE EVENTS Adverse Event\n840004021\nADVERSE EVENTS Subject ID: 840004021\nAdverse Events Yes/No\nAdverse Event Subject: 840004021\nPage: Adverse Event - ADVERSE EVENTS\nCRF History Currently viewing line 20 of 20.\nClick here to return to "Complete View". Apply to Record\n - Adverse\n8E4v0e0n0t4021   Main Adverse Event Description (Term) NEUTROPHIL COUNT DECREASED\n - Adverse\n840004021  \nEvents Yes/No SOC 10022891Investigations\nHLGT10018851Haematology investigations (incl blood groups)\n - Serious\n8A4d0v0e0rs4e0 2E1vent/AESI  # 20 HLT 10047938White blood cell analyses\nPT 10029366Neutrophil count decreased\n - Serious\n840004021   LLT 10029366Neutrophil count decreased\nAdverse Event/AESI # 02\n - Serious Start date (dd-mon-yyyy) 16 JUN 2021\n840004021  \nAdverse Event/AESI # 01\nIf event occurred on study day 1, did the event occur prior to first study drug\nNot Applicable\nadministration\nIf the event is part of an Infusion Related Reaction or Cytokine Release Syndrome,\nplease check the box and complete Immune Related Response/Cytokine Release\nSyndrome CRF\nIs this AE related to the immune-mediated mechanism of action of\nREGN4018/Cemiplimab?\n(Please complete associated CRFs for time frame, symptoms and signs, and\nvital sign changes. On the corresponding CRFs for this AE, please enter\ninterventions for management (eg. Medications, rate reduction))\nSelect if AE is intermittent No\nCAUSALITY\nAE suspected to be caused by REGN4018? Yes\nAE suspected to be caused by cemiplimab?\nStart date is present; however, response to \'AE suspected to be caused by\ncemiplimab?\' is missing. Please review data entered and update as appropriate.\nOpened To Site from System (24 Jun 2021)\nAE suspected to be caused by study conduct?\nStart date is present; however, response to \'AE suspected to be caused by study\nconduct?\' is missing. Please review data entered and update as appropriate.\nOpened To Site from System (24 Jun 2021)\n---If Yes, specify\nACTION TAKEN\nAction taken with REGN4018 Dose Reduced\nAction taken with cemiplimab\nStart date is present; however, response to \'Action taken with cemiplimab\' is\nmissing. Please review data entered and update as appropriate.\nOpened To Site from System (24 Jun 2021)\nData is required. Please complete.\nClick Here for COusptoemneerd S Tuopp Soritt eIn ffroormma tSioynstem (24 Jun 2021) Medidata Classic Rave® 2020.3.2 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(k4kf03qf0kedjt3eelgn2efp))/Modules/EDC/CRFPage.aspx?DP=95593582 1/4 6/24/2021 CRF\nIf Other, specify\niMedidata Messages My Profile Help Home Logout\nUser: Agamdeep Saini (Safety)\nIf the Event is not study drug related but belongs to the sponsor list of immune related\neveRnt4, 0p1le8a-OseN pCr-o1v7id2e1 the e8t4io0lo0g0y4 - O\'Malley - USA ADVERSE EVENTS Adverse Event\n840004021\nIf Other, specify\nADVERSE EVENTS\nAdverse Events Yes/No\nOutcome of AE Not recovered/Not resolved\nAdverse Event\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nCRF History\n - Adverse Resolution date (dd-mon-yyyy)\n840004021  \nEvent\n - Adverse AE initial severity CTCAE grade Grade 4 - Life threatening\n840004021  \nEvents Yes/No\n840004021 - Serious  AE most extreme severity CTCAE grade Grade 4 - Life threatening\nAdverse Event/AESI # 20\n - Serious Date Event Became Grade 3 or higher - if applicable (dd-mon-yyyy)\n840004021  \nAdverse Event/AESI # 02 AE most extreme severity CTCAE grade is Grade 3 or higher, but \'Date Event\n - Serious Became Grade 3 or higher - if applicable\' is blank. Please review data entered\n8A4d0v0e0rs4e0 2E1vent/AESI  # 01 and update as appropriate.\nOpened To Site from System (24 Jun 2021)\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nTreatment for AE (select all that apply except when NONE is noted): for drug\ntherapy or medication please enter into concomitant medications eCRF; If\nprocedure or surgery please enter into the on-study procedure/surgery eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nClick Here for Customer Support Information Medidata Classic Rave® 2020.3.2 \nConcomitant procedure/surgery #3 Copyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(k4kf03qf0kedjt3eelgn2efp))/Modules/EDC/CRFPage.aspx?DP=95593582 2/4 6/24/2021 CRF\niMedidata Messages My Profile Help Home Logout\nUser: Agamdeep Saini (Safety)\nConcomitant procedure/surgery #4\nR4018-ONC-1721 840004 - O\'Malley - USA ADVERSE EVENTS Adverse Event\n840004021\nConcomitant procedure/surgery #5\nADVERSE EVENTS\nAdverse Events Yes/No Other\nAdverse Event\nIf Other, specify\nCRF History\n - Adverse Does this AE qualify as Serious? (If YES, complete SAE/AESI Form) No\n840004021  \nEvent\nComplete the following fields ONLY if Adverse Event qualifies as either serious\n840004021 - Adverse  or as an event of special interest (AESI) per protocol. If AE does not meet criteria\nEvents Yes/No for either SAE or AESI then STOP here.\n - Serious\n8A4d0v0e0rs4e0 2E1vent/AESI  # 20 FOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \n840004021 - Serious  CHECK ALL THAT APPLY\nAdverse Event/AESI # 02\n - Serious It resulted in death\n840004021  \nAdverse Event/AESI # 01\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious\ncriteria, but may jeopardize the subject, and may require medical or surgical\nintervention to prevent one of the outcomes listed above).\nIf Other, specify\nIs this an AE of Special Interest (AESI)? (If YES, complete SAE/AESI Form)\nIs this an AE of Special interest (AESI)? is Yes, yet AESI criteria is not selected.\nYes\nPlease select all that apply.\nOpened To Site from System (24 Jun 2021)\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nAny AE that meets DLT criteria at any time while on treatment\nGrade 2 or greater Infusion-Related Reactions associated with study drug infusions\nGrade 2 or greater pain syndrome temporally related to study drug infusion in the\nopinion of the investigator\nGrade 2 or greater Cytokine Release Syndrome\nGrade 2 or greater allergic/hypersensitivity reactions\nAn irAE of any grade in a patient previously treated with a PI 3-K inhibitor\nPericardial effusions of any size\nGrade ≥2 treatment-emergent pleural effusion (clinically significant new effusion and/or\nClick Hae rec lfoinr Cicuastlolym esr iSgunppifoicrt aInnfotr mcahtiaonnge in size of an existing effusion) Medidata Classic Rave® 2020.3.2 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(k4kf03qf0kedjt3eelgn2efp))/Modules/EDC/CRFPage.aspx?DP=95593582 3/4 6/24/2021 CRF\nGrade ≥2 Treatment-emergent ascites (clinically significant new ascite and/or a\niMedidata Messages My Profile Help Home Logout\nclinically significant change in size of existing ascites)\nUser: Agamdeep Saini (Safety)\nNote: An irAE can occur shortly after the first dose or several months after the last\ndosRe 4o0f 1tr8e-aOtNmCen-1t.7 A21ll AEs of unknown etiology associat  expoAsDuVreE sRhSoEu lEd VENTS Adverse Event\n840004021\nbe evaluated to determine possible immune etiology. If an irAE is suspected, efforts\nADVERSE EVENTS should be made to rule out neoplastic, infectious, metabolic, toxin or other etiologic\nAdverse Events Yes/No causes prior to labeling an AE as an irAE.\nAdverse Event Date Time 24 JUN 2021 08:21:26\nCRF History\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n840004021 - Adverse  CRF Version 9193 - Page Generated: 24 Jun 2021 12:09:51 Eastern Daylight Time\nEvent\n - Adverse\n840004021  \nEvents Yes/No\n - Serious\n840004021  \nAdverse Event/AESI # 20\n - Serious\n840004021  \nAdverse Event/AESI # 02\n - Serious\n840004021  \nAdverse Event/AESI # 01\nClick Here for Customer Support Information Medidata Classic Rave® 2020.3.2 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(k4kf03qf0kedjt3eelgn2efp))/Modules/EDC/CRFPage.aspx?DP=95593582 4/4 6/24/2021 CRF\niMedidata Messages My Profile Help Home Logout\nUser: Agamdeep Saini (Safety)\nR4018-ONC-1721 840004 - O\'Malley - USA SERIOUS ADVERSE EVENTS/AESI (1) Serious Adverse Event/AESI # 20\n840004021\nSERIOUS ADVERSE Subject ID: \n840004021\nEVENTS/AESI (1)\nSerious Adverse Subject: \nEvent/AESI # 01 840004021\nPage: Serious Adverse Event/AESI # 20 - SERIOUS ADVERSE EVENTS/AESI (1)\nSerious Adverse\nEvent/AESI # 02 AE number 20\nSerious Adverse\nEvent/AESI # 20 Adverse Event Description (Term) NEUTROPHIL COUNT DECREASED\nCRF History SOC 10022891Investigations\n - Serious HLGT10018851Haematology investigations (incl blood groups)\n8A4d0v0e0rs4e0 2E1vent/AESI  # 20 HLT 10047938White blood cell analyses\nPT 10029366Neutrophil count decreased\n - Serious\n840004021   LLT 10029366Neutrophil count decreased\nAdverse Event/AESI # 02\n840004021 - Serious  Start Date (dd-mon-yyyy) 16 JUN 2021\nAdverse Event/AESI # 01\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN4018 INVESTIGATORS REVIEWED AS "PROBABLY-RELATED" TO\nREGN4018 THERAPY, TEMPORALLY RELATED TO REGN4018\nINFUSION\nSpecify Rationale for Causality to cemiplimab\nSpecify the Rationale for Causality to Study Conduct\nSAE/AESI NARRATIVE\n#  SAE/AESI Narrative Text\nSUBJECT 840004-020 DEVELOPED GRADE 4 NEUTROPENIA (0.34 K/UL) THE DAY FOLLOWING FIRST COMBINATION DOSE - CYCLE 2 DAY 1:\nREGN4018 @ 60 MG + CEMIPLIMAB @ 350 MG – ON 16-JUN-2021. PATIENT WAS ASYMPTOMATIC AND AFEBRILE AT OCCURRENCE WITH\nNEUTROPHIL COUNT RE-CHECKED BEFORE END OF 24 HOUR OBSERVATION PERIOD ON 16-JUN-2021 WHICH CONTINUED TO\nDEMONSTRATE ONGOING GRADE 4 NEUTROPENIA (0.18 K/UL). PATIENT COMPLETED 48 HOUR (17-JUN-2021 - 0.14 K/UL) AND 72 HOUR (18-\nJUN-2021 - 0.05 K/UL) SAFETY LAB CHECKS THAT CONTINUED TO DEMONSTRATE ONGOING GRADE 4 NEUTROPENIA - PATIENT STILL\nREMAINED ASYMPTOMATIC AND AFEBRILE AND REFUSED STARTING ANY PROPHYLACTIC ANTIBIOTICS. PATIENT WAS PLANNED FOR\nCYCLE 2 DAY 8 REGN4018 @ 60 MG DOSE THE FOLLOWING WEEK WITH PRE-TREATMENT HEMATOLOGY LAB CHECKED ON 21-JUN-2021\n1 THAT SHOWED ONGOING GRADE 4 NEUTROPENIA (0.15 K/UL). SITE PI REVIEWED PATIENT’S GRADE 4 NEUTROPENIA DID NOT MEET SAE\nREPORTING CRITERIA (I.E., “OTHER MEDICALLY SERIOUS IMPORTANT EVENT”) AFTER EXTENSIVE DISCUSSION ON 21-JUN-2021\nCONFERENCE CALL AND CONFIRMED PLAN TO DELAY UNTIL NEUTROPHIL COUNTS RECOVERED TO >/= 1.0 K/UL (GRADE 2). PATIENT\'S\nTREATMENT WAS DELAYED WITH PLAN TO RE-CHECK NEUTROPHIL RECOVERY ON 23-JUN-2021 WHICH CONFIRMED ONGOING GRADE 4\nNEUTROPENIA (0.13 K/UL). SITE INVESTIGATORS MADE AWARE OF PERSISTENT GRADE 4 NEUTROPENIA AND INDICATED AE AS\nPROBABLY-RELATED TO REGN4018 THERAPY. SPONSOR MADE AWARE OF PERSISTENT GRADE 4 NEUTROPENIA AND CONFIRMED\nPATIENT MEETS DOSE LIMITING TOXICITY REQUIRING PATIENT TO DOSE REDUCE TO NEXT LOWEST DOSE LEVEL - DLC4A (NOW TO DOSE\nWITH REGN4018 @ 20 MG + CEMIPLIMAB @ 350 MG).\nNO OTHER DIAGNOSTIC TESTS/LABS WERE USED TO EVALUATE AE. PATIENT IS PLANNED FOR HEMATOLOGY LAB CHECK TODAY TO\n2\nCHECK NEUTROPHIL COUNT STATUS. WILL CONTINUE TO UPDATE REPORT WITH ANY NEW INFORMATION AS IT BECOMES AVAILABLE.\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 9193 - Page Generated: 24 Jun 2021 12:09:21 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.3.2 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(k4kf03qf0kedjt3eelgn2efp))/Modules/EDC/CRFPage.aspx?DP=97248195 1/1']
apiLogger::2021-10-05 23:57:40,615::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 23:57:40,615::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 23:57:40,733::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 23:57:40,791::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 23:57:40,791::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpgmxsrqjj 
apiLogger::2021-10-05 23:57:40,795::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 23:57:40,795::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 23:57:51,073::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 23:57:51,073::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpgmxsrqjj
apiLogger::2021-10-05 23:58:01,588::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 23:58:01,588::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 23:58:01,588::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 23:58:01,588::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 23:58:01,593::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:01,594::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 23:58:01,594::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 23:58:01,594::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 23:58:01,598::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:01,598::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 23:58:01,598::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 23:58:01,598::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 23:58:01,603::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:01,603::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 23:58:01,604::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 23:58:01,604::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 23:58:01,608::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:01,608::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 23:58:01,608::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 23:58:01,608::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 23:58:01,613::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:01,613::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 23:58:01,613::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 23:58:01,613::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', '6/24/2021 CRF\niMedidata Messages My Profile Help Home Logout\nUser: Agamdeep Saini (Safety)\nR4018-ONC-1721 840004 - O\'Malley - USA ADVERSE EVENTS Adverse Event\n840004022\nADVERSE EVENTS Subject ID: 840004022\nAdverse Events Yes/No\nAdverse Event Subject: 840004022\nPage: Adverse Event - ADVERSE EVENTS\nCRF History Currently viewing line 20 of 20.\nClick here to return to "Complete View". Apply to Record\n - Adverse\n8E4v0e0n0t4022   Main Adverse Event Description (Term) NEUTROPHIL COUNT DECREASED\n - Adverse\n840004022  \nEvents Yes/No SOC 10022891Investigations\nHLGT10018851Haematology investigations (incl blood groups)\n - Serious\n8A4d0v0e0rs4e0 2E2vent/AESI  # 20 HLT 10047938White blood cell analyses\nPT 10029366Neutrophil count decreased\n - Serious\n840004022   LLT 10029366Neutrophil count decreased\nAdverse Event/AESI # 02\n - Serious Start date (dd-mon-yyyy) 16 JUN 2021\n840004022  \nAdverse Event/AESI # 01\nIf event occurred on study day 1, did the event occur prior to first study drug\nNot Applicable\nadministration\nIf the event is part of an Infusion Related Reaction or Cytokine Release Syndrome,\nplease check the box and complete Immune Related Response/Cytokine Release\nSyndrome CRF\nIs this AE related to the immune-mediated mechanism of action of\nREGN4018/Cemiplimab?\n(Please complete associated CRFs for time frame, symptoms and signs, and\nvital sign changes. On the corresponding CRFs for this AE, please enter\ninterventions for management (eg. Medications, rate reduction))\nSelect if AE is intermittent No\nCAUSALITY\nAE suspected to be caused by REGN4018? Yes\nAE suspected to be caused by cemiplimab?\nStart date is present; however, response to \'AE suspected to be caused by\ncemiplimab?\' is missing. Please review data entered and update as appropriate.\nOpened To Site from System (24 Jun 2021)\nAE suspected to be caused by study conduct?\nStart date is present; however, response to \'AE suspected to be caused by study\nconduct?\' is missing. Please review data entered and update as appropriate.\nOpened To Site from System (24 Jun 2021)\n---If Yes, specify\nACTION TAKEN\nAction taken with REGN4018 Dose Reduced\nAction taken with cemiplimab\nStart date is present; however, response to \'Action taken with cemiplimab\' is\nmissing. Please review data entered and update as appropriate.\nOpened To Site from System (24 Jun 2021)\nData is required. Please complete.\nClick Here for COusptoemneerd S Tuopp Soritt eIn ffroormma tSioynstem (24 Jun 2021) Medidata Classic Rave® 2020.3.2 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(k4kf03qf0kedjt3eelgn2efp))/Modules/EDC/CRFPage.aspx?DP=95593582 1/4 6/24/2021 CRF\nIf Other, specify\niMedidata Messages My Profile Help Home Logout\nUser: Agamdeep Saini (Safety)\nIf the Event is not study drug related but belongs to the sponsor list of immune related\neveRnt4, 0p1le8a-OseN pCr-o1v7id2e1 the e8t4io0lo0g0y4 - O\'Malley - USA ADVERSE EVENTS Adverse Event\n840004022\nIf Other, specify\nADVERSE EVENTS\nAdverse Events Yes/No\nOutcome of AE Not recovered/Not resolved\nAdverse Event\nIf outcome is Recovered/Resolved with Sequelae; Specify the sequelae.\nCRF History\n - Adverse Resolution date (dd-mon-yyyy)\n840004022  \nEvent\n - Adverse AE initial severity CTCAE grade Grade 4 - Life threatening\n840004022  \nEvents Yes/No\n840004022 - Serious  AE most extreme severity CTCAE grade Grade 4 - Life threatening\nAdverse Event/AESI # 20\n - Serious Date Event Became Grade 3 or higher - if applicable (dd-mon-yyyy)\n840004022  \nAdverse Event/AESI # 02 AE most extreme severity CTCAE grade is Grade 3 or higher, but \'Date Event\n - Serious Became Grade 3 or higher - if applicable\' is blank. Please review data entered\n8A4d0v0e0rs4e0 2E2vent/AESI  # 01 and update as appropriate.\nOpened To Site from System (24 Jun 2021)\nDate Event Became Less than Grade 3 - if applicable (dd-mon-yyyy)\nTreatment for AE (select all that apply except when NONE is noted): for drug\ntherapy or medication please enter into concomitant medications eCRF; If\nprocedure or surgery please enter into the on-study procedure/surgery eCRF\nNone\nDrug therapy/ Medication\nConcomitant Medication #1\nConcomitant Medication #2\nConcomitant Medication #3\nConcomitant Medication #4\nConcomitant Medication #5\nConcomitant Medication #6\nConcomitant Medication #7\nConcomitant Medication #8\nConcomitant Medication #9\nConcomitant Medication #10\nConcomitant Procedure/surgery\nConcomitant procedure/surgery #1\nConcomitant procedure/surgery #2\nClick Here for Customer Support Information Medidata Classic Rave® 2020.3.2 \nConcomitant procedure/surgery #3 Copyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(k4kf03qf0kedjt3eelgn2efp))/Modules/EDC/CRFPage.aspx?DP=95593582 2/4 6/24/2021 CRF\niMedidata Messages My Profile Help Home Logout\nUser: Agamdeep Saini (Safety)\nConcomitant procedure/surgery #4\nR4018-ONC-1721 840004 - O\'Malley - USA ADVERSE EVENTS Adverse Event\n840004022\nConcomitant procedure/surgery #5\nADVERSE EVENTS\nAdverse Events Yes/No Other\nAdverse Event\nIf Other, specify\nCRF History\n - Adverse Does this AE qualify as Serious? (If YES, complete SAE/AESI Form) No\n840004022  \nEvent\nComplete the following fields ONLY if Adverse Event qualifies as either serious\n840004022 - Adverse  or as an event of special interest (AESI) per protocol. If AE does not meet criteria\nEvents Yes/No for either SAE or AESI then STOP here.\n - Serious\n8A4d0v0e0rs4e0 2E2vent/AESI  # 20 FOR SAE - IDENTIFY SERIOUSNESS CRITERION/CRITERIA: \n840004022 - Serious  CHECK ALL THAT APPLY\nAdverse Event/AESI # 02\n - Serious It resulted in death\n840004022  \nAdverse Event/AESI # 01\nIt was life-threatening\nIt required or prolonged inpatient hospitalization\nPersistent or significant disability / incapacity\nIt is a congenital anomaly/birth defect in offspring of study subject\nOther medically serious important event (It does not meet any of the above serious\ncriteria, but may jeopardize the subject, and may require medical or surgical\nintervention to prevent one of the outcomes listed above).\nIf Other, specify\nIs this an AE of Special Interest (AESI)? (If YES, complete SAE/AESI Form)\nIs this an AE of Special interest (AESI)? is Yes, yet AESI criteria is not selected.\nYes\nPlease select all that apply.\nOpened To Site from System (24 Jun 2021)\nThe AE fulfills the following AE of special interest (AESI)\nCHECK ALL THAT APPLY\nAny AE that meets DLT criteria at any time while on treatment\nGrade 2 or greater Infusion-Related Reactions associated with study drug infusions\nGrade 2 or greater pain syndrome temporally related to study drug infusion in the\nopinion of the investigator\nGrade 2 or greater Cytokine Release Syndrome\nGrade 2 or greater allergic/hypersensitivity reactions\nAn irAE of any grade in a patient previously treated with a PI 3-K inhibitor\nPericardial effusions of any size\nGrade ≥2 treatment-emergent pleural effusion (clinically significant new effusion and/or\nClick Hae rec lfoinr Cicuastlolym esr iSgunppifoicrt aInnfotr mcahtiaonnge in size of an existing effusion) Medidata Classic Rave® 2020.3.2 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(k4kf03qf0kedjt3eelgn2efp))/Modules/EDC/CRFPage.aspx?DP=95593582 3/4 6/24/2021 CRF\nGrade ≥2 Treatment-emergent ascites (clinically significant new ascite and/or a\niMedidata Messages My Profile Help Home Logout\nclinically significant change in size of existing ascites)\nUser: Agamdeep Saini (Safety)\ndosRe 4o0f 1tr8e-aOtNmCen-1t.7 A21ll AEs of unknown etiology associat  expoAsDuVreE sRhSoEu lEd VENTS Adverse Event\n840004022\nbe evaluated to determine possible immune etiology. If an irAE is suspected, efforts\nADVERSE EVENTS should be made to rule out neoplastic, infectious, metabolic, toxin or other etiologic\nAdverse Events Yes/No causes prior to labeling an AE as an irAE.\nAdverse Event Date Time 24 JUN 2021 08:21:26\nCRF History\nPrintable Version  View PDF   Icon Key\nSave   Cancel\n840004022 - Adverse  CRF Version 9193 - Page Generated: 24 Jun 2021 12:09:51 Eastern Daylight Time\nEvent\n - Adverse\n840004022  \nEvents Yes/No\n - Serious\n840004022  \nAdverse Event/AESI # 20\n - Serious\n840004022  \nAdverse Event/AESI # 02\n - Serious\n840004022  \nAdverse Event/AESI # 01\nClick Here for Customer Support Information Medidata Classic Rave® 2020.3.2 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(k4kf03qf0kedjt3eelgn2efp))/Modules/EDC/CRFPage.aspx?DP=95593582 4/4 6/24/2021 CRF\niMedidata Messages My Profile Help Home Logout\nUser: Agamdeep Saini (Safety)\nR4018-ONC-1721 840004 - O\'Malley - USA SERIOUS ADVERSE EVENTS/AESI (1) Serious Adverse Event/AESI # 20\n840004022\nSERIOUS ADVERSE Subject ID: \n840004022\nEVENTS/AESI (1)\nSerious Adverse Subject: \nEvent/AESI # 01 840004022\nPage: Serious Adverse Event/AESI # 20 - SERIOUS ADVERSE EVENTS/AESI (1)\nSerious Adverse\nEvent/AESI # 02 AE number 20\nSerious Adverse\nEvent/AESI # 20 Adverse Event Description (Term) NEUTROPHIL COUNT DECREASED\nCRF History SOC 10022891Investigations\n - Serious HLGT10018851Haematology investigations (incl blood groups)\n8A4d0v0e0rs4e0 2E2vent/AESI  # 20 HLT 10047938White blood cell analyses\nPT 10029366Neutrophil count decreased\n - Serious\n840004022   LLT 10029366Neutrophil count decreased\nAdverse Event/AESI # 02\n840004022 - Serious  Start Date (dd-mon-yyyy) 16 JUN 2021\nAdverse Event/AESI # 01\nRATIONALE FOR CAUSALITY ASSESSMENT\nSpecify the Rationale for Causality to REGN4018 INVESTIGATORS REVIEWED AS "PROBABLY-RELATED" TO\nREGN4018 THERAPY, TEMPORALLY RELATED TO REGN4018\nINFUSION\nSpecify Rationale for Causality to cemiplimab\nSpecify the Rationale for Causality to Study Conduct\nSAE/AESI NARRATIVE\n#  SAE/AESI Narrative Text\nSUBJECT 840004-020 DEVELOPED GRADE 4 NEUTROPENIA (0.34 K/UL) THE DAY FOLLOWING FIRST COMBINATION DOSE - CYCLE 2 DAY 1:\nREGN4018 @ 60 MG + CEMIPLIMAB @ 350 MG – ON 16-JUN-2021. PATIENT WAS ASYMPTOMATIC AND AFEBRILE AT OCCURRENCE WITH\nNEUTROPHIL COUNT RE-CHECKED BEFORE END OF 24 HOUR OBSERVATION PERIOD ON 16-JUN-2021 WHICH CONTINUED TO\nDEMONSTRATE ONGOING GRADE 4 NEUTROPENIA (0.18 K/UL). PATIENT COMPLETED 48 HOUR (17-JUN-2021 - 0.14 K/UL) AND 72 HOUR (18-\nJUN-2021 - 0.05 K/UL) SAFETY LAB CHECKS THAT CONTINUED TO DEMONSTRATE ONGOING GRADE 4 NEUTROPENIA - PATIENT STILL\nREMAINED ASYMPTOMATIC AND AFEBRILE AND REFUSED STARTING ANY PROPHYLACTIC ANTIBIOTICS. PATIENT WAS PLANNED FOR\nCYCLE 2 DAY 8 REGN4018 @ 60 MG DOSE THE FOLLOWING WEEK WITH PRE-TREATMENT HEMATOLOGY LAB CHECKED ON 21-JUN-2021\n1 THAT SHOWED ONGOING GRADE 4 NEUTROPENIA (0.15 K/UL). SITE PI REVIEWED PATIENT’S GRADE 4 NEUTROPENIA DID NOT MEET SAE\nREPORTING CRITERIA (I.E., “OTHER MEDICALLY SERIOUS IMPORTANT EVENT”) AFTER EXTENSIVE DISCUSSION ON 21-JUN-2021\nCONFERENCE CALL AND CONFIRMED PLAN TO DELAY UNTIL NEUTROPHIL COUNTS RECOVERED TO >/= 1.0 K/UL (GRADE 2). PATIENT\'S\nTREATMENT WAS DELAYED WITH PLAN TO RE-CHECK NEUTROPHIL RECOVERY ON 23-JUN-2021 WHICH CONFIRMED ONGOING GRADE 4\nNEUTROPENIA (0.13 K/UL). SITE INVESTIGATORS MADE AWARE OF PERSISTENT GRADE 4 NEUTROPENIA AND INDICATED AE AS\nPROBABLY-RELATED TO REGN4018 THERAPY. SPONSOR MADE AWARE OF PERSISTENT GRADE 4 NEUTROPENIA AND CONFIRMED\nPATIENT MEETS DOSE LIMITING TOXICITY REQUIRING PATIENT TO DOSE REDUCE TO NEXT LOWEST DOSE LEVEL - DLC4A (NOW TO DOSE\nWITH REGN4018 @ 20 MG + CEMIPLIMAB @ 350 MG).\nNO OTHER DIAGNOSTIC TESTS/LABS WERE USED TO EVALUATE AE. PATIENT IS PLANNED FOR HEMATOLOGY LAB CHECK TODAY TO\n2\nCHECK NEUTROPHIL COUNT STATUS. WILL CONTINUE TO UPDATE REPORT WITH ANY NEW INFORMATION AS IT BECOMES AVAILABLE.\nPrintable Version  View PDF   Icon Key\nSave   Cancel\nCRF Version 9193 - Page Generated: 24 Jun 2021 12:09:21 Eastern Daylight Time\nClick Here for Customer Support Information Medidata Classic Rave® 2020.3.2 \nCopyright © 1999-2020 Medidata Solutions, Inc.\nhttps://regeneron.mdsol.com/MedidataRave/(S(k4kf03qf0kedjt3eelgn2efp))/Modules/EDC/CRFPage.aspx?DP=97248195 1/1']
apiLogger::2021-10-05 23:58:01,614::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 23:58:01,614::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 23:58:01,732::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 23:58:01,741::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 23:58:01,741::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpyrlcn9vf 
apiLogger::2021-10-05 23:58:01,742::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 23:58:01,742::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 23:58:02,532::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 23:58:02,532::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpyrlcn9vf
apiLogger::2021-10-05 23:58:03,637::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 23:58:03,637::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 23:58:03,637::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 23:58:03,637::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 23:58:03,642::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:03,642::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 23:58:03,642::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 23:58:03,642::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 23:58:03,648::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:03,648::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 23:58:03,648::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 23:58:03,648::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 23:58:03,652::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:03,652::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 23:58:03,652::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 23:58:03,652::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 23:58:03,657::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:03,657::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 23:58:03,657::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 23:58:03,657::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 23:58:03,661::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:03,662::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 23:58:03,662::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 23:58:03,662::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From: noreply@mdsol.com\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 AESI Alert: An adverse event of special interest has been reported \nfor the Site : 1721840004, Subject : 840004021, AE Number : 20\nDate: Thursday, June 24, 2021 8:22:33 AM\nDear Project Member,\nPlease be informed that a new AESI has been reported for Study R4018-ONC-1721.\nCountry : World\nSite Number : 1721840004\nSite Name : 840004 - O\'Malley - USA\nSubject number : 840004021\nAdverse event number : 20\nMain Adverse Event Description (Term) - NEUTROPHIL COUNT DECREASED\nStart date (dd-mon-yyyy) - 16 JUN 2021\nAE suspected to be caused by REGN4018? - Yes\nAE suspected to be caused by cemiplimab? -\nAE suspected to be caused by study conduct? -\nAny AE that meets DLT criteria at any time while on treatment - Checked\nGrade 2 or greater Infusion-Related Reactions associated with study drug infusions - Not Checked\nGrade 2 or greater pain syndrome temporally related to study drug infusion in the opinion of the investigator - Not \nChecked\nGrade 2 or greater Cytokine Release Syndrome - Not Checked\nGrade 2 or greater allergic/hypersensitivity reactions - Not Checked\nAn irAE of any grade in a patient previously treated with a PI 3-K inhibitor - Not Checked\nPericardial effusions of any size - Not Checked\nGrade ≥2 treatment-emergent pleural effusion (clinically significant new effusion and/or a clinically significant \nchange in size of an existing effusion) - Not Checked\nGrade ≥2 Treatment-emergent ascites (clinically significant new ascite\nand/or a clinically significant change in size of existing ascites) - Not Checked\nWWRD (GMT): 24 Jun 2021 12:22\nThank you,\nSyneoa Health Data Management\nCreated by : Ridge Archer [ridge.archer@osumc.edu]\nFor further details, please log on to Medidata Rave using the following link :\nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?\nPage=CRFPage.aspx&DP=95593582__;!!OR9aRoiw!byymHzh-\ndPncgkRYGzcqmzyXVt3A9byeKpIVOGZiV4Dh1v34kOWjB-s4_0WPcrCtq_0el9s$\n***********This is a system generated message, Please do not respond to this e-mail.*********** From: noreply@mdsol.com\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 SAE/AESI form has been updated for Site : 1721840004, Subject : 840004021, \nAE number : 20\nDate: Thursday, June 24, 2021 9:02:05 AM\nDear Project Member,\nPlease be informed that below updates have been made for SAE/AESI in R4018-ONC-1721.\nCountry : World\nSite Number : 1721840004\nSite Name : 840004 - O\'Malley - USA\nSubject number : 840004021\nAdverse event number : 20\nAdverse event term : NEUTROPHIL COUNT DECREASED\nAdverse Start Date : 16 JUN 2021\nSpecify Rationale for Causality to cemiplimab -\nSpecify the Rationale for Causality to REGN4018 - INVESTIGATORS REVIEWED AS "PROBABLY-RELATED" TO \nREGN4018 THERAPY, TEMPORALLY RELATED TO REGN4018 INFUSION\nSpecify the Rationale for Causality to Study Conduct -\nSAE/AESI Narrative Text - SUBJECT 840004-020 DEVELOPED GRADE 4 NEUTROPENIA (0.34 K/UL) THE DAY \nFOLLOWING FIRST COMBINATION DOSE - CYCLE 2 DAY 1: REGN4018 @ 60 MG + CEMIPLIMAB @ 350 MG –\nON 16-JUN-2021. PATIENT WAS ASYMPTOMATIC AND AFEBRILE AT OCCURRENCE WITH NEUTROPHIL \nCOUNT RE-CHECKED BEFORE END OF 24 HOUR OBSERVATION PERIOD ON 16-JUN-2021 WHICH CONTINUED \nTO DEMONSTRATE ONGOING GRADE 4 NEUTROPENIA (0.18 K/UL). PATIENT COMPLETED 48 HOUR (17-JUN-\n2021 - 0.14 K/UL) AND 72 HOUR (18-JUN-2021 - 0.05 K/UL) SAFETY LAB CHECKS THAT CONTINUED TO \nDEMONSTRATE ONGOING GRADE 4 NEUTROPENIA - PATIENT STILL REMAINED ASYMPTOMATIC AND \nAFEBRILE AND REFUSED STARTING ANY PROPHYLACTIC ANTIBIOTICS. PATIENT WAS PLANNED FOR \nCYCLE 2 DAY 8 REGN4018 @ 60 MG DOSE THE FOLLOWING WEEK WITH PRE-TREATMENT HEMATOLOGY \nLAB CHECKED ON 21-JUN-2021 THAT SHOWED ONGOING GRADE 4 NEUTROPENIA (0.15 K/UL). SITE PI \nREVIEWED PATIENT’S GRADE 4 NEUTROPENIA DID NOT MEET SAE REPORTING CRITERIA (I.E., “OTHER \nMEDICALLY SERI!\n OUS IMPORTANT EVENT”) AFTER EXTENSIVE DISCUSSION ON 21-JUN-2021 CONFERENCE CALL AND \nCONFIRMED PLAN TO DELAY UNTIL NEUTROPHIL COUNTS RECOVERED TO >/= 1.0 K/UL (GRADE 2). \nPATIENT\'S TREATMENT WAS DELAYED WITH PLAN TO RE-CHECK NEUTROPHIL RECOVERY ON 23-JUN-2021 \nWHICH CONFIRMED ONGOING GRADE 4 NEUTROPENIA (0.13 K/UL).  SITE INVESTIGATORS MADE AWARE OF \nPERSISTENT GRADE 4 NEUTROPENIA AND INDICATED AE AS PROBABLY-RELATED TO REGN4018 THERAPY. \nSPONSOR MADE AWARE OF PERSISTENT GRADE 4 NEUTROPENIA AND CONFIRMED PATIENT MEETS DOSE \nLIMITING TOXICITY REQUIRING PATIENT TO DOSE REDUCE TO NEXT LOWEST DOSE LEVEL - DLC4A (NOW \nTO DOSE WITH REGN4018 @ 20 MG + CEMIPLIMAB @ 350 MG).\nEvent Description (Split 0-200) -\nEvent Description (Split 201-400) -\nEvent Description (Split 401-600) -\nEvent Description (Split 601-800) -\nEvent Description (Split 801-1000) -\nEvent Description (Split 1001-1200) -\nEvent Description (Split 1201-1400) -\nEvent Description (Split 1401-1600) -\nEvent Description (Split 1601-1800) -\nEvent Description (Split 1801-1999) -\nWWRD (GMT): 24 Jun 2021 01:01\nThank you,\nSyneos Health Data Management\nCreated by : Ridge Archer [ridge.archer@osumc.edu]\nFor further details, please log on to Medidata Rave using the following link :\nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx? Page=CRFPage.aspx&DP=97248195__;!!OR9aRoiw!ZO2X4N_Ys2heO9hqYDuo7FLJ5GRgk_iwh80RyYMoOpFDaOAOumb-\nHpptdOM8j5OaUau6UCY$\n ***********This is a system generated message, Please do not respond to this e-mail.*********** From: noreply@mdsol.com\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 SAE/AESI form has been updated for Site : 1721840004, Subject : \n840004021, AE number : 20\nDate: Thursday, June 24, 2021 9:18:34 AM\nDear Project Member,\nPlease be informed that below updates have been made for SAE/AESI in R4018-ONC-1721.\nCountry : World\nSite Number : 1721840004\nSite Name : 840004 - O\'Malley - USA\nSubject number : 840004021\nAdverse event number : 20\nAdverse event term : NEUTROPHIL COUNT DECREASED\nAdverse Start Date : 16 JUN 2021\nSpecify Rationale for Causality to cemiplimab -\nSpecify the Rationale for Causality to REGN4018 - INVESTIGATORS REVIEWED AS "PROBABLY-\nRELATED" TO REGN4018 THERAPY, TEMPORALLY RELATED TO REGN4018 INFUSION\nSpecify the Rationale for Causality to Study Conduct -\nSAE/AESI Narrative Text - SUBJECT 840004-020 DEVELOPED GRADE 4 NEUTROPENIA (0.34 K/UL) THE \nDAY FOLLOWING FIRST COMBINATION DOSE - CYCLE 2 DAY 1: REGN4018 @ 60 MG + CEMIPLIMAB \n@ 350 MG – ON 16-JUN-2021. PATIENT WAS ASYMPTOMATIC AND AFEBRILE AT OCCURRENCE \nWITH NEUTROPHIL COUNT RE-CHECKED BEFORE END OF 24 HOUR OBSERVATION PERIOD ON 16-\nJUN-2021 WHICH CONTINUED TO DEMONSTRATE ONGOING GRADE 4 NEUTROPENIA (0.18 K/UL). \nPATIENT COMPLETED 48 HOUR (17-JUN-2021 - 0.14 K/UL) AND 72 HOUR (18-JUN-2021 - 0.05 K/UL) \nSAFETY LAB CHECKS THAT CONTINUED TO DEMONSTRATE ONGOING GRADE 4 NEUTROPENIA -\nPATIENT STILL REMAINED ASYMPTOMATIC AND AFEBRILE AND REFUSED STARTING ANY \nPROPHYLACTIC ANTIBIOTICS. PATIENT WAS PLANNED FOR CYCLE 2 DAY 8 REGN4018 @ 60 MG \nDOSE THE FOLLOWING WEEK WITH PRE-TREATMENT HEMATOLOGY LAB CHECKED ON 21-JUN-\n2021 THAT SHOWED ONGOING GRADE 4 NEUTROPENIA (0.15 K/UL). SITE PI REVIEWED PATIENT’S \nGRADE 4 NEUTROPENIA DID NOT MEET SAE REPORTING CRITERIA (I.E., “OTHER MEDICALLY \nSERI!\n OUS IMPORTANT EVENT”) AFTER EXTENSIVE DISCUSSION ON 21-JUN-2021 CONFERENCE CALL \nAND CONFIRMED PLAN TO DELAY UNTIL NEUTROPHIL COUNTS RECOVERED TO >/= 1.0 K/UL\n(GRADE 2). PATIENT\'S TREATMENT WAS DELAYED WITH PLAN TO RE-CHECK NEUTROPHIL \nRECOVERY ON 23-JUN-2021 WHICH CONFIRMED ONGOING GRADE 4 NEUTROPENIA (0.13 K/UL). \nSITE INVESTIGATORS MADE AWARE OF PERSISTENT GRADE 4 NEUTROPENIA AND INDICATED AE \nAS PROBABLY-RELATED TO REGN4018 THERAPY. SPONSOR MADE AWARE OF PERSISTENT GRADE \n4 NEUTROPENIA AND CONFIRMED PATIENT MEETS DOSE LIMITING TOXICITY REQUIRING \nPATIENT TO DOSE REDUCE TO NEXT LOWEST DOSE LEVEL - DLC4A (NOW TO DOSE WITH \nREGN4018 @ 20 MG + CEMIPLIMAB @ 350 MG).\nEvent Description (Split 0-200) -\nEvent Description (Split 201-400) -\nEvent Description (Split 401-600) -\nEvent Description (Split 601-800) -\nEvent Description (Split 801-1000) -\nEvent Description (Split 1001-1200) -\nEvent Description (Split 1201-1400) -\nEvent Description (Split 1401-1600) -\nEvent Description (Split 1601-1800) -\nEvent Description (Split 1801-1999) -\nSAE/AESI Narrative Text -\nEvent Description (Split 0-200) - Event Description (Split 201-400) -\nEvent Description (Split 401-600) -\nEvent Description (Split 601-800) -\nEvent Description (Split 801-1000) -\nEvent Description (Split 1001-1200) -\nEvent Description (Split 1201-1400) -\nEvent Description (Split 1401-1600) -\nEvent Description (Split 1601-1800) -\nEvent Description (Split 1801-1999) -\nWWRD (GMT): 24 Jun 2021 01:18\nThank you,\nSyneos Health Data Management\nCreated by : Ridge Archer [ridge.archer@osumc.edu]\nFor further details, please log on to Medidata Rave using the following link :\nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?\nPage=CRFPage.aspx&DP=97248195__;!!OR9aRoiw!eDCq1Uv8xPDNVNIP8cbF8jHCdnWmtF_uVEK-\nPakjd41_1IGjJzq9cbwN8F0IFMMwD7TtFRM$\n ***********This is a system generated message, Please do not respond to this e-mail.***********']
apiLogger::2021-10-05 23:58:03,662::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 23:58:03,662::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 23:58:03,755::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 23:58:03,765::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 23:58:03,765::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpus4lnfcj 
apiLogger::2021-10-05 23:58:03,766::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 23:58:03,766::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 23:58:04,724::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 23:58:04,724::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpus4lnfcj
apiLogger::2021-10-05 23:58:05,947::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 23:58:05,948::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 23:58:05,948::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 23:58:05,948::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 23:58:05,953::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:05,953::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 23:58:05,953::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 23:58:05,953::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 23:58:05,958::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:05,958::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 23:58:05,958::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 23:58:05,958::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-10-05 23:58:05,962::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:05,963::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-10-05 23:58:05,963::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-10-05 23:58:05,963::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-10-05 23:58:05,968::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:05,968::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-10-05 23:58:05,968::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-10-05 23:58:05,968::content_type.py::(line:131)::find_content_type()::DEBUG : i is 4
apiLogger::2021-10-05 23:58:05,972::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:05,972::content_type.py::(line:134)::find_content_type()::DEBUG : main: 4
apiLogger::2021-10-05 23:58:05,972::content_type.py::(line:178)::find_content_type()::DEBUG : outside:5
apiLogger::2021-10-05 23:58:05,972::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From: noreply@mdsol.com\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 AESI Alert: An adverse event of special interest has been reported \nfor the Site : 1721840004, Subject : 840004022, AE Number : 20\nDate: Thursday, June 24, 2021 8:22:33 AM\nDear Project Member,\nPlease be informed that a new AESI has been reported for Study R4018-ONC-1721.\nCountry : World\nSite Number : 1721840004\nSite Name : 840004 - O\'Malley - USA\nSubject number : 840004022\nAdverse event number : 20\nMain Adverse Event Description (Term) - NEUTROPHIL COUNT DECREASED\nStart date (dd-mon-yyyy) - 16 JUN 2021\nAE suspected to be caused by REGN4018? - Yes\nAE suspected to be caused by cemiplimab? -\nAE suspected to be caused by study conduct? -\nAny AE that meets DLT criteria at any time while on treatment - Checked\nGrade 2 or greater Infusion-Related Reactions associated with study drug infusions - Not Checked\nGrade 2 or greater pain syndrome temporally related to study drug infusion in the opinion of the investigator - Not \nChecked\nGrade 2 or greater Cytokine Release Syndrome - Not Checked\nGrade 2 or greater allergic/hypersensitivity reactions - Not Checked\nAn irAE of any grade in a patient previously treated with a PI 3-K inhibitor - Not Checked\nPericardial effusions of any size - Not Checked\nGrade ≥2 treatment-emergent pleural effusion (clinically significant new effusion and/or a clinically significant \nchange in size of an existing effusion) - Not Checked\nGrade ≥2 Treatment-emergent ascites (clinically significant new ascite\nand/or a clinically significant change in size of existing ascites) - Not Checked\nWWRD (GMT): 24 Jun 2021 12:22\nThank you,\nSyneoa Health Data Management\nCreated by : Ridge Archer [ridge.archer@osumc.edu]\nFor further details, please log on to Medidata Rave using the following link :\nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?\nPage=CRFPage.aspx&DP=95593582__;!!OR9aRoiw!byymHzh-\ndPncgkRYGzcqmzyXVt3A9byeKpIVOGZiV4Dh1v34kOWjB-s4_0WPcrCtq_0el9s$\n***********This is a system generated message, Please do not respond to this e-mail.*********** From: noreply@mdsol.com\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 SAE/AESI form has been updated for Site : 1721840004, Subject : 840004022, \nAE number : 20\nDate: Thursday, June 24, 2021 9:02:05 AM\nDear Project Member,\nPlease be informed that below updates have been made for SAE/AESI in R4018-ONC-1721.\nCountry : World\nSite Number : 1721840004\nSite Name : 840004 - O\'Malley - USA\nSubject number : 840004022\nAdverse event number : 20\nAdverse event term : NEUTROPHIL COUNT DECREASED\nAdverse Start Date : 16 JUN 2021\nSpecify Rationale for Causality to cemiplimab -\nSpecify the Rationale for Causality to REGN4018 - INVESTIGATORS REVIEWED AS "PROBABLY-RELATED" TO \nREGN4018 THERAPY, TEMPORALLY RELATED TO REGN4018 INFUSION\nSpecify the Rationale for Causality to Study Conduct -\nSAE/AESI Narrative Text - SUBJECT 840004-020 DEVELOPED GRADE 4 NEUTROPENIA (0.34 K/UL) THE DAY \nFOLLOWING FIRST COMBINATION DOSE - CYCLE 2 DAY 1: REGN4018 @ 60 MG + CEMIPLIMAB @ 350 MG –\nON 16-JUN-2021. PATIENT WAS ASYMPTOMATIC AND AFEBRILE AT OCCURRENCE WITH NEUTROPHIL \nCOUNT RE-CHECKED BEFORE END OF 24 HOUR OBSERVATION PERIOD ON 16-JUN-2021 WHICH CONTINUED \nTO DEMONSTRATE ONGOING GRADE 4 NEUTROPENIA (0.18 K/UL). PATIENT COMPLETED 48 HOUR (17-JUN-\n2021 - 0.14 K/UL) AND 72 HOUR (18-JUN-2021 - 0.05 K/UL) SAFETY LAB CHECKS THAT CONTINUED TO \nDEMONSTRATE ONGOING GRADE 4 NEUTROPENIA - PATIENT STILL REMAINED ASYMPTOMATIC AND \nAFEBRILE AND REFUSED STARTING ANY PROPHYLACTIC ANTIBIOTICS. PATIENT WAS PLANNED FOR \nCYCLE 2 DAY 8 REGN4018 @ 60 MG DOSE THE FOLLOWING WEEK WITH PRE-TREATMENT HEMATOLOGY \nLAB CHECKED ON 21-JUN-2021 THAT SHOWED ONGOING GRADE 4 NEUTROPENIA (0.15 K/UL). SITE PI \nREVIEWED PATIENT’S GRADE 4 NEUTROPENIA DID NOT MEET SAE REPORTING CRITERIA (I.E., “OTHER \nMEDICALLY SERI!\n OUS IMPORTANT EVENT”) AFTER EXTENSIVE DISCUSSION ON 21-JUN-2021 CONFERENCE CALL AND \nCONFIRMED PLAN TO DELAY UNTIL NEUTROPHIL COUNTS RECOVERED TO >/= 1.0 K/UL (GRADE 2). \nPATIENT\'S TREATMENT WAS DELAYED WITH PLAN TO RE-CHECK NEUTROPHIL RECOVERY ON 23-JUN-2021 \nWHICH CONFIRMED ONGOING GRADE 4 NEUTROPENIA (0.13 K/UL).  SITE INVESTIGATORS MADE AWARE OF \nPERSISTENT GRADE 4 NEUTROPENIA AND INDICATED AE AS PROBABLY-RELATED TO REGN4018 THERAPY. \nSPONSOR MADE AWARE OF PERSISTENT GRADE 4 NEUTROPENIA AND CONFIRMED PATIENT MEETS DOSE \nLIMITING TOXICITY REQUIRING PATIENT TO DOSE REDUCE TO NEXT LOWEST DOSE LEVEL - DLC4A (NOW \nTO DOSE WITH REGN4018 @ 20 MG + CEMIPLIMAB @ 350 MG).\nEvent Description (Split 0-200) -\nEvent Description (Split 201-400) -\nEvent Description (Split 401-600) -\nEvent Description (Split 601-800) -\nEvent Description (Split 801-1000) -\nEvent Description (Split 1001-1200) -\nEvent Description (Split 1201-1400) -\nEvent Description (Split 1401-1600) -\nEvent Description (Split 1601-1800) -\nEvent Description (Split 1801-1999) -\nWWRD (GMT): 24 Jun 2021 01:01\nThank you,\nSyneos Health Data Management\nCreated by : Ridge Archer [ridge.archer@osumc.edu]\nFor further details, please log on to Medidata Rave using the following link :\nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx? Page=CRFPage.aspx&DP=97248195__;!!OR9aRoiw!ZO2X4N_Ys2heO9hqYDuo7FLJ5GRgk_iwh80RyYMoOpFDaOAOumb-\nHpptdOM8j5OaUau6UCY$\n ***********This is a system generated message, Please do not respond to this e-mail.*********** From: noreply@mdsol.com\nTo: Regeneron_Safety\nSubject: [EXTERNAL] ATTENTION! R4018-ONC-1721 SAE/AESI form has been updated for Site : 1721840004, Subject : \n840004022, AE number : 20\nDate: Thursday, June 24, 2021 9:18:34 AM\nDear Project Member,\nPlease be informed that below updates have been made for SAE/AESI in R4018-ONC-1721.\nCountry : World\nSite Number : 1721840004\nSite Name : 840004 - O\'Malley - USA\nSubject number : 840004022\nAdverse event number : 20\nAdverse event term : NEUTROPHIL COUNT DECREASED\nAdverse Start Date : 16 JUN 2021\nSpecify Rationale for Causality to cemiplimab -\nSpecify the Rationale for Causality to REGN4018 - INVESTIGATORS REVIEWED AS "PROBABLY-\nRELATED" TO REGN4018 THERAPY, TEMPORALLY RELATED TO REGN4018 INFUSION\nSpecify the Rationale for Causality to Study Conduct -\nSAE/AESI Narrative Text - SUBJECT 840004-020 DEVELOPED GRADE 4 NEUTROPENIA (0.34 K/UL) THE \nDAY FOLLOWING FIRST COMBINATION DOSE - CYCLE 2 DAY 1: REGN4018 @ 60 MG + CEMIPLIMAB \n@ 350 MG – ON 16-JUN-2021. PATIENT WAS ASYMPTOMATIC AND AFEBRILE AT OCCURRENCE \nWITH NEUTROPHIL COUNT RE-CHECKED BEFORE END OF 24 HOUR OBSERVATION PERIOD ON 16-\nJUN-2021 WHICH CONTINUED TO DEMONSTRATE ONGOING GRADE 4 NEUTROPENIA (0.18 K/UL). \nPATIENT COMPLETED 48 HOUR (17-JUN-2021 - 0.14 K/UL) AND 72 HOUR (18-JUN-2021 - 0.05 K/UL) \nSAFETY LAB CHECKS THAT CONTINUED TO DEMONSTRATE ONGOING GRADE 4 NEUTROPENIA -\nPATIENT STILL REMAINED ASYMPTOMATIC AND AFEBRILE AND REFUSED STARTING ANY \nPROPHYLACTIC ANTIBIOTICS. PATIENT WAS PLANNED FOR CYCLE 2 DAY 8 REGN4018 @ 60 MG \nDOSE THE FOLLOWING WEEK WITH PRE-TREATMENT HEMATOLOGY LAB CHECKED ON 21-JUN-\n2021 THAT SHOWED ONGOING GRADE 4 NEUTROPENIA (0.15 K/UL). SITE PI REVIEWED PATIENT’S \nGRADE 4 NEUTROPENIA DID NOT MEET SAE REPORTING CRITERIA (I.E., “OTHER MEDICALLY \nSERI!\n OUS IMPORTANT EVENT”) AFTER EXTENSIVE DISCUSSION ON 21-JUN-2021 CONFERENCE CALL \nAND CONFIRMED PLAN TO DELAY UNTIL NEUTROPHIL COUNTS RECOVERED TO >/= 1.0 K/UL\n(GRADE 2). PATIENT\'S TREATMENT WAS DELAYED WITH PLAN TO RE-CHECK NEUTROPHIL \nRECOVERY ON 23-JUN-2021 WHICH CONFIRMED ONGOING GRADE 4 NEUTROPENIA (0.13 K/UL). \nSITE INVESTIGATORS MADE AWARE OF PERSISTENT GRADE 4 NEUTROPENIA AND INDICATED AE \nAS PROBABLY-RELATED TO REGN4018 THERAPY. SPONSOR MADE AWARE OF PERSISTENT GRADE \n4 NEUTROPENIA AND CONFIRMED PATIENT MEETS DOSE LIMITING TOXICITY REQUIRING \nPATIENT TO DOSE REDUCE TO NEXT LOWEST DOSE LEVEL - DLC4A (NOW TO DOSE WITH \nREGN4018 @ 20 MG + CEMIPLIMAB @ 350 MG).\nEvent Description (Split 0-200) -\nEvent Description (Split 201-400) -\nEvent Description (Split 401-600) -\nEvent Description (Split 601-800) -\nEvent Description (Split 801-1000) -\nEvent Description (Split 1001-1200) -\nEvent Description (Split 1201-1400) -\nEvent Description (Split 1401-1600) -\nEvent Description (Split 1601-1800) -\nEvent Description (Split 1801-1999) -\nSAE/AESI Narrative Text -\nEvent Description (Split 0-200) - Event Description (Split 201-400) -\nEvent Description (Split 401-600) -\nEvent Description (Split 601-800) -\nEvent Description (Split 801-1000) -\nEvent Description (Split 1001-1200) -\nEvent Description (Split 1201-1400) -\nEvent Description (Split 1401-1600) -\nEvent Description (Split 1601-1800) -\nEvent Description (Split 1801-1999) -\nWWRD (GMT): 24 Jun 2021 01:18\nThank you,\nSyneos Health Data Management\nCreated by : Ridge Archer [ridge.archer@osumc.edu]\nFor further details, please log on to Medidata Rave using the following link :\nhttps://urldefense.com/v3/__https://regeneron.mdsol.com/MedidataRave/SelectRole.aspx?\nPage=CRFPage.aspx&DP=97248195__;!!OR9aRoiw!eDCq1Uv8xPDNVNIP8cbF8jHCdnWmtF_uVEK-\nPakjd41_1IGjJzq9cbwN8F0IFMMwD7TtFRM$\n ***********This is a system generated message, Please do not respond to this e-mail.***********']
apiLogger::2021-10-05 23:58:05,972::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 23:58:05,972::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 23:58:06,062::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 23:58:06,063::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 23:58:06,063::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmplg59kldj 
apiLogger::2021-10-05 23:58:06,064::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 23:58:06,064::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 23:58:06,077::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 23:58:06,077::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmplg59kldj
apiLogger::2021-10-05 23:58:06,190::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 23:58:06,190::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 23:58:06,190::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 23:58:06,190::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 23:58:06,195::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:06,196::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 23:58:06,196::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 23:58:06,196::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 23:58:06,200::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:06,200::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 23:58:06,200::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 23:58:06,200::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 05-Oct-2021 23:55:08 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Initial /R4018-ONC-1721/Subject: 840004-021/SAE Terms: NEUTROPHIL COUNT\nDECREASED/ MFR date 24-Jun-2021\nFrom: Saini, Agamdeep <agamdeep.saini@syneoshealth.com> Sent: Thursday, June 24, 2021\n12:52 PM To: Regeneron Medical Safety <Medical.Safety@regeneron.com> Cc: Paul Curtis\n<paul.curtis@regeneron.com>; Maryan Hussein-External <maryan.hussein@regeneron.com>;\nTracey Rowlands <tracey.rowlands@regeneron.com>; Priscila Goncalves\n<priscila.goncalves@regeneron.com>; Tamara Schmidt <tamara.schmidt@regeneron.com>;\nQuasheeda Fields <quasheeda.fields@regeneron.com>; Saleem Shariff\n<saleem.shariff@regeneron.com>; IRT BCP Regeneron_Safety\n<Regeneron_Safety@syneoshealth.com>; Jevtovic, Jelena <jelena.jevtovic@syneoshealth.com>\nSubject: <External> Initial /R4018-ONC-1721/Subject: 840004-021/SAE Terms: NEUTROPHIL\nCOUNT DECREASED/ MFR date 24-Jun-2021 \n \nEXTERNAL MESSAGE\n \n \nDear Regeneron Colleagues, \n \nPlease find attached an Initial information for R4018-ONC-1721/Subject: 840004-021. \n \nProtocol: R4018-ONC-1721\nDay 0: 24-Jun-2021\nCountry: USA\nSite # /Investigator: 840004/ O\'Malley\nSubject ID: 840004-021\nStudy Drug(s): REGN4018\nEvent Term: NEUTROPHIL COUNT DECREASED\nOnset date: 16 JUN 2021\nSeverity/Grade: Grade 4 - Life threatening\nSAE Criteria and/or AESI Criteria: Non Serious/AESI: Yes, Any AE that meets DLT criteria at any\ntime while on treatment\nInvestigator Relationship to Study Drug: Related to REGN4018\nInvestigator Relationship to Study Conduct (if applicable): Not reported\nList of issued urgent queries: For the event of NEUTROPHIL COUNT DECREASED (onset date:\n16-Jun-2021), It was reported the event is considered as Grade 4 - Life threatening, however no\nseriousness criteria is selected for the event. Could you please review and update appropriately.\nREGN Argus number: Initial  \n******** Updated Items ******** \n \n \nBest Regards, \nAgamdeep Saini \nSr. Safety &PV Specialist \nSyneos Health \nDirect: +1 984 459 5521 \nagamdeep.saini@syneoshealth.com \n \nwww.syneoshealth.com  ']
apiLogger::2021-10-05 23:58:06,200::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 23:58:06,200::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-10-05 23:58:06,743::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-10-05 23:58:06,744::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-10-05 23:58:06,744::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpd3l7k_uj 
apiLogger::2021-10-05 23:58:06,745::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-10-05 23:58:06,745::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-10-05 23:58:06,757::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-10-05 23:58:06,758::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpd3l7k_uj
apiLogger::2021-10-05 23:58:06,865::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-10-05 23:58:06,865::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-10-05 23:58:06,865::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-10-05 23:58:06,865::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-10-05 23:58:06,870::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:06,870::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-10-05 23:58:06,870::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-10-05 23:58:06,870::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-10-05 23:58:06,874::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-10-05 23:58:06,875::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-10-05 23:58:06,875::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-10-05 23:58:06,875::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 05-Oct-2021 23:55:57 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Initial /R4018-ONC-1721/Subject: 840004-022/SAE Terms: NEUTROPHIL COUNT\nDECREASED/ MFR date 24-Jun-2021\nFrom: Saini, Agamdeep <agamdeep.saini@syneoshealth.com> Sent: Thursday, June 24, 2021\n12:52 PM To: Regeneron Medical Safety <Medical.Safety@regeneron.com> Cc: Paul Curtis\n<paul.curtis@regeneron.com>; Maryan Hussein-External <maryan.hussein@regeneron.com>;\nTracey Rowlands <tracey.rowlands@regeneron.com>; Priscila Goncalves\n<priscila.goncalves@regeneron.com>; Tamara Schmidt <tamara.schmidt@regeneron.com>;\nQuasheeda Fields <quasheeda.fields@regeneron.com>; Saleem Shariff\n<saleem.shariff@regeneron.com>; IRT BCP Regeneron_Safety\n<Regeneron_Safety@syneoshealth.com>; Jevtovic, Jelena <jelena.jevtovic@syneoshealth.com>\nSubject: <External> Initial /R4018-ONC-1721/Subject: 840004-022/SAE Terms: NEUTROPHIL\nCOUNT DECREASED/ MFR date 24-Jun-2021 \n \nEXTERNAL MESSAGE\n \n \nDear Regeneron Colleagues, \n \nPlease find attached an Initial information for R4018-ONC-1721/Subject: 840004-022. \n \nProtocol: R4018-ONC-1721\nDay 0: 24-Jun-2021\nCountry: USA\nSite # /Investigator: 840004/ O\'Malley\nSubject ID: 840004-022\nStudy Drug(s): REGN4018\nEvent Term: NEUTROPHIL COUNT DECREASED\nOnset date: 16 JUN 2021\nSeverity/Grade: Grade 4 - Life threatening\nSAE Criteria and/or AESI Criteria: Non Serious/AESI: Yes, Any AE that meets DLT criteria at any\ntime while on treatment\nInvestigator Relationship to Study Drug: Related to REGN4018\nInvestigator Relationship to Study Conduct (if applicable): Not reported\nList of issued urgent queries: For the event of NEUTROPHIL COUNT DECREASED (onset date:\n16-Jun-2021), It was reported the event is considered as Grade 4 - Life threatening, however no\nseriousness criteria is selected for the event. Could you please review and update appropriately.\nREGN Argus number: Initial  \n******** Updated Items ******** \n \n \nBest Regards, \nAgamdeep Saini \nSr. Safety &PV Specialist \nSyneos Health \nDirect: +1 984 459 5521 \nagamdeep.saini@syneoshealth.com \n \nwww.syneoshealth.com  ']
apiLogger::2021-10-05 23:58:06,875::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-10-05 23:58:06,875::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
